0001493152-20-015471.txt : 20200813 0001493152-20-015471.hdr.sgml : 20200813 20200813124940 ACCESSION NUMBER: 0001493152-20-015471 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 90 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200813 DATE AS OF CHANGE: 20200813 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Agape ATP Corp CENTRAL INDEX KEY: 0001713210 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 364838886 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-220144 FILM NUMBER: 201098368 BUSINESS ADDRESS: STREET 1: 1705-1708 LEVEL 17, TOWER 2, FABER TOWER STREET 2: JALAN DESA BAHAGIA, TAMAN DESA CITY: KUALA LUMPUR STATE: N8 ZIP: 58100 BUSINESS PHONE: (603) 27325716 MAIL ADDRESS: STREET 1: 1705-1708 LEVEL 17, TOWER 2, FABER TOWER STREET 2: JALAN DESA BAHAGIA, TAMAN DESA CITY: KUALA LUMPUR STATE: N8 ZIP: 58100 10-Q 1 form10-q.htm
0001713210 false Q2 2020 --12-31 0001713210 2020-01-01 2020-06-30 0001713210 2020-08-10 0001713210 2020-06-30 0001713210 2019-12-31 0001713210 2020-04-01 2020-06-30 0001713210 2019-04-01 2019-06-30 0001713210 2019-01-01 2019-06-30 0001713210 us-gaap:CommonStockMember 2018-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001713210 us-gaap:RetainedEarningsMember 2018-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001713210 2018-12-31 0001713210 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001713210 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001713210 2019-01-01 2019-03-31 0001713210 us-gaap:CommonStockMember 2019-03-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001713210 us-gaap:RetainedEarningsMember 2019-03-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001713210 2019-03-31 0001713210 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001713210 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001713210 us-gaap:CommonStockMember 2019-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001713210 us-gaap:RetainedEarningsMember 2019-06-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001713210 2019-06-30 0001713210 us-gaap:CommonStockMember 2019-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001713210 us-gaap:RetainedEarningsMember 2019-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001713210 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001713210 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001713210 2020-01-01 2020-03-31 0001713210 us-gaap:CommonStockMember 2020-03-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001713210 us-gaap:RetainedEarningsMember 2020-03-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001713210 2020-03-31 0001713210 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001713210 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001713210 us-gaap:CommonStockMember 2020-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001713210 us-gaap:RetainedEarningsMember 2020-06-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001713210 AATP:AgapeATPInternationalHoldingLimitedMember 2020-06-30 0001713210 AATP:ShareExchangeAgreementMember AATP:MrHowKokChoongMember 2020-05-07 2020-05-08 0001713210 AATP:SubsidiaryCompanyTwoMember 2020-06-30 0001713210 AATP:SubsidiaryCompanyMember 2020-01-01 2020-06-30 0001713210 AATP:SubsidiaryCompanyMember 2020-06-30 0001713210 AATP:SubsidiaryCompanyOneMember 2020-01-01 2020-06-30 0001713210 AATP:SubsidiaryCompanyOneMember 2020-06-30 0001713210 AATP:SubsidiaryCompanyTwoMember 2020-01-01 2020-06-30 0001713210 AATP:SubsidiaryCompanyThreeMember 2020-01-01 2020-06-30 0001713210 AATP:ShareExchangeAgreementMember AATP:MrHowKokChoongMember 2020-05-08 0001713210 AATP:ComputerAndOfficeEquipmentMember srt:MinimumMember 2020-01-01 2020-06-30 0001713210 AATP:ComputerAndOfficeEquipmentMember srt:MaximumMember 2020-01-01 2020-06-30 0001713210 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2020-01-01 2020-06-30 0001713210 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2020-01-01 2020-06-30 0001713210 us-gaap:LeaseholdImprovementsMember 2020-01-01 2020-06-30 0001713210 us-gaap:VehiclesMember 2020-01-01 2020-06-30 0001713210 us-gaap:ComputerSoftwareIntangibleAssetMember 2020-01-01 2020-06-30 0001713210 2019-01-01 2019-12-31 0001713210 AATP:HealthAndWellnessProductsMember 2020-01-01 2020-06-30 0001713210 AATP:IonizedCalMagMember 2020-04-01 2020-06-30 0001713210 AATP:IonizedCalMagMember 2019-04-01 2019-06-30 0001713210 AATP:IonizedCalMagMember 2020-01-01 2020-06-30 0001713210 AATP:IonizedCalMagMember 2019-01-01 2019-06-30 0001713210 AATP:OmegaBlendMember 2020-04-01 2020-06-30 0001713210 AATP:OmegaBlendMember 2019-04-01 2019-06-30 0001713210 AATP:OmegaBlendMember 2020-01-01 2020-06-30 0001713210 AATP:OmegaBlendMember 2019-01-01 2019-06-30 0001713210 AATP:YoungFormulaMember 2020-04-01 2020-06-30 0001713210 AATP:YoungFormulaMember 2019-04-01 2019-06-30 0001713210 AATP:YoungFormulaMember 2020-01-01 2020-06-30 0001713210 AATP:YoungFormulaMember 2019-01-01 2019-06-30 0001713210 AATP:OrganicYouthCareCleansingBarMember 2020-04-01 2020-06-30 0001713210 AATP:OrganicYouthCareCleansingBarMember 2019-04-01 2019-06-30 0001713210 AATP:OrganicYouthCareCleansingBarMember 2020-01-01 2020-06-30 0001713210 AATP:OrganicYouthCareCleansingBarMember 2019-01-01 2019-06-30 0001713210 AATP:TrimPlusMember 2020-04-01 2020-06-30 0001713210 AATP:TrimPlusMember 2019-04-01 2019-06-30 0001713210 AATP:TrimPlusMember 2020-01-01 2020-06-30 0001713210 AATP:TrimPlusMember 2019-01-01 2019-06-30 0001713210 AATP:LipomaskMember 2020-04-01 2020-06-30 0001713210 AATP:LipomaskMember 2019-04-01 2019-06-30 0001713210 AATP:LipomaskMember 2020-01-01 2020-06-30 0001713210 AATP:LipomaskMember 2019-01-01 2019-06-30 0001713210 AATP:BetaMaxxmMember 2020-04-01 2020-06-30 0001713210 AATP:BetaMaxxmMember 2019-04-01 2019-06-30 0001713210 AATP:BetaMaxxmMember 2020-01-01 2020-06-30 0001713210 AATP:BetaMaxxmMember 2019-01-01 2019-06-30 0001713210 AATP:EnergizedMineralConcentrateMember 2020-04-01 2020-06-30 0001713210 AATP:EnergizedMineralConcentrateMember 2019-04-01 2019-06-30 0001713210 AATP:EnergizedMineralConcentrateMember 2020-01-01 2020-06-30 0001713210 AATP:EnergizedMineralConcentrateMember 2019-01-01 2019-06-30 0001713210 AATP:SurvivorSelectMember 2020-04-01 2020-06-30 0001713210 AATP:SurvivorSelectMember 2019-04-01 2019-06-30 0001713210 AATP:SurvivorSelectMember 2020-01-01 2020-06-30 0001713210 AATP:SurvivorSelectMember 2019-01-01 2019-06-30 0001713210 AATP:VegeFruitFiberMember 2020-04-01 2020-06-30 0001713210 AATP:VegeFruitFiberMember 2019-04-01 2019-06-30 0001713210 AATP:VegeFruitFiberMember 2020-01-01 2020-06-30 0001713210 AATP:VegeFruitFiberMember 2019-01-01 2019-06-30 0001713210 AATP:MitogizeMember 2020-04-01 2020-06-30 0001713210 AATP:MitogizeMember 2019-04-01 2019-06-30 0001713210 AATP:MitogizeMember 2020-01-01 2020-06-30 0001713210 AATP:MitogizeMember 2019-01-01 2019-06-30 0001713210 AATP:HyaluronicAcidSerumMember 2020-04-01 2020-06-30 0001713210 AATP:HyaluronicAcidSerumMember 2019-04-01 2019-06-30 0001713210 AATP:HyaluronicAcidSerumMember 2020-01-01 2020-06-30 0001713210 AATP:HyaluronicAcidSerumMember 2019-01-01 2019-06-30 0001713210 AATP:MousseFacialCleanserMember 2020-04-01 2020-06-30 0001713210 AATP:MousseFacialCleanserMember 2019-04-01 2019-06-30 0001713210 AATP:MousseFacialCleanserMember 2020-01-01 2020-06-30 0001713210 AATP:MousseFacialCleanserMember 2019-01-01 2019-06-30 0001713210 us-gaap:ShippingAndHandlingMember 2020-04-01 2020-06-30 0001713210 us-gaap:ShippingAndHandlingMember 2019-04-01 2019-06-30 0001713210 us-gaap:ShippingAndHandlingMember 2020-01-01 2020-06-30 0001713210 us-gaap:ShippingAndHandlingMember 2019-01-01 2019-06-30 0001713210 AATP:SocialSecurityOrganizationMember 2020-01-01 2020-06-30 0001713210 AATP:SocialSecurityOrganizationMember AATP:MYRCurrencyMember 2020-01-01 2020-06-30 0001713210 AATP:EmployeesProvidentFundMember 2020-01-01 2020-06-30 0001713210 AATP:EmploymentInsuranceSystemMember 2020-01-01 2020-06-30 0001713210 AATP:EmploymentInsuranceSystemMember AATP:MYRCurrencyMember 2020-01-01 2020-06-30 0001713210 AATP:HumanResourceDevelopmentFundMember 2020-01-01 2020-06-30 0001713210 AATP:PeriodEndMYRMember 2020-06-30 0001713210 AATP:PeriodEndMYRMember 2019-12-31 0001713210 AATP:PeriodEndHKDMember 2020-06-30 0001713210 AATP:PeriodEndHKDMember 2019-12-31 0001713210 AATP:MYRCurrencyMember 2020-04-01 2020-06-30 0001713210 AATP:MYRCurrencyMember 2019-04-01 2019-06-30 0001713210 AATP:MYRCurrencyMember 2020-01-01 2020-06-30 0001713210 AATP:MYRCurrencyMember 2019-01-01 2019-06-30 0001713210 AATP:PeriodAverageMYRMember 2020-04-01 2020-06-30 0001713210 AATP:PeriodAverageMYRMember 2019-04-01 2019-06-30 0001713210 AATP:PeriodAverageMYRMember 2020-01-01 2020-06-30 0001713210 AATP:PeriodAverageMYRMember 2019-01-01 2019-06-30 0001713210 AATP:HKDCurrencyMember 2020-04-01 2020-06-30 0001713210 AATP:HKDCurrencyMember 2019-04-01 2019-06-30 0001713210 AATP:HKDCurrencyMember 2020-01-01 2020-06-30 0001713210 AATP:HKDCurrencyMember 2019-01-01 2019-06-30 0001713210 AATP:PeriodAverageHKDMember 2020-04-01 2020-06-30 0001713210 AATP:PeriodAverageHKDMember 2019-04-01 2019-06-30 0001713210 AATP:PeriodAverageHKDMember 2020-01-01 2020-06-30 0001713210 AATP:PeriodAverageHKDMember 2019-01-01 2019-06-30 0001713210 us-gaap:VariableIncomeInterestRateMember 2020-06-30 0001713210 us-gaap:VariableIncomeInterestRateMember 2020-04-01 2020-06-30 0001713210 us-gaap:VariableIncomeInterestRateMember 2020-01-01 2020-06-30 0001713210 AATP:ShareExchangeAgreementMember AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember 2020-05-08 0001713210 AATP:ShareExchangeAgreementMember AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember us-gaap:SubsequentEventMember 2020-06-29 2020-07-01 0001713210 AATP:ShareExchangeAgreementMember AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember 2020-01-01 2020-03-31 0001713210 AATP:ShareExchangeAgreementMember AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember 2020-03-31 0001713210 us-gaap:SubsequentEventMember AATP:MrHowKokChoongMember 2020-07-31 0001713210 AATP:ShareExchangeAgreementMember AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember 2020-01-01 2020-06-30 0001713210 srt:MinimumMember 2020-06-30 0001713210 srt:MaximumMember 2020-06-30 0001713210 us-gaap:MachineryAndEquipmentMember 2020-06-30 0001713210 us-gaap:MachineryAndEquipmentMember 2019-12-31 0001713210 us-gaap:FurnitureAndFixturesMember 2020-06-30 0001713210 us-gaap:FurnitureAndFixturesMember 2019-12-31 0001713210 us-gaap:LeaseholdImprovementsMember 2020-06-30 0001713210 us-gaap:LeaseholdImprovementsMember 2019-12-31 0001713210 us-gaap:VehiclesMember 2020-06-30 0001713210 us-gaap:VehiclesMember 2019-12-31 0001713210 AATP:GreenproCapitalCorpMember 2018-05-17 0001713210 AATP:GreenproCapitalCorpMember 2018-10-16 0001713210 srt:DirectorMember 2020-06-30 0001713210 srt:DirectorMember AATP:MYRCurrencyMember 2020-06-30 0001713210 AATP:MrHowKokChoongMember 2020-06-30 0001713210 AATP:UnreservedSdnBhdMember 2020-03-02 0001713210 AATP:MrHowKokChoongMember 2019-12-31 0001713210 AATP:MrHowKokChoongMember 2020-03-31 0001713210 AATP:PhoenixPlusCorpMember 2019-04-03 0001713210 AATP:PhoenixPlusCorpMember us-gaap:CommonStockMember 2019-04-03 0001713210 AATP:DirectorsOfUnreservedInvestmentMember 2020-06-30 0001713210 AATP:DirectorsOfUnreservedInvestmentMember 2019-12-31 0001713210 AATP:PhoenixPlusCorpMember 2020-06-30 0001713210 AATP:PhoenixPlusCorpMember 2019-12-31 0001713210 AATP:SeaMember 2020-01-01 2020-06-30 0001713210 AATP:SeaMember 2019-01-01 2019-12-31 0001713210 AATP:SeaMember 2020-06-30 0001713210 AATP:SeaMember 2019-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2020-01-01 2020-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2019-01-01 2019-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2020-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2020-12-31 0001713210 AATP:AgapeATPAsiaLimitedAATPAsiaMember 2020-01-01 2020-06-30 0001713210 AATP:AgapeATPAsiaLimitedAATPAsiaMember 2019-01-01 2019-12-31 0001713210 AATP:AgapeATPAsiaLimitedAATPAsiaMember 2020-06-30 0001713210 AATP:AgapeATPAsiaLimitedAATPAsiaMember 2019-12-31 0001713210 AATP:RedboyPictureSdnBhdRedboyMember 2020-01-01 2020-06-30 0001713210 AATP:RedboyPictureSdnBhdRedboyMember 2019-01-01 2019-12-31 0001713210 AATP:RedboyPictureSdnBhdRedboyMember 2020-06-30 0001713210 AATP:RedboyPictureSdnBhdRedboyMember 2019-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLOneMember 2020-01-01 2020-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLOneMember 2019-01-01 2019-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLOneMember 2020-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLOneMember 2019-12-31 0001713210 AATP:MrHowKokChoongMember 2020-01-01 2020-06-30 0001713210 AATP:MrHowKokChoongMember 2019-01-01 2019-12-31 0001713210 AATP:MrHowKokChoongMember 2020-06-30 0001713210 AATP:MrHowKokChoongMember 2019-12-31 0001713210 us-gaap:SubsequentEventMember AATP:MrHowKokChoongMember 2020-06-29 2020-07-01 0001713210 AATP:MrHowKokChoongMember 2020-03-31 0001713210 AATP:SeaMember 2020-04-01 2020-06-30 0001713210 AATP:SeaMember 2019-04-01 2019-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2020-04-01 2020-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2019-04-01 2019-06-30 0001713210 AATP:SeaMember 2019-01-01 2019-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2019-01-01 2019-06-30 0001713210 AATP:AgapeSuperiorLivingMember 2020-05-01 2020-05-31 0001713210 AATP:AgapeSuperiorLivingMember 2020-06-30 0001713210 AATP:AgapeSuperiorLivingMember 2020-06-01 2020-06-30 0001713210 us-gaap:SubsequentEventMember AATP:AgapeSuperiorLivingMember 2020-06-29 2020-07-01 0001713210 AATP:AgapeSuperiorLivingMember 2020-01-01 2020-06-30 0001713210 AATP:AgapeSuperiorLivingMember 2020-04-01 2020-06-30 0001713210 country:MY 2020-04-01 2020-06-30 0001713210 country:MY 2019-04-01 2019-06-30 0001713210 country:MY 2020-01-01 2020-06-30 0001713210 country:MY 2019-01-01 2019-06-30 0001713210 country:HK 2020-04-01 2020-06-30 0001713210 country:HK 2019-04-01 2019-06-30 0001713210 country:HK 2020-01-01 2020-06-30 0001713210 country:HK 2019-01-01 2019-06-30 0001713210 country:US 2020-06-30 0001713210 country:US AATP:IfUnutilizedMember 2020-06-30 0001713210 country:US 2020-01-01 2020-06-30 0001713210 country:US AATP:IfUnutilizedMember 2020-01-01 2020-06-30 0001713210 country:US 2019-12-31 0001713210 AATP:LabuanMember 2018-12-28 2019-01-02 0001713210 country:MY 2020-06-30 0001713210 country:MY 2019-12-31 0001713210 AATP:NoCustomerMember us-gaap:RevenueFromContractWithCustomerMember srt:MaximumMember 2020-01-01 2020-06-30 0001713210 AATP:OneCustomersMember us-gaap:RevenueFromContractWithCustomerMember 2019-04-01 2019-06-30 0001713210 AATP:OneCustomersMember us-gaap:RevenueFromContractWithCustomerMember 2019-01-01 2019-06-30 0001713210 us-gaap:AccountsReceivableMember AATP:ECommerceCompanyMember 2020-01-01 2020-06-30 0001713210 AATP:OneCustomersMember us-gaap:AccountsReceivableMember 2019-01-01 2019-12-31 0001713210 AATP:VendorOneMember 2020-04-01 2020-06-30 0001713210 AATP:VendorOneMember 2020-01-01 2020-06-30 0001713210 AATP:VendorOneMember 2019-04-01 2019-06-30 0001713210 AATP:VendorTwoMember 2019-04-01 2019-06-30 0001713210 AATP:VendorOneMember 2019-01-01 2019-06-30 0001713210 AATP:VendorTwoMember 2019-01-01 2019-06-30 0001713210 AATP:OneVendorMember us-gaap:AccountsPayableMember 2020-01-01 2020-06-30 0001713210 AATP:OneVendorMember us-gaap:AccountsPayableMember 2019-01-01 2019-12-31 0001713210 AATP:AgapeSuperiorLivingMember 2020-04-02 0001713210 AATP:AgapeSuperiorLivingMember 2020-03-28 2020-04-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure AATP:RM

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

For The Quarterly Period Ended June 30, 2020

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to _______________

 

Commission File Number 333-220144

 

AGAPE ATP CORPORATION

(Exact name of registrant issuer as specified in its charter)

 

Nevada   36-4838886

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

1705 - 1708, Level 17, Tower 2, Faber Tower, Jalan Desa Bahagia,
Taman Desa, 58100 Kuala Lumpur, Malaysia.

(Address of principal executive offices, including zip code)

 

Registrant’s phone number, including area code (60) 192230099

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 232.405 of this chapter) during the preceding twelve months (or shorter period that the registrant was required to submit and post such files).

 

Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer ☐ Accelerated Filer ☐ Non-accelerated Filer ☒ Smaller reporting company

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes ☐ No

 

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY

PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

 

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.

 

Yes ☐ No ☐

 

APPLICABLE ONLY TO CORPORATE ISSUERS:

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

Class   Outstanding at August 10, 2020
Common Stock, $0.0001 par value   376,452,047

 

 

 

   

 

 

TABLE OF CONTENTS

 

      Page
PART I   FINANCIAL INFORMATION  
ITEM 1.   UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS:
    Unaudited Condensed Consolidated Balance Sheets F-1
    Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) F-2
    Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity F-3
    Unaudited Condensed Consolidated Statements of Cash Flows F-4
    Notes to Unaudited Condensed Consolidated Financial Statements F-5 - F-32
ITEM 2.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 3
ITEM 3.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 11
ITEM 4.   CONTROLS AND PROCEDURES 12
PART II   OTHER INFORMATION  
ITEM 1   LEGAL PROCEEDINGS 13
ITEM 1A   RISKS FACTORS 13
ITEM 2   UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 20
ITEM 3   DEFAULTS UPON SENIOR SECURITIES 20
ITEM 4   MINE SAFETY DISCLOSURES 20
ITEM 5   OTHER INFORMATION 20
ITEM 6   EXHIBITS 21
    SIGNATURES 22

 

 2 

 

 

PART I FINANCIAL INFORMATION

 

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS:

 

AGAPE ATP CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

            
   June 30,  December 31, 
   2020  2019 
        
ASSETS           
CURRENT ASSETS           
Cash and cash equivalents (Included $18,680 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of June 30, 2020)  $3,427,664    $2,744,457 
Accounts receivable   325,426     - 
Accounts receivable – related party   8,694     520,786 
Amount due from related parties   5,589     2,217 
Inventories   416,627     - 
Prepaid taxes (Included $3,113 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of June 30, 2020)   1,214,035     - 
Prepayments and deposits (Included $8,399 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of June 30, 2020)   507,989     269,193 
Prepayments and deposits – related party   2,784     - 
Total Current Assets   5,908,808     3,536,653 
            
OTHER ASSETS           
Property and equipment, net   311,859     - 
Intangible assets, net   6,283     - 
Operating right-of-use assets   432,593     - 
Investment in marketable securities   193,663     66,484 
Investment in non-marketable securities   1,500     732,137 
Deferred offering costs   203,238     - 
Deferred tax assets, net   34,431     - 
Total Other Assets   1,183,567     798,621 
            
TOTAL ASSETS  $7,092,375    $4,335,274 
            
LIABILITIES AND STOCKHOLDERS’ EQUITY           
CURRENT LIABILITIES           
Accounts payable  $-    $2,790 
Customer deposits   901,569     - 
Operating lease liabilities - current   134,858     - 
Other payables and accrued liabilities ($2,741 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of June 30, 2020)   467,567     77,246 
Amount due to a related party   90,043     3,952 
Total Current Liabilities   1,594,037     83,988 
            
OTHER LIABILITIES           
Operating lease liabilities – non-current  $298,242    $- 
            
TOTAL LIABILITIES   1,892,279     83,988 
            
STOCKHOLDERS’ EQUITY           
Preferred stock, $0.0001 par value; 200,000,000 shares authorized;
None issued and outstanding
     -   - 
Common stock, par value $0.0001; 1,000,000,000 shares authorized, 376,438,194 and 376,275,500 issued and outstanding as of June 30, 2020 and December 31, 2019, respectively   37,644     37,628 
Additional paid in capital   6,350,574     5,293,082 
Accumulated deficit   (1,233,719 )   (1,089,209)
Accumulated other comprehensive income   45,597     9,785 
TOTAL STOCKHOLDERS’ EQUITY   5,200,096     4,251,286 
            
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $7,092,375    $4,335,274 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 F-1 
 

 

AGAPE ATP CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

                 
   For the three months ended   For the six months ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
                 
REVENUE  $1,510,208   $-   $1,510,208   $- 
REVENUE – RELATED PARTY   13,654    396,472    13,654    860,769 
TOTAL REVENUE   1,523,862    396,472    1,523,862    860,769 
                     
COST OF REVENUE   (471,554)   (397,172)   (471,554)   (817,350)
                     
GROSS PROFIT (LOSS)   1,052,308    (700)   1,052,308    43,419 
                     
SELLING   (108,894)   (6,504)   (109,356)   (7,846)
COMMISSION   (382,498)   -    (382,498)   - 
GENERAL AND ADMINISTRATIVE
   (514,724)   (52,734)   (673,778)   (83,778)
TOTAL OPERATING EXPENSES   (1,006,116)   (59,238)   (1,165,632)   (91,624)
                     
INCOME (LOSS) FROM OPERATIONS   46,192    (59,938)   (113,324)   (48,205)
                     
OTHER INCOME (EXPENSES)                    
Other income (expenses), net   29,911    (21,639)   (23,785)   40,454 
Loss from equity investment   -    -    -    (26,085)
Unrealized holding gain on marketable securities   145,204    -    126,666    - 
Gain on deemed disposal of shares in Investee Company   -    -    -    16,509 
Impairment loss in equity investment   -    (366,834)   -    (366,834)
TOTAL OTHER INCOME (EXPENSES), NET   175,115    (388,473)   102,881    (335,956)
                     
INCOME (LOSS) BEFORE INCOME TAXES   221,307    (448,411)   (10,443)   (384,161)
                     
(PROVISION FOR) BENEFIT OF INCOME TAXES   (134,067)   -    (134,067)   6,965 
                     
NET INCOME (LOSS)   87,240    (448,411)   (144,510)   (377,196)
                     
OTHER COMPREHENSIVE INCOME                    
Foreign currency translation adjustment   28,042    4,412    35,812    1,215 
                     
COMPREHENSIVE INCOME (LOSS)  $115,282   $(443,999)  $(108,698)  $(375,981)
                     
EARNINGS (LOSS) PER SHARE                    
Basic and diluted  $0.00   $(0.00)  $(0.00)  $(0.00)
                     
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING                    
Basic and diluted   376,370,256    376,275,500    376,322,878    376,275,500 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 F-2 
 

 

AGAPE ATP CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF

CHANGES IN STOCKHOLDERS’ EQUITY

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

         1    2    3    4    5 
   COMMON STOCK   ADDITIONAL       ACCUMULATED OTHER   TOTAL 
   Number of shares   Par value  

PAID IN

CAPITAL

   ACCUMULATED DEFICIT  

COMPREHENSIVE

INCOME (LOSS)

   STOCKHOLDERS’ EQUITY 
Balance as of December 31, 2018   376,275,500   $37,628   $5,293,082   $(373,082)  $(1,294)  $4,956,334 
Net income   -    -    -    71,215    -    71,215 
Foreign currency translation adjustment   -    -    -    -    (3,197)   (3,197)
Balance as of March 31, 2019   376,275,500    37,628    5,293,082    (301,867)   (4,491)   5,024,352 
Net loss   -    -    -    (448,411)   -    (448,411)
Foreign currency translation adjustment   -    -    -    -    4,412    4,412 
Balance as of June 30, 2019   376,275,500   $37,628   $5,293,082   $(750,278)  $(79)  $4,580,353 

 

   COMMON STOCK   ADDITIONAL       ACCUMULATED OTHER   TOTAL 
   Number of shares   Par value  

PAID IN

CAPITAL

   ACCUMULATED DEFICIT  

COMPREHENSIVE

INCOME

   STOCKHOLDERS’ EQUITY 
Balance as of December 31, 2019   376,275,500   $37,628   $5,293,082   $(1,089,209)  $9,785   $ 4,251,286 
Net loss   -    -    -    (231,750)   -    (231,750)
Foreign currency translation adjustment   -    -    -    -    7,770    7,770 
Balance as of March 31, 2020   376,275,500    37,628    5,293,082    (1,320,959)   17,555    4,027,306 
Net income   -    -    -    87,240    -    87,240 
Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd   162,694    16    1,057,492    -    -    1,057,508 
Foreign currency translation adjustment   -    -    -    -    28,042    28,042 
Balance as of June 30, 2020   376,438,194   $37,644   $6,350,574   $(1,233,719)  $45,597   $5,200,096 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 F-3 
 

 

AGAPE ATP CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”)

 

           
  

For the six months ended

June 30,

 
   2020   2019 
         
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(144,510)  $(377,196)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation   17,716    - 
Amortization   482    - 
Amortization of operating right-of-use assets   32,756    - 
Loss from equity investment   -    26,085 

Unrealized holding gain on marketable securities

   (126,667)   - 
Gain on deemed disposal of shares in investee company   -    (16,509)

Impairment loss in equity investment

   -    366,834 
Deferred tax expenses   134,067    - 
Changes in operating assets and liabilities:          
Accounts receivables   (322,547)   - 
Accounts receivables – related party   (8,617)   (433,338)
Amount due from a related party   -    (2,210)
Inventories   206,540    - 
Prepaid taxes   4,185    - 
Prepayments and deposits   125,422   11,734 
Prepayments and deposits – related party   (2,780)   - 
Accounts payable   (2,802)   - 
Accounts payable – related party   -    35,145 
Customer deposits   (712,749)   (217,743)
Income taxes payable   -    (6,965)
Other payables and accrued liabilities   

51,093

    23,690 
Operating lease liabilities   (32,253)   - 
Net cash used in operating activities   (780,664)   (590,473)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Cash and cash equivalent acquired through acquisition of Agape Superior Living Sdn Bhd   1,210,818    - 
Proceeds from sale of non-marketable securities to a related party   70,173    - 
Investment in non-marketable securities   -    (1,500)
Net cash provided by (used in) investing activities   1,280,991    (1,500)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Deferred offering costs   (75,738)   - 
Repayments from related parties   216,575    745 
Amount due to a related party   -    (5,318)
Net cash provided by (used in) financing activities   140,837    (4,573)
           
EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS   42,043    1,216 
           
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS   683,207    (595,330)
           
CASH AND CASH EQUIVALENTS, beginning of period   2,744,457    3,452,917 
           
CASH AND CASH EQUIVALENTS, end of period  $3,427,664   $2,857,587 
           
SUPPLEMENTAL CASH FLOWS INFORMATION          
Income taxes paid  $-   $- 
Interest paid  $-   $- 
           
SUPPLEMENTAL NON-CASH FLOWS INFORMATION          
Amount transferred from investment in investee company to investment in non-marketable securities  $-   $724,619 
Initial recognition of right-of-use assets and lease liabilities  $461,522   $- 
Sale of non-marketable securities to a related party in exchange for ASL  $656,495   $- 
Issuance of common stock in exchange for acquisition payment of ASL  $1,057,508   $- 
Unpaid balance due to a related party in connection with acquisition payment of ASL  $90,043   $- 
Unpaid accrued liabilities on deferred offering costs  $127,500   $- 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 F-4 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

1. ORGANIZATION AND BUSINESS BACKGROUND

 

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

 

Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.

 

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

 

On May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire 9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in Agape Superior Living Sdn. Bhd., an entity incorporated in Malaysia.

 

Agape Superior Living Sdn. Bhd. (“ASL”) is a limited company incorporated on August 8, 2003, under the laws of Malaysia.

 

The Company and its subsidiaries engage in the network marketing sales business in the Health and Wellness Industry. The principal activity of the Company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body.

 

The accompanying unaudited condensed consolidated financial statements reflect the activities of the Company, Agape ATP Corporation (“AATP LB”), Agape ATP International Holding Limited (“AATP HK”), ASL and its variable interest entity (“VIE”), Agape S.E.A. Sdn. Bhd. (“SEA”) (See Note 3).

 

Details of the Company’s subsidiaries:

 

 

   

Subsidiary company

name

 

Place and

date of

incorporation

  Particulars of issued capital  Principal activities 

Proportional of ownership

interest and

voting power

held

 
                  
1.    Agape ATP Corporation  Labuan,
March 6, 2017
  100 shares of ordinary share of US$1 each  Investment holding   100%
                   
2.    Agape ATP International Holding Limited  Hong Kong,
June 1, 2017
  1,000,000 shares of ordinary share of HK$1 each  Health and wellness products and health solution advisory services   100%
                   
3.   Agape Superior Living Sdn. Bhd.  Malaysia,
August 8, 2003
  9,590,598 shares of ordinary share of RM1 each  Health and wellness products and health solution advisory services   99.99%
                   
4.   Agape S.E.A. Sdn. Bhd.  Malaysia,
March 4, 2004
  2 shares of ordinary share of RM1 each  VIE of Agape Superior Living Sdn. Bhd.   VIE 

 

 F-5 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Business Overview

 

Agape ATP Corporation is a company that provides health solution advisory services to our clients. We primarily focus our efforts on attracting customers in Malaysia. Our advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.

 

In order to strengthen the Company’s supply chain, on May 8, 2020, the Company has successfully acquired approximately 99.99% of ASL, with the goal of securing an established network marketing sales channel that has been established in Malaysia for the past 15 years. ASL has been offering the Company’s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy in the Company’s operation by boosting the Company’s retail and marketing capabilities. The newly acquired subsidiary allows the Company to fulfill its mission of “helping people to create health and wealth” by providing a financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle.

 

The Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, ÉNERGÉTIQUE and BEAUNIQUE.

 

The ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and distributors.

 

The ÉNERGÉTIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.

 

The BEAUNIQUE product series focuses on the research of our diet’s impact on modifying gene expressions in order to address genetic variations and deliver a nutrigenomic solution for every individual.

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), and include all normal and recurring adjustments that management of the Company considers necessary for a fair presentation of its financial position and operation results. Interim results are not necessarily indicative of results to be expected for any other interim period or for the full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s transition report on Form 10-K for the period ended December 31, 2019, filed with the Securities and Exchange Commission on March 27, 2020.

 

 F-6 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Principles of consolidation

 

The unaudited condensed consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.

 

Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.

 

A VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary and must consolidate the VIE. 

 

Use of estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include allowance for doubtful accounts, allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.

 

Accounts receivable and accounts receivable – related party

 

Accounts receivable and accounts receivable – related party are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of June 30, 2020, and December 31, 2019, no valuation allowance was recorded.

 

 F-7 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Inventories

 

Inventories consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method.

 

Prepaid taxes

 

Prepaid taxes include (i) prepaid income taxes that will either be refundable or utilized to offset future income tax; and (ii) goods and service tax (“GST”) to be refundable.

 

Prepayments and deposits

 

Prepayments and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of June 30, 2020, and December 31, 2019, there is no allowance for the doubtful accounts.

 

Property and equipment, net

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:

 

    Useful Life 
      
Computer and office equipment   5-7 years  
Furniture & fixtures   6-7 years 
Leasehold improvements   Lease Term 
Vehicle   5 years 

 

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates of useful lives.

 

 F-8 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Intangible assets, net

 

Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows:

 

 

Classification   Useful Life 
      
Computer software   5 years 

 

Impairment for long-lived assets

 

Long-lived assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of June 30, 2020, and December 31, 2019, no impairment of long-lived assets was recognized.

 

Deferred offering costs

 

Deferred offering costs represents costs associated with the Company’s current offering which will be netted against the proceeds from the Company’s current offering.

 

Investment in marketable equity securities

 

Prior to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

 

On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s consolidated statements of operations and comprehensive loss in the caption of “unrealized holding losses on marketable securities” in each reporting period.

 

 F-9 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares) 

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Investment in non-marketable equity securities

 

Prior to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

 

On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.

 

At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.

 

Customer deposits

 

Customer deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced when the related sale is recognized in accordance with the Company’s revenue recognition policy.

 

Revenue recognition

 

On July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not result in an adjustment to retained earnings upon adoption of this new guidance as the Company’s revenue was recognized based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.

 

 F-10 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

The core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.

 

The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.

 

The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.

 

Prior to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

 

The application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance and confirmed that there were no differences in the pattern of revenue recognition.

 

Sales of Health and Wellness products

 

- Performance obligations satisfied at a point in time

 

On July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods, which is generally similar to when its delivery has occurred prior to July 1, 2019 Such revenues are recognized at a point in time after all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.

 

 F-11 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

The Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and wellness products transaction price upon such sales transactions occurred. The Company’s coupons have a validity period of six months. If the Company’s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues. For the three and six months ended June 30, 2020, the Company recognized $61,368 as forfeited coupon income.

 

As of June 30, 2020, the Company had contracts for the sales of health and wellness products amounting to $661,900 which it is expected to fulfill within 12 months from June 30, 2020.

 

Disaggregated information of revenues by products are as follows:

 

 

   For the three months ended   For the six months ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
                 
Ionized Cal-Mag  $611,160   $167   $611,160   $55,660 
Omega Blend   162,543    207    162,543    68,896 
Young Formula   349,738    353    349,738    117,332 
Organic Youth Care Cleansing Bar   28,805    53    28,805    17,728 
Trim+   223,497    133,319    223,497    198,614 
Lipomask   8,420    422    8,420    140,588 
Beta Maxx   11,434    123,470    11,434    123,470 
Energized Mineral Concentrate   22,606    138,481    22,606    138,481 
Survivor Select   35,994    -    35,994    - 
Vege-Fruit Fiber   6,106    -    6,106    - 
Mitogize   4,711    -    4,711    - 
Hyaluronic Acid Serum   55,721    -    55,721    - 
Mousse Facial Cleanser   3,127    -    3,127    - 
Total revenues  $1,523,862   $396,472   $1,523,862   $860,769 

 

Cost of revenue

 

Cost of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers.

 

Shipping and handling

 

Shipping and handling charges amounted to $2,555 and $0 for the three months ended June 30, 2020 and 2019, respectively. Shipping and handling charges amounted to $2,555 and $0 for the six months ended June 30, 2020 and 2019, respectively. Shipping and handling charges are expensed as incurred and included in selling expenses.

 

 F-12 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Advertising costs

 

Advertising costs amounted to $2,882 and $0 for the three months ended June 30, 2020 and 2019, respectively. Advertising costs amounted to $2,882 and $0 for the six months ended June 30, 2020 and 2019, respectively. Advertising costs are expensed as incurred and included in selling expenses.

 

Commission expenses

 

Commission expenses are the Company’s most significant expenses. As with all companies in the network marketing industry, the Company’s sales channel is external to the Company. The Company’s “external sales force” is stratified into two levels based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly, are referred to as “sales network members”. The Company pays commission to every sales distributor based on purchases made by its sales network members which includes the independent direct sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain amount of the Company’s inventory on their store premises. The stockists shall account to the Company for all products sales from their store premises as monitored through the Company’s centralized stock tracking system. The Company pays a separate commission to stockists based on revenue generated from the stockists’ physical stores. Commission expenses amounted to $382,498 and $0 for the three months ended June 30, 2020 and 2019, respectively. Commission expenses amounted to $382,498 and $0 for the six months ended June 30, 2020 and 2019, respectively.

 

Defined contribution plan

 

The full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue and pay for these benefits based on certain percentages of the employees’ respective salaries, subject to certain ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan. Total expenses for the plans were $23,710 and $0 for the three months ended June 30, 2020 and 2019, respectively. Total expenses for the plans were $23,710 and $0 for the six months ended June 30, 2020 and 2019, respectively.

 

The related contribution plans include:

 

  - Social Security Organization (“SOSCO”) – 1.75% based on employee’s monthly salary capped of RM 4,000;
  - Employees Provident Fund (“EPF”) – 12% based on employee’s monthly salary;
  - Employment Insurance System (“EIS”) – 0.2% based on employee’s monthly salary capped of RM 4,000;
  - Human Resource Development Fund (“HRDF”) – 1% based on employee’s monthly salary

 

 F-13 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Income taxes

 

The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.

 

Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.

 

An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. No penalties and interest incurred related to underpayment of income tax for the three and six months ended June 30, 2020 and 2019.

 

The Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

Comprehensive income (loss)

 

Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.

 

Non-controlling interest

 

Non-controlling interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals. The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders and the shareholders of the Company. As of June 30, 2020, the non-controlling interest balance was $0 and therefore not presented in the accompanying unaudited condensed consolidated financial statements.

 

 F-14 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Earnings (loss) per share

 

The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. For the three and six months ended June 30, 2020 and 2019, there were no dilutive shares.

 

Foreign currencies translation and transaction

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit (“MYR” or “RM”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency. The Company’s subsidiary and VIE in Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (“MYR” or “RM”), as its functional currency.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

 

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

 

 

   As of 
   June 30, 2020   December 31, 2019 
         
Period-end MYR : US$1 exchange rate   4.28    4.09 
Period-end HKD : US$1 exchange rate   7.75    7.79 

 

 F-15 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

   For the three months ended   For the six months ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
                 
Period-average MYR : US$1 exchange rate   4.32    4.15    4.25    4.12 
Period-average HKD : US$1 exchange rate   7.75    7.84    7.76    7.84 

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments

 

The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.

 

The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:

 

  Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
  Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.

 

Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.

 

Leases

 

Effective July 1, 2019, the Company adopted ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that does not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing leases with a lease term in excess of twelve months on July 1, 2019.

  

 F-16 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Operating lease right-of-use (“ROU”) assets and lease liabilities are recognized at the adoption date of July 1, 2019 or the commencement date, whichever is earlier, based on the present value of lease payments over the lease term. Since the implicit rate for the Company’s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment and over a similar term.

 

Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.

 

The Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future pre-tax cash flows.

 

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its unaudited condensed consolidated financial statements.

 

 F-17 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The Company does not expect the adoption of this standard to have a material impact on its unaudited condensed consolidated financial statements.

 

Reclassification

 

Certain prior period amounts have been reclassified to conform to the current period presentation for the three and six months ended June 30, 2019. These reclassifications have no effect on the unaudited condensed consolidated statements of operations and comprehensive income (loss).

 

3. VARIABLE INTEREST ENTITY (“VIE”)

 

SEA is a trading company incorporated on March 4, 2004, under the laws of Malaysia. SEA provided all of ASL’s purchases. Its equity at risk was insufficient to finance its activities and 100% of its business is transacted with ASL. Therefore it was considered to be a VIE and ASL is the primary beneficiary since it has both of the following characteristics:

 

  a. The power to direct the activities of the VIE that most significantly impact the VIE’s economic performance; and
  b. The obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.

 

Accordingly, the accounts of SEA is consolidated in the accompanying unaudited condensed financial statements.

 

The carrying amount of the VIE’s assets and liabilities were as follows:

 

 

   June 30, 2020 
     
Current assets  $290,630 
Current liabilities   (289,911)
Net assets  $719 

 

 F-18 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

3. VARIABLE INTEREST ENTITY (“VIE”) (Continued)

 

   June 30, 2020 
Current asset:     
Cash and cash equivalents  $18,680 
Accounts receivable – intercompany   260,438 
Prepaid taxes   3,113 
Prepayments and deposits   8,399 
Total current assets   290,630 
      
Current liabilities:     
Accounts payable – intercompany  $286,820 
Other payables and accrued liabilities   2,741 
Other payables – intercompany   350 
Total current liabilities  $289,911 

 

The summarized operating results of the VIE’s are as follows:

 

  

For the Three Months Ended

June 30, 2020

  

For the Six

Months Ended

June 30, 2020

 
         
Operating revenues  $129,492   $129,492 
Gross profit  $1,373   $1,373 
Loss from operations  $(3,749)  $(3,749)
Net loss  $(18,139)  $(18,139)

 

4. BUSNINESS COMBINATION

 

On May 8, 2020, the Company entered into a Share Exchange Agreement (“SPA”) with Mr. How Kok Choong, CEO and director of the Company to acquire 9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in ASL, an entity incorporated in Malaysia. Pursuant to the SPA, as amended on July 1, 2020, Mr. How will receive an aggregate consideration of $1,804,046, which was determined based on the net asset carrying value of ASL as at March 31, 2020. The aggregate consideration shall be satisfied by (i) the offset of the Consideration whereby the Company has a loan receivable of $656,495 as of March 31, 2020 due from Mr. How; and (ii) allotment and issuance of common stock of the Company. The Company shall allot and issue 176,547 shares of the Company’s common stock, par value $0.0001, representing approximately 0.0469% of the total issued and outstanding shares in the Company after the issuance of the Shares, which is valued at $1,147,551 based on the closing price of $6.50 of the Company as quoted on the OTC Market on March 31, 2020. As of June 30, 2020, the Company issued 162,294 shares of the Company’s common stock with the remaining 13,853 shares of the Company’s common stock issued on July 1, 2020.

 

The Company’s acquisition of ASL was accounted for as a business combination in accordance with ASC 805. The Company has allocated the purchase price of ASL based upon the carrying value of the identifiable assets acquired and liabilities assumed on April 1, 2020 as ASL was under the common control of Mr. How.

 

 F-19 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

The following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which represents the net purchase price allocation on the date of the acquisition of ASL.

  

 

   Carry Value 
ASSETS     
Current assets     
Cash  $1,206,493 
Other receivables   33,210 
Other receivables - related parties   219,121 
Inventories   616,880 
Prepaid taxes   1,206,821 
Prepayments and other assets   318,267 
Total current assets   3,600,792 
      
Other assets     
Property and equipment, net   325,648 
Intangible assets, net   6,686 
Deferred taxes asset, net   172,250 
Total other assets   504,584 
      
Total assets  $4,105,376 
      
LIABILITIES AND SHAREHOLDERS’ EQUITY     
Current liabilities     
Accounts payable - related party  $491,628 
Customer deposits   1,600,606 
Other payables and accrued liabilities   209,096 
Total current liabilities   2,301,330 
      
Total liabilities   2,301,330 
      
Total net assets acquired   1,804,046 

 

The following unaudited pro forma combined results of operations presents the Company’s financial results as if the acquisition of ASL had been completed on January 1, 2019. The unaudited pro forma results do not reflect operating efficiencies or potential cost savings which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information is not necessarily indicative of the results of operations that the Company would have recognized had we completed the transaction on January 1, 2019. Future results may vary significantly from the results in this pro forma information because of future events and transactions, as well as other factors.

 

 F-20 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

  

   For the Three Months Ended   For the Six Months Ended   For the Six Months Ended 
   June 30, 2019   June 30, 2020   June 30, 2019 
Revenue  $684,112   $2,765,114   $1,914,362 
Cost of revenue   (108,478)   (571,407)   (309,999)
Gross profit   575,634    2,193,707    1,604,363 
Total operating expenses   (1,269,443)   (2,055,016)   (2,613,015)
Income (loss) from operations   (693,809)   138,691    (1,008,652)
Other income (expense), net   (281,239)   110,912    (237,655)
Income (loss) before income taxes   (975,048)   249,603    (1,246,307)
Benefit of (Provision for) income taxes   137,983    (184,900)   202,180 
Net income (loss)  $(837,065)  $64,703   $(1,044,127)
Net income (loss) per common share - basic and diluted   (0.00)   0.00    (0.00)
Weighted average number of common shares outstanding - basic and diluted  $376,452,047   $376,452,047   $376,452,047 

 

5. CASH AND CASH EQUIVALENTS

 

As of June 30, 2020 and December 31, 2019 the Company has $3,427,664 and $2,744,457, respectively, of cash and cash equivalents, which consists of $917,458 and $238,937, respectively, of cash in banks and $2,483,915 and $2,505,520, respectively, of time deposits placed with banks or other financial institutions and are all highly liquid investments with an original maturity of three months or less. The effective interest rate for the time deposits ranges between 2.95% to 3.25% per annum.

 

6. ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE – RELATED PARTY

 

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
Accounts receivable  $325,426   $- 
Accounts receivable – related party   8,694    520,786 
Allowance for doubtful accounts   -    - 
Total accounts receivable and accounts receivable – related party  $334,120   $520,786 

 

 F-21 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

7. INVENTORIES

 

Inventories consist of the following:

 

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
Finished goods  $416,627   $            - 

 

8. PREPAYMENTS AND DEPOSITS

 

 

   As of
June 30, 2020
   As of
December 31, 2019
 
Prepaid expenses  $8,399   $2,641 
Receivables from sales distributors   33,956    - 
Deposits to suppliers   465,634    266,552 
Total prepaid expenses and deposits  $507,989   $269,193 

 

9. PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consist of the following:

 

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
Computer and office equipment  $71,785   $- 
Furniture & fixtures   119,166    - 
Leasehold improvements   197,564    - 
Vehicle   96,263    - 
Subtotal   484,778    - 
Less: accumulated depreciation   (172,919)   - 
Total  $311,859   $- 

 

Depreciation expense for the three months ended June 30, 2020 and 2019 amounted to $17,716 and $0, respectively. Depreciation expense for the six months ended June 30, 2020 and 2019 amounted to $17,716 and $0, respectively.

 

10. INTANGIBLE ASSETS, NET

 

Intangible assets, net, consist of the following:

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
         
Computer software  $33,426   $- 
Less: accumulated amortization   (27,143)             - 
Total  $6,283   $- 

 

Amortization expense for the three months ended June 30, 2020 and 2019 amounted to $482 and $0, respectively. Amortization expense for the six months ended June 30, 2020 and 2019 amounted to $482 and $0, respectively.

 

 F-22 
 

  

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

11. INVESTMENT IN MARKETABLE SECURITIES

 

  (i) On May 17, 2018, the Company purchased 83,333 shares of common stock in Greenpro Capital Corp. for $500,000 at a purchase price of $6 per share.
     
  (ii) On October 16, 2018, the Company purchased 33,333 shares of common stock in Greenpro Capital Corp. for $1,000 at a purchase price of $0.03 per share.

 

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
Cost of investment  $66,484   $134,166 
Unrealized holding gain (loss)   126,666    (68,391)
Exchange rate effect   513    709 
Investment in marketable securities  $193,663   $66,484 

 

 

12. INVESTMENT IN NON-MARKETABLE SECURITIES

 

The Company invested in Unreserved Sdn Bhd with the investment amount of $863,592 (RM 3,500,000), which approximated 20% of the equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019 Unreserved Sdn Bhd issued additional common stock for working capital. As the Company did not subscribe for the additional common stock, the Company’s equity interest in investee company was diluted from approximately 20.0% to approximately 17.86%. Effective from March 10, 2019, the Company discontinued equity accounting on the investee company. The Company also ceased control over the operations of the investee company on the same date. Accordingly, the investment in investee company was reclassified to investment in non-marketable securities.

 

Unreserved Sdn Bhd was incorporated in Malaysia with 2,500,000 ordinary shares authorized, issued and outstanding. Mr. Lim Hun Soon @ David Lim and Ms. Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr. How Kok Choong was a director of the company from April 30, 2018 to March 27, 2019.

 

On March 2, 2020, the Company agreed to sell the 17.86% ownership interest in Unreserved Sdn Bhd at the December 31, 2019 carrying value of $730,637 to Mr. How Kok Choong, the CEO and director of the Company. The Company received proceeds of $70,173, and had an amount due from director of $660,464 at March 31, 2020. In May 2020, the entire outstanding balance was settled as part of the consideration in a transaction which the Company had acquired the CEO’s ownership interest of Agape Superior Living Sdn. Bhd.

 

On April 3, 2019, the Company purchased a 5% of stock or 15,000,000 shares of common stock in Phoenix Plus Corp. for $1,500 at purchase price of $0.0001 per share.

 

 

Unreserved Sdn Bhd  As of
June 30, 2020
   As of
December 31, 2019
 
Investment in non-marketable securities  $730,637   $730,637 
Less: Sale of investment in non-marketable securities   (730,637)   - 
Investment in non-marketable securities  $-   $730,637 
           
Phoenix Plus Corporation          
Cost of investment  $1,500   $1,500 
           
Total investment in non-marketable securities  $1,500   $732,137 

 

 F-23 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

13. OTHER PAYABLES AND ACCRUED LIABILITIES

 

 

  

As of

June 30, 2020

  


As of

December 31, 2019

 
Accrued professional fees  $322,661   $58,594 
Accrued promotion expenses   59,474    - 
Accrued payroll   22,180    - 
Others   63,252    18,652 
Total other payables and accrued liabilities  $467,567   $77,246 

 

14. RELATED PARTY BALANCES AND TRANSACTIONS

 

Related party balances

 

Accounts receivable – related party

 

 

Name of Related Party  Relationship  Nature  

As of

June 30, 2020

  

As of

December 31, 2019

 
                  
SEA  VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA   Sales of products   $-   $520,786 
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL   Sales of products    8,694    - 
Total          $8,694   $520,786 

 

 F-24 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Amount due from related parties

 

Name of Related Party  Relationship  Nature 

As of

June 30, 2020

  

As of
December 31, 2019

 
                
Agape ATP (Asia) Limited (“AATP Asia”)  Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia  Expenses paid for AATP Asia  $2,228   $2,217 
Redboy Picture Sdn Bhd “Redboy”  Mr. How Kok Choong, the CEO and director of the Company is also the director of Redboy  Paid advance to Redboy for business operational expenses   3,361    - 
Total        $5,589   $2,217 

 

Prepayments and Deposits - related party

 

Name of Related Party  Relationship  Nature 

As of

June 30, 2020

   As of
December 31, 2019
 
                
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL  Prepayment for Printing Label  $2,784   $      - 
Total        $2,784   $- 

 

Amount due to a Related Party

 

Name of Related Party  Relationship  Nature 

As of

June 30, 2020

   As of
December 31, 2019
 
                
Mr. How Kok Choong  CEO and director of the Company  Acquisition payment of ASL and expenses paid for the Company  $90,043(1)  $3,952 
Total        $90,043   $3,952 

 

(1)On July 1, the Company issued additional 13,853 shares of the Company’s common stock valued at $90,043 based on the Company’s closing price of $6.50 at March 31, 2020 to settle the acquisition payment of ASL (See Note 15).

 

 F-25 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Related party transactions

  

Revenue

 

Name of Related Party  Relationship  Nature  

For the Three Months Ended

June 30, 2020

  

For the Three Months Ended

June 30, 2019

 
                 
SEA  VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA   Sales of products   $-   $390,661 
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL   Sales of products    13,654    5,811 
Total          $13,654   $396,472 

 

Name of Related Party  Relationship  Nature  

For the Six Months Ended

June 30, 2020

  

For the Six Months Ended

June 30, 2019

 
                 
SEA  VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA   Sales of products   $-   $839,308 
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL   Sales of products    13,654    21,461 
Total          $13,654   $860,769 

 

 F-26 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

15. STOCKHOLDERS’ EQUITY

 

Preferred stock

 

As of June 30, 2020, and December 31, 2019, there were 200,000,000 preferred stocks authorized but none were issued and outstanding.

 

Common stock

 

As of June 30, 2020, and December 31, 2019, there were 1,000,000,000 common stocks authorized, 376,438,194 and 376,275,500 shares issued and outstanding, respectively.

 

In May 2020, the Company issued 162,694 shares of the Company’s common stock in connection with the acquisition of ASL as part of the acquisition payment.

 

In June 2020, ASL made certain adjustments to its March 31, 2020 financial statements. As a result, the net assets carrying value increased by $90,043, which required the issuance of an additional 13,853 shares of the Company’s common stock to fully satisfy the acquisition payment for ASL to Mr. How Kok Choong, CEO and director of the Company. The 13,853 additional shares were issued in July 2020.

 

There were no stock options, warrants or other potentially dilutive securities outstanding as of June 30, 2020 and December 31, 2019.

 

Non-controlling interest

 

As of June 30, 2020 and for the three and six months ended June 30, 2020, no material transactions of non-controlling interest occurred from the operating results from ASL as the Company holds approximately 99.99% of the equity interest in ASL, non-controlling interests that present in ASL is $0 and therefore not presented separately in the accompanying unaudited condensed consolidated financial statements.

 

16. INCOME TAXES

 

The United States and foreign components of income (loss) before income taxes were comprised of the following:

 

 

   For the three months ended   For the six months ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
             
Tax jurisdictions from:                    
Local  $(161,751)  $(27,608)  $(304,170)  $(42,332)
- Foreign – Malaysia   369,367    (16,875)   313,780    42,799 
- Foreign – Hong Kong   13,691    (403,928)   (20,053)   (384,628)
Income (loss) before income tax  $221,307   $(448,411)  $(10,443)  $(384,161)

 

 F-27 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

The (provision for) benefit of income taxes consisted of the following:

 

 

  

For the Three Months Ended

June 30, 2020

  

For the Three Months Ended

June 30, 2019

  

For the Six Months Ended

June 30, 2020

  

For the Six Months Ended

June 30, 2019

 
                          
Current:                    
- Local  $-   $-   $-   $- 
- Foreign   -    -    -    6,965 
                     
Deferred:                    
- Local   -    -    -    - 
- Foreign   (134,067)   -    (134,067)   - 
                     
(Provision for) benefit of income taxes  $(134,067)  $-   $(134,067)  $6,965 

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Malaysia (including Labuan) and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

Agape ATP Corporation was incorporated in the State of Nevada and is subject to the tax laws of the United States of America. As of June 30, 2020, the operations in the United States of America incurred approximately $511,000 of cumulative net operating losses which can be carried forward to offset future taxable income. Approximately $10,000 and $24,000 of the net operating loss carry forwards will expire in 2027 and 2028, respectively, if unutilized. The remaining balance can be carried forward indefinitely. The deferred tax valuation allowance as of June 30, 2020 and December 31, 2019 were approximately $107,000 and $43,000, respectively.

 

Malaysia

 

Changes to the Labuan Business Activity Tax Act (LBATA) 1990 which was gazetted and came into operation on January 1, 2019 mandate companies incorporated in Labuan to satisfy the “substantial activity requirements” to qualify for the preferential tax rate of 3% on net audited profit. Subsequently, on April 29, 2020, a circular setting out revisions to the “substantial activity requirements” was issued. As Agape ATP Corporation does not maintain a permanent establishment in Labuan, the company is subject to tax at 24% on its net audited profit until such a time it satisfies the said requirements.

 

Agape Superior Living Sdn Bhd and Agape S.E.A. are governed by the income tax laws of Malaysia and the income tax provision in respect of operations in Malaysia is calculated at the applicable tax rates on the taxable income for the periods based on existing legislation, interpretations and practices in respect thereof. Under the Income Tax Act of Malaysia, enterprises that incorporated in Malaysia are usually subject to a unified 24% enterprise income tax rate while preferential tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. The tax rate for small and medium sized companies (generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is 17% for the first RM 600,000 (or approximately $150,000) for the three and six months ended June 30, 2020 and RM 500,000 (or approximately $125,000) income for the three and six months ended June 30, 2019, with the remaining balance being taxed at the 24% rate.

 

 F-28 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Hong Kong

 

Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5% on its assessable income derived from Hong Kong. Business income derived or business expenses incurred outside the Special Administrative Region is not subject to Hong Kong Profits Tax or deduction.

 

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:

 

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
           
Deferred tax assets:          
Net operating loss carry forwards in U.S.  $107,285   $43,410 
Net operating loss carry forwards in Malaysia   98,649    - 
Less: valuation allowance   (107,285)   (43,410)
Deferred tax liabilities:          
Depreciation   (64,218)   - 
Deferred tax assets, net  $34,431   $- 

 

Uncertain tax positions

 

The Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions. As of June 30, 2020, and December 31, 2019, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur interest and penalties tax for the three and six months ended June 30, 2020 and 2019.

 

17. CONCENTRATIONS OF RISKS

 

(a) Major customers

 

For the three and six months ended June 30, 2020, no customer accounted for 10% or more of the Company’s total revenues. For the three months ended June 30, 2019, one related party customer accounted for approximately 98.5% of the Company’s total revenues. For the six months ended June 30, 2019, one related party customer accounted for approximately 97.5% of the Company’s total revenues.

 

As of June 30, 2020, receivables from a third-party e-commerce company accounted for approximately 97.4% of the total balance of accounts receivable. As of December 31, 2019, one related party customer accounted for 100.0% of the total balance of accounts receivable.

 

(b) Major vendors

 

For the three and six months ended June 30, 2020, one vendor accounted for 100.0% of the Company’s total purchases. For the three months ended June 30, 2019, two vendors accounted for approximately 66.8% and 33.2% of the Company’s total purchases, respectively. For the six months ended June 30, 2019, two vendors accounted for approximately 60.7% and 39.3% of the Company’s total purchases, respectively.

 

There are no accounts payable balance as of June 30, 2020. As of December 31, 2019, one vendor accounted for 100% of the total balance of accounts payable.

 

 F-29 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

(c) Commission Expenses to Sales Distributors and Stockists

 

For the three and six months ended June 30, 2020, no sales distributor accounted for 10.0% or more of the Company’s total commission expense.

 

(d) Credit risk

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of June 30, 2020, and December 31, 2019, $917,458 and $238,937 were deposited with financial institutions, respectively, $384,652 and $0 of these balances are not covered by deposit insurance. While management believes that these financial institutions are of high credit quality, it also continually monitors their credit worthiness.

 

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. Historically, the Company did not have any bad debt on its account receivable.

 

(e) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM and HK$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

18. COMMITMENTS AND CONTINGENCIES

 

Lease commitments

 

On April 1, 2020, the Company adopted ASC 842 for ASL’s office space lease and sales and training center as the lease commencement date upon the acquisition of ASL. The Company recognized lease liabilities of approximately $466,000, with a corresponding right-of-use (“ROU”) asset in the same amount based on the present value of the future minimum rental payments of the lease, using an effective interest rate of 5.5%, which was determined using the Company’s estimated incremental borrowing rate. The weighted remaining term of the lease is approximately 3.04 years.

 

 F-30 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

The five-year maturity of the Company’s operating lease liabilities is as follow:

 

 

Twelve Months Ending
June 30,
  Operating lease liabilities 
     
2021  $155,316 
2022   158,236 
2023   149,337 
2024   8,064 
Total lease payments   470,953 
Less: interest   (37,853)
Present value of lease liabilities  $433,100 

 

The Company also leases two distribution centers and one employee apartment with an expiring term of twelve months or fewer, which were classified as operating leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company selected not to recognize lease assets and liabilities on these leases. As of June 30, 2020, the Company’s commitment for minimum lease payments under these operating leases within the next twelve months are $8,620.

 

Rent expense for the three months ended June 30, 2020 and 2019 was $52,672 and $13,391, respectively. Rent expense for the six months ended June 30, 2020 and 2019 was $66,180 and $26,766, respectively.

 

Purchase commitments

 

The total future minimum purchase commitment under a non-cancellable purchase contract as of June 30, 2020 for the next five years and thereafter is as follows:

 

 

Twelve months ending June 30, 

Minimum

purchase

 
2021  $693,900 
2022   693,900 
2023   693,900 
2024   693,900 
2025   693,900 
Thereafter   1,734,750 
Total minimum purchase commitments required  $5,204,250 

 

As of the date of this report, the Company’s vendor is not able to meet the Company’s minimum purchase commitment of the health and wellness products due to the manufacturing process was being delayed by its vendor.

 

Contingencies

 

Legal

 

From time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued, as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are not deemed to be material to the consolidated financial statements.

 

 F-31 
 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

COVID-19

 

On March 11, 2020, the World Health Organization or WHO declared the corona virus or COVID-19 a pandemic. In accordance with the recommendations of the WHO, Malaysia had imposed a nationwide lockdown via the government’s Movement Control Order (“MCO”) effective March 18, 2020. The MCO has resulted in quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia. On May 4, 2020, the MCO was lessen to a Conditional Movement Control Order (“CMCO”) where most business sectors were allowed to operate under strict rules and Standard Operating Procedures mandated by the government of Malaysia.

 

Substantially all of the Company’s revenues are concentrated in Malaysia. Consequently, its results of operations will likely be adversely, and may be materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact to its results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact, almost all of which are beyond its control. Potential impacts include, but are not limited to, the following:

 

  temporary closure of offices, travel restrictions, financial impact of the Company’s customers or suspension supplies may negatively affected, and could continue to negatively affect, the demand for the Company’s product;
  the Company may have to provide significant sales incentives to its customers during the outbreak, which may in turn materially adversely affect its financial condition and operating results; and

 

any disruption of the Company’s supply chain, logistics providers or customers could adversely impact its business and results of operations, including causing the Company or its suppliers to cease manufacturing for a period of time or materially delay delivery to its customers, which may also lead to loss of its customers.

 

Because of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19 cannot be reasonably estimated at this time. There is no guarantee that the Company’s total revenues will grow or remain at the similar level year over year in the remaining period of 2020.

 

 F-32 
 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The information contained in this quarter report on Form 10-Q is intended to update the information contained in our Form 10-K, dated March 27, 2020, for the six months ended December 31, 2019 and presumes that readers have access to, and will have read, the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and other information contained in such Form 10-K. The following discussion and analysis also should be read together with our consolidated financial statements and the notes to the consolidated financial statements included elsewhere in this Form 10-Q.

 

The following discussion contains certain statements that may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements appear in a number of places in this Report, including, without limitation, “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” These statements are not guarantees of future performance and involve risks, uncertainties and requirements that are difficult to predict or are beyond our control. Forward-looking statements speak only as of the date of this quarterly report. You should not put undue reliance on any forward-looking statements. We assume no responsibility to update the forward-looking statements contained in this transition report on Form 10-Q. The following should also be read in conjunction with the unaudited condensed Consolidated Financial Statements and notes thereto that appear elsewhere in this report.

 

Company Overview

 

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

 

Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.

 

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

 

On May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire 9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in Agape Superior Living Sdn. Bhd., an entity incorporated in Malaysia.

 

Agape Superior Living Sdn. Bhd. (“ASL”) is a limited company incorporated on August 8, 2003, under the laws of Malaysia.

 

The Company and its subsidiaries engage in the network marketing sales business in the Health and Wellness Industry. The principal activity of the Company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body.

 

Agape ATP Corporation is a company that provides health solution advisory services to our clients. We primarily focus our efforts on attracting customers in Malaysia. Our advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.

 

In order to strengthen the Company’s supply chain, on May 8, 2020, the Company has successfully acquired approximately 99.99% of ASL, with the goal of securing an established network marketing sales channel that has been established in Malaysia for the past 15 years. On the same date, other than its existing network marketing sales channel, ASL itself has also commenced trading via an e-commerce platform. ASL has been offering the Company’s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy in the Company’s operation by boosting the Company’s retail and marketing capabilities. The newly acquired subsidiary allows the Company to fulfill its mission of “helping people to create health and wealth” by providing a financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle.

 

 3 

 

 

The Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, ÉNERGÉTIQUE and BEAUNIQUE.

 

The ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and distributors.

 

The ÉNERGÉTIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.

 

The BEAUNIQUE product series focuses on the research of our diet’s impact on modifying gene expressions in order to address genetic variations and deliver a nutrigenomic solution for every individual.

 

Results of Operation

 

For the three months ended June 30, 2020 and 2019

 

Revenue

 

The Company generated revenue of $1,523,862 for the three months ended June 30, 2020 as compared to $396,472 for the three months ended June 30, 2019. The revenues for the three months ended June 30, 2020, were mainly derived from the increased sale of health and wellness products as a result of the acquisition of ASL, which brought us to a large group of customers in an established network marketing sales channel that has been established in Malaysia for the past 15 years. During the three months ended June 30, 2019, we were only making sales to our related party on a wholesale basis when they placed the purchase orders.

 

Cost of Revenue

 

Cost of revenue for the three months ended June 30, 2020 amounted to $471,554 as compared to $397,172 for the three months ended June 30, 2019. The costs were predominantly cost of goods and packing materials. The cost of revenue for the current reporting period was incurred by ASL for its retail activities, while the cost of revenue for the corresponding period last year was related to wholesale business of the Company prior to the acquisition of ASL.

 

Gross Profit (Loss)

 

Gross profit for the three months ended June 30, 2020 amounted to $1,052,308 as compared to gross loss of $700 for the three months ended June 30, 2019. Gross margin for the three months ended June 30, 2020 was approximately 69.1% as compared to approximately (0.2%) for the three months ended June 30, 2019. The increase in gross profit was mainly due to the increase in revenue as a result from the acquisition of ASL, which brought us to a large group of customers in an established network marketing sales channel as compared to the three months ended June 30, 2019, which we generated lower or negative gross margins from our sales to our related party wholesales customers.

 

Operating Expenses

 

Our operating expenses consist of selling expenses, commission expenses and general and administrative expenses.

 

 4 

 

 

Selling expenses

 

Selling expenses for three months ended June 30, 2020 amounted to $108,894 as compared to $6,504 for the three months ended June 30, 2019, an increase of $102,390 or approximately 1,574.3%. The increase was mainly due to the acquisition of ASL which attributed additional selling expenses to our operations and resulted from the increase of approximately $84,000 salary and employee benefit expenses of our employees in ASL’s sales center in the three months ended June 30, 2020. As compared to the same period in 2019, we do not have any employees in our sales team. The increase was also attributable to the increase of approximately $10,000 credit card charges of processing sales transactions from our customers and the increase of other miscellaneous selling expenses of approximately $8,000.

 

Commission expenses

 

Commission expenses were $382,498 and $0 for the three months ended June 30, 2020 and 2019, respectively, an increase of $382,498 or 100.0%. The increase in commission expenses was due to the acquisition of ASL which brought us to a new marketing channel that pay commissions to distributors and members in network sales marketing.

 

General and administrative expenses

 

General and administrative (“G&A”) expenses for the three months ended June 30, 2020 amounted to $514,724, as compared to $52,734 for the three months ended June 30, 2019, an increase of $461,990 or approximately 876.1%. The increase was mainly due to the increase of professional fees of approximately $233,000 as we have recently hired new professional firms located in the U.S. and Hong Kong, including legal counsel, auditor, and financial reporting consultant, to strengthen our current Securities and Exchange Commission (“SEC”) listing reporting documents and continue to stay compliant as well as professional services incurred in relation to the acquisition of ASL during the three months ended June 30, 2020 as compared to the same period in 2019, we were using local professional firms in Malaysia. Professional fee incurred by the U.S. and Hong Kong firms are generally higher than the professional fees incurred by the Malaysia firms. The increase of G&A expenses was also attributable to the acquisition of ASL with approximately $230,000 additional general and administrative expenses to our operations, which mainly comprised of rental expenses, salary and employee benefit expenses and depreciation expenses.

 

Other Income (Expenses)

 

For the three months ended June 30, 2020, we recorded an amount of $175,115 as other income, net as compared to $388,473 other expenses, net for the three months ended June 30, 2019. The net other income of $175,115 incurred during the three months ended June 30, 2020 comprised other income of $29,911 and unrealized holding gain on marketable securities of $145,204. The net other expenses of $388,473 incurred during the three months ended June 30, 2019 comprised other expense of $21,639 and $366,834 of impairment loss in our equity investment.

 

Provision for Income Taxes

 

The Company recorded provision for income taxes of $134,067 and $0 for the three months ended June 30, 2020 and 2019, respectively. During the three months ended June 30, 2020, we generated taxable income in ASL that are subject to a unified 24% income tax rate.

 

Net Income (Loss)

 

Net income increased by $535,651 from net loss of $448,411 for the three months ended June 30, 2019 to net income of $87,240 for the three months ended June 30, 2020, mainly due to reasons as discussed above.

 

 5 

 

 

For the six months ended June 30, 2020 and 2019

 

Revenue

 

The Company generated revenue of $1,523,862 for the six months ended June 30, 2020 as compared to $860,769 for the six months ended June 30, 2019. The revenues for the six months ended June 30, 2020, were mainly derived from the increased sales of health and wellness products as a result from the acquisition of ASL, which brought us to a large group of customers in an established network marketing sales channel that has been in established in Malaysia for the past 15 years. During the six months ended June 30, 2019, we were only making sales to our related party on wholesale basis when they placed the purchase orders.

 

Cost of Revenue

 

Cost of revenue for the six months ended June 30, 2020 amounted to $471,554 as compared to $817,350 for the six months ended June 30, 2019. The costs were predominantly cost of goods purchased and packing materials. The cost of revenue for the current reporting period was incurred by ASL for its retail activities, while the cost of revenue for the corresponding period last year was related to wholesale business of the Company prior to the acquisition of ASL.

 

Gross Profit

 

Gross profit for the six months ended June 30, 2020 amounted to $1,052,308 as compared to $43,419 for the six months ended June 30, 2019. Gross margin for the six months ended June 30, 2020 was approximately 69.1% as compared to approximately 5.0% for the six months ended June 30, 2019. The increase of gross margin was mainly due to the increase of revenue and decrease in cost of revenue for the six months ended June 30, 2020 as compared to the same period in 2019 as a result from the acquisition of ASL, which brought us to a large group of customers in an established network marketing sales channel. During the six months ended June 30, 2020, we generated higher gross margins of selling our products directly to the customers in the network channel as compared to the six months ended June 30, 2019, which we generated a much lower gross margins from our sales to our related party wholesales customers.

 

Operating Expenses

 

Our operating expenses consist of selling expenses, commission expenses and general and administrative expenses.

 

Selling expenses

 

Selling expenses for six months ended June 30, 2020 amounted to $109,356 as compared to $7,846 for the six months ended June 30, 2019, an increase of $101,510 or approximately 1,293.8%. The increase was mainly due to the acquisition of ASL which attributed additional selling expenses to our operations and resulted from the increase of approximately $84,000 salary and employee benefit expenses of our employees in ASL’s sales center during the six months ended June 30, 2020. As compared to the same period in 2019, we do not have any employees in our sales team. The increase was also attributable to the increase of approximately $9,000 credit card charges of processing sales transactions from our customers and the increase of other miscellaneous selling expenses of approximately $8,000.

 

Commission expenses

 

Commission expenses were $382,498 and $0 for the six months ended June 30, 2020 and 2019, respectively, an increase of $382,498 or 100.0%. The increase in commission expenses was due to the acquisition of ASL which brought us to a new marketing channel which pays commissions to distributors and members in network sales marketing.

 

 6 

 

 

General and administrative expenses

 

General and administrative expenses for the six months ended June 30, 2020 amounted to $673,778, as compared to $83,778 for the six months ended June 30, 2019, an increase of $590,000 or approximately 704.2%. The increase was mainly due to the increase of professional fees of approximately $333,000 as we have recently hired new professional firms located in the U.S. and Hong Kong, including legal counsel, auditor, and financial reporting consultant, to strengthen our current Securities and Exchange Commission (“SEC”) listing reporting documents and to continue to stay compliant and professional services incurred in relation to the acquisition of ASL during the six months ended June 30, 2020 as compared to the same period in 2019, we were using local professional firms in Malaysia. Professional fee incurred by the U.S. and Hong Kong firms are generally higher than the professional fees incurred by the Malaysia firms. The increase of G&A expenses was also attributable to the acquisition of ASL with approximately $230,000 additional general and administrative expenses to our operations, which mainly comprised of rental expenses, salary and employee benefit expenses and depreciation expenses. In addition, the increase of G&A expenses was also due to the increase of approximately $32,000 of travelling expenses for our CEO for potential business developments.

 

Other Income (Expenses)

 

For the six months ended June 30, 2020, we recorded an amount of $102,881 as other income, net as compared to $335,956 other expenses, net for the six months ended June 30, 2019. The net other income of $102,881 incurred during the six months ended June 30, 2020 comprised other expenses of $23,785 and unrealized holding gain on marketable securities of $126,666. The net other expenses of $335,956 incurred during the six months ended June 30, 2019 comprised other income of $40,454, $26,085 on share of loss in investee company from our equity investment, $16,509 on gain on deemed disposal of shares in investee company and $366,834 of impairment loss in our equity investment.

 

Provision for (Benefit of) Income Taxes

 

The Company recorded provision for (benefit of) income taxes $134,067 and $(6,965) for the six months ended June 30, 2020 and 2019, respectively. During the six months ended June 30, 2020, we generated taxable income in ASL that are subject to a unified 24% income tax rate. On the other hand, during the six months ended March 31, 2019, we incurred taxable losses that can be carried forward for 7 years, which resulted in recognition of deferred tax assets on net operating loss and income tax benefits.

 

Net Loss

 

Net loss decreased by $232,686 from net loss of $377,196 for the six months ended June 30, 2019 to $144,510 for the six months ended June 30, 2020, mainly due to reasons as discussed above.

 

Liquidity and Capital Resources

 

On March 11, 2020, the World Health Organization or WHO declared the corona virus or COVID-19 a pandemic. In accordance with the recommendations of the WHO, Malaysia had imposed a nationwide lockdown via the government’s Movement Control Order (“MCO”) effective March 18, 2020. The MCO has resulted in quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia. On May 4, 2020, the MCO was eased to a Conditional Movement Control Order (“CMCO”) where most business sectors were allowed to operate under strict rules and Standard Operating Procedures mandated by the government of Malaysia.

 

Substantially all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact, almost all of which are beyond our control. Potential impacts include, but are not limited to, the following:

 

 7 

 

 

  temporary closure of offices, travel restrictions, financial impact of our customers or suspension supplies may negatively affected, and could continue to negatively affect, the demand for our products;
  we may have to provide significant sales incentives to our customers during the outbreak, which may in turn materially adversely affect our financial condition and operating results; and
  any disruption of our supply chain, logistics providers or customers could adversely impact our business and results of operations, including causing us or our suppliers to cease manufacturing for a period of time or materially delay delivery to our customers, which may also lead to loss of our customers.

 

Although some of the countries from which our products are sourced are experiencing lockdowns, industries involve in the provision of food especially health products and pharmaceuticals are normally exempted. We may experience slight delay in products delivery lead time but barring unforeseen circumstances, the setback should be temporary.

 

We currently operating primarily in Malaysia and anticipate expanding into the Asian markets in the future, with a particular focus, at least initially, on expanding into Thailand, Indonesia and Taiwan. We will explore expansion via e-commerce. When the pandemic has subsided or is over and restrictions on travelling between nations are uplifted, we will set up offices in the countries in which we operate to better service our customers.

 

Because of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19 cannot be reasonably estimated at this time. There is no guarantee that our total revenues will grow or remain at the similar level year over year in the last two quarters of 2020.

 

As of June 30, 2020, we had working capital of $4,314,771 consisting of cash in bank of $917,458 and time deposits of $2,483,915 as compared to working capital of $3,452,665 consisting of cash in bank of $238,937 and time deposits of $2,505,520 as of December 31, 2019. In assessing our liquidity, we monitor and analyze our cash on-hand and our operating expenditure commitments. Our liquidity needs are to meet our working capital requirements and operating expenses obligations. We believe we will have sufficient liquidity to fund our working capital needs for the next 12 months from the date of issuance of this Form 10-Q.

 

The following summarizes the key components of our cash flows for the six months ended June 30, 2020 and 2019:

 

   For the Six Months Ended 
   June 30, 2020   June 30, 2019 
       
Net cash used in operating activities  $(780,664)  $(590,473)
Net cash provided by (used in) investing activities   1,280,991    (1,500)
Net cash provided by (used in) financing activities   140,837    (4,573)
Effect of exchange rate on cash and cash equivalents   42,043    1,216 
Net change in cash and cash equivalents  $683,207   $(595,330)

 

Operating activities

 

Net cash used in operating activities for the six months ended June 30, 2020 was $780,664 and was mainly comprised of our net loss of $144,510, the non-cash income on unrealized holding gain on marketable securities of $126,667, the increase of accounts receivables, including related party, of $322,547, the decrease of customer deposits of $712,749 and the payment of operating lease liabilities of $32,253. The net cash used in operating activities was mainly offset by the non-cash depreciation expense of $17,716, amortization of operating right-of-use assets of $32,756 and deferred taxes provision of $134,067, the decrease in prepayments and deposits of $125,422, the decrease in inventories of $206,540 and the increase in other payables and accrued liabilities of $51,093.

 

 8 

 

 

Net cash used in operating activities for the six months ended June 30, 2019 was $590,473 and mainly comprised of net loss of $377,196, the non-cash expense of gain on deemed disposal of shares in Investee Company of $16,509, the increase of related party accounts receivable of $433,338, and the decrease in customer deposits of $217,743. The net cash used in operating activities was mainly offset by the non-cash expense of loss from equity investment of $26,085 and the impairment loss in equity investment of $366,834, the decrease of prepayments and deposits of $11,734, the increase in related party accounts payable of $35,145 and the increase in other payables and accrued liabilities of $23,690.

 

Investing activities

 

Net cash provided by investing activities for the six months ended June 30, 2020, were in respect of cash and cash equivalents acquired through acquisition of ASL of $1,210,818 and partial proceeds collected from the sale of our non-marketable securities of $70,173.

 

Net cash used in investing activities for the six months ended June 30, 2019 was $1,500 which was due to the investment in non-marketable securities.

 

Financing activities

 

Net cash provided by financing activities for the six months ended June 30, 2020 was $140,837 which were mainly comprised of repayments from related parties of $216,575 offset by payment of deferred offering cost of $75,738.

 

Net cash used in financing activities for the six months ended June 30, 2019 was $4,573 which were due to the repayment to a director of $5,318 offset by repayment from related parties of $745.

 

Credit Facilities

 

We do not have any credit facilities or other access to bank credit.

 

Off-Balance Sheet Arrangements

 

As of June 30, 2020, we have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our stockholders.

 

Critical Accounting Polices

 

Use of estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include allowance for doubtful accounts, allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.

 

Revenue recognition

 

On July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not result in an adjustment to retained earnings upon adoption of this new guidance as the Company’s revenue was recognized based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.

 

 9 

 

 

The core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.

 

The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.

 

The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.

 

Prior to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

 

The application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance and confirmed that there were no differences in the pattern of revenue recognition.

 

Sales of Health and Wellness products

 

- Performance obligations satisfied at a point in time

 

On July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods, which is generally similar to when its delivery has occurred prior to July 1, 2019 Such revenues are recognized at a point in time after all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.

 

The Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and wellness products transaction price upon such sales transactions occurred. The Company’s coupons have a validity period of six months. If the Company’s customers did not utilized the coupons after six months, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues.

 

Fair value of financial instruments

 

The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.

 

 10 

 

 

The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:

 

  Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
  Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.

 

Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.

 

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its unaudited condensed consolidated financial statements.

 

In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The Company does not expect the adoption of this standard to have a material impact on its unaudited condensed consolidated financial statements.

 

ITEM 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Foreign exchange risk. Substantially most of our revenues are denominated in the U.S. dollar while most of our expenses are denominated in Malaysian Ringgit and Hong Kong Dollar. We do not believe that we currently have any significant direct foreign exchange risk and have not hedged exposures denominated in foreign currencies or any other derivative financial instruments. Although in general, our exposure to foreign exchange risks should be limited, the value of an investment in our Common Stock may be affected by the foreign exchange rate between U.S. dollar and Malaysian Ringgit; and U.S. dollar and Hong Kong Dollar because the value of our business is effectively denominated in Malaysian Ringgit and Hong Kong Dollar, while the Common Stock is traded in U.S. dollars.

 

Credit risk. Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its trade receivables is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information.

 

 11 

 

 

ITEM 4 CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures:

 

We carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of June 30, 2020. This evaluation was carried out under the supervision and with the participation of our Chief Executive Officer. Based upon that evaluation, our Chief Executive Officer concluded that, as of June 30, 2020, our disclosure controls and procedures were not effective due to the presence of material weaknesses in internal control over financial reporting.

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. Management has identified the following material weaknesses which have caused management to conclude that, as of June 30, 2020, our disclosure controls and procedures were not effective:

 

(1) The Company did not have sufficient full-time personnel with appropriate levels of accounting knowledge and experience to monitor the daily recording of transactions, address complex U.S. GAAP accounting issues and to prepare and review financial statements and related disclosures under U.S. GAAP.
   
(2) Lack of a functional internal audit department or personnel that monitors the consistencies of the preventive internal control procedures; lack of adequate policies and procedures in internal audit function to ensure that the Company’s policies and procedures have been carried out as planned.
   
(3) We do not have adequate segregation of duties and effective risk assessment. Lack of segregation of duties and effective risk assessment may cause the Company to face the likelihood of fraud or theft, due to poor oversight, governance and review to detect errors.

 

Management’s Remediation Initiatives

 

In an effort to remediate the identified material weaknesses and other deficiencies and enhance our internal controls, we will prepare written policies and procedures for accounting and financial reporting with respect to the requirements and application of both U.S. GAAP and SEC guidelines, to establish a formal process to close our books monthly on an accrual basis and account for all transactions, including equity and debt transactions.

 

We plan to initiate the following series of measures to further strengthen the Company’s internal controls going forward:

 

1. We intend to engage an external consulting firm to supplement our efforts to the implementation of the 2013 Committee of Sponsoring Organizations of the Treadway Commission, or COSO, framework for internal controls.
   
2. We intend to establish an internal audit function with assessment of Sarbanes-Oxley compliance requirements and improvement of overall internal control.
   
3. Once we hire additional employees, we intend to initiate a comprehensive program and development plan to provide ongoing company-wide trainings regarding internal control, with particular emphasis on our accounting staff.

 

We anticipate that these initiatives will be at least partially, if not fully, implemented by the end of fiscal year 2020.

 

Changes in Internal Control over Financial Reporting:

 

There were no changes in our internal control over financial reporting during the quarter ended June 30, 2020, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 12 

 

 

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We know of no materials, active or pending legal proceedings against us, nor are we involved as a plaintiff in any material proceedings or pending litigation. There are no proceedings in which any of our directors, officers or affiliates, or any beneficial shareholder are an adverse party or has a material interest averse to us.

 

Item 1A. Risk Factors.

 

Risks Related to our Business

 

We are exposed to concentration risk of heavy reliance on our major supplier for the supply of our products, and any shortage of, or delay in, the supply may significantly impact on our business and results of operation.

 

For the six months ended June 30, 2020, we purchased $167,054 from one of our major suppliers, represented 100% of our total purchases. Our business, financial condition and operating results depend on the continuous supply of products from our major supplier and our continuous supplier-customer relationship with it. Our heavy reliance on our major supplier for the supply of our products will have significant impact on our business and results of operation in the event of any shortage of, or delay in the supply.

 

As is customary in distribution arrangements of this type, the distribution agreement with our major supplier is terminable by either party by giving notice. There is no assurance that our major supplier will not terminate the distribution agreement. In the event that it terminates the distribution agreement, we will have to source products from other suppliers and we may not be able to secure supply of products with quantity and quality required to support our business or at all. Such termination may therefore have a material adverse impact on our business, financial condition and operating results if we fail to engage any other suppliers before the termination.

 

There is no assurance that our major supplier will continue to supply its products in the quantities and timeframes required by us to meet the needs of our customers or comply with its supply agreement with us. Our product supply may also be disrupted by potential labor disputes, strike action, natural disasters or other accidents, epidemic and pandemic affecting the supplier. If our major supplier does not supply products to us in a timely manner or in sufficient quantities, our business, financial condition and operating results may be materially and adversely affected. Furthermore, in the event of any delay in delivery of the products to us, our cash flow or working capital may be materially and adversely affected as a result of the corresponding delay in delivery of our products to our customers, and hence the delay in our receipt of payment from our customers.

 

Our major supplier may change its existing sales or marketing strategy in respect of the products supplied to us by changing its export strategy, reducing its sales or production volume or changing its selling prices. Consequently, there is no assurance that our major supplier will not appoint other dealers or distributors which may compete with us in the market where we operate. Furthermore, any significant increase in the selling prices of the products which we source from our supplier will increase our costs and may adversely affect our profit margin if we are not able to pass the increased costs on to our customers.

 

There is no assurance that there will be no deterioration in our relationship with our major supplier which could affect our ability to secure sufficient supply of products for our business. In the event that our major supplier changes its sales or marketing strategy or otherwise appoint other dealers or distributors who may compete with us, our business, financial condition and operating results may be materially and adversely affected.

 

 13 

 

 

We could be adversely affected by a change in consumer preferences, perception and spending habits and failure to develop or enrich our product offering or gain market acceptance of our new products could have a negative effect on our business.

 

The market we operate is subject to changes in consumer preference, perception and spending habits. Our performance depends significantly on factors which may affect the level and pattern of consumer spending in the market we operate. Such factors include consumer preference, consumer confidence, consumer income and consumer perception of the safety and quality of our products. Media coverage regarding the safety or quality of, or diet or health issues relating to, our products or the raw materials, ingredients or processes involved in their manufacturing, may damage consumer confidence in our products. A general decline in the consumption of our products could occur as a result of change in consumer preference, perception and spending habits at any time.

 

Any failure to adapt our product offering to respond to such changes may result in a decrease in our sales if such changes are related to certain of our products. Any changes in consumer preference could result in lower sales of our products, put pressure on pricing or lead to increased levels of selling and promotional expenses. In any event a decrease in customer demand on our products may also result in lower sales and slow down the consumption of our inventory to a low inventory turnover level. Any of these changes could result in a material adverse effect on our business, financial conditions or results of operations.

 

The success of our products depends on a number of factors including our ability to accurately anticipate changes in market demand and consumer preferences, our ability to differentiate the quality of our products from those of our competitors, and the effectiveness of our marketing and advertising campaigns for our products. We may not be successful in identifying trends in consumer preferences and developing products that respond to such trends in a timely manner. We also may not be able to effectively promote our products by our marketing and advertising campaigns and gain market acceptance. If our products fail to gain market acceptance, are restricted by regulatory requirements, or have quality problems, we may not be able to fully recover our costs and expenses incurred in our operation, and our business prospects, financial condition or results of operations may be materially and adversely affected.

 

If we fail to maintain quality products and value, our sales are likely to be negatively affected.

 

Our success depends on the safety and quality of products that we obtain from our suppliers for our customers. Our future customers will identify our brand name with a certain level of quality and value. If we cannot meet this perceived value or level of quality, we may be negatively affected and our operating results may suffer. In addition, any failure on the part of our suppliers to maintain the quality of their products, will in turn substantially harm the results of our business operations, potentially forcing us to identify other suppliers or alter our business strategy significantly.

 

If we are unable to create brand influence, we may not be able to maintain current or attract new users and customers for our products.

 

Our operational and financial performance is highly dependent on the strength of our brand. We believe brand familiarity and preference will continue to have a significant role in winning customers as the decision to buy our products and services. In order to further expand our customer base, we may need to substantially increase our marketing expenditures to enhance brand awareness through various online and offline means. Moreover, negative coverage in the media of our company could threaten the perception of our brand, and we cannot assure you that we will be able to defuse negative press coverage about our company to the satisfaction of our investors, customers and suppliers. If we are unable to defuse negative press coverage about our company, our brand may suffer in the marketplace, our operational and financial performance may be negatively impacted and the price of our shares may decline.

 

Currently, we sell our products, with or without customization, under our brand name “ATP”, to domestic customers in Malaysia and to overseas customers. However, if our competitors initiate a lawsuit against us for infringing their trademark, we may be forced to adopt a new brand name for our products. As a result, we may incur additional marketing cost to raise awareness of such new brand name. We may also be ordered to pay a significant amount of damages, and our business, results of operations and financial condition could be materially and adversely affected.

 

 14 

 

 

We may incur losses resulting from product liability claims or product recalls.

 

We may incur losses resulting from product liability claims with respect to our products supplied by our supplier. We may face claims or liabilities which may arise if there exist any defects in quality of these products or any of these products are deemed or proven to be unsafe, defective or contaminated. In the event that the use or misuse of any product distributed by us results in personal injury or death, product liability and/or indemnity claims may be brought against us, in addition to our product recalls, and the relevant regulatory authorities in the market we operate may close down some of our related operations and take administrative actions against us. If we experience any business disruption and litigation, we may incur additional costs and have to divert our management’s attention and resources on such matters, which may adversely affect our business, financial condition and results of operations.

 

We operate in a heavily regulated industry.

 

Our business is principally regulated by various laws and regulations in the market we operate, such as in Malaysia the Food Act of 1983 (Act 281) and Regulations, Control of Drugs and Cosmetics Regulations 1984 mandate authorization from the Food Safety and and Quality Division and National Pharmaceutical Regulatory Agency of the Ministry of Health for our Company’s products to be sold in the country. Various registrations, certificates and/or licenses for the conduct of our business are required under the above laws, which also contain provisions for requirements on the storage, labelling, advertising and importation of some of our products.

 

Based on our experience, some of the laws and regulations of the place where we operate our business are subject to amendments, uncertainty in interpretation and administrative actions from time to time. Therefore, we cannot assure you that, for the implementation of our business plans and the introduction of any new product, we will be able to obtain all the necessary registrations, certificates and/or licenses. Any failure to comply with the above laws and regulations may give rise to fines, administrative penalties and/or prosecution against us, which may adversely affect our reputation, financial condition or results of operation.

 

Legal disputes or proceedings could expose us to liability, divert our management’s attention and negatively impact our reputation.

 

We may at times be involved in potential legal disputes or proceedings during the ordinary course of business operations relating to product or other types of liability, employees’ claims, labor disputes or contract disputes that could have a material and adverse effect on our reputation, operation and financial condition. If we become involved in material or protracted legal proceedings or other legal disputes in the future, the outcome of such proceedings could be uncertain and could result in settlements or outcomes which adversely affect our financial condition. In addition, any litigation or legal proceedings could incur substantial legal expenses as well as significant time and attention of our management, diverting their attention from our business and operations.

 

If we are unable to successfully develop and timely introduce new products or services or enhance existing products or services, our business, financial condition and results of operations may be materially and adversely affected.

 

We must continually source, develop and introduce new products and services as well as improve and enhance our existing products and services to maintain or increase our sales. The success of new or enhanced products or services may depend on a number of factors including, anticipating and effectively addressing user preferences and demand, the success of our sales and marketing efforts, effective forecasting and management of products and services demands, purchase commitments, and the quality of or defects in our products. The risk of not meeting our customers’ preferences and demands through our products and services may result in a shift in market shares, as customers instead choose products and services offered by our competitors. This may result in lower sales revenue, materially and adversely affecting our business, financial condition and results of operations.

 

 15 

 

 

Fluctuations in foreign currency exchange rates could have a material adverse effect on our financial results.

 

We earn revenues, pay expenses, own assets and incur liabilities in countries using currencies other than the U.S. dollar, including Australian Dollar, Malaysian Ringgit and the Hong Kong Dollar. Because our consolidated financial statements are presented in U.S. dollars, we must translate revenues, income and expenses, as well as assets and liabilities, into U.S. dollars at exchange rates in effect during or at the end of each reporting period. Therefore, increases or decreases in the value of the U.S. dollar against other currencies affect our net operating revenues, operating income and the value of balance sheet items denominated in foreign currencies. We cannot assure you that fluctuations in foreign currency exchange rates, particularly the strengthening of the U.S. dollar against major currencies would not materially affect our financial results.

 

Our business depends on the continued contributions made by Mr. How Kok Choong, as our key executive officer, the loss of who may result in a severe impediment to our business.

 

Our success is dependent upon the continued contributions made by our CEO and President, Mr. How Kok Choong. We rely on his expertise in business operations when we are developing our business. We have no “Key Man” insurance to cover the resulting losses in the event that any of our officer or directors should die or resign.

 

If Mr. How Kok Choong cannot serve the Company or is no longer willing to do so, the Company may not be able to find alternatives in a timely manner or at all. This would likely result in a severe damage to our business operations and would have an adverse material impact on our financial position and operating results. To continue as a viable operation, the Company may have to recruit and train replacement personnel at a higher cost. Additionally, if Mr. How Kok Choong joins our competitors or develops similar businesses that are in competition with our Company, our business may also be negatively impacted.

 

Our future success depends on our ability to attract and retain qualified long-term staff to fill management, technology, sales, marketing, and customer services positions. We have a great need for qualified talent, but we may not be successful in attracting, hiring, developing, and retaining the talent required for our success.

 

If we are not able to achieve our overall long-term growth objectives, the value of an investment in our Company could be negatively affected.

 

We have established and publicly announced certain long-term growth objectives. These objectives were based on, among other things, our evaluation of our growth prospects, which are generally driven by the sales potential of many product types, some of which are more profitable than others, and on an assessment of the potential price and product mix. There can be no assurance that we will realize the sales potential and the price and product mix necessary to achieve our long-term growth objectives.

 

We face risks related to health epidemics, severe weather conditions and other outbreaks.

 

In recent years, there have been outbreaks of epidemics in various countries, including Malaysia. Recently, there was an outbreak of a novel strain of coronavirus (COVID-19), which has spread rapidly to many parts of the world, including Malaysia. In March 2020, the World Health Organization declared the COVID-19 a pandemic. The epidemic has resulted in quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia for the past few weeks.

 

Substantially all of our revenues are concentrated in Malaysia. Consequently, our results of operations will likely be adversely, and may be materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact to our results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact, almost all of which are beyond our control. Potential impacts include, but are not limited to, the following:

 

  temporary closure of offices, travel restrictions, financial impact of our customers or suspension supplies may negatively affected, and could continue to negatively affect, the demand for our products;

 

 16 

 

 

  our customers may require additional time to pay us or fail to pay us at all, which could significantly increase the amount of accounts receivable and require us to record additional allowances for doubtful accounts. We may have to provide significant sales incentives to our customers during the outbreak, which may in turn materially adversely affect our financial condition and operating results;
     
  any disruption of our supply chain, logistics providers or customers could adversely impact our business and results of operations, including causing us or our suppliers to cease manufacturing for a period of time or materially delay delivery to our customers, which may also lead to loss of our customers; and
     
  the global stock markets have experienced, and may continue to experience, significant decline from the COVID-19 outbreak and the marketable securities that we have invested in could be materially adversely affected, which may lead to significant impairment in the fair values of our investments and in turn materially adversely affect our financial condition and operating results.

 

Because of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the coronavirus cannot be reasonably estimated at this time. There is no guarantee that our total revenues will grow or remain at the similar level year over year in the next two quarters of 2020. We may have to record downward adjustments or impairment in the fair value of investments in the third quarter of 2020, if conditions have not been significantly improved and global stock markets have not recovered from recent declines.

 

In general, our business could be adversely affected by the effects of epidemics, including, but not limited to, the COVID-19, avian influenza, severe acute respiratory syndrome (SARS), the influenza A virus, Ebola virus, severe weather conditions such as flood or hazardous air pollution, or other outbreaks. In response to an epidemic, severe weather conditions, or other outbreaks, government and other organizations may adopt regulations and policies that could lead to severe disruption to our daily operations, including temporary closure of our offices and other facilities. These severe conditions may cause us and/or our partners to make internal adjustments, including but

 

not limited to, temporarily closing down business, limiting business hours, and setting restrictions on travel and/or visits with clients and partners for a prolonged period of time. Various impact arising from a severe condition may cause business disruption, resulting in material, adverse impact to our financial condition and results of operations.

 

Risks Related to our Industry

 

Our business and reputation may be affected by product liability claims, litigation, customer complaints, product tampering, food safety issues, food-borne illnesses, health threats, quality control concerns or adverse publicity relating to our products. Product liability insurance of our supplier may not cover our liability sufficiently or at all.

 

Like other consumer product manufacturers, sale of our products involves an inherent risk of our products being found to be unfit for consumption or cause illness. Products may be rendered unfit for consumption due to raw materials or product contamination or degeneration, presence of microbials, illegal tampering of products by unauthorized third parties or other problems arising during the various stages of the procurement, production, transportation and storage processes. The occurrence of such problems may result in customer complaints, fines, penalties or adverse publicity causing serious damage to our reputation and brand, as well as product liability claims, other legal disputes and loss of revenues. Under certain circumstances, we may be required to recall our products. Even if a situation does not necessitate a product recall, we cannot assure you that product liability claims or other legal disputes will not be asserted against us as a result. Product liability insurance of our supplier may not cover our liability sufficiently or at all and will not cover liability that arises out of our default such as mishandling, poor storage condition and/or contamination of the products by us. As a result, a product liability or other judgment against us, or a product recall, could have a material adverse effect on our business, financial condition or results of operations.

 

 17 

 

 

Our business is susceptible to food-borne illnesses. We cannot assure you that we are able to effectively prevent all diseases or illnesses caused by our products or contamination of our products. Furthermore, our reliance on third-party product suppliers means that food-borne illness incidents could be caused by our suppliers outside of our control. New illnesses may develop in the future, or diseases with long incubation periods could arise that could give rise to claims or allegations on a retroactive basis. Reports in the media of instances of food-borne illnesses or health threats of our products or any of their major ingredients could adversely and significantly affect our sales, and have significant negative impact on our results of operations. This risk exists even if it were later determined that the illness or health threat in fact was not caused by our products.

 

In addition, adverse publicity about health and safety concerns, whether unfounded or not, may discourage consumers from buying our products. Even if a product liability claim is unsuccessful or is not fully pursued, the negative publicity surrounding any assertion that our products caused personal injury or illness could adversely affect our reputation and our corporate and brand image. If consumers were to lose confidence in our brand and reputation, we could suffer long-term or even permanent declines in our sales and results of operation. The amount of negative news, customers complaints and claims against us may also be very costly and may divert our management’s attention from our business operation.

 

Increased competition and capabilities in the marketplace could hurt our business.

 

The market where we operate is highly competitive. We compete with other companies that operate in multiple geographic areas, as well as numerous companies that are primarily regional or local in operation. Our ability to gain or maintain share of sales in the market where we operate or in various local markets may be limited as a result of actions by competitors. If we do not continue to strengthen our capabilities in marketing and innovation to maintain our brand loyalty and market share while we selectively expand into other product categories, our business could be negatively affected.

 

Risks Related to our Common Stock

 

The market price of our shares is likely to be highly volatile and subject to wide fluctuations in response to factors such as:

 

  variations in our actual and perceived operating results, especially during this time when the COVID-19 pandemic poses a threat;
     
  news regarding gains or losses of customers or suppliers by us or our competitors;
     
  news regarding gains or losses of key personnel by us or our competitors;
     
  announcements of competitive developments, acquisitions or strategic alliances in our industry by us or our competitors;
     
  changes in earnings estimates or buy/sell recommendations by financial analysts;
     
  potential litigation;
     
  the imposition of fines or penalties related to our activities in the market where we operate and failure to comply with applicable rules and regulations;
     
  general market conditions or other developments affecting us or our industry; and
     
  the operating and stock price performance of other companies, other industries and other events or factors beyond our control.

 

In addition, the securities markets have from time to time experienced significant price and volume fluctuations that are not related to the operating performance of particular companies. These market fluctuations may also materially and adversely affect the market price of the shares.

 

 18 

 

 

We may never be able to pay dividends and are unlikely to do so.

 

To date, we have not paid, nor do we intend to pay in the foreseeable future, dividends on our common stock, even if we become profitable. Earnings, if any, are expected to be used to advance our activities and for working capital and general corporate purposes, rather than to make distributions to stockholders. Since we are not in a financial position to pay dividends on our common stock and future dividends are not presently being contemplated, investors are advised that return on investment in our common stock is restricted to an appreciation in the share price. The potential or likelihood of an increase in share price is uncertain.

 

In addition, under Nevada law, we may only pay dividends subject to our ability to service our debts as they become due and provided that our assets will exceed our liabilities after the dividend. Our ability to pay dividends will therefore depend on our ability to generate sufficient profits.

 

Shareholders may be diluted significantly through our efforts to obtain financing and satisfy obligations through the issuance of securities.

 

Wherever possible, our board of directors will attempt to use non-cash consideration to satisfy obligations. In many instances, we believe that the non-cash consideration will consist of shares of our common stock, warrants to purchase shares of our common stock or other securities. Our board of directors has authority, without action or vote of the shareholders, to issue all or part of the authorized but unissued shares of common stock or warrants to purchase such shares of common stock. In addition, we may attempt to raise capital by selling shares of our common stock, possibly at a discount to market in the future. These actions will result in dilution of the ownership interests of existing shareholders and may further dilute common stock book value, and that dilution may be material. Such issuances may also serve to enhance existing management’s ability to maintain control of us, because the shares may be issued to parties or entities committed to supporting existing management.

 

 19 

 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information.

 

None.

 

 20 

 

 

ITEM 6. Exhibits

 

Exhibit No.   Description
     
31.1   Rule 13(a)-14(a)/15(d)-14(a) Certification of principal executive officer*
     
32.1   Section 1350 Certification of principal executive officer *
     
101.INS   XBRL Instance Document*
     
101.SCH   XBRL Schema Document*
     
101.CAL   XBRL Calculation Linkbase Document*
     
101.DEF   XBRL Definition Linkbase Document*
     
101.LAB   XBRL Label Linkbase Document*
     
101.PRE   XBRL Presentation Linkbase Document*

 

* Filed herewith.

 

 21 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  AGAPE ATP CORPORATION
  (Name of Registrant)
     
Date: August 13, 2020    
  By: /s/ How Kok Choong
  Title:

Chief Executive Officer,

President, Director, Secretary and Treasurer

    (Principal Executive Officer)

 

 22 

 

EX-31.1 2 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATION

 

I, HOW KOK CHOONG, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q of Agape ATP Corporation (the “Company”) for the quarter ended June 30, 2020;

 

2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
     
  b. Designed such internal control over financial reporting, or caused such internal control to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.
     
  c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 13, 2020 By: /s/ How Kok Choong
    HOW KOK CHOONG
   

Chief Executive Officer,

President, Director, Secretary, Treasurer

    (Principal Executive Officer)

 

 

 

EX-32.1 3 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Agape ATP Corporation (the “Company”) on Form 10-Q for the quarter ended June 30, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), The undersigned hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Date: August 13, 2020 By: /s/ How Kok Choong
    HOW KOK CHOONG
    Chief Executive Officer, President, Director
    (Principal Executive Officer)

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

EX-101.SCH 4 aatp-20200630.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - VARIABLE INTEREST ENTITY (“VIE”) link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - BUSNINESS COMBINATION link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - CASH AND CASH EQUIVALENTS link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE – RELATED PARTY link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - PREPAYMENTS AND DEPOSITS link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - PROPERTY AND EQUIPMENT, NET link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - INTANGIBLE ASSETS, NET link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - CONCENTRATIONS OF RISKS link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - VARIABLE INTEREST ENTITY (“VIE”) (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - BUSNINESS COMBINATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE – RELATED PARTY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - INTANGIBLE ASSETS, NET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Schedule of Subsidiaries and Associates (Details) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - SCHEDULE OF DISAGGREGATED INFORMATION OF REVENUES (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - VARIABLE INTEREST ENTITY (“VIE”) (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - Summary of Assets Acquired and Liabilities Assumed (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - Schedule of Pro Forma Busniness Combination (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - BUSNINESS COMBINATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - Schedule of Accounts Receivables - Related Party (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - Schedule of Inventories (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - Schedule of Prepaid Expenses and Deposits (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - Schedule of Property and Equipment. Net (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - Schedule of Intangible Assets, Net (Details) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - SCHEDULE OF RELATED PARTIES RELATIONSHIPS (Details) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAX (Details) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - SCHEDULE OF FUTURE MINIMUM OPERATING LEASE LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - SCHEDULE OF FUTURE MINIMUM PURCHASE COMMITMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000075 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 5 aatp-20200630_cal.xml XBRL CALCULATION FILE EX-101.DEF 6 aatp-20200630_def.xml XBRL DEFINITION FILE EX-101.LAB 7 aatp-20200630_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] AOCI Attributable to Parent [Member] Consolidated Entities [Axis] Agape ATP International Holding Limited [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Share Exchange Agreement [Member] Title of Individual [Axis] Mr. How Kok Choong [Member] Subsidiary Company Two [Member] Subsidiary Company [Member] Subsidiary Company One [Member] Subsidiary Company Three [Member] Long-Lived Tangible Asset [Axis] Computer and Office Equipment [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Furniture and Fixtures [Member] Leasehold Improvements [Member] Vehicles [Member] Finite-Lived Intangible Assets by Major Class [Axis] Computer Software, Intangible Asset [Member] Product and Service [Axis] Health And Wellness Products [Member] Ionized Cal-Mag [Member] Omega Blend [Member] Young Formula [Member] Organic Youth Care Cleansing Bar [Member] Trim+ [Member] Lipomask [Member] Beta Maxx [Member] Energized Mineral Concentrate [Member] Survivor Select [Member] Vege-Fruit Fiber [Member] Mitogize [Member] Hyaluronic Acid Serum [Member] Mousse Facial Cleanser [Member] Shipping and Handling [Member] Legal Entity [Axis] Social Security Organization [Member] Award Type [Axis] MYR Currency [Member] Employees Provident Fund [Member] Employment Insurance System [Member] Human Resource Development Fund [Member] Variable Rate [Axis] Period-end MYR [Member] Period-end HKD [Member] Period-average MYR [Member] HKD Currency [Member] Period-average HKD [Member] Trading Activity [Axis] Variable Income Interest Rate [Member] Related Party [Axis] Agape Superior Living Sdn Bhd [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Machinery and Equipment [Member] Greenpro Capital Corp. [Member] Director [Member] Unreserved Sdn Bhd [Member] Phoenix Plus Corporation [Member] Directors of Unreserved Investments [Member] SEA [Member] Agape Superior Living Pty Ltd ASLPL [Member] Agape A T P Asia Limited A A T P Asia [Member] Redboy Picture Sdn Bhd Redboy [Member] Agape Superior Living Pty Ltd A S L P L One [Member] Business Acquisition [Axis] ASL [Member] Geographical [Axis] MALAYSIA HONG KONG UNITED STATES Scenario [Axis] If Unutilized [Member] Labuan [Member] Customer [Axis] No Customer [Member] Concentration Risk Benchmark [Axis] Revenue from Contract with Customer Benchmark [Member] One Customer [Member] Accounts Receivable [Member] E-commerce [Member] Vendor One [Member] Vendor Two [Member] One Vendor [Member] Extinguishment of Debt [Axis] Accounts Payable [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS CURRENT ASSETS Cash and cash equivalents (Included $18,680 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of June 30, 2020) Accounts receivable Accounts receivable – related party Amount due from related parties Inventories Prepaid taxes (Included $3,113 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of June 30, 2020) Prepayments and deposits (Included $8,399 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of June 30, 2020) Prepayments and deposits – related party Total Current Assets OTHER ASSETS Property and equipment, net Intangible assets, net Operating right-of-use assets Investment in marketable securities Investment in non-marketable securities Deferred offering costs Deferred tax assets, net Total Other Assets TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ EQUITY CURRENT LIABILITIES Accounts payable Customer deposits Operating lease liabilities - current Other payables and accrued liabilities ($2,741 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of June 30, 2020) Amount due to a related party Total Current Liabilities OTHER LIABILITIES Operating lease liabilities – non-current TOTAL LIABILITIES STOCKHOLDERS’ EQUITY Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding Common stock, par value $0.0001; 1,000,000,000 shares authorized, 376,438,194 and 376,275,500 issued and outstanding as of June 30, 2020 and December 31, 2019, respectively Additional paid in capital Accumulated deficit Accumulated other comprehensive income TOTAL STOCKHOLDERS’ EQUITY TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY VIE consolidated amount of cash and cash equivalents VIE consolidated amount of prepaid taxes VIE consolidated amount of prepayments and deposits VIE consolidated amount of other payables and accrued liabilities Preferred stock, par value Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] REVENUE REVENUE – RELATED PARTY TOTAL REVENUE COST OF REVENUE GROSS PROFIT (LOSS) SELLING COMMISSION GENERAL AND ADMINISTRATIVE TOTAL OPERATING EXPENSES INCOME (LOSS) FROM OPERATIONS OTHER INCOME (EXPENSES) Other income (expenses), net Loss from equity investment Unrealized holding gain on marketable securities Gain on deemed disposal of shares in Investee Company Impairment loss in equity investment TOTAL OTHER INCOME (EXPENSES), NET INCOME (LOSS) BEFORE INCOME TAXES (PROVISION FOR) BENEFIT OF INCOME TAXES NET INCOME (LOSS) OTHER COMPREHENSIVE INCOME Foreign currency translation adjustment COMPREHENSIVE INCOME (LOSS) EARNINGS (LOSS) PER SHARE Basic and diluted WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING Basic and diluted Statement [Table] Statement [Line Items] Beginning balance, value Beginning balance, shares Net income Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd, shares Foreign currency translation adjustment Ending balance, value Ending balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Amortization Amortization of operating right-of-use assets Loss from equity investment Unrealized holding gain on marketable securities Gain on deemed disposal of shares in investee company Impairment loss in equity investment Deferred tax expenses Changes in operating assets and liabilities: Accounts receivables Accounts receivables – related party Amount due from a related party Inventories Prepaid taxes Prepayments and deposits Prepayments and deposits – related party Accounts payable Accounts payable – related party Customer deposits Income taxes payable Other payables and accrued liabilities Operating lease liabilities Net cash used in operating activities CASH FLOWS FROM INVESTING ACTIVITIES: Cash and cash equivalent acquired through acquisition of Agape Superior Living Sdn Bhd Proceeds from sale of non-marketable securities to a related party Investment in non-marketable securities Net cash provided by (used in) investing activities CASH FLOWS FROM FINANCING ACTIVITIES: Deferred offering costs Repayments from related parties Amount due to a related party Net cash provided by (used in) financing activities EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, beginning of period CASH AND CASH EQUIVALENTS, end of period SUPPLEMENTAL CASH FLOWS INFORMATION Income taxes paid Interest paid SUPPLEMENTAL NON-CASH FLOWS INFORMATION Amount transferred from investment in investee company to investment in non-marketable securities Initial recognition of right-of-use assets and lease liabilities Sale of non-marketable securities to a related party in exchange for ASL Issuance of common stock in exchange for acquisition payment of ASL Unpaid balance due to a related party in connection with acquisition payment of ASL Unpaid accrued liabilities on deferred offering costs Accounting Policies [Abstract] ORGANIZATION AND BUSINESS BACKGROUND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization, Consolidation and Presentation of Financial Statements [Abstract] VARIABLE INTEREST ENTITY (“VIE”) Business Combinations [Abstract] BUSNINESS COMBINATION Cash and Cash Equivalents [Abstract] CASH AND CASH EQUIVALENTS Receivables [Abstract] ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE – RELATED PARTY Inventory Disclosure [Abstract] INVENTORIES Prepayments And Deposits PREPAYMENTS AND DEPOSITS Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT, NET Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS, NET Investment In Marketable Securities INVESTMENT IN MARKETABLE SECURITIES Investment In Non-marketable Securities INVESTMENT IN NON-MARKETABLE SECURITIES Other Liabilities Disclosure [Abstract] OTHER PAYABLES AND ACCRUED LIABILITIES Related Party Transactions [Abstract] RELATED PARTY BALANCES AND TRANSACTIONS Equity [Abstract] STOCKHOLDERS’ EQUITY Income Tax Disclosure [Abstract] INCOME TAXES Risks and Uncertainties [Abstract] CONCENTRATIONS OF RISKS Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Basis of presentation Principles of consolidation Use of estimates Cash and cash equivalents Accounts receivable and accounts receivable – related party Inventories Prepaid taxes Prepayments and deposits Property and equipment, net Intangible assets, net Impairment for long-lived assets Deferred offering costs Investment in marketable equity securities Investment in non-marketable equity securities Customer deposits Revenue recognition Cost of revenue Shipping and handling Advertising costs Commission expenses Defined contribution plan Income taxes Comprehensive income (loss) Non-controlling interest Earnings (loss) per share Foreign currencies translation and transaction Related parties Fair value of financial instruments Leases Recent accounting pronouncements Reclassification Schedule of Subsidiaries and Associates SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET SCHEDULE OF DISAGGREGATED INFORMATION OF REVENUES SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES SCHEDULE OF VARIABLE INTEREST ENTITY Summary of Assets Acquired and Liabilities Assumed Schedule of Pro Forma Busniness Combination Schedule of Accounts Receivables - Related Party Schedule of Inventories Schedule of Prepaid Expenses and Deposits Schedule of Property and Equipment. Net Schedule of Intangible Assets, Net SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES SCHEDULE OF RELATED PARTIES RELATIONSHIPS SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX SCHEDULE OF PROVISION FOR INCOME TAX SCHEDULE OF DEFERRED TAX ASSETS SCHEDULE OF FUTURE MINIMUM OPERATING LEASE LIABILITIES SCHEDULE OF FUTURE MINIMUM PURCHASE COMMITMENT Condensed Cash Flow Statements, Captions [Line Items] Subsidiary company name Place and date of incorporation Particulars of issued capital Principal activities Proportional of ownership interest and voting power held Ownership interest percentage Stock issued during period acquisitions, shares Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Estimated Useful Life of Property and Equipment Estimated Useful Lives of Property and Equipment Schedule of Finite-Lived Intangible Assets [Table] Acquired Finite-Lived Intangible Assets [Line Items] Estimated useful lives of intangible assets Schedule of Product Information [Table] Product Information [Line Items] Total revenues Schedule of Long-term Debt Instruments [Table] Derivative [Line Items] Foreign Currency Exchange Rate, Translation Exchange rate Foreign currency exchange rate period average Accounts Receivable, Allowance for Credit Loss Allowance for doubtful accounts Impairment of long-lived assets Forfeited coupon income Revenue Selling expenses Advertising costs Commission expenses Defined contribution plan expense Salary percentage Monthly salary Income tax examination, likelihood of unfavorable settlement Penalties and interest incurred Noncontrolling interest, description Non-controlling interest Potentially dilutive securities outstanding Trading Activities, Gain and Losses, by Type, by Income Statement Location [Table] Trading Activity, Gains and Losses, Net [Line Items] Total current assets Current liabilities Net assets Cash and cash equivalents Accounts receivable - intercompany Prepaid taxes Prepayments and Deposits Accounts payable &nbsp intercompany Other payables and accrued liabilities Other payables &nbsp intercompany Total current liabilities Gross profit Loss from operations ASSETS Current assets Cash Other receivables Other receivables - related parties Inventories Prepaid taxes Prepayments and other assets Total current assets Other assets Property and equipment, net Intangible assets, net Deferred taxes asset, net Total other assets Total assets LIABILITIES AND SHAREHOLDERS’ EQUITY Current liabilities Accounts payable - related party Customer deposits Other payables and accrued liabilities Total current liabilities Total liabilities Total net assets acquired Revenue Cost of revenue Gross profit Total operating expenses Income (loss) from operations Other income (expense), net Income (loss) before income taxes Benefit of (Provision for) income taxes Net income (loss) Net income (loss) per common share - basic and diluted Weighted average number of common shares outstanding - basic and diluted Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Ordinary shares no par value Purchase consideration value Loan payable Common stock par value Percentage of common stock issued and outstanding Stock issued during period, value, acquisitions Purchased price per shares Issuance of common stock shares SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items] Cash in bank Time deposits Percentage of Interest rate for time deposits Accounts receivable Allowance for doubtful accounts Total accounts receivable and accounts receivable – related party Finished goods Schedule Of Prepaid Expenses And Deposits Prepaid expenses Receivables from sales distributors Deposits to suppliers Total prepaid expenses and deposits Subtotal Less: accumulated depreciation Total Depreciation expense Computer software Less: accumulated amortization Total Amortization expense Schedule Of Investment In Marketable Securities Cost of investment Unrealized holding gain (loss) Exchange rate effect Investment in marketable securities Entity Listings [Line Items] Investment in securities, shares Investment amount Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items] Investment in non-marketable securities Less: Sale of investment in non-marketable securities Investment in non-marketable securities Total investment in non-marketable securities Equity interest percentage Ordinary shares authorized Proceeds from investments Amount due from director Shares purchased during period Share purchased price per share Accrued professional fees Accrued promotion expenses Accrued payroll Others Total other payables and accrued liabilities Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Related parties relationship, description Related parties nature, description Accounts Receivable - related party Prepayments and Deposits - related party Amount due to a Related Party Issuance of common stock in acquisition, shares Issuance of common stock in acquisition, value shares issued price per share Revenue Schedule of Restructuring and Related Costs [Table] Acquired Indefinite-lived Intangible Assets [Line Items] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Business acquisition percentage of voting interests Non controlling interests SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] Local Foreign Loss before income tax - Local - Foreign - Local - Foreign (Provision for) benefit of income taxes Net operating loss carry forwards Less: valuation allowance Depreciation Deferred tax assets, net Cumulative net operating loss Operating loss carryforwards expire year, description Valuation allowance Tax percentage Statutory income tax rate Income tax examination, description Concentration Risk [Table] Concentration Risk [Line Items] Concentrations of risk percentage Commission expense, percentage Deposit for insurance 2021 2022 2023 2024 Total lease payments Less: interest Present value of lease liabilities 2021 2022 2023 2024 2025 Thereafter Total minimum purchase commitments required Operating lease liability Operating lease effective interest rate Operating lease, weighted average remaining lease term Operating lease payments Operating lease, rent expenses Prepayments and deposits – related party. Investment in non-marketable securities. Customer deposits. VIE consolidated amount of cash and cash equivalents. VIE consolidated amount of Prepaid taxes . VIE consolidated amount of prepayments and deposits. VIE consolidated amount of other payables and accrued liabilities. Impairment loss in equity investment. Increase decrease in prepayments and deposits – related party. Proceeds from sale of non-marketable securities to a related party. Investment in non-marketable securities. Amount transferred from investment in investee company to investment in non-marketable securities. Initial recognition of right-of-use assets and lease liabilities. Sale of non-marketable securities to a related party in exchange for ASL. Issuance of common stock in exchange for acquisition payment of ASL. Unpaid balance due to a related party in connection with acquisition payment of ASL. Unpaid accrued liabilities on deferred offering costs. Share Exchange Agreement [Member] Mr. How Kok Choong [Member] Agape ATP International Holding Limited [Member] Subsidiary Company Two [Member] Name of the company name. Subsidiary Company One [Member] Subsidiary Company Three [Member] Subsidiary Company [Member] Place and date of incorporation. Particulars of issued capital. Principal activities. Agape Superior Living Sdn Bhd [Member] Schedule of Prepaid Expenses and Deposits [Table Text Block] Deposits to supplier. Investment in Marketable Securities [Text Block] Receivables from sales distributors. Schedule of Estimated Useful Lives of Property and Equipment [Table Text Block] Schedule of Estimated Useful Lives of Intangible Assets, Net [Table Text Block] Forfeited coupon income. Health And Wellness Products [Member] Salary percentage. Social Security Organization [Member] Monthly salary. Employees Provident Fund [Member] Employment Insurance System [Member] Human Resource Development Fund [Member] Prepaid Taxes [Policy Text Block] Prepayments and deposits [Policy Text Block] Deferred offering costs [Policy Text Block] Investment in non-marketable securities [Policy Text Block] Customer Deposits [Policy Text Block] Shipping and handling [Policy Text Block] Defined Contribution Plan [Policy Text Block] Non-controlling Interest [Policy Text Block] Related Parties [Policy Text Block] Ionized Cal-Mag [Member] Omega Blend [Member] Young Formula [Member] Trim+ [Member] Organic Youth Care Cleansing Bar [Member] Lipomask [Member] Beta Maxx [Member] Energized Mineral Concentrate [Member] Survivor Select [Member] Vege-Fruit Fiber [Member] Mitogize [Member] Hyaluronic Acid Serum [Member] Mousse Facial Cleanser [Member] Period-end MYR [Member] Period-end HKD [Member] Foreign currency exchange rate period average. Period-average MYR [Member] Period-average HKD [Member] Other payables - related party. MYR Currency [Member] HKD Currency [Member] Accounts receivable and accounts receivable related parties. Greenpro Capital Corp. [Member] Unrealized holding loss. Exchange rate effect. Investment In Non- Marketable Securities [Text Block] Tabular disclosure of Non-marketable securities. RM Currency [Member] Unreserved Sdn Bhd [Member] Phoenix Plus Corporation [Member] Investment in non-marketable securities. Directors of Unreserved Investments [Member] Sale of investment in non-marketable securities. Investment in non-marketable securities, net. Schedule of Other Payables and Accrued Liabilities [Table Text Block] Accrued promotion expenses. Schedule Of Related Parties Relationships [Table Text Block] Related parties, relationships, description. SEA [Member] Related parties nature, description. Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. Revenues from related party. ASL [Member] If Unutilized [Member] Operating loss carryforwards expire year. Labuan [Member] Deferred Tax Assets,Depreciation, One Customer [Member] Vendor One [Member] Vendor Two [Member] One Vendor [Member] Commission expense, percentage. Deposit for insurance. Schedule Of Future Minimum Purchase Commitments [Table Text Block] Operating Lease effective interest rate. Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller). Amount of unrealized gain (loss) on investment in marketable security. Computer and Office Equipment [Member] Percentage of common stock issued and outstanding. Agape Superior Living Pty Ltd ASLPL [Member] Unrecognized tax expense benefits. Operating loss carryforwards expire year, description. Allowance for doubtful accounts, Proceeds from deferred offering costs Amount due to a related party. Repayments from related parties. No Customer [Member]. E-commerce [Member]. Other Assets Liabilities Stockholders' Equity Attributable to Parent Liabilities and Equity Cost of Goods and Services Sold Sales Commissions and Fees General and Administrative Expense Operating Expenses Nonoperating Income (Expense) Income Tax Expense (Benefit) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Weighted Average Number of Shares Outstanding, Basic and Diluted Shares, Outstanding Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax MarketableSecuritiesUnrealizedGainLoss1 Increase (Decrease) in Accounts Receivable Increase (Decrease) in Accounts Receivable, Related Parties Increase (Decrease) in Due from Related Parties, Current Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Taxes Increase (Decrease) in Prepaid Expense IncreaseDecreasePrepaymentsAndDepositsRelatedParty Increase (Decrease) in Accounts Payable Increase (Decrease) in Contract with Customer, Liability Net Cash Provided by (Used in) Operating Activities PaymentsToAcquireNonMarketableSecurities Net Cash Provided by (Used in) Investing Activities ProceedsFromDeferredOfferingCosts Repayments from related parties Amount due to a related party [Default Label] Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Stockholders' Equity Note Disclosure [Text Block] Inventory, Policy [Policy Text Block] Property, Plant and Equipment, Policy [Policy Text Block] Intangible Assets, Finite-Lived, Policy [Policy Text Block] Deferred offering costs [Policy Text Block] Customer Deposits [Policy Text Block] Advertising Expense Commission expenses [Default Label] Stockholders' Equity Attributable to Noncontrolling Interest Accounts Payable and Other Accrued Liabilities, Current Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net BusinessAcquisitionsProFormaCostOfRevenue BusinessAcquisitionsProFormaGrossProfit Accounts Receivable, before Allowance for Credit Loss, Current Accounts Receivable, Allowance for Credit Loss, Current Accounts receivable and accounts receivable related parties Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Finite-Lived Intangible Assets, Net Investment in non-marketable securities [Default Label] Investment in non-marketable securities, net RevenuesFromRelatedParty Deferred State and Local Income Tax Expense (Benefit) Deferred Foreign Income Tax Expense (Benefit) Other Income Tax Expense (Benefit), Continuing Operations Deferred Tax Assets, Valuation Allowance, Current DeferredTaxAssetsDepreciation Deferred Tax Assets, Net of Valuation Allowance Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Purchase Obligation, to be Paid, Year One Purchase Obligation, to be Paid, Year Two Purchase Obligation, to be Paid, Year Three Purchase Obligation, to be Paid, Year Four Purchase Obligation EX-101.PRE 8 aatp-20200630_pre.xml XBRL PRESENTATION FILE XML 9 form10-q_htm.xml IDEA: XBRL DOCUMENT 0001713210 2020-01-01 2020-06-30 0001713210 2020-08-10 0001713210 2020-06-30 0001713210 2019-12-31 0001713210 2020-04-01 2020-06-30 0001713210 2019-04-01 2019-06-30 0001713210 2019-01-01 2019-06-30 0001713210 us-gaap:CommonStockMember 2018-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001713210 us-gaap:RetainedEarningsMember 2018-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001713210 2018-12-31 0001713210 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001713210 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0001713210 2019-01-01 2019-03-31 0001713210 us-gaap:CommonStockMember 2019-03-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001713210 us-gaap:RetainedEarningsMember 2019-03-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0001713210 2019-03-31 0001713210 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001713210 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0001713210 us-gaap:CommonStockMember 2019-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001713210 us-gaap:RetainedEarningsMember 2019-06-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0001713210 2019-06-30 0001713210 us-gaap:CommonStockMember 2019-12-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001713210 us-gaap:RetainedEarningsMember 2019-12-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001713210 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001713210 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0001713210 2020-01-01 2020-03-31 0001713210 us-gaap:CommonStockMember 2020-03-31 0001713210 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001713210 us-gaap:RetainedEarningsMember 2020-03-31 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001713210 2020-03-31 0001713210 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001713210 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2020-06-30 0001713210 us-gaap:CommonStockMember 2020-06-30 0001713210 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001713210 us-gaap:RetainedEarningsMember 2020-06-30 0001713210 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001713210 AATP:AgapeATPInternationalHoldingLimitedMember 2020-06-30 0001713210 AATP:MrHowKokChoongMember AATP:ShareExchangeAgreementMember 2020-05-07 2020-05-08 0001713210 AATP:SubsidiaryCompanyTwoMember 2020-06-30 0001713210 AATP:SubsidiaryCompanyMember 2020-01-01 2020-06-30 0001713210 AATP:SubsidiaryCompanyMember 2020-06-30 0001713210 AATP:SubsidiaryCompanyOneMember 2020-01-01 2020-06-30 0001713210 AATP:SubsidiaryCompanyOneMember 2020-06-30 0001713210 AATP:SubsidiaryCompanyTwoMember 2020-01-01 2020-06-30 0001713210 AATP:SubsidiaryCompanyThreeMember 2020-01-01 2020-06-30 0001713210 AATP:MrHowKokChoongMember AATP:ShareExchangeAgreementMember 2020-05-08 0001713210 srt:MinimumMember AATP:ComputerAndOfficeEquipmentMember 2020-01-01 2020-06-30 0001713210 srt:MaximumMember AATP:ComputerAndOfficeEquipmentMember 2020-01-01 2020-06-30 0001713210 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2020-01-01 2020-06-30 0001713210 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2020-01-01 2020-06-30 0001713210 us-gaap:LeaseholdImprovementsMember 2020-01-01 2020-06-30 0001713210 us-gaap:VehiclesMember 2020-01-01 2020-06-30 0001713210 us-gaap:ComputerSoftwareIntangibleAssetMember 2020-01-01 2020-06-30 0001713210 2019-01-01 2019-12-31 0001713210 AATP:HealthAndWellnessProductsMember 2020-01-01 2020-06-30 0001713210 AATP:IonizedCalMagMember 2020-04-01 2020-06-30 0001713210 AATP:IonizedCalMagMember 2019-04-01 2019-06-30 0001713210 AATP:IonizedCalMagMember 2020-01-01 2020-06-30 0001713210 AATP:IonizedCalMagMember 2019-01-01 2019-06-30 0001713210 AATP:OmegaBlendMember 2020-04-01 2020-06-30 0001713210 AATP:OmegaBlendMember 2019-04-01 2019-06-30 0001713210 AATP:OmegaBlendMember 2020-01-01 2020-06-30 0001713210 AATP:OmegaBlendMember 2019-01-01 2019-06-30 0001713210 AATP:YoungFormulaMember 2020-04-01 2020-06-30 0001713210 AATP:YoungFormulaMember 2019-04-01 2019-06-30 0001713210 AATP:YoungFormulaMember 2020-01-01 2020-06-30 0001713210 AATP:YoungFormulaMember 2019-01-01 2019-06-30 0001713210 AATP:OrganicYouthCareCleansingBarMember 2020-04-01 2020-06-30 0001713210 AATP:OrganicYouthCareCleansingBarMember 2019-04-01 2019-06-30 0001713210 AATP:OrganicYouthCareCleansingBarMember 2020-01-01 2020-06-30 0001713210 AATP:OrganicYouthCareCleansingBarMember 2019-01-01 2019-06-30 0001713210 AATP:TrimPlusMember 2020-04-01 2020-06-30 0001713210 AATP:TrimPlusMember 2019-04-01 2019-06-30 0001713210 AATP:TrimPlusMember 2020-01-01 2020-06-30 0001713210 AATP:TrimPlusMember 2019-01-01 2019-06-30 0001713210 AATP:LipomaskMember 2020-04-01 2020-06-30 0001713210 AATP:LipomaskMember 2019-04-01 2019-06-30 0001713210 AATP:LipomaskMember 2020-01-01 2020-06-30 0001713210 AATP:LipomaskMember 2019-01-01 2019-06-30 0001713210 AATP:BetaMaxxmMember 2020-04-01 2020-06-30 0001713210 AATP:BetaMaxxmMember 2019-04-01 2019-06-30 0001713210 AATP:BetaMaxxmMember 2020-01-01 2020-06-30 0001713210 AATP:BetaMaxxmMember 2019-01-01 2019-06-30 0001713210 AATP:EnergizedMineralConcentrateMember 2020-04-01 2020-06-30 0001713210 AATP:EnergizedMineralConcentrateMember 2019-04-01 2019-06-30 0001713210 AATP:EnergizedMineralConcentrateMember 2020-01-01 2020-06-30 0001713210 AATP:EnergizedMineralConcentrateMember 2019-01-01 2019-06-30 0001713210 AATP:SurvivorSelectMember 2020-04-01 2020-06-30 0001713210 AATP:SurvivorSelectMember 2019-04-01 2019-06-30 0001713210 AATP:SurvivorSelectMember 2020-01-01 2020-06-30 0001713210 AATP:SurvivorSelectMember 2019-01-01 2019-06-30 0001713210 AATP:VegeFruitFiberMember 2020-04-01 2020-06-30 0001713210 AATP:VegeFruitFiberMember 2019-04-01 2019-06-30 0001713210 AATP:VegeFruitFiberMember 2020-01-01 2020-06-30 0001713210 AATP:VegeFruitFiberMember 2019-01-01 2019-06-30 0001713210 AATP:MitogizeMember 2020-04-01 2020-06-30 0001713210 AATP:MitogizeMember 2019-04-01 2019-06-30 0001713210 AATP:MitogizeMember 2020-01-01 2020-06-30 0001713210 AATP:MitogizeMember 2019-01-01 2019-06-30 0001713210 AATP:HyaluronicAcidSerumMember 2020-04-01 2020-06-30 0001713210 AATP:HyaluronicAcidSerumMember 2019-04-01 2019-06-30 0001713210 AATP:HyaluronicAcidSerumMember 2020-01-01 2020-06-30 0001713210 AATP:HyaluronicAcidSerumMember 2019-01-01 2019-06-30 0001713210 AATP:MousseFacialCleanserMember 2020-04-01 2020-06-30 0001713210 AATP:MousseFacialCleanserMember 2019-04-01 2019-06-30 0001713210 AATP:MousseFacialCleanserMember 2020-01-01 2020-06-30 0001713210 AATP:MousseFacialCleanserMember 2019-01-01 2019-06-30 0001713210 us-gaap:ShippingAndHandlingMember 2020-04-01 2020-06-30 0001713210 us-gaap:ShippingAndHandlingMember 2019-04-01 2019-06-30 0001713210 us-gaap:ShippingAndHandlingMember 2020-01-01 2020-06-30 0001713210 us-gaap:ShippingAndHandlingMember 2019-01-01 2019-06-30 0001713210 AATP:SocialSecurityOrganizationMember 2020-01-01 2020-06-30 0001713210 AATP:MYRCurrencyMember AATP:SocialSecurityOrganizationMember 2020-01-01 2020-06-30 0001713210 AATP:EmployeesProvidentFundMember 2020-01-01 2020-06-30 0001713210 AATP:EmploymentInsuranceSystemMember 2020-01-01 2020-06-30 0001713210 AATP:MYRCurrencyMember AATP:EmploymentInsuranceSystemMember 2020-01-01 2020-06-30 0001713210 AATP:HumanResourceDevelopmentFundMember 2020-01-01 2020-06-30 0001713210 AATP:PeriodEndMYRMember 2020-06-30 0001713210 AATP:PeriodEndMYRMember 2019-12-31 0001713210 AATP:PeriodEndHKDMember 2020-06-30 0001713210 AATP:PeriodEndHKDMember 2019-12-31 0001713210 AATP:MYRCurrencyMember 2020-04-01 2020-06-30 0001713210 AATP:MYRCurrencyMember 2019-04-01 2019-06-30 0001713210 AATP:MYRCurrencyMember 2020-01-01 2020-06-30 0001713210 AATP:MYRCurrencyMember 2019-01-01 2019-06-30 0001713210 AATP:PeriodAverageMYRMember 2020-04-01 2020-06-30 0001713210 AATP:PeriodAverageMYRMember 2019-04-01 2019-06-30 0001713210 AATP:PeriodAverageMYRMember 2020-01-01 2020-06-30 0001713210 AATP:PeriodAverageMYRMember 2019-01-01 2019-06-30 0001713210 AATP:HKDCurrencyMember 2020-04-01 2020-06-30 0001713210 AATP:HKDCurrencyMember 2019-04-01 2019-06-30 0001713210 AATP:HKDCurrencyMember 2020-01-01 2020-06-30 0001713210 AATP:HKDCurrencyMember 2019-01-01 2019-06-30 0001713210 AATP:PeriodAverageHKDMember 2020-04-01 2020-06-30 0001713210 AATP:PeriodAverageHKDMember 2019-04-01 2019-06-30 0001713210 AATP:PeriodAverageHKDMember 2020-01-01 2020-06-30 0001713210 AATP:PeriodAverageHKDMember 2019-01-01 2019-06-30 0001713210 us-gaap:VariableIncomeInterestRateMember 2020-06-30 0001713210 us-gaap:VariableIncomeInterestRateMember 2020-04-01 2020-06-30 0001713210 us-gaap:VariableIncomeInterestRateMember 2020-01-01 2020-06-30 0001713210 AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember AATP:ShareExchangeAgreementMember 2020-05-08 0001713210 AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember us-gaap:SubsequentEventMember AATP:ShareExchangeAgreementMember 2020-06-29 2020-07-01 0001713210 AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember AATP:ShareExchangeAgreementMember 2020-01-01 2020-03-31 0001713210 AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember AATP:ShareExchangeAgreementMember 2020-03-31 0001713210 AATP:MrHowKokChoongMember us-gaap:SubsequentEventMember 2020-07-31 0001713210 AATP:MrHowKokChoongMember AATP:AgapeSuperiorLivingSdnBhdMember AATP:ShareExchangeAgreementMember 2020-01-01 2020-06-30 0001713210 srt:MinimumMember 2020-06-30 0001713210 srt:MaximumMember 2020-06-30 0001713210 us-gaap:MachineryAndEquipmentMember 2020-06-30 0001713210 us-gaap:MachineryAndEquipmentMember 2019-12-31 0001713210 us-gaap:FurnitureAndFixturesMember 2020-06-30 0001713210 us-gaap:FurnitureAndFixturesMember 2019-12-31 0001713210 us-gaap:LeaseholdImprovementsMember 2020-06-30 0001713210 us-gaap:LeaseholdImprovementsMember 2019-12-31 0001713210 us-gaap:VehiclesMember 2020-06-30 0001713210 us-gaap:VehiclesMember 2019-12-31 0001713210 AATP:GreenproCapitalCorpMember 2018-05-17 0001713210 AATP:GreenproCapitalCorpMember 2018-10-16 0001713210 srt:DirectorMember 2020-06-30 0001713210 srt:DirectorMember AATP:MYRCurrencyMember 2020-06-30 0001713210 AATP:MrHowKokChoongMember 2020-06-30 0001713210 AATP:UnreservedSdnBhdMember 2020-03-02 0001713210 AATP:MrHowKokChoongMember 2019-12-31 0001713210 AATP:MrHowKokChoongMember 2020-03-31 0001713210 AATP:PhoenixPlusCorpMember 2019-04-03 0001713210 us-gaap:CommonStockMember AATP:PhoenixPlusCorpMember 2019-04-03 0001713210 AATP:DirectorsOfUnreservedInvestmentMember 2020-06-30 0001713210 AATP:DirectorsOfUnreservedInvestmentMember 2019-12-31 0001713210 AATP:PhoenixPlusCorpMember 2020-06-30 0001713210 AATP:PhoenixPlusCorpMember 2019-12-31 0001713210 AATP:SeaMember 2020-01-01 2020-06-30 0001713210 AATP:SeaMember 2019-01-01 2019-12-31 0001713210 AATP:SeaMember 2020-06-30 0001713210 AATP:SeaMember 2019-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2020-01-01 2020-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2019-01-01 2019-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2020-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2020-12-31 0001713210 AATP:AgapeATPAsiaLimitedAATPAsiaMember 2020-01-01 2020-06-30 0001713210 AATP:AgapeATPAsiaLimitedAATPAsiaMember 2019-01-01 2019-12-31 0001713210 AATP:AgapeATPAsiaLimitedAATPAsiaMember 2020-06-30 0001713210 AATP:AgapeATPAsiaLimitedAATPAsiaMember 2019-12-31 0001713210 AATP:RedboyPictureSdnBhdRedboyMember 2020-01-01 2020-06-30 0001713210 AATP:RedboyPictureSdnBhdRedboyMember 2019-01-01 2019-12-31 0001713210 AATP:RedboyPictureSdnBhdRedboyMember 2020-06-30 0001713210 AATP:RedboyPictureSdnBhdRedboyMember 2019-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLOneMember 2020-01-01 2020-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLOneMember 2019-01-01 2019-12-31 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLOneMember 2020-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLOneMember 2019-12-31 0001713210 AATP:MrHowKokChoongMember 2020-01-01 2020-06-30 0001713210 AATP:MrHowKokChoongMember 2019-01-01 2019-12-31 0001713210 AATP:MrHowKokChoongMember 2020-06-30 0001713210 AATP:MrHowKokChoongMember 2019-12-31 0001713210 AATP:MrHowKokChoongMember us-gaap:SubsequentEventMember 2020-06-29 2020-07-01 0001713210 AATP:MrHowKokChoongMember 2020-03-31 0001713210 AATP:SeaMember 2020-04-01 2020-06-30 0001713210 AATP:SeaMember 2019-04-01 2019-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2020-04-01 2020-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2019-04-01 2019-06-30 0001713210 AATP:SeaMember 2019-01-01 2019-06-30 0001713210 AATP:AgapeSuperiorLivingPtyLtdASLPLMember 2019-01-01 2019-06-30 0001713210 AATP:AgapeSuperiorLivingMember 2020-05-01 2020-05-31 0001713210 AATP:AgapeSuperiorLivingMember 2020-06-30 0001713210 AATP:AgapeSuperiorLivingMember 2020-06-01 2020-06-30 0001713210 AATP:AgapeSuperiorLivingMember us-gaap:SubsequentEventMember 2020-06-29 2020-07-01 0001713210 AATP:AgapeSuperiorLivingMember 2020-01-01 2020-06-30 0001713210 AATP:AgapeSuperiorLivingMember 2020-04-01 2020-06-30 0001713210 country:MY 2020-04-01 2020-06-30 0001713210 country:MY 2019-04-01 2019-06-30 0001713210 country:MY 2020-01-01 2020-06-30 0001713210 country:MY 2019-01-01 2019-06-30 0001713210 country:HK 2020-04-01 2020-06-30 0001713210 country:HK 2019-04-01 2019-06-30 0001713210 country:HK 2020-01-01 2020-06-30 0001713210 country:HK 2019-01-01 2019-06-30 0001713210 country:US 2020-06-30 0001713210 country:US AATP:IfUnutilizedMember 2020-06-30 0001713210 country:US 2020-01-01 2020-06-30 0001713210 country:US AATP:IfUnutilizedMember 2020-01-01 2020-06-30 0001713210 country:US 2019-12-31 0001713210 AATP:LabuanMember 2018-12-28 2019-01-02 0001713210 country:MY 2020-06-30 0001713210 country:MY 2019-12-31 0001713210 AATP:NoCustomerMember srt:MaximumMember us-gaap:RevenueFromContractWithCustomerMember 2020-01-01 2020-06-30 0001713210 AATP:OneCustomersMember us-gaap:RevenueFromContractWithCustomerMember 2019-04-01 2019-06-30 0001713210 AATP:OneCustomersMember us-gaap:RevenueFromContractWithCustomerMember 2019-01-01 2019-06-30 0001713210 us-gaap:AccountsReceivableMember AATP:ECommerceCompanyMember 2020-01-01 2020-06-30 0001713210 AATP:OneCustomersMember us-gaap:AccountsReceivableMember 2019-01-01 2019-12-31 0001713210 AATP:VendorOneMember 2020-04-01 2020-06-30 0001713210 AATP:VendorOneMember 2020-01-01 2020-06-30 0001713210 AATP:VendorOneMember 2019-04-01 2019-06-30 0001713210 AATP:VendorTwoMember 2019-04-01 2019-06-30 0001713210 AATP:VendorOneMember 2019-01-01 2019-06-30 0001713210 AATP:VendorTwoMember 2019-01-01 2019-06-30 0001713210 AATP:OneVendorMember us-gaap:AccountsPayableMember 2020-01-01 2020-06-30 0001713210 AATP:OneVendorMember us-gaap:AccountsPayableMember 2019-01-01 2019-12-31 0001713210 AATP:AgapeSuperiorLivingMember 2020-04-02 0001713210 AATP:AgapeSuperiorLivingMember 2020-03-28 2020-04-02 iso4217:USD shares iso4217:USD shares pure AATP:RM 0001713210 false Q2 2020 --12-31 10-Q true 2020-06-30 false 333-220144 AGAPE ATP CORPORATION NV 36-4838886 Tower 2 Faber Tower Jalan Desa Bahagia 58100 Kuala Lumpur MY (60) 192230099 Yes Yes Non-accelerated Filer true true false false Common Stock, $0.0001 par value 376452047 18680 3427664 2744457 325426 8694 520786 5589 2217 416627 3113 1214035 8399 507989 269193 2784 5908808 3536653 311859 6283 432593 193663 66484 1500 732137 203238 34431 1183567 798621 7092375 4335274 2790 901569 134858 2741 467567 77246 90043 3952 1594037 83988 298242 1892279 83988 0.0001 0.0001 200000000 200000000 0 0 0 0 0.0001 0.0001 1000000000 1000000000 376438194 376438194 376275500 376275500 37644 37628 6350574 5293082 -1233719 -1089209 45597 9785 5200096 4251286 7092375 4335274 1510208 1510208 13654 396472 13654 860769 1523862 396472 1523862 860769 471554 397172 471554 817350 1052308 -700 1052308 43419 108894 6504 109356 7846 382498 382498 514724 52734 673778 83778 1006116 59238 1165632 91624 46192 -59938 -113324 -48205 29911 -21639 -23785 40454 -26085 145204 126666 16509 -366834 -366834 175115 -388473 102881 -335956 221307 -448411 -10443 -384161 134067 134067 -6965 87240 -448411 -144510 -377196 28042 4412 35812 1215 115282 -443999 -108698 -375981 0.00 -0.00 -0.00 -0.00 376370256 376275500 376322878 376275500 376275500 37628 5293082 -373082 -1294 4956334 71215 71215 -3197 -3197 376275500 37628 5293082 -301867 -4491 5024352 376275500 37628 5293082 -301867 -4491 5024352 -448411 -448411 4412 4412 376275500 37628 5293082 -750278 -79 4580353 376275500 37628 5293082 -1089209 9785 4251286 -231750 -231750 7770 7770 376275500 37628 5293082 -1320959 17555 4027306 376275500 37628 5293082 -1320959 17555 4027306 87240 87240 162694 16 1057492 1057508 28042 28042 376438194 37644 6350574 -1233719 45597 5200096 -144510 -377196 17716 482 32756 -26085 126667 16509 -366834 134067 322547 8617 433338 2210 -206540 -4185 -125422 -11734 2780 -2802 35145 -712749 -217743 -6965 51093 23690 -32253 -780664 -590473 1210818 70173 1500 1280991 -1500 -75738 -216575 -745 -5318 140837 -4573 42043 1216 683207 -595330 2744457 3452917 3427664 2857587 724619 461522 656495 1057508 90043 127500 <p id="xdx_802_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zOMthWaVDqve" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>1. <span id="xdx_825_z4IOJee3Jqwg">ORGANIZATION AND BUSINESS BACKGROUND</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with <span id="xdx_902_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200630__srt--ConsolidatedEntitiesAxis__custom--AgapeATPInternationalHoldingLimitedMember_z9w4no0Iisd1" title="Ownership interest percentage">100</span>% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_pii" title="Stock issued during period acquisitions, shares">9,590,596</span> ordinary shares, no par value, equivalent to approximately <span id="xdx_905_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zyj2rRx9fnl1" title="Ownership interest percentage">99.99</span>% of the equity interest in Agape Superior Living Sdn. Bhd., an entity incorporated in Malaysia.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape Superior Living Sdn. Bhd. (“ASL”) is a limited company incorporated on August 8, 2003, under the laws of Malaysia.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company and its subsidiaries engage in the network marketing sales business in the Health and Wellness Industry. The principal activity of the Company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The accompanying unaudited condensed consolidated financial statements reflect the activities of the Company, Agape ATP Corporation (“AATP LB”), Agape ATP International Holding Limited (“AATP HK”), ASL and its variable interest entity (“VIE”), Agape S.E.A. Sdn. Bhd. (“SEA”) (See Note 3).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_zbbYSoz90elh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Details of the Company’s subsidiaries:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B9_zxhSur3vmMxg" style="display: none">Schedule of Subsidiaries and Associates</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Subsidiary company</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>name</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Place and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>date of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>incorporation</b></span></p></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Particulars of issued capital</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal activities</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Proportional of ownership</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>interest and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>voting power</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>held</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 13%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">1. </span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td id="xdx_98F_ecustom--NameOftheCompany_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember" style="width: 20%; text-align: left" title="Subsidiary company name">Agape ATP Corporation</td><td style="width: 2%"> </td> <td id="xdx_983_ecustom--PlaceAndDateOfIncorporation_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember" style="width: 14%; text-align: center" title="Place and date of incorporation">Labuan, <br/> March 6, 2017</td><td style="width: 2%"> </td> <td id="xdx_986_ecustom--ParticularsOfIssuedCapital_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember" style="width: 14%; text-align: center" title="Particulars of issued capital">100 shares of ordinary share of US$1 each</td><td style="width: 2%"> </td> <td id="xdx_98F_ecustom--PrincipalActivities_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember" style="width: 14%; text-align: center" title="Principal activities">Investment holding</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zRvbTdSI2C29" style="width: 12%; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2. </span></td><td style="text-align: left"> </td><td> </td> <td id="xdx_982_ecustom--NameOftheCompany_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember" style="text-align: left" title="Subsidiary company name">Agape ATP International Holding Limited</td><td> </td> <td id="xdx_986_ecustom--PlaceAndDateOfIncorporation_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember" style="text-align: center" title="Place and date of incorporation">Hong Kong,<br/> June 1, 2017</td><td> </td> <td id="xdx_98B_ecustom--ParticularsOfIssuedCapital_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember" style="text-align: center" title="Particulars of issued capital">1,000,000 shares of ordinary share of HK$1 each</td><td> </td> <td id="xdx_98C_ecustom--PrincipalActivities_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember" style="text-align: center" title="Principal activities">Health and wellness products and health solution advisory services</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_z4WYJw00kBFa" style="text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">3.</span></td><td style="text-align: left"> </td><td> </td> <td id="xdx_98B_ecustom--NameOftheCompany_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember" style="text-align: left" title="Subsidiary company name">Agape Superior Living Sdn. Bhd.</td><td> </td> <td id="xdx_98F_ecustom--PlaceAndDateOfIncorporation_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember" style="text-align: center" title="Place and date of incorporation">Malaysia, <br/>August 8, 2003</td><td> </td> <td id="xdx_981_ecustom--ParticularsOfIssuedCapital_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember" style="text-align: center" title="Particulars of issued capital">9,590,598 shares of ordinary share of RM1 each</td><td> </td> <td id="xdx_98B_ecustom--PrincipalActivities_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember" style="text-align: center" title="Principal activities">Health and wellness products and health solution advisory services</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zGOcMfe3U3F7" style="text-align: right" title="Proportional of ownership interest and voting power held">99.99</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">4.</span></td><td style="text-align: left"> </td><td> </td> <td id="xdx_982_ecustom--NameOftheCompany_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember" style="text-align: left" title="Subsidiary company name">Agape S.E.A. Sdn. Bhd.</td><td> </td> <td id="xdx_987_ecustom--PlaceAndDateOfIncorporation_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember" style="text-align: center" title="Place and date of incorporation">Malaysia, <br/>March 4, 2004</td><td> </td> <td id="xdx_981_ecustom--ParticularsOfIssuedCapital_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember" style="text-align: center" title="Particulars of issued capital">2 shares of ordinary share of RM1 each</td><td> </td> <td id="xdx_981_ecustom--PrincipalActivities_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember" style="text-align: center" title="Principal activities">VIE of Agape Superior Living Sdn. Bhd.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">VIE</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AE_zMIcfIoRDnpa" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Business Overview</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape ATP Corporation is a company that provides health solution advisory services to our clients. We primarily focus our efforts on attracting customers in Malaysia. Our advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In order to strengthen the Company’s supply chain, on May 8, 2020, the Company has successfully acquired approximately <span id="xdx_900_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zrEpBCY4GoOf" title="Ownership interest percentage">99.99</span>% of ASL, with the goal of securing an established network marketing sales channel that has been established in Malaysia for the past 15 years. ASL has been offering the Company’s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy in the Company’s operation by boosting the Company’s retail and marketing capabilities. The newly acquired subsidiary allows the Company to fulfill its mission of “helping people to create health and wealth” by providing a financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, ÉNERGÉTIQUE and BEAUNIQUE.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and distributors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The ÉNERGÉTIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The BEAUNIQUE product series focuses on the research of our diet’s impact on modifying gene expressions in order to address genetic variations and deliver a nutrigenomic solution for every individual.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 1 9590596 0.9999 <p id="xdx_89E_eus-gaap--ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock_zbbYSoz90elh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Details of the Company’s subsidiaries:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B9_zxhSur3vmMxg" style="display: none">Schedule of Subsidiaries and Associates</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Subsidiary company</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>name</b></span></p></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Place and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>date of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>incorporation</b></span></p></td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Particulars of issued capital</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Principal activities</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Proportional of ownership</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>interest and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>voting power</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>held</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 13%; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">1. </span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td id="xdx_98F_ecustom--NameOftheCompany_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember" style="width: 20%; text-align: left" title="Subsidiary company name">Agape ATP Corporation</td><td style="width: 2%"> </td> <td id="xdx_983_ecustom--PlaceAndDateOfIncorporation_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember" style="width: 14%; text-align: center" title="Place and date of incorporation">Labuan, <br/> March 6, 2017</td><td style="width: 2%"> </td> <td id="xdx_986_ecustom--ParticularsOfIssuedCapital_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember" style="width: 14%; text-align: center" title="Particulars of issued capital">100 shares of ordinary share of US$1 each</td><td style="width: 2%"> </td> <td id="xdx_98F_ecustom--PrincipalActivities_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember" style="width: 14%; text-align: center" title="Principal activities">Investment holding</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyMember_zRvbTdSI2C29" style="width: 12%; text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">2. </span></td><td style="text-align: left"> </td><td> </td> <td id="xdx_982_ecustom--NameOftheCompany_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember" style="text-align: left" title="Subsidiary company name">Agape ATP International Holding Limited</td><td> </td> <td id="xdx_986_ecustom--PlaceAndDateOfIncorporation_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember" style="text-align: center" title="Place and date of incorporation">Hong Kong,<br/> June 1, 2017</td><td> </td> <td id="xdx_98B_ecustom--ParticularsOfIssuedCapital_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember" style="text-align: center" title="Particulars of issued capital">1,000,000 shares of ordinary share of HK$1 each</td><td> </td> <td id="xdx_98C_ecustom--PrincipalActivities_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember" style="text-align: center" title="Principal activities">Health and wellness products and health solution advisory services</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyOneMember_z4WYJw00kBFa" style="text-align: right" title="Proportional of ownership interest and voting power held">100</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">3.</span></td><td style="text-align: left"> </td><td> </td> <td id="xdx_98B_ecustom--NameOftheCompany_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember" style="text-align: left" title="Subsidiary company name">Agape Superior Living Sdn. Bhd.</td><td> </td> <td id="xdx_98F_ecustom--PlaceAndDateOfIncorporation_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember" style="text-align: center" title="Place and date of incorporation">Malaysia, <br/>August 8, 2003</td><td> </td> <td id="xdx_981_ecustom--ParticularsOfIssuedCapital_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember" style="text-align: center" title="Particulars of issued capital">9,590,598 shares of ordinary share of RM1 each</td><td> </td> <td id="xdx_98B_ecustom--PrincipalActivities_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember" style="text-align: center" title="Principal activities">Health and wellness products and health solution advisory services</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyTwoMember_zGOcMfe3U3F7" style="text-align: right" title="Proportional of ownership interest and voting power held">99.99</td><td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"> </td><td style="text-align: left"> </td><td> </td> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">4.</span></td><td style="text-align: left"> </td><td> </td> <td id="xdx_982_ecustom--NameOftheCompany_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember" style="text-align: left" title="Subsidiary company name">Agape S.E.A. Sdn. Bhd.</td><td> </td> <td id="xdx_987_ecustom--PlaceAndDateOfIncorporation_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember" style="text-align: center" title="Place and date of incorporation">Malaysia, <br/>March 4, 2004</td><td> </td> <td id="xdx_981_ecustom--ParticularsOfIssuedCapital_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember" style="text-align: center" title="Particulars of issued capital">2 shares of ordinary share of RM1 each</td><td> </td> <td id="xdx_981_ecustom--PrincipalActivities_c20200101__20200630__srt--ConsolidatedEntitiesAxis__custom--SubsidiaryCompanyThreeMember" style="text-align: center" title="Principal activities">VIE of Agape Superior Living Sdn. Bhd.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif">VIE</span></td><td style="text-align: left"> </td></tr> </table> Agape ATP Corporation Labuan, March 6, 2017 100 shares of ordinary share of US$1 each Investment holding 1 Agape ATP International Holding Limited Hong Kong, June 1, 2017 1,000,000 shares of ordinary share of HK$1 each Health and wellness products and health solution advisory services 1 Agape Superior Living Sdn. Bhd. Malaysia, August 8, 2003 9,590,598 shares of ordinary share of RM1 each Health and wellness products and health solution advisory services 0.9999 Agape S.E.A. Sdn. Bhd. Malaysia, March 4, 2004 2 shares of ordinary share of RM1 each VIE of Agape Superior Living Sdn. Bhd. 0.9999 <p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zzCm1p2yLiUl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. <span id="xdx_824_zjZXiGgMxJ0a">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_845_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zcOYq2YnXVAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zKRffswhLqH1">Basis of presentation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), and include all normal and recurring adjustments that management of the Company considers necessary for a fair presentation of its financial position and operation results. Interim results are not necessarily indicative of results to be expected for any other interim period or for the full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s transition report on Form 10-K for the period ended December 31, 2019, filed with the Securities and Exchange Commission on March 27, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zktuik5e6Seh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zdV1R7uAU701">Principles of consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The unaudited condensed consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary and must consolidate the VIE. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_842_eus-gaap--UseOfEstimates_zKswYcDZ052l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_ziXNHNS2haKe">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include allowance for doubtful accounts, allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zEgrnfnvnUC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86C_z2jAzDh2zE4k">Cash and cash equivalents</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84F_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zzhtqadacz2l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86A_z7h1O50GLPfa">Accounts receivable and accounts receivable – related party</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accounts receivable and accounts receivable – related party are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of June 30, 2020, and December 31, 2019, <span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20191231_zvxr1T30wXS2">no </span></span><span style="font: 10pt Times New Roman, Times, Serif">valuation allowance was recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_846_eus-gaap--InventoryPolicyTextBlock_zenoau4dzwJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_z6WjkgYawYIl">Inventories</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inventories consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_841_ecustom--PrepaidTaxesPolicyTextBlock_zOgVrNu2ulub" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_869_zlz8rqKOxMCk">Prepaid taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prepaid taxes include (i) prepaid income taxes that will either be refundable or utilized to offset future income tax; and (ii) goods and service tax (“GST”) to be refundable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_841_ecustom--PrepaymentsAndDepositsPolicyTextBlock_zC5JroYMdy2j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86E_zshXbngNQCw4">Prepayments and deposits</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prepayments and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of June 30, 2020, and December 31, 2019, there is <span id="xdx_902_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20200630_zC4Ybb80YRQi" title="Allowance for doubtful accounts"><span id="xdx_90B_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20191231_zk9wWjCgEjl1" title="Allowance for doubtful accounts">no</span></span> allowance for the doubtful accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zYEQe4VCnRCj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zh3KystFPh2l">Property and equipment, net</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_895_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zhW1QzjRieA6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_zVlMmrIigpbe" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.5pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Useful Life</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.5pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 71%; text-align: justify; padding-left: 0.5pt">Computer and office equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 25%; text-align: center" title="Estimated Useful Life of Property and Equipment"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zHLN9lUG3bG" title="Estimated Useful Life of Property and Equipment">5</span>-<span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zTU1X7H0YJ67" title="Estimated Useful Life of Property and Equipment">7</span> years </span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.5pt">Furniture &amp; fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zlMtL4Sl9tC1" title="Estimated Useful Life of Property and Equipment">6</span>-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_z0Sb8uf2Yhde" title="Estimated Useful Life of Property and Equipment">7</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.5pt">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember" title="Estimated Useful Lives of Property and Equipment">Lease Term</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.5pt">Vehicle</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center" title="Estimated Useful Life of Property and Equipment"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zlJseTRPyd86" title="Estimated Useful Life of Property and Equipment">5</span> years</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A4_zW0kv1aOUDzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates of useful lives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_848_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zs0KjCzz1lng" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zSGhisgVIbZ4">Intangible assets, net</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89D_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_zFCXpTIeMX0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B5_ztRg3NWPpAU4" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; width: 71%; font-weight: bold; padding-left: 0.5pt">Classification</td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 25%; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Useful Life</b></span></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.5pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.5pt">Computer software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center" title="Estimated useful lives of intangible assets"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200101__20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zXjlZ1tZrwj6" title="Estimated useful lives of intangible assets">5</span> years</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AA_zISccNW2IsC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zCMoRajgRvi1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_860_zNRFY7JUJr1a">Impairment for long-lived assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Long-lived assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of June 30, 2020, and December 31, 2019, <span id="xdx_901_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20200101__20200630_z3SuvbsDddNd" title="Impairment of long-lived assets"><span id="xdx_90A_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20190101__20191231_zc4GGrP3s7D8" title="Impairment of long-lived assets">no</span></span> impairment of long-lived assets was recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84B_ecustom--DeferredOfferingCostsPolicyTextBlock_z98msM5qzz8i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_zvxwWmAyEJ7l">Deferred offering costs</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Deferred offering costs represents costs associated with the Company’s current offering which will be netted against the proceeds from the Company’s current offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84D_eus-gaap--MarketableSecuritiesPolicy_zOanJU6YQHV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86C_z1hObp8JBpgk">Investment in marketable equity securities</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 1, 2019, the Company adopted ASU 2016-01, <i>Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities</i>. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s consolidated statements of operations and comprehensive loss in the caption of “unrealized holding losses on marketable securities” in each reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_841_ecustom--NonMarketableSecuritiesPolicyTextBlock_zxnhlLwKjzre" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_865_ziIUscL6a7a2">Investment in non-marketable equity securities</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 1, 2019, the Company adopted ASU 2016-01, <i>Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities</i>. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_849_ecustom--CustomerDepositsPolicyTextBlock_zZPJgIzeDVh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86E_zHSB2e4R79Wi">Customer deposits</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Customer deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced when the related sale is recognized in accordance with the Company’s revenue recognition policy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84C_eus-gaap--RevenueRecognitionPolicyTextBlock_z7mOKx3BYII1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zW7IEdukcFwg">Revenue recognition</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not result in an adjustment to retained earnings upon adoption of this new guidance as the Company’s revenue was recognized based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance and confirmed that there were no differences in the pattern of revenue recognition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Sales of Health and Wellness products</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">- <i>Performance obligations satisfied at a point in time</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods, which is generally similar to when its delivery has occurred prior to July 1, 2019 Such revenues are recognized at a point in time after all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and wellness products transaction price upon such sales transactions occurred. The Company’s coupons have a validity period of six months. If the Company’s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues. For the three and six months ended June 30, 2020, the Company recognized $<span id="xdx_90D_ecustom--ForfeitedCouponIncome_c20200101__20200630_pp0p0" title="Forfeited coupon income">61,368</span> as forfeited coupon income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2020, the Company had contracts for the sales of health and wellness products amounting to $<span id="xdx_907_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__custom--HealthAndWellnessProductsMember_pp0p0" title="Revenue">661,900</span> which it is expected to fulfill within 12 months from June 30, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_zzZRr8Ia8vi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Disaggregated information of revenues by products are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B6_zTpzNAylW8ij" style="display: none">SCHEDULE OF DISAGGREGATED INFORMATION OF REVENUES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the three months ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Ionized Cal-Mag</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="width: 11%; text-align: right" title="Total revenues">611,160</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="width: 11%; text-align: right" title="Total revenues">167</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="width: 11%; text-align: right" title="Total revenues">611,160</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="width: 11%; text-align: right" title="Total revenues">55,660</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Omega Blend</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">162,543</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">207</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">162,543</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">68,896</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Young Formula</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--YoungFormulaMember_pp0p0" style="text-align: right" title="Total revenues">349,738</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--YoungFormulaMember_pp0p0" style="text-align: right" title="Total revenues">353</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--YoungFormulaMember_pp0p0" style="text-align: right" title="Total revenues">349,738</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--YoungFormulaMember_pp0p0" style="text-align: right" title="Total revenues">117,332</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Organic Youth Care Cleansing Bar</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_pp0p0" style="text-align: right">28,805</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_pp0p0" style="text-align: right" title="Total revenues">53</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_pp0p0" style="text-align: right" title="Total revenues">28,805</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_pp0p0" style="text-align: right" title="Total revenues">17,728</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Trim+</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--TrimPlusMember_zqGHZ5XclYul" style="text-align: right" title="Total revenues">223,497</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--TrimPlusMember_pp0p0" style="text-align: right" title="Total revenues">133,319</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--TrimPlusMember_pp0p0" style="text-align: right" title="Total revenues">223,497</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--TrimPlusMember_pp0p0" style="text-align: right" title="Total revenues">198,614</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Lipomask</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--LipomaskMember_pp0p0" style="text-align: right" title="Total revenues">8,420</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--LipomaskMember_pp0p0" style="text-align: right" title="Total revenues">422</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--LipomaskMember_pp0p0" style="text-align: right" title="Total revenues">8,420</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--LipomaskMember_pp0p0" style="text-align: right" title="Total revenues">140,588</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Beta Maxx</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--BetaMaxxmMember_pp0p0" style="text-align: right" title="Total revenues">11,434</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--BetaMaxxmMember_pp0p0" style="text-align: right" title="Total revenues">123,470</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--BetaMaxxmMember_pp0p0" style="text-align: right" title="Total revenues">11,434</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--BetaMaxxmMember_pp0p0" style="text-align: right" title="Total revenues">123,470</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Energized Mineral Concentrate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">22,606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">138,481</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">22,606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">138,481</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Survivor Select</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="text-align: right" title="Total revenues">35,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0805">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="text-align: right" title="Total revenues">35,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0809">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Vege-Fruit Fiber</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_pp0p0" style="text-align: right" title="Total revenues">6,106</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0813">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_pp0p0" style="text-align: right" title="Total revenues">6,106</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0817">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Mitogize</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--MitogizeMember_pp0p0" style="text-align: right" title="Total revenues">4,711</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--MitogizeMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0821">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--MitogizeMember_pp0p0" style="text-align: right" title="Total revenues">4,711</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--MitogizeMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0825">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Hyaluronic Acid Serum</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--HyaluronicAcidSerumMember_pp0p0" style="text-align: right" title="Total revenues">55,721</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--HyaluronicAcidSerumMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0829">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--HyaluronicAcidSerumMember_pp0p0" style="text-align: right" title="Total revenues">55,721</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--HyaluronicAcidSerumMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0833">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Mousse Facial Cleanser</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--MousseFacialCleanserMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues">3,127</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--MousseFacialCleanserMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0837">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--MousseFacialCleanserMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues">3,127</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--MousseFacialCleanserMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0841">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">1,523,862</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20190401__20190630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">396,472</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">1,523,862</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20190101__20190630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">860,769</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zDI9OvC6SP5k" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_849_eus-gaap--CostOfSalesPolicyTextBlock_znuBmw9nRach" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zKscReCBjQee">Cost of revenue</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cost of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84A_ecustom--ShippingAndHandlingPolicyTextBlock_zUMdCXxbp0J9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_zEuItBfHEdb">Shipping and handling</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Shipping and handling charges amounted to $<span id="xdx_902_eus-gaap--SellingExpense_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zMQ05FIzu4ql" title="Selling expenses">2,555</span> and $<span id="xdx_907_eus-gaap--SellingExpense_c20190401__20190630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Selling expenses">0</span> for the three months ended June 30, 2020 and 2019, respectively. Shipping and handling charges amounted to $<span id="xdx_90C_eus-gaap--SellingExpense_c20200101__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Selling expenses">2,555</span> and $<span id="xdx_90B_eus-gaap--SellingExpense_c20190101__20190630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Selling expenses">0</span> for the six months ended June 30, 2020 and 2019, respectively. Shipping and handling charges are expensed as incurred and included in selling expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_846_eus-gaap--AdvertisingCostsPolicyTextBlock_zCrmOoRd1FS8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_zxjsITGKjfZg">Advertising costs</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Advertising costs amounted to $<span id="xdx_900_eus-gaap--AdvertisingExpense_c20200401__20200630_pp0p0" title="Advertising costs">2,882</span> and $<span id="xdx_901_eus-gaap--AdvertisingExpense_c20190401__20190630_pp0p0" title="Advertising costs">0</span> for the three months ended June 30, 2020 and 2019, respectively. Advertising costs amounted to $<span id="xdx_903_eus-gaap--AdvertisingExpense_c20200101__20200630_pp0p0" title="Advertising costs">2,882</span> and $<span id="xdx_902_eus-gaap--AdvertisingExpense_c20190101__20190630_pp0p0" title="Advertising costs">0</span> for the six months ended June 30, 2020 and 2019, respectively. Advertising costs are expensed as incurred and included in selling expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84B_eus-gaap--CommissionsExpensePolicyPolicyTextBlock_zPeARW0xc8Cg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="text-decoration: underline"><span id="xdx_862_zkYvCbD9ztpj">Commission expenses</span> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Commission expenses are the Company’s most significant expenses. As with all companies in the network marketing industry, the Company’s sales channel is external to the Company. The Company’s “external sales force” is stratified into two levels based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly, are referred to as “sales network members”. The Company pays commission to every sales distributor based on purchases made by its sales network members which includes the independent direct sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain amount of the Company’s inventory on their store premises. The stockists shall account to the Company for all products sales from their store premises as monitored through the Company’s centralized stock tracking system. The Company pays a separate commission to stockists based on revenue generated from the stockists’ physical stores. Commission expenses amounted to $<span id="xdx_90C_ecustom--SalesCommissionsAndFees1_pp0p0_c20200401__20200630_z4Wz6qcIApGf" title="Commission expenses">382,498</span> and $<span id="xdx_900_ecustom--SalesCommissionsAndFees1_pp0p0_c20190401__20190630_zvIwlJ5pXP1l" title="Commission expenses">0</span> for the three months ended June 30, 2020 and 2019, respectively. Commission expenses amounted to $<span id="xdx_90C_ecustom--SalesCommissionsAndFees1_pp0p0_c20200101__20200630_zSH2Hn6KvAhi" title="Commission expenses">382,498</span> and $<span id="xdx_908_ecustom--SalesCommissionsAndFees1_pp0p0_c20190101__20190630_zHQ4tSWVYv35" title="Commission expenses">0</span> for the six months ended June 30, 2020 and 2019, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84F_ecustom--DefinedContributionPlanPolicyTextBlock_zjjWcEZi6J55" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="text-decoration: underline"><span id="xdx_86F_zjzFHqF0GfEg">Defined contribution plan</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue and pay for these benefits based on certain percentages of the employees’ respective salaries, subject to certain ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan. Total expenses for the plans were $<span id="xdx_904_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_c20200401__20200630_pp0p0" title="Defined contribution plan expense">23,710</span> and $<span id="xdx_905_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_c20190401__20190630_pp0p0" title="Defined contribution plan expense">0</span> for the three months ended June 30, 2020 and 2019, respectively. Total expenses for the plans were $<span id="xdx_901_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_c20200101__20200630_pp0p0" title="Defined contribution plan expense">23,710</span> and $<span id="xdx_900_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_c20190101__20190630_pp0p0" title="Defined contribution plan expense">0</span> for the six months ended June 30, 2020 and 2019, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The related contribution plans include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Social Security Organization (“SOSCO”) – <span id="xdx_903_ecustom--SalaryPercentage_pii_dp_c20200101__20200630__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember_zsDcpS3Ujllf" title="Salary percentage">1.75%</span> based on employee’s monthly salary capped of RM <span id="xdx_901_ecustom--MonthlySalary_pp0p0_c20200101__20200630__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zv6dq4jnqurg" title="Monthly salary">4,000</span>;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Employees Provident Fund (“EPF”) – <span id="xdx_907_ecustom--SalaryPercentage_pii_dp_c20200101__20200630__dei--LegalEntityAxis__custom--EmployeesProvidentFundMember_z4doc6uiSTY3" title="Salary percentage">12%</span> based on employee’s monthly salary;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Employment Insurance System (“EIS”) – <span id="xdx_901_ecustom--SalaryPercentage_pii_dp_c20200101__20200630__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember_zs4y3M6mkIgg" title="Salary percentage">0.2%</span> based on employee’s monthly salary capped of RM <span id="xdx_906_ecustom--MonthlySalary_pp0p0_c20200101__20200630__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zgVp2qOP8Zok" title="Monthly salary">4,000</span>;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Human Resource Development Fund (“HRDF”) – <span id="xdx_909_ecustom--SalaryPercentage_pii_dp_c20200101__20200630__dei--LegalEntityAxis__custom--HumanResourceDevelopmentFundMember_zpbNFP0r11N4" title="Salary percentage">1%</span> based on employee’s monthly salary</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zNiCGuDpZPNf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zu9NSjgRA534">Income taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is <span id="xdx_906_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20200101__20200630" title="Income tax examination, likelihood of unfavorable settlement">greater than 50%</span> likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded.<span id="xdx_905_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20200101__20200630_zk2HzgUPWJ02" title="Penalties and interest incurred"> <span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20190101__20190630_zYfNN6H9jp82" title="Penalties and interest incurred">No</span></span> penalties and interest incurred related to underpayment of income tax for the three and six months ended June 30, 2020 and 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84F_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zV4cZpDkRmj3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zwEfQ8PeFnfa">Comprehensive income (loss)</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_843_ecustom--NoncontrollingInterestPolicyTextBlock_zc5Enj97N2Q3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zmeoqu5ADT7h">Non-controlling interest</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--MinorityInterestDescription_c20200101__20200630_zFdoKN9YhnH1" title="Noncontrolling interest, description">Non-controlling interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals.</span> The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders and the shareholders of the Company. As of June 30, 2020, the non-controlling interest balance was $<span id="xdx_906_eus-gaap--MinorityInterest_iI_c20200630_z9iVTLP6hxn9" title="Non-controlling interest">0</span> and therefore not presented in the accompanying unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zNS1Ogmh4XNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zWdT0ugusPe7">Earnings (loss) per share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. For the three and six months ended June 30, 2020 and 2019, there were <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20200101__20200630_zAaAm3m2xCC5" title="Potentially dilutive securities outstanding"><span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20190101__20191231_zFATpwHrGhzh" title="Potentially dilutive securities outstanding">no</span></span> dilutive shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_840_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z66VqssJISF4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_864_zGbjhqiMJxWg">Foreign currencies translation and transaction</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit (“MYR” or “RM”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency. The Company’s subsidiary and VIE in Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (“MYR” or “RM”), as its functional currency.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “<i>Translation of Financial Statement”</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zE1nM40yyTjd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B3_zvaGDI8K8hF1" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Period-end MYR : US$1 exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_pii" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation">4.28</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_pii" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation">4.09</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Period-end HKD : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_pii" style="text-align: right" title="Foreign Currency Exchange Rate, Translation">7.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_pii" style="text-align: right" title="Foreign Currency Exchange Rate, Translation">7.79</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the three months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: left">Period-average MYR : US$<span id="xdx_909_eus-gaap--EffectOfExchangeRateOnCash_c20200401__20200630__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_90E_eus-gaap--EffectOfExchangeRateOnCash_c20190401__20190630__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_905_eus-gaap--EffectOfExchangeRateOnCash_c20200101__20200630__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_904_eus-gaap--EffectOfExchangeRateOnCash_c20190101__20190630__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_pp0p0" title="Exchange rate">1</span></span></span></span> exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20200401__20200630__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_pii" style="width: 10%; text-align: right" title="Foreign currency exchange rate period average">4.32</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20190401__20190630__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_pii" style="width: 10%; text-align: right" title="Foreign currency exchange rate period average">4.15</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20200101__20200630__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_pii" style="width: 10%; text-align: right" title="Foreign currency exchange rate period average">4.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20190101__20190630__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_pii" style="width: 10%; text-align: right" title="Foreign currency exchange rate period average">4.12</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Period-average HKD : US$<span id="xdx_908_eus-gaap--EffectOfExchangeRateOnCash_c20200401__20200630__us-gaap--AwardTypeAxis__custom--HKDCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_90B_eus-gaap--EffectOfExchangeRateOnCash_c20190401__20190630__us-gaap--AwardTypeAxis__custom--HKDCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_906_eus-gaap--EffectOfExchangeRateOnCash_c20200101__20200630__us-gaap--AwardTypeAxis__custom--HKDCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_907_eus-gaap--EffectOfExchangeRateOnCash_c20190101__20190630__us-gaap--AwardTypeAxis__custom--HKDCurrencyMember_pp0p0" title="Exchange rate">1</span></span></span></span> exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20200401__20200630__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_pii" style="text-align: right" title="Foreign currency exchange rate period average">7.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20190401__20190630__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_pii" style="text-align: right" title="Foreign currency exchange rate period average">7.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20200101__20200630__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_pii" style="text-align: right" title="Foreign currency exchange rate period average">7.76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20190101__20190630__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_pii" style="text-align: right" title="Foreign currency exchange rate period average">7.84</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A4_zB1WYaaGw5qd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_844_ecustom--RelatedPartiesPolicyTextBlock_zq5uBaePxFFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_865_zVZD34Aptwkl">Related parties</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zBitYtm8HEXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_869_z9xqaQMnwpI1">Fair value of financial instruments</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_846_eus-gaap--LesseeLeasesPolicyTextBlock_zA8KyNsY9iM" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zE1buhAOrBMl">Leases</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective July 1, 2019, the Company adopted ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that does not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing leases with a lease term in excess of twelve months on July 1, 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Operating lease right-of-use (“ROU”) assets and lease liabilities are recognized at the adoption date of July 1, 2019 or the commencement date, whichever is earlier, based on the present value of lease payments over the lease term. Since the implicit rate for the Company’s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment and over a similar term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future pre-tax cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znvcQgQx3MHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_z2pCYx5IvFhk">Recent accounting pronouncements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The Company does not expect the adoption of this standard to have a material impact on its unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zy1YsdaIphzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86A_zZnFlMK4KZw3">Reclassification</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Certain prior period amounts have been reclassified to conform to the current period presentation for the three and six months ended June 30, 2019. These reclassifications have no effect on the unaudited condensed consolidated statements of operations and comprehensive income (loss).</span></p> <p id="xdx_85C_zhgrp23ywvQl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_845_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zcOYq2YnXVAd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zKRffswhLqH1">Basis of presentation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), and include all normal and recurring adjustments that management of the Company considers necessary for a fair presentation of its financial position and operation results. Interim results are not necessarily indicative of results to be expected for any other interim period or for the full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s transition report on Form 10-K for the period ended December 31, 2019, filed with the Securities and Exchange Commission on March 27, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84C_eus-gaap--ConsolidationPolicyTextBlock_zktuik5e6Seh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zdV1R7uAU701">Principles of consolidation</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The unaudited condensed consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">A VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary and must consolidate the VIE. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_842_eus-gaap--UseOfEstimates_zKswYcDZ052l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_ziXNHNS2haKe">Use of estimates</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include allowance for doubtful accounts, allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zEgrnfnvnUC5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86C_z2jAzDh2zE4k">Cash and cash equivalents</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84F_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zzhtqadacz2l" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86A_z7h1O50GLPfa">Accounts receivable and accounts receivable – related party</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accounts receivable and accounts receivable – related party are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of June 30, 2020, and December 31, 2019, <span id="xdx_90F_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_pp0p0_do_c20191231_zvxr1T30wXS2">no </span></span><span style="font: 10pt Times New Roman, Times, Serif">valuation allowance was recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 0 <p id="xdx_846_eus-gaap--InventoryPolicyTextBlock_zenoau4dzwJi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_z6WjkgYawYIl">Inventories</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inventories consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_841_ecustom--PrepaidTaxesPolicyTextBlock_zOgVrNu2ulub" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_869_zlz8rqKOxMCk">Prepaid taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prepaid taxes include (i) prepaid income taxes that will either be refundable or utilized to offset future income tax; and (ii) goods and service tax (“GST”) to be refundable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_841_ecustom--PrepaymentsAndDepositsPolicyTextBlock_zC5JroYMdy2j" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86E_zshXbngNQCw4">Prepayments and deposits</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prepayments and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of June 30, 2020, and December 31, 2019, there is <span id="xdx_902_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20200630_zC4Ybb80YRQi" title="Allowance for doubtful accounts"><span id="xdx_90B_ecustom--AllowanceForDoubtfulAccountsReceivablesCurrent_iI_pp0p0_do_c20191231_zk9wWjCgEjl1" title="Allowance for doubtful accounts">no</span></span> allowance for the doubtful accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 0 0 <p id="xdx_84B_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_zYEQe4VCnRCj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zh3KystFPh2l">Property and equipment, net</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_895_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zhW1QzjRieA6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_zVlMmrIigpbe" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.5pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Useful Life</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.5pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 71%; text-align: justify; padding-left: 0.5pt">Computer and office equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 25%; text-align: center" title="Estimated Useful Life of Property and Equipment"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zHLN9lUG3bG" title="Estimated Useful Life of Property and Equipment">5</span>-<span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zTU1X7H0YJ67" title="Estimated Useful Life of Property and Equipment">7</span> years </span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.5pt">Furniture &amp; fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zlMtL4Sl9tC1" title="Estimated Useful Life of Property and Equipment">6</span>-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_z0Sb8uf2Yhde" title="Estimated Useful Life of Property and Equipment">7</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.5pt">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember" title="Estimated Useful Lives of Property and Equipment">Lease Term</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.5pt">Vehicle</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center" title="Estimated Useful Life of Property and Equipment"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zlJseTRPyd86" title="Estimated Useful Life of Property and Equipment">5</span> years</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A4_zW0kv1aOUDzh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates of useful lives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_ecustom--ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock_zhW1QzjRieA6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B9_zVlMmrIigpbe" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center; padding-bottom: 1.5pt; padding-left: 0.5pt"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Useful Life</b></span></td><td style="padding-bottom: 1.5pt; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.5pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 71%; text-align: justify; padding-left: 0.5pt">Computer and office equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 25%; text-align: center" title="Estimated Useful Life of Property and Equipment"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MinimumMember_zHLN9lUG3bG" title="Estimated Useful Life of Property and Equipment">5</span>-<span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ComputerAndOfficeEquipmentMember__srt--RangeAxis__srt--MaximumMember_zTU1X7H0YJ67" title="Estimated Useful Life of Property and Equipment">7</span> years </span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-left: 0.5pt">Furniture &amp; fixtures</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zlMtL4Sl9tC1" title="Estimated Useful Life of Property and Equipment">6</span>-<span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_z0Sb8uf2Yhde" title="Estimated Useful Life of Property and Equipment">7</span> years</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.5pt">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentEstimatedUsefulLives_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember" title="Estimated Useful Lives of Property and Equipment">Lease Term</span></span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.5pt">Vehicle</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center" title="Estimated Useful Life of Property and Equipment"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20200101__20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_zlJseTRPyd86" title="Estimated Useful Life of Property and Equipment">5</span> years</span></td><td style="text-align: left"> </td></tr> </table> P5Y P7Y P6Y P7Y Lease Term P5Y <p id="xdx_848_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zs0KjCzz1lng" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zSGhisgVIbZ4">Intangible assets, net</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89D_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_zFCXpTIeMX0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B5_ztRg3NWPpAU4" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; width: 71%; font-weight: bold; padding-left: 0.5pt">Classification</td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 25%; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Useful Life</b></span></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.5pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.5pt">Computer software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center" title="Estimated useful lives of intangible assets"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200101__20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zXjlZ1tZrwj6" title="Estimated useful lives of intangible assets">5</span> years</span></td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8AA_zISccNW2IsC8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89D_ecustom--ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock_zFCXpTIeMX0c" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B5_ztRg3NWPpAU4" style="display: none">SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="vertical-align: bottom; background-color: White"> <td style="border-bottom: Black 1.5pt solid; width: 71%; font-weight: bold; padding-left: 0.5pt">Classification</td><td style="width: 2%; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; width: 1%; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 25%; font-weight: bold; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>Useful Life</b></span></td><td style="width: 1%; padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 0.5pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.5pt">Computer software</td><td> </td> <td style="text-align: left"> </td><td style="text-align: center" title="Estimated useful lives of intangible assets"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20200101__20200630__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--ComputerSoftwareIntangibleAssetMember_zXjlZ1tZrwj6" title="Estimated useful lives of intangible assets">5</span> years</span></td><td style="text-align: left"> </td></tr> </table> P5Y <p id="xdx_849_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zCMoRajgRvi1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_860_zNRFY7JUJr1a">Impairment for long-lived assets</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Long-lived assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of June 30, 2020, and December 31, 2019, <span id="xdx_901_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20200101__20200630_z3SuvbsDddNd" title="Impairment of long-lived assets"><span id="xdx_90A_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_pp0p0_do_c20190101__20191231_zc4GGrP3s7D8" title="Impairment of long-lived assets">no</span></span> impairment of long-lived assets was recognized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 0 0 <p id="xdx_84B_ecustom--DeferredOfferingCostsPolicyTextBlock_z98msM5qzz8i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_zvxwWmAyEJ7l">Deferred offering costs</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Deferred offering costs represents costs associated with the Company’s current offering which will be netted against the proceeds from the Company’s current offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84D_eus-gaap--MarketableSecuritiesPolicy_zOanJU6YQHV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86C_z1hObp8JBpgk">Investment in marketable equity securities</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 1, 2019, the Company adopted ASU 2016-01, <i>Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities</i>. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s consolidated statements of operations and comprehensive loss in the caption of “unrealized holding losses on marketable securities” in each reporting period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"/> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_841_ecustom--NonMarketableSecuritiesPolicyTextBlock_zxnhlLwKjzre" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_865_ziIUscL6a7a2">Investment in non-marketable equity securities</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 1, 2019, the Company adopted ASU 2016-01, <i>Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities</i>. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_849_ecustom--CustomerDepositsPolicyTextBlock_zZPJgIzeDVh6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86E_zHSB2e4R79Wi">Customer deposits</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Customer deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced when the related sale is recognized in accordance with the Company’s revenue recognition policy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84C_eus-gaap--RevenueRecognitionPolicyTextBlock_z7mOKx3BYII1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zW7IEdukcFwg">Revenue recognition</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not result in an adjustment to retained earnings upon adoption of this new guidance as the Company’s revenue was recognized based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Prior to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance and confirmed that there were no differences in the pattern of revenue recognition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Sales of Health and Wellness products</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">- <i>Performance obligations satisfied at a point in time</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods, which is generally similar to when its delivery has occurred prior to July 1, 2019 Such revenues are recognized at a point in time after all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and wellness products transaction price upon such sales transactions occurred. The Company’s coupons have a validity period of six months. If the Company’s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues. For the three and six months ended June 30, 2020, the Company recognized $<span id="xdx_90D_ecustom--ForfeitedCouponIncome_c20200101__20200630_pp0p0" title="Forfeited coupon income">61,368</span> as forfeited coupon income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2020, the Company had contracts for the sales of health and wellness products amounting to $<span id="xdx_907_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__srt--ProductOrServiceAxis__custom--HealthAndWellnessProductsMember_pp0p0" title="Revenue">661,900</span> which it is expected to fulfill within 12 months from June 30, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_zzZRr8Ia8vi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Disaggregated information of revenues by products are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B6_zTpzNAylW8ij" style="display: none">SCHEDULE OF DISAGGREGATED INFORMATION OF REVENUES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the three months ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Ionized Cal-Mag</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="width: 11%; text-align: right" title="Total revenues">611,160</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="width: 11%; text-align: right" title="Total revenues">167</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="width: 11%; text-align: right" title="Total revenues">611,160</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="width: 11%; text-align: right" title="Total revenues">55,660</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Omega Blend</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">162,543</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">207</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">162,543</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">68,896</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Young Formula</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--YoungFormulaMember_pp0p0" style="text-align: right" title="Total revenues">349,738</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--YoungFormulaMember_pp0p0" style="text-align: right" title="Total revenues">353</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--YoungFormulaMember_pp0p0" style="text-align: right" title="Total revenues">349,738</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--YoungFormulaMember_pp0p0" style="text-align: right" title="Total revenues">117,332</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Organic Youth Care Cleansing Bar</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_pp0p0" style="text-align: right">28,805</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_pp0p0" style="text-align: right" title="Total revenues">53</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_pp0p0" style="text-align: right" title="Total revenues">28,805</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_pp0p0" style="text-align: right" title="Total revenues">17,728</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Trim+</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--TrimPlusMember_zqGHZ5XclYul" style="text-align: right" title="Total revenues">223,497</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--TrimPlusMember_pp0p0" style="text-align: right" title="Total revenues">133,319</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--TrimPlusMember_pp0p0" style="text-align: right" title="Total revenues">223,497</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--TrimPlusMember_pp0p0" style="text-align: right" title="Total revenues">198,614</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Lipomask</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--LipomaskMember_pp0p0" style="text-align: right" title="Total revenues">8,420</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--LipomaskMember_pp0p0" style="text-align: right" title="Total revenues">422</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--LipomaskMember_pp0p0" style="text-align: right" title="Total revenues">8,420</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--LipomaskMember_pp0p0" style="text-align: right" title="Total revenues">140,588</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Beta Maxx</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--BetaMaxxmMember_pp0p0" style="text-align: right" title="Total revenues">11,434</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--BetaMaxxmMember_pp0p0" style="text-align: right" title="Total revenues">123,470</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--BetaMaxxmMember_pp0p0" style="text-align: right" title="Total revenues">11,434</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--BetaMaxxmMember_pp0p0" style="text-align: right" title="Total revenues">123,470</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Energized Mineral Concentrate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">22,606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">138,481</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">22,606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">138,481</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Survivor Select</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="text-align: right" title="Total revenues">35,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0805">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="text-align: right" title="Total revenues">35,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0809">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Vege-Fruit Fiber</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_pp0p0" style="text-align: right" title="Total revenues">6,106</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0813">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_pp0p0" style="text-align: right" title="Total revenues">6,106</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0817">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Mitogize</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--MitogizeMember_pp0p0" style="text-align: right" title="Total revenues">4,711</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--MitogizeMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0821">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--MitogizeMember_pp0p0" style="text-align: right" title="Total revenues">4,711</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--MitogizeMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0825">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Hyaluronic Acid Serum</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--HyaluronicAcidSerumMember_pp0p0" style="text-align: right" title="Total revenues">55,721</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--HyaluronicAcidSerumMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0829">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--HyaluronicAcidSerumMember_pp0p0" style="text-align: right" title="Total revenues">55,721</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--HyaluronicAcidSerumMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0833">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Mousse Facial Cleanser</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--MousseFacialCleanserMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues">3,127</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--MousseFacialCleanserMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0837">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--MousseFacialCleanserMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues">3,127</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--MousseFacialCleanserMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0841">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">1,523,862</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20190401__20190630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">396,472</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">1,523,862</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20190101__20190630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">860,769</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zDI9OvC6SP5k" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 61368 661900 <p id="xdx_897_eus-gaap--DisaggregationOfRevenueTableTextBlock_zzZRr8Ia8vi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Disaggregated information of revenues by products are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B6_zTpzNAylW8ij" style="display: none">SCHEDULE OF DISAGGREGATED INFORMATION OF REVENUES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the three months ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="font-weight: bold; text-align: center">For the six months ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%; text-align: left">Ionized Cal-Mag</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="width: 11%; text-align: right" title="Total revenues">611,160</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="width: 11%; text-align: right" title="Total revenues">167</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="width: 11%; text-align: right" title="Total revenues">611,160</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--IonizedCalMagMember_pp0p0" style="width: 11%; text-align: right" title="Total revenues">55,660</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Omega Blend</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">162,543</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">207</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">162,543</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--OmegaBlendMember_pp0p0" style="text-align: right" title="Total revenues">68,896</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Young Formula</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--YoungFormulaMember_pp0p0" style="text-align: right" title="Total revenues">349,738</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--YoungFormulaMember_pp0p0" style="text-align: right" title="Total revenues">353</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--YoungFormulaMember_pp0p0" style="text-align: right" title="Total revenues">349,738</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--YoungFormulaMember_pp0p0" style="text-align: right" title="Total revenues">117,332</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Organic Youth Care Cleansing Bar</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_pp0p0" style="text-align: right">28,805</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_pp0p0" style="text-align: right" title="Total revenues">53</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_pp0p0" style="text-align: right" title="Total revenues">28,805</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--OrganicYouthCareCleansingBarMember_pp0p0" style="text-align: right" title="Total revenues">17,728</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Trim+</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__custom--TrimPlusMember_zqGHZ5XclYul" style="text-align: right" title="Total revenues">223,497</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--TrimPlusMember_pp0p0" style="text-align: right" title="Total revenues">133,319</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--TrimPlusMember_pp0p0" style="text-align: right" title="Total revenues">223,497</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--TrimPlusMember_pp0p0" style="text-align: right" title="Total revenues">198,614</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Lipomask</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--LipomaskMember_pp0p0" style="text-align: right" title="Total revenues">8,420</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--LipomaskMember_pp0p0" style="text-align: right" title="Total revenues">422</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--LipomaskMember_pp0p0" style="text-align: right" title="Total revenues">8,420</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--LipomaskMember_pp0p0" style="text-align: right" title="Total revenues">140,588</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Beta Maxx</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--BetaMaxxmMember_pp0p0" style="text-align: right" title="Total revenues">11,434</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--BetaMaxxmMember_pp0p0" style="text-align: right" title="Total revenues">123,470</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--BetaMaxxmMember_pp0p0" style="text-align: right" title="Total revenues">11,434</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--BetaMaxxmMember_pp0p0" style="text-align: right" title="Total revenues">123,470</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Energized Mineral Concentrate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">22,606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">138,481</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">22,606</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--EnergizedMineralConcentrateMember_pp0p0" style="text-align: right" title="Total revenues">138,481</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Survivor Select</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="text-align: right" title="Total revenues">35,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0805">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="text-align: right" title="Total revenues">35,994</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--SurvivorSelectMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0809">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Vege-Fruit Fiber</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_pp0p0" style="text-align: right" title="Total revenues">6,106</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0813">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_pp0p0" style="text-align: right" title="Total revenues">6,106</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--VegeFruitFiberMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0817">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Mitogize</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--MitogizeMember_pp0p0" style="text-align: right" title="Total revenues">4,711</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--MitogizeMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0821">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--MitogizeMember_pp0p0" style="text-align: right" title="Total revenues">4,711</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--MitogizeMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0825">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Hyaluronic Acid Serum</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--HyaluronicAcidSerumMember_pp0p0" style="text-align: right" title="Total revenues">55,721</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--HyaluronicAcidSerumMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0829">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--HyaluronicAcidSerumMember_pp0p0" style="text-align: right" title="Total revenues">55,721</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--HyaluronicAcidSerumMember_pp0p0" style="text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0833">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Mousse Facial Cleanser</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_eus-gaap--Revenues_c20200401__20200630__srt--ProductOrServiceAxis__custom--MousseFacialCleanserMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues">3,127</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_eus-gaap--Revenues_c20190401__20190630__srt--ProductOrServiceAxis__custom--MousseFacialCleanserMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0837">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--Revenues_c20200101__20200630__srt--ProductOrServiceAxis__custom--MousseFacialCleanserMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues">3,127</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--Revenues_c20190101__20190630__srt--ProductOrServiceAxis__custom--MousseFacialCleanserMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total revenues"><span style="-sec-ix-hidden: xdx2ixbrl0841">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total revenues</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Revenues_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">1,523,862</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--Revenues_c20190401__20190630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">396,472</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">1,523,862</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20190101__20190630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total revenues">860,769</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 611160 167 611160 55660 162543 207 162543 68896 349738 353 349738 117332 28805 53 28805 17728 223497 133319 223497 198614 8420 422 8420 140588 11434 123470 11434 123470 22606 138481 22606 138481 35994 35994 6106 6106 4711 4711 55721 55721 3127 3127 1523862 396472 1523862 860769 <p id="xdx_849_eus-gaap--CostOfSalesPolicyTextBlock_znuBmw9nRach" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_868_zKscReCBjQee">Cost of revenue</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Cost of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_84A_ecustom--ShippingAndHandlingPolicyTextBlock_zUMdCXxbp0J9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_zEuItBfHEdb">Shipping and handling</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Shipping and handling charges amounted to $<span id="xdx_902_eus-gaap--SellingExpense_pp0p0_c20200401__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_zMQ05FIzu4ql" title="Selling expenses">2,555</span> and $<span id="xdx_907_eus-gaap--SellingExpense_c20190401__20190630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Selling expenses">0</span> for the three months ended June 30, 2020 and 2019, respectively. Shipping and handling charges amounted to $<span id="xdx_90C_eus-gaap--SellingExpense_c20200101__20200630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Selling expenses">2,555</span> and $<span id="xdx_90B_eus-gaap--SellingExpense_c20190101__20190630__srt--ProductOrServiceAxis__us-gaap--ShippingAndHandlingMember_pp0p0" title="Selling expenses">0</span> for the six months ended June 30, 2020 and 2019, respectively. Shipping and handling charges are expensed as incurred and included in selling expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 2555 0 2555 0 <p id="xdx_846_eus-gaap--AdvertisingCostsPolicyTextBlock_zCrmOoRd1FS8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_862_zxjsITGKjfZg">Advertising costs</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Advertising costs amounted to $<span id="xdx_900_eus-gaap--AdvertisingExpense_c20200401__20200630_pp0p0" title="Advertising costs">2,882</span> and $<span id="xdx_901_eus-gaap--AdvertisingExpense_c20190401__20190630_pp0p0" title="Advertising costs">0</span> for the three months ended June 30, 2020 and 2019, respectively. Advertising costs amounted to $<span id="xdx_903_eus-gaap--AdvertisingExpense_c20200101__20200630_pp0p0" title="Advertising costs">2,882</span> and $<span id="xdx_902_eus-gaap--AdvertisingExpense_c20190101__20190630_pp0p0" title="Advertising costs">0</span> for the six months ended June 30, 2020 and 2019, respectively. Advertising costs are expensed as incurred and included in selling expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 2882 0 2882 0 <p id="xdx_84B_eus-gaap--CommissionsExpensePolicyPolicyTextBlock_zPeARW0xc8Cg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="text-decoration: underline"><span id="xdx_862_zkYvCbD9ztpj">Commission expenses</span> </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Commission expenses are the Company’s most significant expenses. As with all companies in the network marketing industry, the Company’s sales channel is external to the Company. The Company’s “external sales force” is stratified into two levels based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly, are referred to as “sales network members”. The Company pays commission to every sales distributor based on purchases made by its sales network members which includes the independent direct sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain amount of the Company’s inventory on their store premises. The stockists shall account to the Company for all products sales from their store premises as monitored through the Company’s centralized stock tracking system. The Company pays a separate commission to stockists based on revenue generated from the stockists’ physical stores. Commission expenses amounted to $<span id="xdx_90C_ecustom--SalesCommissionsAndFees1_pp0p0_c20200401__20200630_z4Wz6qcIApGf" title="Commission expenses">382,498</span> and $<span id="xdx_900_ecustom--SalesCommissionsAndFees1_pp0p0_c20190401__20190630_zvIwlJ5pXP1l" title="Commission expenses">0</span> for the three months ended June 30, 2020 and 2019, respectively. Commission expenses amounted to $<span id="xdx_90C_ecustom--SalesCommissionsAndFees1_pp0p0_c20200101__20200630_zSH2Hn6KvAhi" title="Commission expenses">382,498</span> and $<span id="xdx_908_ecustom--SalesCommissionsAndFees1_pp0p0_c20190101__20190630_zHQ4tSWVYv35" title="Commission expenses">0</span> for the six months ended June 30, 2020 and 2019, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 382498 0 382498 0 <p id="xdx_84F_ecustom--DefinedContributionPlanPolicyTextBlock_zjjWcEZi6J55" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><span style="text-decoration: underline"><span id="xdx_86F_zjzFHqF0GfEg">Defined contribution plan</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue and pay for these benefits based on certain percentages of the employees’ respective salaries, subject to certain ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan. Total expenses for the plans were $<span id="xdx_904_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_c20200401__20200630_pp0p0" title="Defined contribution plan expense">23,710</span> and $<span id="xdx_905_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_c20190401__20190630_pp0p0" title="Defined contribution plan expense">0</span> for the three months ended June 30, 2020 and 2019, respectively. Total expenses for the plans were $<span id="xdx_901_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_c20200101__20200630_pp0p0" title="Defined contribution plan expense">23,710</span> and $<span id="xdx_900_eus-gaap--DefinedContributionPlanEmployerDiscretionaryContributionAmount_c20190101__20190630_pp0p0" title="Defined contribution plan expense">0</span> for the six months ended June 30, 2020 and 2019, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The related contribution plans include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Social Security Organization (“SOSCO”) – <span id="xdx_903_ecustom--SalaryPercentage_pii_dp_c20200101__20200630__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember_zsDcpS3Ujllf" title="Salary percentage">1.75%</span> based on employee’s monthly salary capped of RM <span id="xdx_901_ecustom--MonthlySalary_pp0p0_c20200101__20200630__dei--LegalEntityAxis__custom--SocialSecurityOrganizationMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zv6dq4jnqurg" title="Monthly salary">4,000</span>;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Employees Provident Fund (“EPF”) – <span id="xdx_907_ecustom--SalaryPercentage_pii_dp_c20200101__20200630__dei--LegalEntityAxis__custom--EmployeesProvidentFundMember_z4doc6uiSTY3" title="Salary percentage">12%</span> based on employee’s monthly salary;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Employment Insurance System (“EIS”) – <span id="xdx_901_ecustom--SalaryPercentage_pii_dp_c20200101__20200630__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember_zs4y3M6mkIgg" title="Salary percentage">0.2%</span> based on employee’s monthly salary capped of RM <span id="xdx_906_ecustom--MonthlySalary_pp0p0_c20200101__20200630__dei--LegalEntityAxis__custom--EmploymentInsuranceSystemMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zgVp2qOP8Zok" title="Monthly salary">4,000</span>;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Human Resource Development Fund (“HRDF”) – <span id="xdx_909_ecustom--SalaryPercentage_pii_dp_c20200101__20200630__dei--LegalEntityAxis__custom--HumanResourceDevelopmentFundMember_zpbNFP0r11N4" title="Salary percentage">1%</span> based on employee’s monthly salary</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 23710 0 23710 0 0.0175 4000 0.12 0.002 4000 0.01 <p id="xdx_84E_eus-gaap--IncomeTaxPolicyTextBlock_zNiCGuDpZPNf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86D_zu9NSjgRA534">Income taxes</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is <span id="xdx_906_eus-gaap--IncomeTaxExaminationLikelihoodOfUnfavorableSettlement_c20200101__20200630" title="Income tax examination, likelihood of unfavorable settlement">greater than 50%</span> likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded.<span id="xdx_905_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20200101__20200630_zk2HzgUPWJ02" title="Penalties and interest incurred"> <span id="xdx_90E_eus-gaap--IncomeTaxExaminationPenaltiesAndInterestExpense_pp0p0_do_c20190101__20190630_zYfNN6H9jp82" title="Penalties and interest incurred">No</span></span> penalties and interest incurred related to underpayment of income tax for the three and six months ended June 30, 2020 and 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> greater than 50% 0 0 <p id="xdx_84F_eus-gaap--ComprehensiveIncomePolicyPolicyTextBlock_zV4cZpDkRmj3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_861_zwEfQ8PeFnfa">Comprehensive income (loss)</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_843_ecustom--NoncontrollingInterestPolicyTextBlock_zc5Enj97N2Q3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zmeoqu5ADT7h">Non-controlling interest</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_eus-gaap--MinorityInterestDescription_c20200101__20200630_zFdoKN9YhnH1" title="Noncontrolling interest, description">Non-controlling interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals.</span> The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders and the shareholders of the Company. As of June 30, 2020, the non-controlling interest balance was $<span id="xdx_906_eus-gaap--MinorityInterest_iI_c20200630_z9iVTLP6hxn9" title="Non-controlling interest">0</span> and therefore not presented in the accompanying unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> Non-controlling interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals. 0 <p id="xdx_84A_eus-gaap--EarningsPerSharePolicyTextBlock_zNS1Ogmh4XNd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_866_zWdT0ugusPe7">Earnings (loss) per share</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. For the three and six months ended June 30, 2020 and 2019, there were <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20200101__20200630_zAaAm3m2xCC5" title="Potentially dilutive securities outstanding"><span id="xdx_907_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20190101__20191231_zFATpwHrGhzh" title="Potentially dilutive securities outstanding">no</span></span> dilutive shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> 0 0 <p id="xdx_840_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_z66VqssJISF4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_864_zGbjhqiMJxWg">Foreign currencies translation and transaction</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit (“MYR” or “RM”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency. The Company’s subsidiary and VIE in Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (“MYR” or “RM”), as its functional currency.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “<i>Translation of Financial Statement”</i>, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zE1nM40yyTjd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B3_zvaGDI8K8hF1" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Period-end MYR : US$1 exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_pii" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation">4.28</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_pii" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation">4.09</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Period-end HKD : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_pii" style="text-align: right" title="Foreign Currency Exchange Rate, Translation">7.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_pii" style="text-align: right" title="Foreign Currency Exchange Rate, Translation">7.79</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the three months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: left">Period-average MYR : US$<span id="xdx_909_eus-gaap--EffectOfExchangeRateOnCash_c20200401__20200630__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_90E_eus-gaap--EffectOfExchangeRateOnCash_c20190401__20190630__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_905_eus-gaap--EffectOfExchangeRateOnCash_c20200101__20200630__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_904_eus-gaap--EffectOfExchangeRateOnCash_c20190101__20190630__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_pp0p0" title="Exchange rate">1</span></span></span></span> exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20200401__20200630__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_pii" style="width: 10%; text-align: right" title="Foreign currency exchange rate period average">4.32</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20190401__20190630__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_pii" style="width: 10%; text-align: right" title="Foreign currency exchange rate period average">4.15</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20200101__20200630__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_pii" style="width: 10%; text-align: right" title="Foreign currency exchange rate period average">4.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20190101__20190630__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_pii" style="width: 10%; text-align: right" title="Foreign currency exchange rate period average">4.12</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Period-average HKD : US$<span id="xdx_908_eus-gaap--EffectOfExchangeRateOnCash_c20200401__20200630__us-gaap--AwardTypeAxis__custom--HKDCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_90B_eus-gaap--EffectOfExchangeRateOnCash_c20190401__20190630__us-gaap--AwardTypeAxis__custom--HKDCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_906_eus-gaap--EffectOfExchangeRateOnCash_c20200101__20200630__us-gaap--AwardTypeAxis__custom--HKDCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_907_eus-gaap--EffectOfExchangeRateOnCash_c20190101__20190630__us-gaap--AwardTypeAxis__custom--HKDCurrencyMember_pp0p0" title="Exchange rate">1</span></span></span></span> exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20200401__20200630__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_pii" style="text-align: right" title="Foreign currency exchange rate period average">7.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20190401__20190630__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_pii" style="text-align: right" title="Foreign currency exchange rate period average">7.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20200101__20200630__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_pii" style="text-align: right" title="Foreign currency exchange rate period average">7.76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20190101__20190630__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_pii" style="text-align: right" title="Foreign currency exchange rate period average">7.84</td><td style="text-align: left"> </td></tr> </table> <p id="xdx_8A4_zB1WYaaGw5qd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_895_eus-gaap--ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock_zE1nM40yyTjd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B3_zvaGDI8K8hF1" style="display: none">SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Period-end MYR : US$1 exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_pii" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation">4.28</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndMYRMember_pii" style="width: 16%; text-align: right" title="Foreign Currency Exchange Rate, Translation">4.09</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Period-end HKD : US$1 exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20200630__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_pii" style="text-align: right" title="Foreign Currency Exchange Rate, Translation">7.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--ForeignCurrencyExchangeRateTranslation1_c20191231__us-gaap--VariableRateAxis__custom--PeriodEndHKDMember_pii" style="text-align: right" title="Foreign Currency Exchange Rate, Translation">7.79</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the three months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 44%; text-align: left">Period-average MYR : US$<span id="xdx_909_eus-gaap--EffectOfExchangeRateOnCash_c20200401__20200630__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_90E_eus-gaap--EffectOfExchangeRateOnCash_c20190401__20190630__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_905_eus-gaap--EffectOfExchangeRateOnCash_c20200101__20200630__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_904_eus-gaap--EffectOfExchangeRateOnCash_c20190101__20190630__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_pp0p0" title="Exchange rate">1</span></span></span></span> exchange rate</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_989_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20200401__20200630__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_pii" style="width: 10%; text-align: right" title="Foreign currency exchange rate period average">4.32</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_988_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20190401__20190630__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_pii" style="width: 10%; text-align: right" title="Foreign currency exchange rate period average">4.15</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20200101__20200630__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_pii" style="width: 10%; text-align: right" title="Foreign currency exchange rate period average">4.25</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_984_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20190101__20190630__us-gaap--VariableRateAxis__custom--PeriodAverageMYRMember_pii" style="width: 10%; text-align: right" title="Foreign currency exchange rate period average">4.12</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Period-average HKD : US$<span id="xdx_908_eus-gaap--EffectOfExchangeRateOnCash_c20200401__20200630__us-gaap--AwardTypeAxis__custom--HKDCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_90B_eus-gaap--EffectOfExchangeRateOnCash_c20190401__20190630__us-gaap--AwardTypeAxis__custom--HKDCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_906_eus-gaap--EffectOfExchangeRateOnCash_c20200101__20200630__us-gaap--AwardTypeAxis__custom--HKDCurrencyMember_pp0p0" title="Exchange rate"><span id="xdx_907_eus-gaap--EffectOfExchangeRateOnCash_c20190101__20190630__us-gaap--AwardTypeAxis__custom--HKDCurrencyMember_pp0p0" title="Exchange rate">1</span></span></span></span> exchange rate</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20200401__20200630__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_pii" style="text-align: right" title="Foreign currency exchange rate period average">7.75</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20190401__20190630__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_pii" style="text-align: right" title="Foreign currency exchange rate period average">7.84</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20200101__20200630__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_pii" style="text-align: right" title="Foreign currency exchange rate period average">7.76</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--ForeignCurrencyExchangeRatePeriodAverage_c20190101__20190630__us-gaap--VariableRateAxis__custom--PeriodAverageHKDMember_pii" style="text-align: right" title="Foreign currency exchange rate period average">7.84</td><td style="text-align: left"> </td></tr> </table> 4.28 4.09 7.75 7.79 1 1 1 1 4.32 4.15 4.25 4.12 1 1 1 1 7.75 7.84 7.76 7.84 <p id="xdx_844_ecustom--RelatedPartiesPolicyTextBlock_zq5uBaePxFFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_865_zVZD34Aptwkl">Related parties</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_845_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zBitYtm8HEXe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_869_z9xqaQMnwpI1">Fair value of financial instruments</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_846_eus-gaap--LesseeLeasesPolicyTextBlock_zA8KyNsY9iM" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_zE1buhAOrBMl">Leases</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Effective July 1, 2019, the Company adopted ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that does not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing leases with a lease term in excess of twelve months on July 1, 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Operating lease right-of-use (“ROU”) assets and lease liabilities are recognized at the adoption date of July 1, 2019 or the commencement date, whichever is earlier, based on the present value of lease payments over the lease term. Since the implicit rate for the Company’s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment and over a similar term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future pre-tax cash flows.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_843_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_znvcQgQx3MHi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86F_z2pCYx5IvFhk">Recent accounting pronouncements</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The Company does not expect the adoption of this standard to have a material impact on its unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_846_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zy1YsdaIphzl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline"><span id="xdx_86A_zZnFlMK4KZw3">Reclassification</span></span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Certain prior period amounts have been reclassified to conform to the current period presentation for the three and six months ended June 30, 2019. These reclassifications have no effect on the unaudited condensed consolidated statements of operations and comprehensive income (loss).</span></p> <p id="xdx_80E_eus-gaap--VariableInterestEntityDisclosureTextBlock_zfwccTeYxzGf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>3. <span id="xdx_829_zYPAzI33LQGg">VARIABLE INTEREST ENTITY (“VIE”)</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">SEA is a trading company incorporated on March 4, 2004, under the laws of Malaysia. SEA provided all of ASL’s purchases. Its equity at risk was insufficient to finance its activities and <span id="xdx_90E_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_c20200630_zP4W3ADbrcG5" title="Ownership interest percentage">100%</span> of its business is transacted with ASL. Therefore it was considered to be a VIE and ASL is the primary beneficiary since it has both of the following characteristics:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 24px; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">a.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">The power to direct the activities of the VIE that most significantly impact the VIE’s economic performance; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">b.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">The obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE</span><span style="font: 10pt Times New Roman, Times, Serif">.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Accordingly, the accounts of SEA is consolidated in the accompanying unaudited condensed financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_z0eOdm1h49Ej" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">The carrying amount of the VIE’s assets and liabilities were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B3_z4qkXv3aQBD7" style="display: none">SCHEDULE OF VARIABLE INTEREST ENTITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; text-align: left">Current assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsCurrent_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="width: 15%; text-align: right" title="Current assets">290,630</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Current liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--LiabilitiesCurrent_iNI_pp0p0_di_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zDxkqLc2nkMi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current liabilities">(289,911</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Assets_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net assets">719</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>3. </b></span><span style="font: 10pt Times New Roman, Times, Serif"><b>VARIABLE INTEREST ENTITY (“VIE”) (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Current asset:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 81%; text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="width: 15%; text-align: right" title="Cash and cash equivalents"><span style="font-family: Times New Roman, Times, Serif">18,680</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Accounts receivable – intercompany</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zHIaJL3GlvGj" style="text-align: right" title="Accounts receivable - intercompany"><span style="font-family: Times New Roman, Times, Serif">260,438</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--PrepaidTaxes_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="text-align: right" title="Prepaid taxes"><span style="font-family: Times New Roman, Times, Serif">3,113</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepayments and deposits</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Prepayments and Deposits"><span style="font-family: Times New Roman, Times, Serif">8,399</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AssetsCurrent_iI_pp0p0_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zpxjddciWVlf" style="border-bottom: Black 2.5pt double; text-align: right" title="Total current assets"><span style="font-family: Times New Roman, Times, Serif">290,630</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Current liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Accounts payable – intercompany</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--AccountsPayableCurrent_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="text-align: right" title="Accounts payable &amp;nbsp intercompany"><span style="font-family: Times New Roman, Times, Serif">286,820</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Other payables and accrued liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="text-align: right" title="Other payables and accrued liabilities"><span style="font-family: Times New Roman, Times, Serif">2,741</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Other payables – intercompany</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--OtherPayablesRelatedPartyCurrent_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other payables &amp;nbsp intercompany"><span style="font-family: Times New Roman, Times, Serif">350</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--LiabilitiesCurrent_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total current liabilities"><span style="font-family: Times New Roman, Times, Serif">289,911</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The summarized operating results of the VIE’s are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">June 30, 2020</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Six</p> <p style="margin-top: 0; margin-bottom: 0">Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">June 30, 2020</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Operating revenues</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Revenue">129,492</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Revenue">129,492</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Gross profit</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--GrossProfit_c20200401__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross profit">1,373</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--GrossProfit_c20200101__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross profit">1,373</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Loss from operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingIncomeLoss_c20200401__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss from operations">(3,749</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--OperatingIncomeLoss_c20200101__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss from operations">(3,749</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--NetIncomeLoss_c20200401__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss">(18,139</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20200101__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss">(18,139</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A7_zKHPYN7ZdTPk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> 1 <p id="xdx_89B_eus-gaap--ScheduleOfVariableInterestEntitiesTextBlock_z0eOdm1h49Ej" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif">The carrying amount of the VIE’s assets and liabilities were as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8B3_z4qkXv3aQBD7" style="display: none">SCHEDULE OF VARIABLE INTEREST ENTITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; text-align: left">Current assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsCurrent_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="width: 15%; text-align: right" title="Current assets">290,630</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Current liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--LiabilitiesCurrent_iNI_pp0p0_di_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zDxkqLc2nkMi" style="border-bottom: Black 1.5pt solid; text-align: right" title="Current liabilities">(289,911</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--Assets_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net assets">719</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>3. </b></span><span style="font: 10pt Times New Roman, Times, Serif"><b>VARIABLE INTEREST ENTITY (“VIE”) (Continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Current asset:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 81%; text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Cash and cash equivalents</span></td><td style="width: 2%"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_988_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="width: 15%; text-align: right" title="Cash and cash equivalents"><span style="font-family: Times New Roman, Times, Serif">18,680</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Accounts receivable – intercompany</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_989_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zHIaJL3GlvGj" style="text-align: right" title="Accounts receivable - intercompany"><span style="font-family: Times New Roman, Times, Serif">260,438</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepaid taxes</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_eus-gaap--PrepaidTaxes_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="text-align: right" title="Prepaid taxes"><span style="font-family: Times New Roman, Times, Serif">3,113</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Prepayments and deposits</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98E_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Prepayments and Deposits"><span style="font-family: Times New Roman, Times, Serif">8,399</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current assets</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_984_eus-gaap--AssetsCurrent_iI_pp0p0_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_zpxjddciWVlf" style="border-bottom: Black 2.5pt double; text-align: right" title="Total current assets"><span style="font-family: Times New Roman, Times, Serif">290,630</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Current liabilities:</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Accounts payable – intercompany</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_989_eus-gaap--AccountsPayableCurrent_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="text-align: right" title="Accounts payable &amp;nbsp intercompany"><span style="font-family: Times New Roman, Times, Serif">286,820</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Other payables and accrued liabilities</span></td><td><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_986_eus-gaap--AccountsPayableAndOtherAccruedLiabilitiesCurrent_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="text-align: right" title="Other payables and accrued liabilities"><span style="font-family: Times New Roman, Times, Serif">2,741</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Other payables – intercompany</span></td><td style="padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td><td id="xdx_98F_ecustom--OtherPayablesRelatedPartyCurrent_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Other payables &amp;nbsp intercompany"><span style="font-family: Times New Roman, Times, Serif">350</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 0.5pt"><span style="font-family: Times New Roman, Times, Serif">Total current liabilities</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif">$</span></td><td id="xdx_984_eus-gaap--LiabilitiesCurrent_c20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total current liabilities"><span style="font-family: Times New Roman, Times, Serif">289,911</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The summarized operating results of the VIE’s are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Three Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">June 30, 2020</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the Six</p> <p style="margin-top: 0; margin-bottom: 0">Months Ended</p> <p style="margin-top: 0; margin-bottom: 0">June 30, 2020</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Operating revenues</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200401__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Revenue">129,492</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Revenue">129,492</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Gross profit</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--GrossProfit_c20200401__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross profit">1,373</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--GrossProfit_c20200101__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross profit">1,373</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Loss from operations</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--OperatingIncomeLoss_c20200401__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss from operations">(3,749</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--OperatingIncomeLoss_c20200101__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss from operations">(3,749</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net loss</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--NetIncomeLoss_c20200401__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss">(18,139</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--NetIncomeLoss_c20200101__20200630__us-gaap--TradingActivityByTypeAxis__us-gaap--VariableIncomeInterestRateMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Net loss">(18,139</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 290630 289911 719 18680 260438 3113 8399 290630 286820 2741 350 289911 129492 129492 1373 1373 -3749 -3749 -18139 -18139 <p id="xdx_805_eus-gaap--BusinessCombinationDisclosureTextBlock_zMN2GssMmAl2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>4. <span id="xdx_824_zucyhrURYuc2">BUSNINESS COMBINATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On May 8, 2020, the Company entered into a Share Exchange Agreement (“SPA”) with Mr. How Kok Choong, CEO and director of the Company to acquire <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pii_c20200507__20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_zNc6fpsZmPMb" title="Stock issued during period acquisitions, shares">9,590,596</span> ordinary shares, <span id="xdx_90D_eus-gaap--CommonStockNoParValue_iI_pii_do_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zbwLMVlCV3Kl" title="Ordinary shares no par value">no</span> par value, equivalent to approximately <span id="xdx_90D_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200508__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zSGJcrDLgFCe" title="Ownership interest percentage">99.99</span>% of the equity interest in ASL, an entity incorporated in Malaysia. Pursuant to the SPA, as amended on July 1, 2020, Mr. How will receive an aggregate consideration of $<span id="xdx_90B_eus-gaap--BusinessCombinationConsiderationTransferred1_pp0p0_c20200629__20200701__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zuXRe8mGNEs5" title="Purchase consideration value">1,804,046</span>, which was determined based on the net asset carrying value of ASL as at March 31, 2020. The aggregate consideration shall be satisfied by (i) the offset of the Consideration whereby the Company has a loan receivable of $<span id="xdx_90F_eus-gaap--BusinessCombinationConsiderationTransferredLiabilitiesIncurred_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pp0p0" title="Loan payable">656,495</span> as of March 31, 2020 due from Mr. How; and (ii) allotment and issuance of common stock of the Company. The Company shall allot and issue <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pii" title="Stock issued during period acquisitions, shares">176,547</span> shares of the Company’s common stock, par value $<span id="xdx_906_eus-gaap--CommonStockParOrStatedValuePerShare_c20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pii" title="Common stock par value">0.0001</span>, representing approximately <span id="xdx_90F_ecustom--PercentageOfCommonStockIssuedAndOutstanding_dp_uPure_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_zCp93xEd2O52" title="Percentage of common stock issued and outstanding">0.0469</span>% of the total issued and outstanding shares in the Company after the issuance of the Shares, which is valued at $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_c20200101__20200331__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pp0p0" title="Stock issued during period, value, acquisitions">1,147,551</span> based on the closing price of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_pii_uUSDPShares_c20200731__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_zQoxH18FCjT7" title="Purchased price per shares">6.50</span> of the Company as quoted on the OTC Market on March 31, 2020. As of June 30, 2020, the Company issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200101__20200630__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember_pii" title="Issuance of common stock shares">162,294</span> shares of the Company’s common stock with the remaining <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pii_c20200629__20200701__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingSdnBhdMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYwFHuBiDqD8" title="Issuance of common stock shares">13,853</span> shares of the Company’s common stock issued on July 1, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company’s acquisition of ASL was accounted for as a business combination in accordance with ASC 805. The Company has allocated the purchase price of ASL based upon the carrying value of the identifiable assets acquired and liabilities assumed on April 1, 2020 as ASL was under the common control of Mr. How.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zojKAPi5Rmjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which represents the net purchase price allocation on the date of the acquisition of ASL.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  <span id="xdx_8B1_zQf48TJNcAyg" style="display: none">Summary of Assets Acquired and Liabilities Assumed</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20200331_z0Q7PvR6pqmf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carry Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_iB_zKusvRDnpSZa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">ASSETS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_i01B_zTNewLwAZq5l" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_i02I_maCzTpj_zrbvt6MEMWI" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; padding-left: 10pt">Cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">1,206,493</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_i02I_maCzTpj_zc0aOXAnVXta" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Other receivables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,210</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_i02I_maCzTpj_zrTDVCJqRV9b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Other receivables - related parties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">219,121</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_i02I_maCzTpj_ztsyvGwtHGp4" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">616,880</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_i02I_maCzTpj_zDjPq2zQ1PC4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Prepaid taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,206,821</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_i02I_maCzTpj_zqlikSSmjwMf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prepayments and other assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">318,267</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_i02TI_mtCzTpj_maCzlob_zK6LZ73boq0d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total current assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,600,792</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssetsAbstract_i01B_zwSmXaE2VjV9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Other assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_i02I_maCzP0J_zOIty4eSRCaa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Property and equipment, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">325,648</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_i02I_maCzP0J_zvYDmFrvEFJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Intangible assets, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,686</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_i02I_maCzP0J_zehFjxCgTuhl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Deferred taxes asset, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">172,250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_i02TI_mtCzP0J_maCzlob_zI6HjOjO63Q1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total other assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">504,584</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_i01TI_mtCzlob_maCzSF3_zYZM9HdDIMCj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 30pt">Total assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,105,376</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB_zMWxYnMs1Jzl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">LIABILITIES AND SHAREHOLDERS’ EQUITY</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_i01B_z4hvzYx6pj1g" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-left: 0">Current liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_i02I_maCzQfK_zew3zbtHx4W1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Accounts payable - related party</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">491,628</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_i02I_maCzQfK_zJAwcRZhIfQ6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Customer deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,600,606</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_i02I_maCzQfK_zLBLijlQzt17" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other payables and accrued liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">209,096</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_i02TI_mtCzQfK_maCznK5_zx62ddw5wrS9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total current liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,301,330</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_i01TI_mtCznK5_msCzSF3_z0Ykvtu9cSBi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 30pt">Total liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,301,330</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_mtCzSF3_zVAVYC0x8uTi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total net assets acquired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,804,046</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zWWncACreWy6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zRywzeXd9a4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following unaudited pro forma combined results of operations presents the Company’s financial results as if the acquisition of ASL had been completed on January 1, 2019. The unaudited pro forma results do not reflect operating efficiencies or potential cost savings which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information is not necessarily indicative of the results of operations that the Company would have recognized had we completed the transaction on January 1, 2019. Future results may vary significantly from the results in this pro forma information because of future events and transactions, as well as other factors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span><span id="xdx_8B7_zqGtofPFXTz6" style="display: none">Schedule of Pro Forma Busniness Combination</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_490_20190401__20190630_zZuoFOfdEcbf" style="font-weight: bold; text-align: center">For the Three Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_493_20200101__20200630_zhjtMP8akdK1" style="font-weight: bold; text-align: center">For the Six Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_491_20190101__20190630_z1g9C4p4P7Ak" style="font-weight: bold; text-align: center">For the Six Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaRevenue_zQbGWTVIiCE3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">684,112</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,765,114</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,914,362</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_z9bdJc2lM304" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(108,478</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(571,407</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(309,999</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_ecustom--BusinessAcquisitionsProFormaGrossProfit_z4WmzwlDFQY7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">575,634</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,193,707</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,604,363</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_zsv1LutT6NGf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,269,443</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,055,016</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,613,015</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_zslZi1ODPrch" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income (loss) from operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(693,809</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">138,691</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,008,652</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_z8yvyv1Mny56" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Other income (expense), net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(281,239</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">110,912</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(237,655</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_znld9UEc5Woh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income (loss) before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(975,048</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">249,603</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,246,307</td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_zB6Js58knvZ3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Benefit of (Provision for) income taxes</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">137,983</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(184,900</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">202,180</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zNrfY2pBJHj3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(837,065</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">64,703</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,044,127</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_402_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_zPu7doU5ost2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Net income (loss) per common share - basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">0.00</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_404_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_zAukjAJziQo7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding - basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">376,452,047</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">376,452,047</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">376,452,047</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zXbuAFe2zEJk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> 9590596 0 0.9999 1804046 656495 176547 0.0001 0.000469 1147551 6.50 162294 13853 <p id="xdx_891_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zojKAPi5Rmjb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which represents the net purchase price allocation on the date of the acquisition of ASL.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">  <span id="xdx_8B1_zQf48TJNcAyg" style="display: none">Summary of Assets Acquired and Liabilities Assumed</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20200331_z0Q7PvR6pqmf" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Carry Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_iB_zKusvRDnpSZa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">ASSETS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract_i01B_zTNewLwAZq5l" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left">Current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_i02I_maCzTpj_zrbvt6MEMWI" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; padding-left: 10pt">Cash</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right">1,206,493</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_i02I_maCzTpj_zc0aOXAnVXta" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Other receivables</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,210</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties_i02I_maCzTpj_zrTDVCJqRV9b" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Other receivables - related parties</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">219,121</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_i02I_maCzTpj_ztsyvGwtHGp4" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Inventories</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">616,880</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes_i02I_maCzTpj_zDjPq2zQ1PC4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Prepaid taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,206,821</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_i02I_maCzTpj_zqlikSSmjwMf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Prepayments and other assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">318,267</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_i02TI_mtCzTpj_maCzlob_zK6LZ73boq0d" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total current assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,600,792</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssetsAbstract_i01B_zwSmXaE2VjV9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">Other assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_i02I_maCzP0J_zOIty4eSRCaa" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Property and equipment, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">325,648</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_i02I_maCzP0J_zvYDmFrvEFJ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Intangible assets, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,686</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets_i02I_maCzP0J_zehFjxCgTuhl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Deferred taxes asset, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">172,250</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_i02TI_mtCzP0J_maCzlob_zI6HjOjO63Q1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total other assets</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">504,584</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_i01TI_mtCzlob_maCzSF3_zYZM9HdDIMCj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; padding-left: 30pt">Total assets</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">4,105,376</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_iB_zMWxYnMs1Jzl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left">LIABILITIES AND SHAREHOLDERS’ EQUITY</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract_i01B_z4hvzYx6pj1g" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-left: 0">Current liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_i02I_maCzQfK_zew3zbtHx4W1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Accounts payable - related party</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">491,628</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_i02I_maCzQfK_zJAwcRZhIfQ6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 10pt">Customer deposits</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,600,606</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_i02I_maCzQfK_zLBLijlQzt17" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Other payables and accrued liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">209,096</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities_i02TI_mtCzQfK_maCznK5_zx62ddw5wrS9" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total current liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,301,330</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_i01TI_mtCznK5_msCzSF3_z0Ykvtu9cSBi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 30pt">Total liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,301,330</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_mtCzSF3_zVAVYC0x8uTi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 20pt">Total net assets acquired</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,804,046</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 1206493 33210 219121 616880 1206821 318267 3600792 325648 6686 172250 504584 4105376 491628 1600606 209096 2301330 2301330 1804046 <p id="xdx_89D_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zRywzeXd9a4a" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following unaudited pro forma combined results of operations presents the Company’s financial results as if the acquisition of ASL had been completed on January 1, 2019. The unaudited pro forma results do not reflect operating efficiencies or potential cost savings which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information is not necessarily indicative of the results of operations that the Company would have recognized had we completed the transaction on January 1, 2019. Future results may vary significantly from the results in this pro forma information because of future events and transactions, as well as other factors.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span><span id="xdx_8B7_zqGtofPFXTz6" style="display: none">Schedule of Pro Forma Busniness Combination</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_490_20190401__20190630_zZuoFOfdEcbf" style="font-weight: bold; text-align: center">For the Three Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_493_20200101__20200630_zhjtMP8akdK1" style="font-weight: bold; text-align: center">For the Six Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" id="xdx_491_20190101__20190630_z1g9C4p4P7Ak" style="font-weight: bold; text-align: center">For the Six Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessAcquisitionsProFormaRevenue_zQbGWTVIiCE3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%">Revenue</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">684,112</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,765,114</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">1,914,362</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--BusinessAcquisitionsProFormaCostOfRevenue_z9bdJc2lM304" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(108,478</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(571,407</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(309,999</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_ecustom--BusinessAcquisitionsProFormaGrossProfit_z4WmzwlDFQY7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Gross profit</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">575,634</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,193,707</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,604,363</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_zsv1LutT6NGf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,269,443</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,055,016</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(2,613,015</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax_zslZi1ODPrch" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income (loss) from operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(693,809</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">138,691</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,008,652</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_ecustom--BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet_z8yvyv1Mny56" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Other income (expense), net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(281,239</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">110,912</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(237,655</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_ecustom--BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes_znld9UEc5Woh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Income (loss) before income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(975,048</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">249,603</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,246,307</td><td style="text-align: left">)</td></tr> <tr id="xdx_40D_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_zB6Js58knvZ3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Benefit of (Provision for) income taxes</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">137,983</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(184,900</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">202,180</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_zNrfY2pBJHj3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(837,065</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">64,703</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(1,044,127</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_402_ecustom--BusinessAcquisitionProFormaEarningsPerShareBasicDiluted_zPu7doU5ost2" style="vertical-align: bottom; background-color: White"> <td style="text-align: justify; padding-bottom: 2.5pt">Net income (loss) per common share - basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">0.00</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right">(0.00</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr id="xdx_404_ecustom--BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted_zAukjAJziQo7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Weighted average number of common shares outstanding - basic and diluted</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">376,452,047</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">376,452,047</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">376,452,047</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 684112 2765114 1914362 -108478 -571407 -309999 575634 2193707 1604363 -1269443 -2055016 -2613015 -693809 138691 -1008652 -281239 110912 -237655 -975048 249603 -1246307 137983 -184900 202180 -837065 64703 -1044127 -0.00 0.00 -0.00 376452047 376452047 376452047 <p id="xdx_809_eus-gaap--CashAndCashEquivalentsDisclosureTextBlock_zbSoidAsDvYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>5. <span id="xdx_829_zAvhPbaP0bLi">CASH AND CASH EQUIVALENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">As of June 30, 2020 and December 31, 2019 the Company has $<span id="xdx_90A_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20200630_pp0p0" title="Cash and cash equivalents">3,427,664</span> and $<span id="xdx_900_eus-gaap--CashAndCashEquivalentsAtCarryingValue_c20191231_pp0p0" title="Cash and cash equivalents">2,744,457</span>, respectively, of cash and cash equivalents, which consists of $<span id="xdx_90B_eus-gaap--Cash_c20200630_pp0p0" title="Cash in bank">917,458</span> and $<span id="xdx_901_eus-gaap--Cash_c20191231_pp0p0" title="Cash in bank">238,937</span>, respectively, of cash in banks and </span><span style="font: 10pt Times New Roman, Times, Serif">$<span id="xdx_908_eus-gaap--TimeDeposits_c20200630_pp0p0" title="Time deposits">2,483,915</span> <span style="background-color: white">and $<span id="xdx_901_eus-gaap--TimeDeposits_c20191231_pp0p0" title="Time deposits">2,505,520</span>, respectively, of time deposits placed with banks or other financial institutions and are all highly liquid investments with an original maturity of three months or less. The effective interest rate for the time deposits ranges between <span id="xdx_90D_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pii_dp_uPure_c20200630__srt--RangeAxis__srt--MinimumMember_zBYmOMFgzCwi" title="Percentage of Interest rate for time deposits">2.95</span>% to <span id="xdx_905_eus-gaap--PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits_iI_pii_dp_uPure_c20200630__srt--RangeAxis__srt--MaximumMember_zh6BUhc5EPj8" title="Percentage of Interest rate for time deposits">3.25</span>% per annum.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 3427664 2744457 917458 238937 2483915 2505520 0.0295 0.0325 <p id="xdx_80D_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zsyRfy1bo6Rg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><b>6. <span id="xdx_82E_zChkzGW3nFca">ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE – RELATED PARTY</span></b></span></p> <p id="xdx_895_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zT4WCkOmmrzi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><span style="font: 10pt Times New Roman, Times, Serif"><span style="background-color: white"> </span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><span style="font: 10pt Times New Roman, Times, Serif"><span style="background-color: white"> <span id="xdx_8B7_zXHxlfHMdb8e" style="display: none">Schedule of Accounts Receivables - Related Party</span></span></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20200630_zxA0lelFw1bj" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20191231_zj44IFdOdIx7" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40B_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARAARz44g_zCiUZcDy7dE4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">325,426</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1170">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_maARAARz44g_zbePj4Vx4ve2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts receivable – related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,694</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">520,786</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_msARAARz44g_zjg7fSqENIy4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Allowance for doubtful accounts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1175"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1176"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--AccountsReceivableAndAccountsReceivableRelatedParties_iTI_pp0p0_mtARAARz44g_zESXbPn84Gyk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total accounts receivable and accounts receivable – related party</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">334,120</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">520,786</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zT4WCkOmmrzi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><span style="font: 10pt Times New Roman, Times, Serif"><span style="background-color: white"> </span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><b><span style="font: 10pt Times New Roman, Times, Serif"><span style="background-color: white"> <span id="xdx_8B7_zXHxlfHMdb8e" style="display: none">Schedule of Accounts Receivables - Related Party</span></span></span></b></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20200630_zxA0lelFw1bj" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20191231_zj44IFdOdIx7" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40B_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARAARz44g_zCiUZcDy7dE4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accounts receivable</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">325,426</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1170">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccountsReceivableRelatedPartiesCurrent_iI_pp0p0_maARAARz44g_zbePj4Vx4ve2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts receivable – related party</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">8,694</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">520,786</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iI_pp0p0_msARAARz44g_zjg7fSqENIy4" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Allowance for doubtful accounts</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1175"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1176"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--AccountsReceivableAndAccountsReceivableRelatedParties_iTI_pp0p0_mtARAARz44g_zESXbPn84Gyk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total accounts receivable and accounts receivable – related party</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">334,120</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">520,786</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 325426 8694 520786 334120 520786 <p id="xdx_80F_eus-gaap--InventoryDisclosureTextBlock_zMoxsc6xv108" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>7. <span id="xdx_823_zRGvlDQDdegj">INVENTORIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zNqul1mK83Uf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inventories consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B1_zsThpeybJgs6" style="display: none">Schedule of Inventories</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20200630_zFgK1tL9K38g" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20191231_zcCdOwPY2yE5" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Finished goods</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">416,627</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">           <span style="-sec-ix-hidden: xdx2ixbrl1186"> </span>-</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zzZ7Kjhj3eAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zNqul1mK83Uf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Inventories consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B1_zsThpeybJgs6" style="display: none">Schedule of Inventories</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20200630_zFgK1tL9K38g" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20191231_zcCdOwPY2yE5" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--InventoryFinishedGoods_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; padding-bottom: 2.5pt">Finished goods</td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">416,627</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 16%; text-align: right">           <span style="-sec-ix-hidden: xdx2ixbrl1186"> </span>-</td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 416627 <p id="xdx_800_ecustom--PrepaymentsAndDepositsTextBlock_zkakruqEEeG6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white"><b>8. <span id="xdx_826_z7E1g4byCoJl">PREPAYMENTS AND DEPOSITS</span></b></span></p> <p id="xdx_89A_ecustom--ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_z7bDgSWduT1g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B2_zGeVOc3H8SIc" style="display: none">Schedule of Prepaid Expenses and Deposits</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20200630_z6dqEpI2pS04" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> June 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20191231_zhV35oqkmmRe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzG37_zSQs7DQN1VC2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Prepaid expenses</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">8,399</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,641</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--ReceivablesFromSalesDistributors_iI_pp0p0_maPEAOAzG37_zH7QkYDsATzk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Receivables from sales distributors</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,956</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1196"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DepositsToSupplier_iI_pp0p0_maPEAOAzG37_zUcvtaCPedH6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Deposits to suppliers</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">465,634</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">266,552</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzG37_zwYt0pt7QZ4c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total prepaid expenses and deposits</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">507,989</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">269,193</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zy7ZSagVBYk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89A_ecustom--ScheduleOfPrepaidExpensesAndDepositsTableTextBlock_z7bDgSWduT1g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B2_zGeVOc3H8SIc" style="display: none">Schedule of Prepaid Expenses and Deposits</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20200630_z6dqEpI2pS04" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> June 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20191231_zhV35oqkmmRe" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_401_eus-gaap--PrepaidExpenseCurrent_iI_pp0p0_maPEAOAzG37_zSQs7DQN1VC2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Prepaid expenses</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">8,399</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">2,641</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--ReceivablesFromSalesDistributors_iI_pp0p0_maPEAOAzG37_zH7QkYDsATzk" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Receivables from sales distributors</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">33,956</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1196"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_408_ecustom--DepositsToSupplier_iI_pp0p0_maPEAOAzG37_zUcvtaCPedH6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Deposits to suppliers</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">465,634</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">266,552</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iTI_pp0p0_mtPEAOAzG37_zwYt0pt7QZ4c" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total prepaid expenses and deposits</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">507,989</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">269,193</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 8399 2641 33956 465634 266552 507989 269193 <p id="xdx_80B_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zplwnAhEiNMg" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>9. <span id="xdx_82C_z7rBNFXV1S5l">PROPERTY AND EQUIPMENT, NET</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zwavJS6EuhZj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Property and equipment, net consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B1_zdzhJ4XeqMJd" style="display: none">Schedule of Property and Equipment. Net</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20200630_zTEI8nhGA6Vg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20191231_zkGud9vzDymf" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Computer and office equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="width: 16%; text-align: right" title="Subtotal">71,785</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pip0" style="width: 16%; text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1210">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture &amp; fixtures</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Subtotal">119,166</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pip0" style="text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1214">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="text-align: right" title="Subtotal">197,564</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pip0" style="text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1218">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Vehicle</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subtotal">96,263</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pip0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1222">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzvyH_zVe42IQA1VLa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Subtotal</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">484,778</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1225"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzvyH_zbuUM1madh85" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(172,919</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1228"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzvyH_ziLRjQr8zUed" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">311,859</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Depreciation expense for the three months ended June 30, 2020 and 2019 amounted to $<span id="xdx_90C_eus-gaap--Depreciation_c20200401__20200630_pp0p0" title="Depreciation expense">17,716</span> and $<span id="xdx_90D_eus-gaap--Depreciation_c20190401__20190630_pp0p0" title="Depreciation expense">0</span>, respectively. Depreciation expense for the six months ended June 30, 2020 and 2019 amounted to $<span id="xdx_902_eus-gaap--Depreciation_c20200101__20200630_pp0p0" title="Depreciation expense">17,716</span> and $<span id="xdx_901_eus-gaap--Depreciation_c20190101__20190630_pp0p0" title="Depreciation expense">0</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zwavJS6EuhZj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Property and equipment, net consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_8B1_zdzhJ4XeqMJd" style="display: none">Schedule of Property and Equipment. Net</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20200630_zTEI8nhGA6Vg" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20191231_zkGud9vzDymf" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Computer and office equipment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pp0p0" style="width: 16%; text-align: right" title="Subtotal">71,785</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_pip0" style="width: 16%; text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1210">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Furniture &amp; fixtures</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pp0p0" style="text-align: right" title="Subtotal">119,166</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_pip0" style="text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1214">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Leasehold improvements</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pp0p0" style="text-align: right" title="Subtotal">197,564</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_pip0" style="text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1218">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Vehicle</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_984_eus-gaap--PropertyPlantAndEquipmentGross_c20200630__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subtotal">96,263</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_c20191231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--VehiclesMember_pip0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl1222">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_maPPAENzvyH_zVe42IQA1VLa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Subtotal</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">484,778</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1225"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_msPPAENzvyH_zbuUM1madh85" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Less: accumulated depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(172,919</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1228"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PropertyPlantAndEquipmentNet_iTI_pp0p0_mtPPAENzvyH_ziLRjQr8zUed" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">311,859</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1231">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Depreciation expense for the three months ended June 30, 2020 and 2019 amounted to $<span id="xdx_90C_eus-gaap--Depreciation_c20200401__20200630_pp0p0" title="Depreciation expense">17,716</span> and $<span id="xdx_90D_eus-gaap--Depreciation_c20190401__20190630_pp0p0" title="Depreciation expense">0</span>, respectively. Depreciation expense for the six months ended June 30, 2020 and 2019 amounted to $<span id="xdx_902_eus-gaap--Depreciation_c20200101__20200630_pp0p0" title="Depreciation expense">17,716</span> and $<span id="xdx_901_eus-gaap--Depreciation_c20190101__20190630_pp0p0" title="Depreciation expense">0</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 71785 119166 197564 96263 484778 172919 311859 17716 0 17716 0 <p id="xdx_80E_eus-gaap--IntangibleAssetsDisclosureTextBlock_zpNQu4SGYfy2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>10. <span id="xdx_825_zrk3RZruTPV5">INTANGIBLE ASSETS, NET</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zq8O11xJUtoj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangible assets, net, consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8BE_zyiwiv71GeTl" style="display: none">Schedule of Intangible Assets, Net</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20200630_zoR6Z5c4SHVd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20191231_zL47NCbeo6Ek" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_400_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_maFLIANzwwR_zowi8iIlEq59" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; text-indent: -19.8pt; padding-left: 19.8pt">Computer software</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">33,426</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1246">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_msFLIANzwwR_z1VXbmYaXe39" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -19.8pt; padding-left: 19.8pt">Less: accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(27,143</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">         <span style="-sec-ix-hidden: xdx2ixbrl1249"> </span>-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzwwR_zPqtqxzcMg6i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,283</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_z4J89HYIqKz9" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Amortization expense for the three months ended June 30, 2020 and 2019 amounted to $<span id="xdx_90A_eus-gaap--AmortizationOfIntangibleAssets_c20200401__20200630_pp0p0" title="Amortization expense">482</span> and $<span id="xdx_90D_eus-gaap--AmortizationOfIntangibleAssets_c20190401__20190630_pp0p0" title="Amortization expense">0</span>, respectively. Amortization expense for the six months ended June 30, 2020 and 2019 amounted to $<span id="xdx_904_eus-gaap--AmortizationOfIntangibleAssets_c20200101__20200630_pp0p0" title="Amortization expense">482</span> and $<span id="xdx_905_eus-gaap--AmortizationOfIntangibleAssets_c20190101__20190630_pp0p0" title="Amortization expense">0</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zq8O11xJUtoj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Intangible assets, net, consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_8BE_zyiwiv71GeTl" style="display: none">Schedule of Intangible Assets, Net</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20200630_zoR6Z5c4SHVd" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20191231_zL47NCbeo6Ek" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr id="xdx_400_eus-gaap--CapitalizedComputerSoftwareGross_iI_pp0p0_maFLIANzwwR_zowi8iIlEq59" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left; text-indent: -19.8pt; padding-left: 19.8pt">Computer software</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">33,426</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1246">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_msFLIANzwwR_z1VXbmYaXe39" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -19.8pt; padding-left: 19.8pt">Less: accumulated amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(27,143</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">         <span style="-sec-ix-hidden: xdx2ixbrl1249"> </span>-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzwwR_zPqtqxzcMg6i" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,283</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1252">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 33426 -27143 6283 482 0 482 0 <p id="xdx_80A_ecustom--InvestmentInMarketableSecuritiesTextBlock_z9jNZ5QZ8iH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>11. <span id="xdx_822_zzq5YBSq7IHl">INVESTMENT IN MARKETABLE SECURITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 14px"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 34px; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(i)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On May 17, 2018, the Company purchased <span id="xdx_909_eus-gaap--InvestmentOwnedBalanceShares_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pii" title="Investment in securities, shares">83,333</span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_90E_eus-gaap--InvestmentOwnedAtCost_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pp0p0" title="Investment amount">500,000</span> at a purchase price of $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_pii_uUSDPShares_c20180517__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zXXMKHRVnv9" title="Purchased price per shares">6</span> per share.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(ii)</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On October 16, 2018, the Company purchased <span id="xdx_90C_eus-gaap--InvestmentOwnedBalanceShares_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pii" title="Investment in securities, shares">33,333</span> shares of common stock in Greenpro Capital Corp. for $<span id="xdx_90B_eus-gaap--InvestmentOwnedAtCost_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_pp0p0" title="Investment amount">1,000</span> at a purchase price of $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_pii_uUSDPShares_c20181016__dei--LegalEntityAxis__custom--GreenproCapitalCorpMember_zGlLmVbaQ1K" title="Purchased price per shares">0.03</span> per share.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> <span/></span></p> <p id="xdx_894_eus-gaap--MarketableSecuritiesTextBlock_ziFtJATLBjG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span><span id="xdx_8B6_zfUhVDpH4YW" style="display: none">SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20200630_zseTnF86lQ09" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20191231_zlY6zSG21Xh5" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_maMSNzV7i_ztGuGMviKmw8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Cost of investment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">66,484</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">134,166</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--MarketableSecuritiesUnrealizedHoldingLoss_iI_pp0p0_msMSNzV7i_z38nSubwbPZf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unrealized holding gain (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">126,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(68,391</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_ecustom--ExchangeRateEffectOnInvestmentInMarketableSecurites_iI_pp0p0_maMSNzV7i_z9nuDOn0jNBj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Exchange rate effect</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">513</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">709</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--MarketableSecuritiesNoncurrent_iTI_pp0p0_mtMSNzV7i_zlvPMp8JotWc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Investment in marketable securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">193,663</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">66,484</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zYggCgcIQSw5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 83333 500000 6 33333 1000 0.03 <p id="xdx_894_eus-gaap--MarketableSecuritiesTextBlock_ziFtJATLBjG5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span><span id="xdx_8B6_zfUhVDpH4YW" style="display: none">SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20200630_zseTnF86lQ09" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20191231_zlY6zSG21Xh5" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40A_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_maMSNzV7i_ztGuGMviKmw8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%">Cost of investment</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">66,484</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">134,166</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--MarketableSecuritiesUnrealizedHoldingLoss_iI_pp0p0_msMSNzV7i_z38nSubwbPZf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Unrealized holding gain (loss)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">126,666</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(68,391</td><td style="text-align: left">)</td></tr> <tr id="xdx_404_ecustom--ExchangeRateEffectOnInvestmentInMarketableSecurites_iI_pp0p0_maMSNzV7i_z9nuDOn0jNBj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Exchange rate effect</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">513</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">709</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--MarketableSecuritiesNoncurrent_iTI_pp0p0_mtMSNzV7i_zlvPMp8JotWc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Investment in marketable securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">193,663</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">66,484</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 66484 134166 126666 -68391 513 709 193663 66484 <p id="xdx_804_ecustom--InvestmentInNonMarketableSecuritiesTextBlock_zue9c8g1TW34" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>12. <span id="xdx_827_zUc7ssLhFbY">INVESTMENT IN NON-MARKETABLE SECURITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company invested in Unreserved Sdn Bhd with the investment amount of $<span id="xdx_903_eus-gaap--InvestmentOwnedAtCost_c20200630__srt--TitleOfIndividualAxis__srt--DirectorMember_pp0p0" title="Investment amount">863,592</span> (RM <span id="xdx_901_eus-gaap--InvestmentOwnedAtCost_iI_pp0p0_uUSD_c20200630__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__custom--MYRCurrencyMember_zv3TVrR4Tev7" title="Investment amount">3,500,000</span>), which approximated <span id="xdx_90A_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200630__srt--TitleOfIndividualAxis__srt--DirectorMember_z1eCKWUB2xI5" title="Equity interest percentage">20</span>% of the equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019 Unreserved Sdn Bhd issued additional common stock for working capital. As the Company did not subscribe for the additional common stock, the Company’s equity interest in investee company was diluted from approximately <span id="xdx_90F_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200630__srt--RangeAxis__srt--MaximumMember_zI2ObnPTzhKk" title="Equity interest percentage">20.0</span>% to approximately <span id="xdx_908_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20200630__srt--RangeAxis__srt--MinimumMember_zRMVbONXJXFi" title="Equity interest percentage">17.86</span>%. Effective from March 10, 2019, the Company discontinued equity accounting on the investee company. The Company also ceased control over the operations of the investee company on the same date. Accordingly, the investment in investee company was reclassified to investment in non-marketable securities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Unreserved Sdn Bhd was incorporated in Malaysia with <span id="xdx_908_eus-gaap--CommonStockSharesAuthorized_c20200630__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_pii" title="Ordinary shares authorized">2,500,000</span> ordinary shares authorized, issued and outstanding. Mr. Lim Hun Soon @ David Lim and Ms. Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr. How Kok Choong was a director of the company from April 30, 2018 to March 27, 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On March 2, 2020, the Company agreed to sell the <span id="xdx_90B_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_dp_uPure_c20200302__srt--TitleOfIndividualAxis__custom--UnreservedSdnBhdMember_zQsZ5wTR1Yij" title="Equity interest percentage">17.86</span>% ownership interest in Unreserved Sdn Bhd at the December 31, 2019 carrying value of $<span id="xdx_900_eus-gaap--InvestmentOwnedAtCost_c20191231__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_pp0p0" title="Investment amount">730,637</span> to Mr. How Kok Choong, the CEO and director of the Company. The Company received proceeds of $<span id="xdx_901_ecustom--ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty_c20200101__20200630_pp0p0" title="Proceeds from investments">70,173</span>, and had an amount due from director of $<span id="xdx_90A_eus-gaap--DueFromOfficersOrStockholdersCurrent_iI_pp0p0_c20200331__srt--TitleOfIndividualAxis__custom--MrHowKokChoongMember_ztZFk9bijhI8" title="Amount due from director">660,464</span> at March 31, 2020. In May 2020, the entire outstanding balance was settled as part of the consideration in a transaction which the Company had acquired the CEO’s ownership interest of Agape Superior Living Sdn. Bhd.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On April 3, 2019, the Company purchased a <span id="xdx_901_eus-gaap--EquityMethodInvestmentOwnershipPercentage_iI_pii_dp_uPure_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zNvKIroXshfi" title="Equity interest percentage">5</span>% of stock or <span id="xdx_900_eus-gaap--InvestmentOwnedBalanceShares_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_pii" title="Shares purchased during period">15,000,000</span> shares of common stock in Phoenix Plus Corp. for $<span id="xdx_90E_eus-gaap--InvestmentOwnedAtCost_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" title="Investment amount">1,500</span> at purchase price of $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_pii_uUSDPShares_c20190403__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_zNvaZ3e6tPnj" title="Share purchased price per share">0.0001</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_892_ecustom--NonMarketableSecuritiesTableTextBlock_zZMfbwxnNVM8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B7_zDEtzgrXJRI3" style="display: none">SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Unreserved Sdn Bhd</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> June 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Investment in non-marketable securities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentInNonMarketableSecuritiesGross_c20200630__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="width: 16%; text-align: right" title="Investment in non-marketable securities">730,637</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--InvestmentInNonMarketableSecuritiesGross_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="width: 16%; text-align: right" title="Investment in non-marketable securities">730,637</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">Less: Sale of investment in non-marketable securities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--SaleOfInvestmentInNonmarketableSecurities_c20200630__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities">(730,637</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--SaleOfInvestmentInNonmarketableSecurities_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl1328">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Investment in non-marketable securities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_ecustom--InvestmentInNonmarketableSecuritiesNet_c20200630__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl1330">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_ecustom--InvestmentInNonmarketableSecuritiesNet_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities">730,637</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1.5pt solid; text-align: left">Phoenix Plus Corporation</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Cost of investment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--InvestmentOwnedAtCost_c20200630__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of investment">1,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentOwnedAtCost_c20191231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of investment">1,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total investment in non-marketable securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_c20200630__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities">1,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_c20191231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities">732,137</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AD_zLtexuVTb7S4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> 863592 3500000 0.20 0.200 0.1786 2500000 0.1786 730637 70173 660464 0.05 15000000 1500 0.0001 <p id="xdx_892_ecustom--NonMarketableSecuritiesTableTextBlock_zZMfbwxnNVM8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B7_zDEtzgrXJRI3" style="display: none">SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid">Unreserved Sdn Bhd</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> June 30, 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of<br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Investment in non-marketable securities</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--InvestmentInNonMarketableSecuritiesGross_c20200630__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="width: 16%; text-align: right" title="Investment in non-marketable securities">730,637</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--InvestmentInNonMarketableSecuritiesGross_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="width: 16%; text-align: right" title="Investment in non-marketable securities">730,637</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-style: italic; text-align: left; padding-bottom: 1.5pt">Less: Sale of investment in non-marketable securities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_ecustom--SaleOfInvestmentInNonmarketableSecurities_c20200630__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities">(730,637</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--SaleOfInvestmentInNonmarketableSecurities_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Less: Sale of investment in non-marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl1328">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Investment in non-marketable securities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_982_ecustom--InvestmentInNonmarketableSecuritiesNet_c20200630__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl1330">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98D_ecustom--InvestmentInNonmarketableSecuritiesNet_c20191231__srt--TitleOfIndividualAxis__custom--DirectorsOfUnreservedInvestmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Investment in non-marketable securities">730,637</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1.5pt solid; text-align: left">Phoenix Plus Corporation</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Cost of investment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_98C_eus-gaap--InvestmentOwnedAtCost_c20200630__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of investment">1,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td id="xdx_986_eus-gaap--InvestmentOwnedAtCost_c20191231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Cost of investment">1,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total investment in non-marketable securities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_c20200630__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities">1,500</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_ecustom--InvestmentInNonMarketableSecuritiesNoncurrent_c20191231__dei--LegalEntityAxis__custom--PhoenixPlusCorpMember_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Total investment in non-marketable securities">732,137</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 730637 730637 -730637 730637 1500 1500 1500 732137 <p id="xdx_803_eus-gaap--OtherLiabilitiesDisclosureTextBlock_zVxkh6COhMr2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>13. <span id="xdx_827_z2tnh6S43ja">OTHER PAYABLES AND ACCRUED LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p id="xdx_89A_ecustom--ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_zsYWfxc4bWvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span><span id="xdx_8B9_zXyLVUAZpTbl" style="display: none">SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20200630_zbu2oFvZChD7" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20191231_zbacAREAuVCh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><br/>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOAPAAzRsB_zbdSM6vky9x" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accrued professional fees</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">322,661</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">58,594</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--AccruedPromotionExpenses_iI_pp0p0_maOAPAAzRsB_ziCNbIubL1d7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued promotion expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">59,474</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1350"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0_maOAPAAzRsB_zl7fBw5inzd7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued payroll</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,180</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1353"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0_maOAPAAzRsB_zwkfibYhIbz2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,252</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,652</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzRsB_zimgP4anW57e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total other payables and accrued liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">467,567</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,246</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zjmbkuCnN9ji" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p id="xdx_89A_ecustom--ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock_zsYWfxc4bWvk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span><span id="xdx_8B9_zXyLVUAZpTbl" style="display: none">SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20200630_zbu2oFvZChD7" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20191231_zbacAREAuVCh" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b><br/>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40E_eus-gaap--AccruedProfessionalFeesCurrent_iI_pp0p0_maOAPAAzRsB_zbdSM6vky9x" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 60%; text-align: left">Accrued professional fees</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">322,661</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">58,594</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--AccruedPromotionExpenses_iI_pp0p0_maOAPAAzRsB_ziCNbIubL1d7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accrued promotion expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">59,474</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1350"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AccruedPayrollTaxesCurrent_iI_pp0p0_maOAPAAzRsB_zl7fBw5inzd7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accrued payroll</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">22,180</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1353"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_pp0p0_maOAPAAzRsB_zwkfibYhIbz2" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Others</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,252</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">18,652</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OtherAccountsPayableAndAccruedLiabilities_iTI_pp0p0_mtOAPAAzRsB_zimgP4anW57e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Total other payables and accrued liabilities</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">467,567</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">77,246</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 322661 58594 59474 22180 63252 18652 467567 77246 <p id="xdx_80D_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zSaa9G6SWJZ2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>14. <span id="xdx_82C_zej6SWwdCGz6">RELATED PARTY BALANCES AND TRANSACTIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Related party balances</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_89D_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zz3RLpk6bd9k" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Accounts receivable – related party</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_8B1_zaZahEt2mk0e" style="display: none">SCHEDULE OF RELATED PARTIES RELATIONSHIPS</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: center"/><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 18%; vertical-align: top">SEA</td><td style="width: 2%"> </td> <td style="vertical-align: top; width: 22%; text-align: center"><span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties relationship, description"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties relationship, description">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</span></span></td><td style="text-align: center; width: 2%; vertical-align: top"> </td> <td style="vertical-align: top; width: 1%; text-align: center"> </td><td style="vertical-align: top; width: 16%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties nature, description"><span id="xdx_900_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties nature, description">Sales of products</span></span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccountsReceivableRelatedPartiesCurrent_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_pp0p0" style="width: 15%; text-align: right" title="Accounts Receivable - related party"><span style="-sec-ix-hidden: xdx2ixbrl1373">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsReceivableRelatedPartiesCurrent_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_pp0p0" style="width: 15%; text-align: right" title="Accounts Receivable - related party">520,786</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd (“ASLPL”)</td><td style="padding-bottom: 1.5pt"> </td> <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties relationship, description"><span id="xdx_901_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties relationship, description">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: top"> </td> <td style="vertical-align: top; padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_ecustom--RelatedPartiesNatureDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties nature, description"><span id="xdx_90C_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties nature, description">Sales of products</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AccountsReceivableRelatedPartiesCurrent_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts Receivable - related party">8,694</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AccountsReceivableRelatedPartiesCurrent_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts Receivable - related party"><span style="-sec-ix-hidden: xdx2ixbrl1387">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--AccountsReceivableRelatedPartiesCurrent_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts Receivable - related party">8,694</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AccountsReceivableRelatedPartiesCurrent_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts Receivable - related party">520,786</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Amount due from related parties</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of <br/> December 31, 2019</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: center"/><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 18%; text-align: left">Agape ATP (Asia) Limited (“AATP Asia”)</td><td style="width: 2%"> </td> <td style="width: 22%; text-align: center"><span id="xdx_901_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedAATPAsiaMember" title="Related parties relationship, description"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedAATPAsiaMember" title="Related parties relationship, description">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia</span></span></td><td style="width: 2%"> </td> <td style="vertical-align: top; width: 18%; text-align: center"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedAATPAsiaMember" title="Related parties nature, description"><span id="xdx_90F_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedAATPAsiaMember" title="Related parties nature, description">Expenses paid for AATP Asia</span></span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--DueFromRelatedPartiesCurrent_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedAATPAsiaMember_pp0p0" style="width: 15%; text-align: right" title="Amount due from related parties">2,228</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--DueFromRelatedPartiesCurrent_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedAATPAsiaMember_pp0p0" style="width: 15%; text-align: right" title="Amount due from related parties">2,217</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Redboy Picture Sdn Bhd “Redboy”</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedboyPictureSdnBhdRedboyMember" title="Related parties relationship, description"><span id="xdx_907_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedboyPictureSdnBhdRedboyMember" title="Related parties relationship, description">Mr. How Kok Choong, the CEO and director of the Company is also the director of Redboy</span></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedboyPictureSdnBhdRedboyMember" title="Related parties nature, description"><span id="xdx_90B_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedboyPictureSdnBhdRedboyMember" title="Related parties nature, description">Paid advance to Redboy for business operational expenses</span></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--DueFromRelatedPartiesCurrent_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedboyPictureSdnBhdRedboyMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties">3,361</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--DueFromRelatedPartiesCurrent_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedboyPictureSdnBhdRedboyMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"><span style="-sec-ix-hidden: xdx2ixbrl1415">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--DueFromRelatedPartiesCurrent_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties">5,589</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--DueFromRelatedPartiesCurrent_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties">2,217</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Prepayments and Deposits - related party</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"/><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 18%; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd (“ASLPL”)</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="width: 22%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLOneMember" title="Related parties relationship, description"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLOneMember" title="Related parties relationship, description">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="vertical-align: top; width: 18%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_90C_ecustom--RelatedPartiesNatureDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLOneMember" title="Related parties nature, description"><span id="xdx_90B_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLOneMember" title="Related parties nature, description">Prepayment for Printing Label</span></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--PrepaidExpenseAndOtherAssetCurrent_iI_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLOneMember_zOasq2acAqQ7" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Prepayments and Deposits - related party">2,784</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--PrepaidExpenseAndOtherAssetCurrent_iI_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLOneMember_za9BuDUWP4i9" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right">     <span style="-sec-ix-hidden: xdx2ixbrl1430"> </span>-</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--PrepaidExpenseAndOtherAssetCurrent_iI_c20200630_zUeeYNtyv7r6" style="border-bottom: Black 2.5pt double; text-align: right">2,784</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--PrepaidExpenseAndOtherAssetCurrent_iI_c20191231_zS1yEL3X3L5d" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1432">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Amount due to a Related Party </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"/><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F45_zhfdMQGYauZf" style="vertical-align: top; width: 18%; text-align: left; padding-bottom: 1.5pt">Mr. How Kok Choong</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="vertical-align: top; width: 22%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_904_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember" title="Related parties relationship, description"><span id="xdx_901_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember" title="Related parties relationship, description">CEO and director of the Company</span></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="vertical-align: top; width: 18%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember" title="Related parties nature, description"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember" title="Related parties nature, description">Acquisition payment of ASL and expenses paid for the Company</span></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_fKDEp_zXAGZRR9WnK8" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Amount due to a Related Party">90,043</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">(1)</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DueToRelatedPartiesCurrent_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_pp0p0" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Amount due to a Related Party">3,952</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DueToRelatedPartiesCurrent_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due to a Related Party">90,043</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--DueToRelatedPartiesCurrent_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due to a Related Party">3,952</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zA7V8Plb65L3" style="font: 10pt Times New Roman, Times, Serif">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_zmzGxal9Tfd8" style="font: 10pt Times New Roman, Times, Serif">On July 1, the Company issued additional <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pii_c20200629__20200701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_z1d53qTf2kA1" title="Issuance of common stock in acquisition, shares">13,853</span> shares of the Company’s common stock valued at $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20200629__20200701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_z9vuNezYeUl5" title="Issuance of common stock in acquisition, value">90,043</span> based on the Company’s closing price of $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_pii_uUSDPShares_c20200331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_z58FT4E0HrEi" title="shares issued price per share">6.50</span> at March 31, 2020 to settle the acquisition payment of ASL (See Note 15).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Related party transactions </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> <span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Revenue</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"/></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"/><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 18%; vertical-align: top">SEA</td><td style="width: 2%"> </td> <td style="width: 22%; text-align: center"><span id="xdx_901_ecustom--RelatedPartiesRelationshipsDescription_c20200401__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties relationship, description"><span id="xdx_900_ecustom--RelatedPartiesRelationshipsDescription_c20190401__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties relationship, description">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</span></span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="vertical-align: top; width: 16%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200401__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties nature, description"><span id="xdx_90F_ecustom--RelatedPartiesNatureDescription_c20190401__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties nature, description">Sales of products</span></span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--RevenuesFromRelatedParty_c20200401__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_pp0p0" style="width: 15%; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1465">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--RevenuesFromRelatedParty_c20190401__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_pp0p0" style="width: 15%; text-align: right" title="Revenue">390,661</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd (“ASLPL”)</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20200401__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties relationship, description"><span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190401__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties relationship, description">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--RelatedPartiesNatureDescription_c20200401__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties nature, description"><span id="xdx_90B_ecustom--RelatedPartiesNatureDescription_c20190401__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties nature, description">Sales of products</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--RevenuesFromRelatedParty_c20200401__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">13,654</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--RevenuesFromRelatedParty_c20190401__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">5,811</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--RevenuesFromRelatedParty_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue">13,654</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--RevenuesFromRelatedParty_c20190401__20190630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue">396,472</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"/></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"/></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 18%; vertical-align: top">SEA</td><td style="width: 2%"> </td> <td style="width: 22%; text-align: center"><span id="xdx_90C_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties relationship, description">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="vertical-align: top; width: 16%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20190101__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties nature, description">Sales of products</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--RevenuesFromRelatedParty_pp0p0_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zd6ldWyXf77g" style="width: 15%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1488">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--RevenuesFromRelatedParty_c20190101__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_pp0p0" style="width: 15%; text-align: right" title="Revenue">839,308</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd (“ASLPL”)</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties relationship, description">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties nature, description">Sales of products</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--RevenuesFromRelatedParty_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zLtFGLwxSVtd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">13,654</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--RevenuesFromRelatedParty_c20190101__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">21,461</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--RevenuesFromRelatedParty_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue">13,654</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--RevenuesFromRelatedParty_c20190101__20190630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue">860,769</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zAsG2y1bs4bb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfRelatedPartyTransactionsTableTextBlock_zz3RLpk6bd9k" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Accounts receivable – related party</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span id="xdx_8B1_zaZahEt2mk0e" style="display: none">SCHEDULE OF RELATED PARTIES RELATIONSHIPS</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: center"/><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 18%; vertical-align: top">SEA</td><td style="width: 2%"> </td> <td style="vertical-align: top; width: 22%; text-align: center"><span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties relationship, description"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties relationship, description">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</span></span></td><td style="text-align: center; width: 2%; vertical-align: top"> </td> <td style="vertical-align: top; width: 1%; text-align: center"> </td><td style="vertical-align: top; width: 16%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties nature, description"><span id="xdx_900_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties nature, description">Sales of products</span></span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--AccountsReceivableRelatedPartiesCurrent_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_pp0p0" style="width: 15%; text-align: right" title="Accounts Receivable - related party"><span style="-sec-ix-hidden: xdx2ixbrl1373">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--AccountsReceivableRelatedPartiesCurrent_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_pp0p0" style="width: 15%; text-align: right" title="Accounts Receivable - related party">520,786</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd (“ASLPL”)</td><td style="padding-bottom: 1.5pt"> </td> <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties relationship, description"><span id="xdx_901_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties relationship, description">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></span></td><td style="text-align: center; padding-bottom: 1.5pt; vertical-align: top"> </td> <td style="vertical-align: top; padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90F_ecustom--RelatedPartiesNatureDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties nature, description"><span id="xdx_90C_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties nature, description">Sales of products</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_eus-gaap--AccountsReceivableRelatedPartiesCurrent_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts Receivable - related party">8,694</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--AccountsReceivableRelatedPartiesCurrent_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accounts Receivable - related party"><span style="-sec-ix-hidden: xdx2ixbrl1387">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--AccountsReceivableRelatedPartiesCurrent_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts Receivable - related party">8,694</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--AccountsReceivableRelatedPartiesCurrent_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Accounts Receivable - related party">520,786</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Amount due from related parties</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of <br/> December 31, 2019</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="vertical-align: top; text-align: center"/><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 18%; text-align: left">Agape ATP (Asia) Limited (“AATP Asia”)</td><td style="width: 2%"> </td> <td style="width: 22%; text-align: center"><span id="xdx_901_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedAATPAsiaMember" title="Related parties relationship, description"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedAATPAsiaMember" title="Related parties relationship, description">Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia</span></span></td><td style="width: 2%"> </td> <td style="vertical-align: top; width: 18%; text-align: center"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedAATPAsiaMember" title="Related parties nature, description"><span id="xdx_90F_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedAATPAsiaMember" title="Related parties nature, description">Expenses paid for AATP Asia</span></span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--DueFromRelatedPartiesCurrent_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedAATPAsiaMember_pp0p0" style="width: 15%; text-align: right" title="Amount due from related parties">2,228</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--DueFromRelatedPartiesCurrent_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeATPAsiaLimitedAATPAsiaMember_pp0p0" style="width: 15%; text-align: right" title="Amount due from related parties">2,217</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Redboy Picture Sdn Bhd “Redboy”</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_90F_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedboyPictureSdnBhdRedboyMember" title="Related parties relationship, description"><span id="xdx_907_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedboyPictureSdnBhdRedboyMember" title="Related parties relationship, description">Mr. How Kok Choong, the CEO and director of the Company is also the director of Redboy</span></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="vertical-align: top; text-align: center; padding-bottom: 1.5pt"><span id="xdx_908_ecustom--RelatedPartiesNatureDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedboyPictureSdnBhdRedboyMember" title="Related parties nature, description"><span id="xdx_90B_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedboyPictureSdnBhdRedboyMember" title="Related parties nature, description">Paid advance to Redboy for business operational expenses</span></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--DueFromRelatedPartiesCurrent_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedboyPictureSdnBhdRedboyMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties">3,361</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_eus-gaap--DueFromRelatedPartiesCurrent_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--RedboyPictureSdnBhdRedboyMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Amount due from related parties"><span style="-sec-ix-hidden: xdx2ixbrl1415">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--DueFromRelatedPartiesCurrent_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties">5,589</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_eus-gaap--DueFromRelatedPartiesCurrent_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due from related parties">2,217</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Prepayments and Deposits - related party</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"/><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="vertical-align: top; width: 18%; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd (“ASLPL”)</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="width: 22%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLOneMember" title="Related parties relationship, description"><span id="xdx_909_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLOneMember" title="Related parties relationship, description">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="vertical-align: top; width: 18%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_90C_ecustom--RelatedPartiesNatureDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLOneMember" title="Related parties nature, description"><span id="xdx_90B_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLOneMember" title="Related parties nature, description">Prepayment for Printing Label</span></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--PrepaidExpenseAndOtherAssetCurrent_iI_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLOneMember_zOasq2acAqQ7" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Prepayments and Deposits - related party">2,784</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--PrepaidExpenseAndOtherAssetCurrent_iI_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLOneMember_za9BuDUWP4i9" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right">     <span style="-sec-ix-hidden: xdx2ixbrl1430"> </span>-</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_ecustom--PrepaidExpenseAndOtherAssetCurrent_iI_c20200630_zUeeYNtyv7r6" style="border-bottom: Black 2.5pt double; text-align: right">2,784</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_ecustom--PrepaidExpenseAndOtherAssetCurrent_iI_c20191231_zS1yEL3X3L5d" style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1432">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Amount due to a Related Party </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of <br/> December 31, 2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"/><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td id="xdx_F45_zhfdMQGYauZf" style="vertical-align: top; width: 18%; text-align: left; padding-bottom: 1.5pt">Mr. How Kok Choong</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="vertical-align: top; width: 22%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_904_ecustom--RelatedPartiesRelationshipsDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember" title="Related parties relationship, description"><span id="xdx_901_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember" title="Related parties relationship, description">CEO and director of the Company</span></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="vertical-align: top; width: 18%; text-align: center; padding-bottom: 1.5pt"><span id="xdx_903_ecustom--RelatedPartiesNatureDescription_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember" title="Related parties nature, description"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20190101__20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember" title="Related parties nature, description">Acquisition payment of ASL and expenses paid for the Company</span></span></td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--DueToRelatedPartiesCurrent_iI_pp0p0_c20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_fKDEp_zXAGZRR9WnK8" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Amount due to a Related Party">90,043</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left">(1)</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DueToRelatedPartiesCurrent_c20191231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_pp0p0" style="border-bottom: Black 1.5pt solid; width: 15%; text-align: right" title="Amount due to a Related Party">3,952</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98F_eus-gaap--DueToRelatedPartiesCurrent_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due to a Related Party">90,043</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--DueToRelatedPartiesCurrent_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Amount due to a Related Party">3,952</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F00_zA7V8Plb65L3" style="font: 10pt Times New Roman, Times, Serif">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_zmzGxal9Tfd8" style="font: 10pt Times New Roman, Times, Serif">On July 1, the Company issued additional <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pii_c20200629__20200701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_z1d53qTf2kA1" title="Issuance of common stock in acquisition, shares">13,853</span> shares of the Company’s common stock valued at $<span id="xdx_900_eus-gaap--StockIssuedDuringPeriodValueAcquisitions_pp0p0_c20200629__20200701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_z9vuNezYeUl5" title="Issuance of common stock in acquisition, value">90,043</span> based on the Company’s closing price of $<span id="xdx_90B_eus-gaap--SharesIssuedPricePerShare_iI_pii_uUSDPShares_c20200331__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--MrHowKokChoongMember_z58FT4E0HrEi" title="shares issued price per share">6.50</span> at March 31, 2020 to settle the acquisition payment of ASL (See Note 15).</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Related party transactions </span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> <span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b>Revenue</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font: 10pt Times New Roman, Times, Serif"/></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"/><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 18%; vertical-align: top">SEA</td><td style="width: 2%"> </td> <td style="width: 22%; text-align: center"><span id="xdx_901_ecustom--RelatedPartiesRelationshipsDescription_c20200401__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties relationship, description"><span id="xdx_900_ecustom--RelatedPartiesRelationshipsDescription_c20190401__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties relationship, description">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</span></span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="vertical-align: top; width: 16%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20200401__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties nature, description"><span id="xdx_90F_ecustom--RelatedPartiesNatureDescription_c20190401__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties nature, description">Sales of products</span></span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98E_ecustom--RevenuesFromRelatedParty_c20200401__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_pp0p0" style="width: 15%; text-align: right" title="Revenue"><span style="-sec-ix-hidden: xdx2ixbrl1465">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_ecustom--RevenuesFromRelatedParty_c20190401__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_pp0p0" style="width: 15%; text-align: right" title="Revenue">390,661</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd (“ASLPL”)</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_90A_ecustom--RelatedPartiesRelationshipsDescription_c20200401__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties relationship, description"><span id="xdx_90B_ecustom--RelatedPartiesRelationshipsDescription_c20190401__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties relationship, description">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90A_ecustom--RelatedPartiesNatureDescription_c20200401__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties nature, description"><span id="xdx_90B_ecustom--RelatedPartiesNatureDescription_c20190401__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties nature, description">Sales of products</span></span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--RevenuesFromRelatedParty_c20200401__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">13,654</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98B_ecustom--RevenuesFromRelatedParty_c20190401__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">5,811</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_ecustom--RevenuesFromRelatedParty_c20200401__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue">13,654</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_ecustom--RevenuesFromRelatedParty_c20190401__20190630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue">396,472</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Name of Related Party</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Relationship</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Nature</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: center"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"/></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"/></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 18%; vertical-align: top">SEA</td><td style="width: 2%"> </td> <td style="width: 22%; text-align: center"><span id="xdx_90C_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties relationship, description">VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA</span></td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="vertical-align: top; width: 16%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_902_ecustom--RelatedPartiesNatureDescription_c20190101__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember" title="Related parties nature, description">Sales of products</span></span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--RevenuesFromRelatedParty_pp0p0_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_zd6ldWyXf77g" style="width: 15%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1488">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--RevenuesFromRelatedParty_c20190101__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SeaMember_pp0p0" style="width: 15%; text-align: right" title="Revenue">839,308</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="vertical-align: top; text-align: left; padding-bottom: 1.5pt">Agape Superior Living Pty Ltd (“ASLPL”)</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"><span id="xdx_90E_ecustom--RelatedPartiesRelationshipsDescription_c20190101__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties relationship, description">Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; vertical-align: top; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_ecustom--RelatedPartiesNatureDescription_c20190101__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember" title="Related parties nature, description">Sales of products</span></span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--RevenuesFromRelatedParty_c20200101__20200630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_zLtFGLwxSVtd" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">13,654</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--RevenuesFromRelatedParty_c20190101__20190630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--AgapeSuperiorLivingPtyLtdASLPLMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Revenue">21,461</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="text-align: center; padding-bottom: 2.5pt"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt; text-align: right"> </td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--RevenuesFromRelatedParty_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue">13,654</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--RevenuesFromRelatedParty_c20190101__20190630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Revenue">860,769</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA Sales of products Sales of products 520786 Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Sales of products Sales of products 8694 8694 520786 Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia Expenses paid for AATP Asia Expenses paid for AATP Asia 2228 2217 Mr. How Kok Choong, the CEO and director of the Company is also the director of Redboy Mr. How Kok Choong, the CEO and director of the Company is also the director of Redboy Paid advance to Redboy for business operational expenses Paid advance to Redboy for business operational expenses 3361 5589 2217 Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Prepayment for Printing Label Prepayment for Printing Label 2784 2784 CEO and director of the Company CEO and director of the Company Acquisition payment of ASL and expenses paid for the Company Acquisition payment of ASL and expenses paid for the Company 90043 3952 90043 3952 13853 90043 6.50 VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA Sales of products Sales of products 390661 Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Sales of products Sales of products 13654 5811 13654 396472 VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA Sales of products 839308 Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Sales of products 13654 21461 13654 860769 <p id="xdx_808_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zq8fL3GPPlF9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>15. <span id="xdx_828_z4kngfmHlne6">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Preferred stock</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2020, and December 31, 2019, there were <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_pii_c20200630_zVA43tJBpqv2" title="Preferred stock, shares authorized"><span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_pii_c20191231_zAoYtWk3ZdMh" title="Preferred stock, shares authorized">200,000,000</span></span> preferred stocks authorized but <span id="xdx_90E_eus-gaap--PreferredStockSharesIssued_iI_pii_dn_c20200630_zumOToEDekje" title="Preferred stock, shares issued"><span id="xdx_909_eus-gaap--PreferredStockSharesOutstanding_iI_pii_dn_c20200630_zZbcKXzb8P3f" title="Preferred stock, shares outstanding"><span id="xdx_903_eus-gaap--PreferredStockSharesIssued_iI_pii_dn_c20191231_zpfCSf7hCjE1" title="Preferred stock, shares issued"><span id="xdx_907_eus-gaap--PreferredStockSharesOutstanding_iI_pii_dn_c20191231_z7Ug6EfR9cf5" title="Preferred stock, shares outstanding">none</span></span></span></span> were issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Common stock</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2020, and December 31, 2019, there were <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pii_c20200630_zrHXGacEMpA6" title="Common stock, shares authorized"><span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_pii_c20191231_zgBum6t0Omy3" title="Common stock, shares authorized">1,000,000,000</span></span> common stocks authorized, <span id="xdx_905_eus-gaap--CommonStockSharesIssued_iI_pii_c20200630_zOi3aSQ1gpUb" title="Common stock, shares issued"><span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pii_c20200630_zLOOvqEgtpb4" title="Common stock, shares outstanding">376,438,194</span></span> and <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pii_c20191231_zKHj9lgT0AW" title="Common stock, shares issued"><span id="xdx_902_eus-gaap--CommonStockSharesOutstanding_iI_pii_c20191231_z2dTGbOxjjs5" title="Common stock, shares outstanding">376,275,500</span></span> shares issued and outstanding, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In May 2020, the Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200501__20200531__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_pii" title="Stock issued during period acquisitions, shares">162,694</span> shares of the Company’s common stock in connection with the acquisition of ASL as part of the acquisition payment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">In June 2020, ASL made certain adjustments to its March 31, 2020 financial statements. As a result, the net assets carrying value increased by $<span id="xdx_906_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_c20200630__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_pp0p0">90,043</span></span><span style="font: 10pt Times New Roman, Times, Serif">, which required the issuance of an additional <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20200601__20200630__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_pii">13,853 </span></span><span style="font: 10pt Times New Roman, Times, Serif">shares of the Company’s common stock to fully satisfy the acquisition payment for ASL to Mr. How Kok Choong, CEO and director of the Company. The <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_pii_c20200629__20200701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zhpSqLB7TKQb">13,853 </span></span><span style="font: 10pt Times New Roman, Times, Serif">additional shares were issued in July 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There were <span id="xdx_909_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20200101__20200630_zsjKIIV4hcAk" title="Potentially dilutive securities outstanding"><span id="xdx_900_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_pii_do_c20190101__20191231_z2Cwop8vqgk4" title="Potentially dilutive securities outstanding">no</span></span> stock options, warrants or other potentially dilutive securities outstanding as of June 30, 2020 and December 31, 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i><span style="text-decoration: underline">Non-controlling interest</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2020 and for the three and six months ended June 30, 2020, no material transactions of non-controlling interest occurred from the operating results from ASL as the Company holds approximately <span id="xdx_909_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pii_dp_uPure_c20200630__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zMIuP8iy4dr" title="Business acquisition percentage of voting interests">99.99</span>% of the equity interest in ASL, non-controlling interests that present in ASL is $<span id="xdx_902_eus-gaap--NoncontrollingInterestIncreaseFromBusinessCombination_c20200101__20200630__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_pp0p0" title="Non controlling interests"><span id="xdx_901_eus-gaap--NoncontrollingInterestIncreaseFromBusinessCombination_c20200401__20200630__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_pp0p0" title="Non controlling interests">0</span></span> and therefore not presented separately in the accompanying unaudited condensed consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> 200000000 200000000 0 0 0 0 1000000000 1000000000 376438194 376438194 376275500 376275500 162694 90043 13853 13853 0 0 0.9999 0 0 <p id="xdx_80D_eus-gaap--IncomeTaxDisclosureTextBlock_z6AiPcBALhEe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>16. <span id="xdx_82E_zlsD0w8DFaEc">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zTFcLi1YVGoh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The United States and foreign components of income (loss) before income taxes were comprised of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BF_zBmA3BDtoi77" style="display: none">SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the three months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"/><td> </td><td> </td> <td colspan="2" style="text-align: center"/><td> </td><td> </td> <td colspan="2" style="text-align: center"/><td> </td><td> </td> <td colspan="2" style="text-align: center"/><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Tax jurisdictions from:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 44%">Local</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"><b>$</b></td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20200401__20200630_zqAg0u5INse8" style="width: 10%; text-align: right" title="Local">(161,751</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"><b>$</b></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20190401__20190630_zJmivlkZiVQ4" style="width: 10%; text-align: right" title="Local">(27,608</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20200101__20200630_pp0p0" style="width: 10%; text-align: right" title="Local">(304,170</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"><b>$</b></td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20190101__20190630_pp0p0" style="width: 10%; text-align: right" title="Local">(42,332</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.25in; padding-left: 0.5in">- Foreign – Malaysia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200401__20200630__srt--StatementGeographicalAxis__country--MY_pp0p0" style="text-align: right" title="Foreign">369,367</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20190401__20190630__srt--StatementGeographicalAxis__country--MY_pp0p0" style="text-align: right" title="Foreign">(16,875</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20200630__srt--StatementGeographicalAxis__country--MY_pp0p0" style="text-align: right" title="Foreign">313,780</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20190101__20190630__srt--StatementGeographicalAxis__country--MY_pp0p0" style="text-align: right" title="Foreign">42,799</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.5in">- Foreign – Hong Kong</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200401__20200630__srt--StatementGeographicalAxis__country--HK_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign">13,691</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20190401__20190630__srt--StatementGeographicalAxis__country--HK_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign">(403,928</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20200630__srt--StatementGeographicalAxis__country--HK_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign">(20,053</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20190101__20190630__srt--StatementGeographicalAxis__country--HK_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign">(384,628</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Income (loss) before income tax</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200401__20200630_zN0KOA4Dc6j5" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax">221,307</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20190401__20190630_zRxlhNgGnkIg" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax">(448,411</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax">(10,443</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20190101__20190630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax">(384,161</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A0_zBnW5MzGOKYe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_895_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zrtH7RSrFCYl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The (provision for) benefit of income taxes consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B0_zQ2dIKOP3N5i" style="display: none">SCHEDULE OF PROVISION FOR INCOME TAX</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20200401__20200630_zei03mMtCaXc" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20190401__20190630_zO1Kk5lNJMJ9" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20200101__20200630_zluEnvKXvXzk" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20190101__20190630_zC2mEnHV5yLb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"/><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center">         </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"/><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"/><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -19.8pt; padding-left: 19.8pt">Current:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maITEBziQf_zcJlLToVr7q" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -19.8pt; padding-left: 19.8pt">- Local</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1583">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1584">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1585">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1586">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--CurrentForeignTaxExpenseBenefit_maITEBziQf_zojSrjcMokPb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-indent: -19.8pt; padding-left: 19.8pt">- Foreign</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1588"> </span></td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1589"> </span></td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1590"> </span></td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">6,965</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -19.8pt; padding-left: 19.8pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -19.8pt; padding-left: 19.8pt">Deferred:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maITEBziQf_zRCEvoz58zB9" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -19.8pt; padding-left: 19.8pt">- Local</td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1593"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1594"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1595"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1596"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_maITEBziQf_zBtirYeLPaAa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -19.8pt; padding-left: 19.8pt">- Foreign</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(134,067</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1599"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(134,067</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1601"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -19.8pt; padding-left: 19.8pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OtherIncomeTaxExpenseBenefitContinuingOperations_iT_pp0p0_mtITEBziQf_zr77rhgkkDQf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt; text-indent: -19.8pt; padding-left: 19.8pt">(Provision for) benefit of income taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(134,067</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1604">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(134,067</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,965</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zlrZbgKvgxvj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Malaysia (including Labuan) and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>United States of America</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape ATP Corporation was incorporated in the State of Nevada and is subject to the tax laws of the United States of America. As of June 30, 2020, the operations in the United States of America incurred approximately $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_c20200630__srt--StatementGeographicalAxis__country--US_pp0p0" title="Cumulative net operating loss">511,000</span> of cumulative net operating losses which can be carried forward to offset future taxable income. Approximately $<span id="xdx_904_eus-gaap--OperatingLossCarryforwards_c20200630_pp0p0" title="Cumulative net operating loss">10,000</span> and $<span id="xdx_907_eus-gaap--OperatingLossCarryforwards_c20200630__srt--StatementGeographicalAxis__country--US__srt--StatementScenarioAxis__custom--IfUnutilizedMember_pp0p0" title="Cumulative net operating loss">24,000</span> of the net operating loss carry forwards will expire in <span id="xdx_904_ecustom--OperatingLossCarryforwardsExpireYearDescription_dt_c20200101__20200630__srt--StatementGeographicalAxis__country--US_z8z1Wbmkj8T6" title="Operating loss carryforwards expire year, description">2027</span> and <span id="xdx_904_ecustom--OperatingLossCarryforwardsExpireYearDescription_dt_c20200101__20200630__srt--StatementGeographicalAxis__country--US__srt--StatementScenarioAxis__custom--IfUnutilizedMember_ziYTrBRYlvPa" title="Operating loss carryforwards expire year, description">2028</span>, respectively, if unutilized. The remaining balance can be carried forward indefinitely. The deferred tax valuation allowance as of June 30, 2020 and December 31, 2019 were approximately $<span id="xdx_90D_eus-gaap--DeferredTaxAssetsValuationAllowance_iI_pp0p0_c20200630__srt--StatementGeographicalAxis__country--US_zmhwRDimd3xi">107,000</span> and $<span id="xdx_903_eus-gaap--DeferredTaxAssetsValuationAllowance_c20191231__srt--StatementGeographicalAxis__country--US_pp0p0" title="Valuation allowance">43,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Malaysia</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Changes to the Labuan Business Activity Tax Act (LBATA) 1990 which was gazetted and came into operation on January 1, 2019 mandate companies incorporated in Labuan to satisfy the “substantial activity requirements” to qualify for the preferential tax rate of <span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pii_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zL6na5SMO0Ca" title="Tax percentage">3</span>% on net audited profit. Subsequently, on April 29, 2020, a circular setting out revisions to the “substantial activity requirements” was issued. As Agape ATP Corporation does not maintain a permanent establishment in Labuan, the company is subject to tax at <span id="xdx_903_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pii_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_z0cp0LIfGkL9" title="Statutory income tax rate">24</span>% on its net audited profit until such a time it satisfies the said requirements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape Superior Living Sdn Bhd and Agape S.E.A. are governed by the income tax laws of Malaysia and the income tax provision in respect of operations in Malaysia is calculated at the applicable tax rates on the taxable income for the periods based on existing legislation, interpretations and practices in respect thereof. Under the Income Tax Act of Malaysia, enterprises that incorporated in Malaysia are usually subject to a unified <span id="xdx_90A_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pii_dp_uPure_c20181228__20190102__srt--StatementGeographicalAxis__custom--LabuanMember_zU1iPcXWcaG6" title="Statutory income tax rate">24</span>% enterprise income tax rate while preferential tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. <span id="xdx_902_eus-gaap--IncomeTaxExaminationDescription_c20200101__20200630__srt--StatementGeographicalAxis__country--MY" title="Income tax examination, description">The tax rate for small and medium sized companies (generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is <span id="xdx_908_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pii_dp_uPure_c20200101__20200630__srt--StatementGeographicalAxis__country--MY_z0rokPB0BUyg" title="Statutory income tax rate">17</span>% for the first RM 600,000 (or approximately $150,000) for the three and six months ended June 30, 2020 and RM 500,000 (or approximately $125,000) income for the three and six months ended June 30, 2019, with the remaining balance being taxed at the 24% rate.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><i>Hong Kong</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of <span id="xdx_901_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pii_dp_uPure_c20200101__20200630__srt--StatementGeographicalAxis__country--HK_z7r2OO2yTNdi" title="Statutory income tax rate">16.5</span>% on its assessable income derived from Hong Kong. Business income derived or business expenses incurred outside the Special Administrative Region is not subject to Hong Kong Profits Tax or deduction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zl0BJzLhwW8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BE_zmbkFdBV2YI5" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">Net operating loss carry forwards in U.S.</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20200630__srt--StatementGeographicalAxis__country--US_pp0p0" style="width: 16%; text-align: right" title="Net operating loss carry forwards">107,285</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--US_zqZlxhA3Suua" style="width: 16%; text-align: right" title="Net operating loss carry forwards">43,410</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Net operating loss carry forwards in Malaysia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20200630__srt--StatementGeographicalAxis__country--MY_pp0p0" style="text-align: right" title="Net operating loss carry forwards">98,649</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--MY_zs0jk3BPpwff" style="text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl1641">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Less: valuation allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowanceCurrent_iNI_pp0p0_di_c20200630_zlT2Cqkmlogd" style="text-align: right" title="Less: valuation allowance">(107,285</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsValuationAllowanceCurrent_iNI_pp0p0_di_c20191231_zR1LZTcSB9lj" style="text-align: right" title="Less: valuation allowance">(43,410</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_ecustom--DeferredTaxAssetsDepreciation_c20200630_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Depreciation">(64,218</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_ecustom--DeferredTaxAssetsDepreciation_c20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Depreciation"><span style="-sec-ix-hidden: xdx2ixbrl1649">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Deferred tax assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DeferredTaxAssetsNet_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets, net">34,431</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DeferredTaxAssetsNet_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets, net"><span style="-sec-ix-hidden: xdx2ixbrl1653">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_z7UZxjnmDOwf" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Uncertain tax positions</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions. As of June 30, 2020, and December 31, 2019, the Company did <span title="Unrecognized uncertain tax positions"><span>not</span></span> have any significant unrecognized uncertain tax positions. The Company did <span title="Unrecognized interest and penalties tax"><span><span><span>not</span></span></span></span> incur interest and penalties tax for the three and six months ended June 30, 2020 and 2019.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_zTFcLi1YVGoh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The United States and foreign components of income (loss) before income taxes were comprised of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BF_zBmA3BDtoi77" style="display: none">SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the three months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2019</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"/><td> </td><td> </td> <td colspan="2" style="text-align: center"/><td> </td><td> </td> <td colspan="2" style="text-align: center"/><td> </td><td> </td> <td colspan="2" style="text-align: center"/><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Tax jurisdictions from:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 44%">Local</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"><b>$</b></td><td id="xdx_98C_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20200401__20200630_zqAg0u5INse8" style="width: 10%; text-align: right" title="Local">(161,751</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"><b>$</b></td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_pp0p0_c20190401__20190630_zJmivlkZiVQ4" style="width: 10%; text-align: right" title="Local">(27,608</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20200101__20200630_pp0p0" style="width: 10%; text-align: right" title="Local">(304,170</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"><b>$</b></td><td id="xdx_986_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_c20190101__20190630_pp0p0" style="width: 10%; text-align: right" title="Local">(42,332</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -0.25in; padding-left: 0.5in">- Foreign – Malaysia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200401__20200630__srt--StatementGeographicalAxis__country--MY_pp0p0" style="text-align: right" title="Foreign">369,367</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20190401__20190630__srt--StatementGeographicalAxis__country--MY_pp0p0" style="text-align: right" title="Foreign">(16,875</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20200630__srt--StatementGeographicalAxis__country--MY_pp0p0" style="text-align: right" title="Foreign">313,780</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_988_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20190101__20190630__srt--StatementGeographicalAxis__country--MY_pp0p0" style="text-align: right" title="Foreign">42,799</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -0.25in; padding-left: 0.5in">- Foreign – Hong Kong</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98E_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200401__20200630__srt--StatementGeographicalAxis__country--HK_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign">13,691</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98F_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20190401__20190630__srt--StatementGeographicalAxis__country--HK_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign">(403,928</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_980_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20200101__20200630__srt--StatementGeographicalAxis__country--HK_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign">(20,053</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_c20190101__20190630__srt--StatementGeographicalAxis__country--HK_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Foreign">(384,628</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Income (loss) before income tax</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20200401__20200630_zN0KOA4Dc6j5" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax">221,307</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_pp0p0_c20190401__20190630_zRxlhNgGnkIg" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax">(448,411</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20200101__20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax">(10,443</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_985_eus-gaap--IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_c20190101__20190630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss before income tax">(384,161</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> -161751 -27608 -304170 -42332 369367 -16875 313780 42799 13691 -403928 -20053 -384628 221307 -448411 -10443 -384161 <p id="xdx_895_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zrtH7RSrFCYl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The (provision for) benefit of income taxes consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B0_zQ2dIKOP3N5i" style="display: none">SCHEDULE OF PROVISION FOR INCOME TAX</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20200401__20200630_zei03mMtCaXc" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20190401__20190630_zO1Kk5lNJMJ9" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Three Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20200101__20200630_zluEnvKXvXzk" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20190101__20190630_zC2mEnHV5yLb" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>For the Six Months Ended </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"/><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center">         </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"/><td style="text-align: center"> </td><td style="text-align: center"> </td> <td style="text-align: center"> </td><td style="text-align: center"/><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -19.8pt; padding-left: 19.8pt">Current:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_maITEBziQf_zcJlLToVr7q" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -19.8pt; padding-left: 19.8pt">- Local</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1583">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1584">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1585">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1586">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--CurrentForeignTaxExpenseBenefit_maITEBziQf_zojSrjcMokPb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 36%; text-indent: -19.8pt; padding-left: 19.8pt">- Foreign</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1588"> </span></td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1589"> </span></td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1590"> </span></td><td style="width: 12%; text-align: right">-</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 12%; text-align: right">6,965</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -19.8pt; padding-left: 19.8pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -19.8pt; padding-left: 19.8pt">Deferred:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_maITEBziQf_zRCEvoz58zB9" style="vertical-align: bottom; background-color: White"> <td style="text-indent: -19.8pt; padding-left: 19.8pt">- Local</td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1593"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1594"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1595"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1596"> </span></td><td style="text-align: right">-</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_maITEBziQf_zBtirYeLPaAa" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -19.8pt; padding-left: 19.8pt">- Foreign</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(134,067</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1599"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(134,067</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-sec-ix-hidden: xdx2ixbrl1601"> </span></td><td style="border-bottom: Black 1.5pt solid; text-align: right">-</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -19.8pt; padding-left: 19.8pt"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--OtherIncomeTaxExpenseBenefitContinuingOperations_iT_pp0p0_mtITEBziQf_zr77rhgkkDQf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 2.5pt; text-indent: -19.8pt; padding-left: 19.8pt">(Provision for) benefit of income taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(134,067</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1604">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(134,067</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">6,965</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 6965 -134067 -134067 -134067 -134067 6965 511000 10000 24000 2027 2028 107000 43000 0.03 0.24 0.24 The tax rate for small and medium sized companies (generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is 17% for the first RM 600,000 (or approximately $150,000) for the three and six months ended June 30, 2020 and RM 500,000 (or approximately $125,000) income for the three and six months ended June 30, 2019, with the remaining balance being taxed at the 24% rate. 0.17 0.165 <p id="xdx_89A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zl0BJzLhwW8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BE_zmbkFdBV2YI5" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>June 30, 2020</b></span></p></td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>As of </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>December 31, 2019</b></span></p></td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax assets:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 60%; text-align: left">Net operating loss carry forwards in U.S.</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20200630__srt--StatementGeographicalAxis__country--US_pp0p0" style="width: 16%; text-align: right" title="Net operating loss carry forwards">107,285</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--US_zqZlxhA3Suua" style="width: 16%; text-align: right" title="Net operating loss carry forwards">43,410</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Net operating loss carry forwards in Malaysia</td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_c20200630__srt--StatementGeographicalAxis__country--MY_pp0p0" style="text-align: right" title="Net operating loss carry forwards">98,649</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_c20191231__srt--StatementGeographicalAxis__country--MY_zs0jk3BPpwff" style="text-align: right" title="Net operating loss carry forwards"><span style="-sec-ix-hidden: xdx2ixbrl1641">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Less: valuation allowance</td><td> </td> <td style="text-align: left"> </td><td id="xdx_984_eus-gaap--DeferredTaxAssetsValuationAllowanceCurrent_iNI_pp0p0_di_c20200630_zlT2Cqkmlogd" style="text-align: right" title="Less: valuation allowance">(107,285</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--DeferredTaxAssetsValuationAllowanceCurrent_iNI_pp0p0_di_c20191231_zR1LZTcSB9lj" style="text-align: right" title="Less: valuation allowance">(43,410</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Deferred tax liabilities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Depreciation</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_ecustom--DeferredTaxAssetsDepreciation_c20200630_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Depreciation">(64,218</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_985_ecustom--DeferredTaxAssetsDepreciation_c20191231_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Depreciation"><span style="-sec-ix-hidden: xdx2ixbrl1649">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Deferred tax assets, net</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98C_eus-gaap--DeferredTaxAssetsNet_c20200630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets, net">34,431</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_eus-gaap--DeferredTaxAssetsNet_c20191231_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Deferred tax assets, net"><span style="-sec-ix-hidden: xdx2ixbrl1653">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 107285 43410 98649 107285 43410 -64218 34431 <p id="xdx_802_eus-gaap--ConcentrationRiskDisclosureTextBlock_zUPX2XnhPQXb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>17. <span id="xdx_825_zKhlHukWheGd">CONCENTRATIONS OF RISKS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(a) Major customers</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For the three and six months ended June 30, 2020, no customer accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20200630__srt--MajorCustomersAxis__custom--NoCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__srt--RangeAxis__srt--MaximumMember_zzul7bJyiT78">10</span></span><span style="font: 10pt Times New Roman, Times, Serif">% or more of the Company’s total revenues. For the three months ended June 30, 2019, one related party customer accounted for approximately <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190401__20190630__srt--MajorCustomersAxis__custom--OneCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zbmLNAjzsuN3">98.5</span></span><span style="font: 10pt Times New Roman, Times, Serif">% of the Company’s total revenues. For the six months ended June 30, 2019, one related party customer accounted for approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190101__20190630__srt--MajorCustomersAxis__custom--OneCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember_zsxhTxmGBbQ7">97.5</span></span><span style="font: 10pt Times New Roman, Times, Serif">% of the Company’s total revenues.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of June 30, 2020, receivables from a third-party e-commerce company accounted for approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20200630__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__dei--LegalEntityAxis__custom--ECommerceCompanyMember_zXrgp1iaAaP8">97.4</span></span><span style="font: 10pt Times New Roman, Times, Serif">% of the total balance of accounts receivable. As of December 31, 2019, one related party customer accounted for <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190101__20191231__srt--MajorCustomersAxis__custom--OneCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zf2puPnRVqhl">100.0</span></span><span style="font: 10pt Times New Roman, Times, Serif">% of the total balance of accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(b) Major vendors</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For the three and six months ended June 30, 2020, one vendor accounted for <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200401__20200630__srt--MajorCustomersAxis__custom--VendorOneMember_zgirfrMnUMt6" title="Concentrations of risk percentage"><span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20200101__20200630__srt--MajorCustomersAxis__custom--VendorOneMember_z8ENLBj42zu3" title="Concentrations of risk percentage">100.0</span></span>% of the Company’s total purchases. For the three months ended June 30, 2019, two vendors accounted for approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190401__20190630__srt--MajorCustomersAxis__custom--VendorOneMember_z1uASrqyHVMb" title="Concentrations of risk percentage">66.8</span>% and <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190401__20190630__srt--MajorCustomersAxis__custom--VendorTwoMember_zXsuzkBtNlq" title="Concentrations of risk percentage">33.2</span>% of the Company’s total purchases, respectively. For the six months ended June 30, 2019, two vendors accounted for approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190101__20190630__srt--MajorCustomersAxis__custom--VendorOneMember_zmc7wAcZY4J6" title="Concentrations of risk percentage">60.7</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190101__20190630__srt--MajorCustomersAxis__custom--VendorTwoMember_zL8sYFxgpKj2" title="Concentrations of risk percentage">39.3</span>% of the Company’s total purchases, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">There are <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pii_dpo_uPure_c20200101__20200630__srt--MajorCustomersAxis__custom--OneVendorMember__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--AccountsPayableMember_zcBS5s8TGqBa" title="Concentrations of risk percentage">no</span> accounts payable balance as of June 30, 2020. As of December 31, 2019, one vendor accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pii_dp_uPure_c20190101__20191231__srt--MajorCustomersAxis__custom--OneVendorMember__us-gaap--ExtinguishmentOfDebtAxis__us-gaap--AccountsPayableMember_zNNxRAABQ1Id" title="Concentrations of risk percentage">100</span>% of the total balance of accounts payable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(c) Commission Expenses to Sales Distributors and Stockists</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">For the three and six months ended June 30, 2020, no sales distributor accounted for <span id="xdx_90B_ecustom--CommissionExpensePercentage_iI_pii_dp_uPure_c20200630_zAm5lSfEwprl" title="Commission expense, percentage">10.0</span>% or more of the Company’s total commission expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(d) Credit risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of June 30, 2020, and December 31, 2019, $<span id="xdx_90E_eus-gaap--Cash_iI_pp0p0_c20200630_zaETG0BGR4j3" title="Cash in bank">917,458</span> and $<span id="xdx_90D_eus-gaap--Cash_iI_pp0p0_c20191231_znxQGtf1ElZe" title="Cash in bank">238,937</span> were deposited with financial institutions, respectively, $<span id="xdx_90E_ecustom--DepositForInsurance_c20200630_pp0p0" title="Deposit for insurance">384,652</span> and $<span id="xdx_908_ecustom--DepositForInsurance_c20191231_pp0p0" title="Deposit for insurance">0</span> of these balances are not covered by deposit insurance. While management believes that these financial institutions are of high credit quality, it also continually monitors their credit worthiness.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. Historically, the Company did not have any bad debt on its account receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">(e) Exchange rate risk</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif; background-color: white">The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM and HK$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> 0.10 0.985 0.975 0.974 1.000 1.000 1.000 0.668 0.332 0.607 0.393 0 1 0.100 917458 238937 384652 0 <p id="xdx_805_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zf4WKPx2xCRg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>18. <span id="xdx_820_z0qjaLwSYSbl">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Lease commitments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On April 1, 2020, the Company adopted ASC 842 for ASL’s office space lease and sales and training center as the lease commencement date upon the acquisition of ASL. The Company recognized lease liabilities of approximately $<span id="xdx_903_eus-gaap--OperatingLeaseLiability_c20200402__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_pp0p0" title="Operating lease liability">466,000</span>, with a corresponding right-of-use (“ROU”) asset in the same amount based on the present value of the future minimum rental payments of the lease, using an effective interest rate of <span id="xdx_90E_ecustom--OperatingLeaseEffectiveInterestRate_pii_dp_uPure_c20200328__20200402__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zQ0QM6J3UBOb" title="Operating lease effective interest rate">5.5</span>%, which was determined using the Company’s estimated incremental borrowing rate. The weighted remaining term of the lease is approximately <span id="xdx_901_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20200402__us-gaap--BusinessAcquisitionAxis__custom--AgapeSuperiorLivingMember_zc6nlB1Y5Y8d" title="Operating lease, weighted average remaining lease term">3.04</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_899_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zjiqzRBidKw5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The five-year maturity of the Company’s operating lease liabilities is as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BE_zZIrNRd5z1B8" style="display: none">SCHEDULE OF FUTURE MINIMUM OPERATING LEASE LIABILITIES</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Twelve Months Ending <br/> June 30,</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20200630_zC1igYYGf875" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Operating lease liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pp0p0_maLOLLPzVKN_zF3uKlXFutG9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; text-align: left">2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">155,316</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pp0p0_maLOLLPzVKN_zM874qZf1vtf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">158,236</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pp0p0_maLOLLPzVKN_z3hkI3wXLkeg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">149,337</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_iI_pp0p0_maLOLLPzVKN_zfmf1PPASdG" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,064</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzVKN_zDGysYdGBVM1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total lease payments</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">470,953</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zmRNEgUr5QBi" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Less: interest</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(37,853</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Present value of lease liabilities</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">433,100</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zr78fwQWt1m9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The Company also leases two distribution centers and one employee apartment with an expiring term of twelve months or fewer, which were classified as operating leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company selected not to recognize lease assets and liabilities on these leases. As of June 30, 2020, the Company’s commitment for minimum lease payments under these operating leases within the next twelve months are $<span id="xdx_906_eus-gaap--OperatingLeasePayments_c20200101__20200630_pp0p0" title="Operating lease payments">8,620</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Rent expense for the three months ended June 30, 2020 and 2019 was $<span id="xdx_904_eus-gaap--OperatingLeaseExpense_pp0p0_c20200401__20200630_zi10gMef0X4c" title="Operating lease, rent expenses">52,672</span> and $<span id="xdx_907_eus-gaap--OperatingLeaseExpense_pp0p0_c20190401__20190630_ziGXuqtiKeYb" title="Operating lease, rent expenses">13,391</span>, respectively. Rent expense for the six months ended June 30, 2020 and 2019 was $<span id="xdx_900_eus-gaap--OperatingLeaseExpense_c20200101__20200630_pp0p0" title="Operating lease, rent expenses">66,180</span> and $<span id="xdx_90F_eus-gaap--OperatingLeaseExpense_pp0p0_c20190101__20190630_zl38mefzfAIk" title="Operating lease, rent expenses">26,766</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Purchase commitments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p id="xdx_890_ecustom--ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock_z16i7rF9aadb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The total future minimum purchase commitment under a non-cancellable purchase contract as of June 30, 2020 for the next five years and thereafter is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B8_zry4KUZPMwi1" style="display: none">SCHEDULE OF FUTURE MINIMUM PURCHASE COMMITMENT</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Twelve months ending June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_493_20200630_zziGNDHzgf6j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Minimum</p> <p style="margin-top: 0; margin-bottom: 0">purchase</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--PurchaseObligationDueInNextTwelveMonths_iI_pp0p0_maPOzFFW_zE7JZWwNnmF8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; text-align: left">2021</td><td style="width: 2%; text-align: left"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">693,900</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PurchaseObligationDueInSecondYear_iI_pp0p0_maPOzFFW_z8OZjSGj86Ag" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2022</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">693,900</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PurchaseObligationDueInThirdYear_iI_pp0p0_maPOzFFW_zLOcAA97qnVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2023</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">693,900</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PurchaseObligationDueInFourthYear_iI_pp0p0_maPOzFFW_zjX644ZPJRe7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">693,900</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--PurchaseObligationDueInFifthYear_iI_pp0p0_maPOzFFW_zjl27B7TXhB6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">693,900</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PurchaseObligationDueAfterFifthYear_iI_pp0p0_maPOzFFW_zgvMOA7IWlg9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Thereafter</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,734,750</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PurchaseObligation_iTI_pp0p0_mtPOzFFW_zP205cIWHgqc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total minimum purchase commitments required</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,204,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zasTQ0UY8old" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">As of the date of this report, the Company’s vendor is not able to meet the Company’s minimum purchase commitment of the health and wellness products due to the manufacturing process was being delayed by its vendor.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><span style="text-decoration: underline">Contingencies</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>Legal</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">From time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued, as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are not deemed to be material to the consolidated financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify; background-color: white"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>AGAPE ATP CORPORATION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(UNAUDITED)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b>(Currency expressed in United States Dollars (“US$”), except for number of shares)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"><b>COVID-19</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">On March 11, 2020, the World Health Organization or WHO declared the corona virus or COVID-19 a pandemic. In accordance with the recommendations of the WHO, Malaysia had imposed a nationwide lockdown via the government’s Movement Control Order (“MCO”) effective March 18, 2020. The MCO has resulted in quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia. On May 4, 2020, the MCO was lessen to a Conditional Movement Control Order (“CMCO”) where most business sectors were allowed to operate under strict rules and Standard Operating Procedures mandated by the government of Malaysia.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Substantially all of the Company’s revenues are concentrated in Malaysia. Consequently, its results of operations will likely be adversely, and may be materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact to its results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact, almost all of which are beyond its control. Potential impacts include, but are not limited to, the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">temporary closure of offices, travel restrictions, financial impact of the Company’s customers or suspension supplies may negatively affected, and could continue to negatively affect, the demand for the Company’s product;</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font: 10pt Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">the Company may have to provide significant sales incentives to its customers during the outbreak, which may in turn materially adversely affect its financial condition and operating results; and</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-align: justify; text-indent: -0.25in; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">any disruption of the Company’s supply chain, logistics providers or customers could adversely impact its business and results of operations, including causing the Company or its suppliers to cease manufacturing for a period of time or materially delay delivery to its customers, which may also lead to loss of its customers.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font: 10pt Times New Roman, Times, Serif">Because of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19 cannot be reasonably estimated at this time. There is no guarantee that the Company’s total revenues will grow or remain at the similar level year over year in the remaining period of 2020.</span></p> 466000 0.055 P3Y14D <p id="xdx_899_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zjiqzRBidKw5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The five-year maturity of the Company’s operating lease liabilities is as follow:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8BE_zZIrNRd5z1B8" style="display: none">SCHEDULE OF FUTURE MINIMUM OPERATING LEASE LIABILITIES</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Twelve Months Ending <br/> June 30,</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20200630_zC1igYYGf875" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Operating lease liabilities</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_iI_pp0p0_maLOLLPzVKN_zF3uKlXFutG9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; text-align: left">2021</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">155,316</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_iI_pp0p0_maLOLLPzVKN_zM874qZf1vtf" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2022</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">158,236</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_iI_pp0p0_maLOLLPzVKN_z3hkI3wXLkeg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">149,337</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_iI_pp0p0_maLOLLPzVKN_zfmf1PPASdG" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left">2024</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">8,064</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzVKN_zDGysYdGBVM1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total lease payments</span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">470,953</td><td style="text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zmRNEgUr5QBi" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Less: interest</span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(37,853</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Present value of lease liabilities</span></td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">433,100</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 155316 158236 149337 8064 470953 37853 433100 8620 52672 13391 66180 26766 <p id="xdx_890_ecustom--ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock_z16i7rF9aadb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">The total future minimum purchase commitment under a non-cancellable purchase contract as of June 30, 2020 for the next five years and thereafter is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_8B8_zry4KUZPMwi1" style="display: none">SCHEDULE OF FUTURE MINIMUM PURCHASE COMMITMENT</span><span style="font: 10pt Times New Roman, Times, Serif"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; text-align: left; font-weight: bold">Twelve months ending June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" id="xdx_493_20200630_zziGNDHzgf6j" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0">Minimum</p> <p style="margin-top: 0; margin-bottom: 0">purchase</p></td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--PurchaseObligationDueInNextTwelveMonths_iI_pp0p0_maPOzFFW_zE7JZWwNnmF8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 81%; text-align: left">2021</td><td style="width: 2%; text-align: left"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 20%; text-align: right">693,900</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--PurchaseObligationDueInSecondYear_iI_pp0p0_maPOzFFW_z8OZjSGj86Ag" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2022</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">693,900</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--PurchaseObligationDueInThirdYear_iI_pp0p0_maPOzFFW_zLOcAA97qnVi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2023</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">693,900</td><td style="text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--PurchaseObligationDueInFourthYear_iI_pp0p0_maPOzFFW_zjX644ZPJRe7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">2024</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">693,900</td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--PurchaseObligationDueInFifthYear_iI_pp0p0_maPOzFFW_zjl27B7TXhB6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">2025</td><td style="text-align: left"> </td> <td style="text-align: left"> </td><td style="text-align: right">693,900</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--PurchaseObligationDueAfterFifthYear_iI_pp0p0_maPOzFFW_zgvMOA7IWlg9" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Thereafter</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,734,750</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--PurchaseObligation_iTI_pp0p0_mtPOzFFW_zP205cIWHgqc" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; padding-bottom: 2.5pt; text-align: left"><span style="font: 10pt Times New Roman, Times, Serif">Total minimum purchase commitments required</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">5,204,250</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 693900 693900 693900 693900 693900 1734750 5204250 On July 1, the Company issued additional 13,853 shares of the Company’s common stock valued at $90,043 based on the Company’s closing price of $6.50 at March 31, 2020 to settle the acquisition payment of ASL (See Note 15). XML 10 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Cover - shares
6 Months Ended
Jun. 30, 2020
Aug. 10, 2020
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2020  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2020  
Current Fiscal Year End Date --12-31  
Entity File Number 333-220144  
Entity Registrant Name AGAPE ATP CORPORATION  
Entity Central Index Key 0001713210  
Entity Tax Identification Number 36-4838886  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One Tower 2  
Entity Address, Address Line Two Faber Tower  
Entity Address, Address Line Three Jalan Desa Bahagia  
Entity Address, City or Town Kuala Lumpur  
Entity Address, Country MY  
Entity Address, Postal Zip Code 58100  
City Area Code (60)  
Local Phone Number 192230099  
Title of 12(b) Security Common Stock, $0.0001 par value  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   376,452,047
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
CURRENT ASSETS    
Cash and cash equivalents (Included $18,680 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of June 30, 2020) $ 3,427,664 $ 2,744,457
Accounts receivable 325,426
Accounts receivable – related party 8,694 520,786
Amount due from related parties 5,589 2,217
Inventories 416,627
Prepaid taxes (Included $3,113 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of June 30, 2020) 1,214,035
Prepayments and deposits (Included $8,399 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of June 30, 2020) 507,989 269,193
Prepayments and deposits – related party 2,784
Total Current Assets 5,908,808 3,536,653
OTHER ASSETS    
Property and equipment, net 311,859
Intangible assets, net 6,283
Operating right-of-use assets 432,593
Investment in marketable securities 193,663 66,484
Investment in non-marketable securities 1,500 732,137
Deferred offering costs 203,238
Deferred tax assets, net 34,431
Total Other Assets 1,183,567 798,621
TOTAL ASSETS 7,092,375 4,335,274
CURRENT LIABILITIES    
Accounts payable 2,790
Customer deposits 901,569
Operating lease liabilities - current 134,858
Other payables and accrued liabilities ($2,741 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of June 30, 2020) 467,567 77,246
Amount due to a related party 90,043 3,952
Total Current Liabilities 1,594,037 83,988
OTHER LIABILITIES    
Operating lease liabilities – non-current 298,242
TOTAL LIABILITIES 1,892,279 83,988
STOCKHOLDERS’ EQUITY    
Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding  
Common stock, par value $0.0001; 1,000,000,000 shares authorized, 376,438,194 and 376,275,500 issued and outstanding as of June 30, 2020 and December 31, 2019, respectively 37,644 37,628
Additional paid in capital 6,350,574 5,293,082
Accumulated deficit (1,233,719) (1,089,209)
Accumulated other comprehensive income 45,597 9,785
TOTAL STOCKHOLDERS’ EQUITY 5,200,096 4,251,286
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 7,092,375 $ 4,335,274
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Statement of Financial Position [Abstract]    
VIE consolidated amount of cash and cash equivalents $ 18,680  
VIE consolidated amount of prepaid taxes 3,113  
VIE consolidated amount of prepayments and deposits 8,399  
VIE consolidated amount of other payables and accrued liabilities $ 2,741  
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 200,000,000 200,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 1,000,000,000 1,000,000,000
Common stock, shares issued 376,438,194 376,275,500
Common stock, shares outstanding 376,438,194 376,275,500
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Statement [Abstract]        
REVENUE $ 1,510,208 $ 1,510,208
REVENUE – RELATED PARTY 13,654 396,472 13,654 860,769
TOTAL REVENUE 1,523,862 396,472 1,523,862 860,769
COST OF REVENUE (471,554) (397,172) (471,554) (817,350)
GROSS PROFIT (LOSS) 1,052,308 (700) 1,052,308 43,419
SELLING (108,894) (6,504) (109,356) (7,846)
COMMISSION (382,498) (382,498)
GENERAL AND ADMINISTRATIVE (514,724) (52,734) (673,778) (83,778)
TOTAL OPERATING EXPENSES (1,006,116) (59,238) (1,165,632) (91,624)
INCOME (LOSS) FROM OPERATIONS 46,192 (59,938) (113,324) (48,205)
OTHER INCOME (EXPENSES)        
Other income (expenses), net 29,911 (21,639) (23,785) 40,454
Loss from equity investment (26,085)
Unrealized holding gain on marketable securities 145,204 126,666
Gain on deemed disposal of shares in Investee Company 16,509
Impairment loss in equity investment (366,834) (366,834)
TOTAL OTHER INCOME (EXPENSES), NET 175,115 (388,473) 102,881 (335,956)
INCOME (LOSS) BEFORE INCOME TAXES 221,307 (448,411) (10,443) (384,161)
(PROVISION FOR) BENEFIT OF INCOME TAXES (134,067) (134,067) 6,965
NET INCOME (LOSS) 87,240 (448,411) (144,510) (377,196)
OTHER COMPREHENSIVE INCOME        
Foreign currency translation adjustment 28,042 4,412 35,812 1,215
COMPREHENSIVE INCOME (LOSS) $ 115,282 $ (443,999) $ (108,698) $ (375,981)
EARNINGS (LOSS) PER SHARE        
Basic and diluted $ 0.00 $ (0.00) $ (0.00) $ (0.00)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING        
Basic and diluted 376,370,256 376,275,500 376,322,878 376,275,500
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Dec. 31, 2018 $ 37,628 $ 5,293,082 $ (373,082) $ (1,294) $ 4,956,334
Beginning balance, shares at Dec. 31, 2018 376,275,500        
Net income 71,215 71,215
Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd, shares        
Foreign currency translation adjustment (3,197) (3,197)
Ending balance, value at Mar. 31, 2019 $ 37,628 5,293,082 (301,867) (4,491) 5,024,352
Ending balance, shares at Mar. 31, 2019 376,275,500        
Beginning balance, value at Dec. 31, 2018 $ 37,628 5,293,082 (373,082) (1,294) 4,956,334
Beginning balance, shares at Dec. 31, 2018 376,275,500        
Net income         (377,196)
Ending balance, value at Jun. 30, 2019 $ 37,628 5,293,082 (750,278) (79) 4,580,353
Ending balance, shares at Jun. 30, 2019 376,275,500        
Beginning balance, value at Mar. 31, 2019 $ 37,628 5,293,082 (301,867) (4,491) 5,024,352
Beginning balance, shares at Mar. 31, 2019 376,275,500        
Net income (448,411) (448,411)
Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd, shares        
Foreign currency translation adjustment 4,412 4,412
Ending balance, value at Jun. 30, 2019 $ 37,628 5,293,082 (750,278) (79) 4,580,353
Ending balance, shares at Jun. 30, 2019 376,275,500        
Beginning balance, value at Dec. 31, 2019 $ 37,628 5,293,082 (1,089,209) 9,785 4,251,286
Beginning balance, shares at Dec. 31, 2019 376,275,500        
Net income (231,750) (231,750)
Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd, shares        
Foreign currency translation adjustment 7,770 7,770
Ending balance, value at Mar. 31, 2020 $ 37,628 5,293,082 (1,320,959) 17,555 4,027,306
Ending balance, shares at Mar. 31, 2020 376,275,500        
Beginning balance, value at Dec. 31, 2019 $ 37,628 5,293,082 (1,089,209) 9,785 4,251,286
Beginning balance, shares at Dec. 31, 2019 376,275,500        
Net income         (144,510)
Ending balance, value at Jun. 30, 2020 $ 37,644 6,350,574 (1,233,719) 45,597 5,200,096
Ending balance, shares at Jun. 30, 2020 376,438,194        
Beginning balance, value at Mar. 31, 2020 $ 37,628 5,293,082 (1,320,959) 17,555 4,027,306
Beginning balance, shares at Mar. 31, 2020 376,275,500        
Net income 87,240 87,240
Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd $ 16 1,057,492 1,057,508
Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd, shares 162,694        
Foreign currency translation adjustment 28,042 28,042
Ending balance, value at Jun. 30, 2020 $ 37,644 $ 6,350,574 $ (1,233,719) $ 45,597 $ 5,200,096
Ending balance, shares at Jun. 30, 2020 376,438,194        
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (144,510) $ (377,196)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 17,716
Amortization 482
Amortization of operating right-of-use assets 32,756
Loss from equity investment 26,085
Unrealized holding gain on marketable securities (126,667)
Gain on deemed disposal of shares in investee company (16,509)
Impairment loss in equity investment 366,834
Deferred tax expenses 134,067
Changes in operating assets and liabilities:    
Accounts receivables (322,547)
Accounts receivables – related party (8,617) (433,338)
Amount due from a related party (2,210)
Inventories 206,540
Prepaid taxes 4,185
Prepayments and deposits 125,422 11,734
Prepayments and deposits – related party (2,780)
Accounts payable (2,802)
Accounts payable – related party 35,145
Customer deposits (712,749) (217,743)
Income taxes payable (6,965)
Other payables and accrued liabilities 51,093 23,690
Operating lease liabilities (32,253)
Net cash used in operating activities (780,664) (590,473)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Cash and cash equivalent acquired through acquisition of Agape Superior Living Sdn Bhd 1,210,818
Proceeds from sale of non-marketable securities to a related party 70,173
Investment in non-marketable securities (1,500)
Net cash provided by (used in) investing activities 1,280,991 (1,500)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Deferred offering costs (75,738)
Repayments from related parties 216,575 745
Amount due to a related party (5,318)
Net cash provided by (used in) financing activities 140,837 (4,573)
EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS 42,043 1,216
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 683,207 (595,330)
CASH AND CASH EQUIVALENTS, beginning of period 2,744,457 3,452,917
CASH AND CASH EQUIVALENTS, end of period 3,427,664 2,857,587
SUPPLEMENTAL CASH FLOWS INFORMATION    
Income taxes paid
Interest paid
SUPPLEMENTAL NON-CASH FLOWS INFORMATION    
Amount transferred from investment in investee company to investment in non-marketable securities 724,619
Initial recognition of right-of-use assets and lease liabilities 461,522
Sale of non-marketable securities to a related party in exchange for ASL 656,495
Issuance of common stock in exchange for acquisition payment of ASL 1,057,508
Unpaid balance due to a related party in connection with acquisition payment of ASL 90,043
Unpaid accrued liabilities on deferred offering costs $ 127,500
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.20.2
ORGANIZATION AND BUSINESS BACKGROUND
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
ORGANIZATION AND BUSINESS BACKGROUND

1. ORGANIZATION AND BUSINESS BACKGROUND

 

Agape ATP Corporation, a Nevada corporation (“the Company”) was incorporated under the laws of the State of Nevada on June 1, 2016.

 

Agape ATP Corporation operates through its wholly owned subsidiary, Agape ATP Corporation, a Company organized in Labuan, Malaysia.

 

Agape ATP Corporation, incorporated in Labuan, Malaysia, is an investment holding company with 100% equity interest in Agape ATP International Holding Limited, a company incorporated in Hong Kong.

 

On May 8, 2020, the Company entered into a Share Exchange Agreement with Mr. How Kok Choong, CEO and director of the Company to acquire 9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in Agape Superior Living Sdn. Bhd., an entity incorporated in Malaysia.

 

Agape Superior Living Sdn. Bhd. (“ASL”) is a limited company incorporated on August 8, 2003, under the laws of Malaysia.

 

The Company and its subsidiaries engage in the network marketing sales business in the Health and Wellness Industry. The principal activity of the Company is to supply high-quality health and wellness products, including supplements to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system of the human body.

 

The accompanying unaudited condensed consolidated financial statements reflect the activities of the Company, Agape ATP Corporation (“AATP LB”), Agape ATP International Holding Limited (“AATP HK”), ASL and its variable interest entity (“VIE”), Agape S.E.A. Sdn. Bhd. (“SEA”) (See Note 3).

 

Details of the Company’s subsidiaries:

 

 

   

Subsidiary company

name

 

Place and

date of

incorporation

  Particulars of issued capital  Principal activities 

Proportional of ownership

interest and

voting power

held

 
                  
1.    Agape ATP Corporation  Labuan,
March 6, 2017
  100 shares of ordinary share of US$1 each  Investment holding   100%
                   
2.    Agape ATP International Holding Limited  Hong Kong,
June 1, 2017
  1,000,000 shares of ordinary share of HK$1 each  Health and wellness products and health solution advisory services   100%
                   
3.   Agape Superior Living Sdn. Bhd.  Malaysia,
August 8, 2003
  9,590,598 shares of ordinary share of RM1 each  Health and wellness products and health solution advisory services   99.99%
                   
4.   Agape S.E.A. Sdn. Bhd.  Malaysia,
March 4, 2004
  2 shares of ordinary share of RM1 each  VIE of Agape Superior Living Sdn. Bhd.   VIE 

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Business Overview

 

Agape ATP Corporation is a company that provides health solution advisory services to our clients. We primarily focus our efforts on attracting customers in Malaysia. Our advisory services center on the “ATP Zeta Health Program”, which is a health program designed to effectively prevent diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles, and promotion of health. The program aims to promote improved health and longevity in our clients through a combination of modern medicine, proper nutrition and advice from skilled nutritionists and/or dieticians.

 

In order to strengthen the Company’s supply chain, on May 8, 2020, the Company has successfully acquired approximately 99.99% of ASL, with the goal of securing an established network marketing sales channel that has been established in Malaysia for the past 15 years. ASL has been offering the Company’s ATP Zeta Health Program as part of its product lineup. As such, the acquisition creates synergy in the Company’s operation by boosting the Company’s retail and marketing capabilities. The newly acquired subsidiary allows the Company to fulfill its mission of “helping people to create health and wealth” by providing a financially rewarding business opportunity to distributors and quality products to distributors and customers who seek a healthy lifestyle.

 

The Company offers three series of programs which consist of different services and products: ATP Zeta Health Program, ÉNERGÉTIQUE and BEAUNIQUE.

 

The ATP Zeta Health Program is a health program designed to promote health and general wellbeing designed to prevent health diseases caused by polluted environments, unhealthy dietary intake and unhealthy lifestyles. The program aims to promote improved health and longevity through a combination of modern health supplements, proper nutrition and advice from skilled dieticians as well as trained members and distributors.

 

The ÉNERGÉTIQUE series aims to provide a total dermal solution for a healthy skin beginning from the cellular level. The series is comprised of the Energy Mask series, Hyaluronic Acid Serum and Mousse Facial Cleanser.

 

The BEAUNIQUE product series focuses on the research of our diet’s impact on modifying gene expressions in order to address genetic variations and deliver a nutrigenomic solution for every individual.

 

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), and include all normal and recurring adjustments that management of the Company considers necessary for a fair presentation of its financial position and operation results. Interim results are not necessarily indicative of results to be expected for any other interim period or for the full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s transition report on Form 10-K for the period ended December 31, 2019, filed with the Securities and Exchange Commission on March 27, 2020.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Principles of consolidation

 

The unaudited condensed consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.

 

Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.

 

A VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary and must consolidate the VIE. 

 

Use of estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include allowance for doubtful accounts, allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.

 

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.

 

Accounts receivable and accounts receivable – related party

 

Accounts receivable and accounts receivable – related party are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of June 30, 2020, and December 31, 2019, no valuation allowance was recorded.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Inventories

 

Inventories consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method.

 

Prepaid taxes

 

Prepaid taxes include (i) prepaid income taxes that will either be refundable or utilized to offset future income tax; and (ii) goods and service tax (“GST”) to be refundable.

 

Prepayments and deposits

 

Prepayments and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of June 30, 2020, and December 31, 2019, there is no allowance for the doubtful accounts.

 

Property and equipment, net

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:

 

    Useful Life 
      
Computer and office equipment   5-7 years  
Furniture & fixtures   6-7 years 
Leasehold improvements   Lease Term 
Vehicle   5 years 

 

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates of useful lives.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Intangible assets, net

 

Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows:

 

 

Classification   Useful Life 
      
Computer software   5 years 

 

Impairment for long-lived assets

 

Long-lived assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of June 30, 2020, and December 31, 2019, no impairment of long-lived assets was recognized.

 

Deferred offering costs

 

Deferred offering costs represents costs associated with the Company’s current offering which will be netted against the proceeds from the Company’s current offering.

 

Investment in marketable equity securities

 

Prior to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

 

On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s consolidated statements of operations and comprehensive loss in the caption of “unrealized holding losses on marketable securities” in each reporting period.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares) 

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Investment in non-marketable equity securities

 

Prior to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

 

On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.

 

At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.

 

Customer deposits

 

Customer deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced when the related sale is recognized in accordance with the Company’s revenue recognition policy.

 

Revenue recognition

 

On July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not result in an adjustment to retained earnings upon adoption of this new guidance as the Company’s revenue was recognized based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

The core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.

 

The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.

 

The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.

 

Prior to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

 

The application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance and confirmed that there were no differences in the pattern of revenue recognition.

 

Sales of Health and Wellness products

 

- Performance obligations satisfied at a point in time

 

On July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods, which is generally similar to when its delivery has occurred prior to July 1, 2019 Such revenues are recognized at a point in time after all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

The Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and wellness products transaction price upon such sales transactions occurred. The Company’s coupons have a validity period of six months. If the Company’s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues. For the three and six months ended June 30, 2020, the Company recognized $61,368 as forfeited coupon income.

 

As of June 30, 2020, the Company had contracts for the sales of health and wellness products amounting to $661,900 which it is expected to fulfill within 12 months from June 30, 2020.

 

Disaggregated information of revenues by products are as follows:

 

 

   For the three months ended   For the six months ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
                 
Ionized Cal-Mag  $611,160   $167   $611,160   $55,660 
Omega Blend   162,543    207    162,543    68,896 
Young Formula   349,738    353    349,738    117,332 
Organic Youth Care Cleansing Bar   28,805    53    28,805    17,728 
Trim+   223,497    133,319    223,497    198,614 
Lipomask   8,420    422    8,420    140,588 
Beta Maxx   11,434    123,470    11,434    123,470 
Energized Mineral Concentrate   22,606    138,481    22,606    138,481 
Survivor Select   35,994    -    35,994    - 
Vege-Fruit Fiber   6,106    -    6,106    - 
Mitogize   4,711    -    4,711    - 
Hyaluronic Acid Serum   55,721    -    55,721    - 
Mousse Facial Cleanser   3,127    -    3,127    - 
Total revenues  $1,523,862   $396,472   $1,523,862   $860,769 

 

Cost of revenue

 

Cost of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers.

 

Shipping and handling

 

Shipping and handling charges amounted to $2,555 and $0 for the three months ended June 30, 2020 and 2019, respectively. Shipping and handling charges amounted to $2,555 and $0 for the six months ended June 30, 2020 and 2019, respectively. Shipping and handling charges are expensed as incurred and included in selling expenses.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Advertising costs

 

Advertising costs amounted to $2,882 and $0 for the three months ended June 30, 2020 and 2019, respectively. Advertising costs amounted to $2,882 and $0 for the six months ended June 30, 2020 and 2019, respectively. Advertising costs are expensed as incurred and included in selling expenses.

 

Commission expenses

 

Commission expenses are the Company’s most significant expenses. As with all companies in the network marketing industry, the Company’s sales channel is external to the Company. The Company’s “external sales force” is stratified into two levels based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly, are referred to as “sales network members”. The Company pays commission to every sales distributor based on purchases made by its sales network members which includes the independent direct sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain amount of the Company’s inventory on their store premises. The stockists shall account to the Company for all products sales from their store premises as monitored through the Company’s centralized stock tracking system. The Company pays a separate commission to stockists based on revenue generated from the stockists’ physical stores. Commission expenses amounted to $382,498 and $0 for the three months ended June 30, 2020 and 2019, respectively. Commission expenses amounted to $382,498 and $0 for the six months ended June 30, 2020 and 2019, respectively.

 

Defined contribution plan

 

The full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue and pay for these benefits based on certain percentages of the employees’ respective salaries, subject to certain ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan. Total expenses for the plans were $23,710 and $0 for the three months ended June 30, 2020 and 2019, respectively. Total expenses for the plans were $23,710 and $0 for the six months ended June 30, 2020 and 2019, respectively.

 

The related contribution plans include:

 

  - Social Security Organization (“SOSCO”) – 1.75% based on employee’s monthly salary capped of RM 4,000;
  - Employees Provident Fund (“EPF”) – 12% based on employee’s monthly salary;
  - Employment Insurance System (“EIS”) – 0.2% based on employee’s monthly salary capped of RM 4,000;
  - Human Resource Development Fund (“HRDF”) – 1% based on employee’s monthly salary

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Income taxes

 

The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.

 

Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.

 

An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. No penalties and interest incurred related to underpayment of income tax for the three and six months ended June 30, 2020 and 2019.

 

The Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

Comprehensive income (loss)

 

Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.

 

Non-controlling interest

 

Non-controlling interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals. The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders and the shareholders of the Company. As of June 30, 2020, the non-controlling interest balance was $0 and therefore not presented in the accompanying unaudited condensed consolidated financial statements.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Earnings (loss) per share

 

The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. For the three and six months ended June 30, 2020 and 2019, there were no dilutive shares.

 

Foreign currencies translation and transaction

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit (“MYR” or “RM”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency. The Company’s subsidiary and VIE in Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (“MYR” or “RM”), as its functional currency.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

 

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

 

 

   As of 
   June 30, 2020   December 31, 2019 
         
Period-end MYR : US$1 exchange rate   4.28    4.09 
Period-end HKD : US$1 exchange rate   7.75    7.79 

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

   For the three months ended   For the six months ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
                 
Period-average MYR : US$1 exchange rate   4.32    4.15    4.25    4.12 
Period-average HKD : US$1 exchange rate   7.75    7.84    7.76    7.84 

 

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments

 

The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.

 

The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:

 

  Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
  Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.

 

Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.

 

Leases

 

Effective July 1, 2019, the Company adopted ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that does not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing leases with a lease term in excess of twelve months on July 1, 2019.

  

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Operating lease right-of-use (“ROU”) assets and lease liabilities are recognized at the adoption date of July 1, 2019 or the commencement date, whichever is earlier, based on the present value of lease payments over the lease term. Since the implicit rate for the Company’s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment and over a similar term.

 

Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.

 

The Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future pre-tax cash flows.

 

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its unaudited condensed consolidated financial statements.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The Company does not expect the adoption of this standard to have a material impact on its unaudited condensed consolidated financial statements.

 

Reclassification

 

Certain prior period amounts have been reclassified to conform to the current period presentation for the three and six months ended June 30, 2019. These reclassifications have no effect on the unaudited condensed consolidated statements of operations and comprehensive income (loss).

 

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.20.2
VARIABLE INTEREST ENTITY (“VIE”)
6 Months Ended
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
VARIABLE INTEREST ENTITY (“VIE”)

3. VARIABLE INTEREST ENTITY (“VIE”)

 

SEA is a trading company incorporated on March 4, 2004, under the laws of Malaysia. SEA provided all of ASL’s purchases. Its equity at risk was insufficient to finance its activities and 100% of its business is transacted with ASL. Therefore it was considered to be a VIE and ASL is the primary beneficiary since it has both of the following characteristics:

 

  a. The power to direct the activities of the VIE that most significantly impact the VIE’s economic performance; and
  b. The obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE.

 

Accordingly, the accounts of SEA is consolidated in the accompanying unaudited condensed financial statements.

 

The carrying amount of the VIE’s assets and liabilities were as follows:

 

 

   June 30, 2020 
     
Current assets  $290,630 
Current liabilities   (289,911)
Net assets  $719 

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

3. VARIABLE INTEREST ENTITY (“VIE”) (Continued)

 

   June 30, 2020 
Current asset:     
Cash and cash equivalents  $18,680 
Accounts receivable – intercompany   260,438 
Prepaid taxes   3,113 
Prepayments and deposits   8,399 
Total current assets   290,630 
      
Current liabilities:     
Accounts payable – intercompany  $286,820 
Other payables and accrued liabilities   2,741 
Other payables – intercompany   350 
Total current liabilities  $289,911 

 

The summarized operating results of the VIE’s are as follows:

 

  

For the Three Months Ended

June 30, 2020

  

For the Six

Months Ended

June 30, 2020

 
         
Operating revenues  $129,492   $129,492 
Gross profit  $1,373   $1,373 
Loss from operations  $(3,749)  $(3,749)
Net loss  $(18,139)  $(18,139)

 

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.20.2
BUSNINESS COMBINATION
6 Months Ended
Jun. 30, 2020
Business Combinations [Abstract]  
BUSNINESS COMBINATION

4. BUSNINESS COMBINATION

 

On May 8, 2020, the Company entered into a Share Exchange Agreement (“SPA”) with Mr. How Kok Choong, CEO and director of the Company to acquire 9,590,596 ordinary shares, no par value, equivalent to approximately 99.99% of the equity interest in ASL, an entity incorporated in Malaysia. Pursuant to the SPA, as amended on July 1, 2020, Mr. How will receive an aggregate consideration of $1,804,046, which was determined based on the net asset carrying value of ASL as at March 31, 2020. The aggregate consideration shall be satisfied by (i) the offset of the Consideration whereby the Company has a loan receivable of $656,495 as of March 31, 2020 due from Mr. How; and (ii) allotment and issuance of common stock of the Company. The Company shall allot and issue 176,547 shares of the Company’s common stock, par value $0.0001, representing approximately 0.0469% of the total issued and outstanding shares in the Company after the issuance of the Shares, which is valued at $1,147,551 based on the closing price of $6.50 of the Company as quoted on the OTC Market on March 31, 2020. As of June 30, 2020, the Company issued 162,294 shares of the Company’s common stock with the remaining 13,853 shares of the Company’s common stock issued on July 1, 2020.

 

The Company’s acquisition of ASL was accounted for as a business combination in accordance with ASC 805. The Company has allocated the purchase price of ASL based upon the carrying value of the identifiable assets acquired and liabilities assumed on April 1, 2020 as ASL was under the common control of Mr. How.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

The following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which represents the net purchase price allocation on the date of the acquisition of ASL.

  

 

   Carry Value 
ASSETS     
Current assets     
Cash  $1,206,493 
Other receivables   33,210 
Other receivables - related parties   219,121 
Inventories   616,880 
Prepaid taxes   1,206,821 
Prepayments and other assets   318,267 
Total current assets   3,600,792 
      
Other assets     
Property and equipment, net   325,648 
Intangible assets, net   6,686 
Deferred taxes asset, net   172,250 
Total other assets   504,584 
      
Total assets  $4,105,376 
      
LIABILITIES AND SHAREHOLDERS’ EQUITY     
Current liabilities     
Accounts payable - related party  $491,628 
Customer deposits   1,600,606 
Other payables and accrued liabilities   209,096 
Total current liabilities   2,301,330 
      
Total liabilities   2,301,330 
      
Total net assets acquired   1,804,046 

 

The following unaudited pro forma combined results of operations presents the Company’s financial results as if the acquisition of ASL had been completed on January 1, 2019. The unaudited pro forma results do not reflect operating efficiencies or potential cost savings which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information is not necessarily indicative of the results of operations that the Company would have recognized had we completed the transaction on January 1, 2019. Future results may vary significantly from the results in this pro forma information because of future events and transactions, as well as other factors.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

  

   For the Three Months Ended   For the Six Months Ended   For the Six Months Ended 
   June 30, 2019   June 30, 2020   June 30, 2019 
Revenue  $684,112   $2,765,114   $1,914,362 
Cost of revenue   (108,478)   (571,407)   (309,999)
Gross profit   575,634    2,193,707    1,604,363 
Total operating expenses   (1,269,443)   (2,055,016)   (2,613,015)
Income (loss) from operations   (693,809)   138,691    (1,008,652)
Other income (expense), net   (281,239)   110,912    (237,655)
Income (loss) before income taxes   (975,048)   249,603    (1,246,307)
Benefit of (Provision for) income taxes   137,983    (184,900)   202,180 
Net income (loss)  $(837,065)  $64,703   $(1,044,127)
Net income (loss) per common share - basic and diluted   (0.00)   0.00    (0.00)
Weighted average number of common shares outstanding - basic and diluted  $376,452,047   $376,452,047   $376,452,047 

 

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.20.2
CASH AND CASH EQUIVALENTS
6 Months Ended
Jun. 30, 2020
Cash and Cash Equivalents [Abstract]  
CASH AND CASH EQUIVALENTS

5. CASH AND CASH EQUIVALENTS

 

As of June 30, 2020 and December 31, 2019 the Company has $3,427,664 and $2,744,457, respectively, of cash and cash equivalents, which consists of $917,458 and $238,937, respectively, of cash in banks and $2,483,915 and $2,505,520, respectively, of time deposits placed with banks or other financial institutions and are all highly liquid investments with an original maturity of three months or less. The effective interest rate for the time deposits ranges between 2.95% to 3.25% per annum.

 

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.20.2
ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE – RELATED PARTY
6 Months Ended
Jun. 30, 2020
Receivables [Abstract]  
ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE – RELATED PARTY

6. ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE – RELATED PARTY

 

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
Accounts receivable  $325,426   $- 
Accounts receivable – related party   8,694    520,786 
Allowance for doubtful accounts   -    - 
Total accounts receivable and accounts receivable – related party  $334,120   $520,786 

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.20.2
INVENTORIES
6 Months Ended
Jun. 30, 2020
Inventory Disclosure [Abstract]  
INVENTORIES

7. INVENTORIES

 

Inventories consist of the following:

 

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
Finished goods  $416,627   $            - 

 

XML 23 R14.htm IDEA: XBRL DOCUMENT v3.20.2
PREPAYMENTS AND DEPOSITS
6 Months Ended
Jun. 30, 2020
Prepayments And Deposits  
PREPAYMENTS AND DEPOSITS

8. PREPAYMENTS AND DEPOSITS

 

 

   As of
June 30, 2020
   As of
December 31, 2019
 
Prepaid expenses  $8,399   $2,641 
Receivables from sales distributors   33,956    - 
Deposits to suppliers   465,634    266,552 
Total prepaid expenses and deposits  $507,989   $269,193 

 

XML 24 R15.htm IDEA: XBRL DOCUMENT v3.20.2
PROPERTY AND EQUIPMENT, NET
6 Months Ended
Jun. 30, 2020
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT, NET

9. PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consist of the following:

 

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
Computer and office equipment  $71,785   $- 
Furniture & fixtures   119,166    - 
Leasehold improvements   197,564    - 
Vehicle   96,263    - 
Subtotal   484,778    - 
Less: accumulated depreciation   (172,919)   - 
Total  $311,859   $- 

 

Depreciation expense for the three months ended June 30, 2020 and 2019 amounted to $17,716 and $0, respectively. Depreciation expense for the six months ended June 30, 2020 and 2019 amounted to $17,716 and $0, respectively.

 

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.20.2
INTANGIBLE ASSETS, NET
6 Months Ended
Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS, NET

10. INTANGIBLE ASSETS, NET

 

Intangible assets, net, consist of the following:

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
         
Computer software  $33,426   $- 
Less: accumulated amortization   (27,143)             - 
Total  $6,283   $- 

 

Amortization expense for the three months ended June 30, 2020 and 2019 amounted to $482 and $0, respectively. Amortization expense for the six months ended June 30, 2020 and 2019 amounted to $482 and $0, respectively.

 

  

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.20.2
INVESTMENT IN MARKETABLE SECURITIES
6 Months Ended
Jun. 30, 2020
Investment In Marketable Securities  
INVESTMENT IN MARKETABLE SECURITIES

11. INVESTMENT IN MARKETABLE SECURITIES

 

  (i) On May 17, 2018, the Company purchased 83,333 shares of common stock in Greenpro Capital Corp. for $500,000 at a purchase price of $6 per share.
     
  (ii) On October 16, 2018, the Company purchased 33,333 shares of common stock in Greenpro Capital Corp. for $1,000 at a purchase price of $0.03 per share.

 

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
Cost of investment  $66,484   $134,166 
Unrealized holding gain (loss)   126,666    (68,391)
Exchange rate effect   513    709 
Investment in marketable securities  $193,663   $66,484 

 

 

XML 27 R18.htm IDEA: XBRL DOCUMENT v3.20.2
INVESTMENT IN NON-MARKETABLE SECURITIES
6 Months Ended
Jun. 30, 2020
Investment In Non-marketable Securities  
INVESTMENT IN NON-MARKETABLE SECURITIES

12. INVESTMENT IN NON-MARKETABLE SECURITIES

 

The Company invested in Unreserved Sdn Bhd with the investment amount of $863,592 (RM 3,500,000), which approximated 20% of the equity interest of Unreserved Sdn Bhd and is accounted for under the equity method of accounting. On March 10, 2019 Unreserved Sdn Bhd issued additional common stock for working capital. As the Company did not subscribe for the additional common stock, the Company’s equity interest in investee company was diluted from approximately 20.0% to approximately 17.86%. Effective from March 10, 2019, the Company discontinued equity accounting on the investee company. The Company also ceased control over the operations of the investee company on the same date. Accordingly, the investment in investee company was reclassified to investment in non-marketable securities.

 

Unreserved Sdn Bhd was incorporated in Malaysia with 2,500,000 ordinary shares authorized, issued and outstanding. Mr. Lim Hun Soon @ David Lim and Ms. Aniza Helina Akmi Karim are the directors of Unreserved Sdn Bhd. Mr. How Kok Choong was a director of the company from April 30, 2018 to March 27, 2019.

 

On March 2, 2020, the Company agreed to sell the 17.86% ownership interest in Unreserved Sdn Bhd at the December 31, 2019 carrying value of $730,637 to Mr. How Kok Choong, the CEO and director of the Company. The Company received proceeds of $70,173, and had an amount due from director of $660,464 at March 31, 2020. In May 2020, the entire outstanding balance was settled as part of the consideration in a transaction which the Company had acquired the CEO’s ownership interest of Agape Superior Living Sdn. Bhd.

 

On April 3, 2019, the Company purchased a 5% of stock or 15,000,000 shares of common stock in Phoenix Plus Corp. for $1,500 at purchase price of $0.0001 per share.

 

 

Unreserved Sdn Bhd  As of
June 30, 2020
   As of
December 31, 2019
 
Investment in non-marketable securities  $730,637   $730,637 
Less: Sale of investment in non-marketable securities   (730,637)   - 
Investment in non-marketable securities  $-   $730,637 
           
Phoenix Plus Corporation          
Cost of investment  $1,500   $1,500 
           
Total investment in non-marketable securities  $1,500   $732,137 

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

XML 28 R19.htm IDEA: XBRL DOCUMENT v3.20.2
OTHER PAYABLES AND ACCRUED LIABILITIES
6 Months Ended
Jun. 30, 2020
Other Liabilities Disclosure [Abstract]  
OTHER PAYABLES AND ACCRUED LIABILITIES

13. OTHER PAYABLES AND ACCRUED LIABILITIES

 

 

  

As of

June 30, 2020

  


As of

December 31, 2019

 
Accrued professional fees  $322,661   $58,594 
Accrued promotion expenses   59,474    - 
Accrued payroll   22,180    - 
Others   63,252    18,652 
Total other payables and accrued liabilities  $467,567   $77,246 

 

XML 29 R20.htm IDEA: XBRL DOCUMENT v3.20.2
RELATED PARTY BALANCES AND TRANSACTIONS
6 Months Ended
Jun. 30, 2020
Related Party Transactions [Abstract]  
RELATED PARTY BALANCES AND TRANSACTIONS

14. RELATED PARTY BALANCES AND TRANSACTIONS

 

Related party balances

 

Accounts receivable – related party

 

 

Name of Related Party  Relationship  Nature  

As of

June 30, 2020

  

As of

December 31, 2019

 
                  
SEA  VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA   Sales of products   $-   $520,786 
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL   Sales of products    8,694    - 
Total          $8,694   $520,786 

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Amount due from related parties

 

Name of Related Party  Relationship  Nature 

As of

June 30, 2020

  

As of
December 31, 2019

 
                
Agape ATP (Asia) Limited (“AATP Asia”)  Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia  Expenses paid for AATP Asia  $2,228   $2,217 
Redboy Picture Sdn Bhd “Redboy”  Mr. How Kok Choong, the CEO and director of the Company is also the director of Redboy  Paid advance to Redboy for business operational expenses   3,361    - 
Total        $5,589   $2,217 

 

Prepayments and Deposits - related party

 

Name of Related Party  Relationship  Nature 

As of

June 30, 2020

   As of
December 31, 2019
 
                
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL  Prepayment for Printing Label  $2,784   $      - 
Total        $2,784   $- 

 

Amount due to a Related Party

 

Name of Related Party  Relationship  Nature 

As of

June 30, 2020

   As of
December 31, 2019
 
                
Mr. How Kok Choong  CEO and director of the Company  Acquisition payment of ASL and expenses paid for the Company  $90,043(1)  $3,952 
Total        $90,043   $3,952 

 

(1)On July 1, the Company issued additional 13,853 shares of the Company’s common stock valued at $90,043 based on the Company’s closing price of $6.50 at March 31, 2020 to settle the acquisition payment of ASL (See Note 15).

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Related party transactions

  

Revenue

 

Name of Related Party  Relationship  Nature  

For the Three Months Ended

June 30, 2020

  

For the Three Months Ended

June 30, 2019

 
                 
SEA  VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA   Sales of products   $-   $390,661 
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL   Sales of products    13,654    5,811 
Total          $13,654   $396,472 

 

Name of Related Party  Relationship  Nature  

For the Six Months Ended

June 30, 2020

  

For the Six Months Ended

June 30, 2019

 
                 
SEA  VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA   Sales of products   $-   $839,308 
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL   Sales of products    13,654    21,461 
Total          $13,654   $860,769 

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

XML 30 R21.htm IDEA: XBRL DOCUMENT v3.20.2
STOCKHOLDERS’ EQUITY
6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

15. STOCKHOLDERS’ EQUITY

 

Preferred stock

 

As of June 30, 2020, and December 31, 2019, there were 200,000,000 preferred stocks authorized but none were issued and outstanding.

 

Common stock

 

As of June 30, 2020, and December 31, 2019, there were 1,000,000,000 common stocks authorized, 376,438,194 and 376,275,500 shares issued and outstanding, respectively.

 

In May 2020, the Company issued 162,694 shares of the Company’s common stock in connection with the acquisition of ASL as part of the acquisition payment.

 

In June 2020, ASL made certain adjustments to its March 31, 2020 financial statements. As a result, the net assets carrying value increased by $90,043, which required the issuance of an additional 13,853 shares of the Company’s common stock to fully satisfy the acquisition payment for ASL to Mr. How Kok Choong, CEO and director of the Company. The 13,853 additional shares were issued in July 2020.

 

There were no stock options, warrants or other potentially dilutive securities outstanding as of June 30, 2020 and December 31, 2019.

 

Non-controlling interest

 

As of June 30, 2020 and for the three and six months ended June 30, 2020, no material transactions of non-controlling interest occurred from the operating results from ASL as the Company holds approximately 99.99% of the equity interest in ASL, non-controlling interests that present in ASL is $0 and therefore not presented separately in the accompanying unaudited condensed consolidated financial statements.

 

XML 31 R22.htm IDEA: XBRL DOCUMENT v3.20.2
INCOME TAXES
6 Months Ended
Jun. 30, 2020
Income Tax Disclosure [Abstract]  
INCOME TAXES

16. INCOME TAXES

 

The United States and foreign components of income (loss) before income taxes were comprised of the following:

 

 

   For the three months ended   For the six months ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
             
Tax jurisdictions from:                    
Local  $(161,751)  $(27,608)  $(304,170)  $(42,332)
- Foreign – Malaysia   369,367    (16,875)   313,780    42,799 
- Foreign – Hong Kong   13,691    (403,928)   (20,053)   (384,628)
Income (loss) before income tax  $221,307   $(448,411)  $(10,443)  $(384,161)

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

The (provision for) benefit of income taxes consisted of the following:

 

 

  

For the Three Months Ended

June 30, 2020

  

For the Three Months Ended

June 30, 2019

  

For the Six Months Ended

June 30, 2020

  

For the Six Months Ended

June 30, 2019

 
                          
Current:                    
- Local  $-   $-   $-   $- 
- Foreign   -    -    -    6,965 
                     
Deferred:                    
- Local   -    -    -    - 
- Foreign   (134,067)   -    (134,067)   - 
                     
(Provision for) benefit of income taxes  $(134,067)  $-   $(134,067)  $6,965 

 

The effective tax rate in the periods presented is the result of the mix of income earned in various tax jurisdictions that apply a broad range of income tax rates. The Company and its subsidiary that operate in various countries: United States, Malaysia (including Labuan) and Hong Kong that are subject to taxes in the jurisdictions in which they operate, as follows:

 

United States of America

 

Agape ATP Corporation was incorporated in the State of Nevada and is subject to the tax laws of the United States of America. As of June 30, 2020, the operations in the United States of America incurred approximately $511,000 of cumulative net operating losses which can be carried forward to offset future taxable income. Approximately $10,000 and $24,000 of the net operating loss carry forwards will expire in 2027 and 2028, respectively, if unutilized. The remaining balance can be carried forward indefinitely. The deferred tax valuation allowance as of June 30, 2020 and December 31, 2019 were approximately $107,000 and $43,000, respectively.

 

Malaysia

 

Changes to the Labuan Business Activity Tax Act (LBATA) 1990 which was gazetted and came into operation on January 1, 2019 mandate companies incorporated in Labuan to satisfy the “substantial activity requirements” to qualify for the preferential tax rate of 3% on net audited profit. Subsequently, on April 29, 2020, a circular setting out revisions to the “substantial activity requirements” was issued. As Agape ATP Corporation does not maintain a permanent establishment in Labuan, the company is subject to tax at 24% on its net audited profit until such a time it satisfies the said requirements.

 

Agape Superior Living Sdn Bhd and Agape S.E.A. are governed by the income tax laws of Malaysia and the income tax provision in respect of operations in Malaysia is calculated at the applicable tax rates on the taxable income for the periods based on existing legislation, interpretations and practices in respect thereof. Under the Income Tax Act of Malaysia, enterprises that incorporated in Malaysia are usually subject to a unified 24% enterprise income tax rate while preferential tax rates, tax holidays and even tax exemption may be granted on case-by-case basis. The tax rate for small and medium sized companies (generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is 17% for the first RM 600,000 (or approximately $150,000) for the three and six months ended June 30, 2020 and RM 500,000 (or approximately $125,000) income for the three and six months ended June 30, 2019, with the remaining balance being taxed at the 24% rate.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Hong Kong

 

Agape ATP International Holding (HK) Limited is subject to Hong Kong Profits Tax, which is charged at the statutory income rate of 16.5% on its assessable income derived from Hong Kong. Business income derived or business expenses incurred outside the Special Administrative Region is not subject to Hong Kong Profits Tax or deduction.

 

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:

 

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
           
Deferred tax assets:          
Net operating loss carry forwards in U.S.  $107,285   $43,410 
Net operating loss carry forwards in Malaysia   98,649    - 
Less: valuation allowance   (107,285)   (43,410)
Deferred tax liabilities:          
Depreciation   (64,218)   - 
Deferred tax assets, net  $34,431   $- 

 

Uncertain tax positions

 

The Company evaluates each uncertain tax position (including the potential application of interest and penalties) based on the technical merits, and measure the unrecognized benefits associated with the tax positions. As of June 30, 2020, and December 31, 2019, the Company did not have any significant unrecognized uncertain tax positions. The Company did not incur interest and penalties tax for the three and six months ended June 30, 2020 and 2019.

 

XML 32 R23.htm IDEA: XBRL DOCUMENT v3.20.2
CONCENTRATIONS OF RISKS
6 Months Ended
Jun. 30, 2020
Risks and Uncertainties [Abstract]  
CONCENTRATIONS OF RISKS

17. CONCENTRATIONS OF RISKS

 

(a) Major customers

 

For the three and six months ended June 30, 2020, no customer accounted for 10% or more of the Company’s total revenues. For the three months ended June 30, 2019, one related party customer accounted for approximately 98.5% of the Company’s total revenues. For the six months ended June 30, 2019, one related party customer accounted for approximately 97.5% of the Company’s total revenues.

 

As of June 30, 2020, receivables from a third-party e-commerce company accounted for approximately 97.4% of the total balance of accounts receivable. As of December 31, 2019, one related party customer accounted for 100.0% of the total balance of accounts receivable.

 

(b) Major vendors

 

For the three and six months ended June 30, 2020, one vendor accounted for 100.0% of the Company’s total purchases. For the three months ended June 30, 2019, two vendors accounted for approximately 66.8% and 33.2% of the Company’s total purchases, respectively. For the six months ended June 30, 2019, two vendors accounted for approximately 60.7% and 39.3% of the Company’s total purchases, respectively.

 

There are no accounts payable balance as of June 30, 2020. As of December 31, 2019, one vendor accounted for 100% of the total balance of accounts payable.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

(c) Commission Expenses to Sales Distributors and Stockists

 

For the three and six months ended June 30, 2020, no sales distributor accounted for 10.0% or more of the Company’s total commission expense.

 

(d) Credit risk

 

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash. As of June 30, 2020, and December 31, 2019, $917,458 and $238,937 were deposited with financial institutions, respectively, $384,652 and $0 of these balances are not covered by deposit insurance. While management believes that these financial institutions are of high credit quality, it also continually monitors their credit worthiness.

 

Financial instruments that are potentially subject to credit risk consist principally of accounts receivable. The Company believes the concentration of credit risk in its account receivable is substantially mitigated by its ongoing credit evaluation process and relatively short collection terms. The Company does not generally require collateral from customers. The Company evaluates the need for an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. Historically, the Company did not have any bad debt on its account receivable.

 

(e) Exchange rate risk

 

The Company cannot guarantee that the current exchange rate will remain steady; therefore, there is a possibility that the Company could post the same amount of profit for two comparable periods and because of the fluctuating exchange rate actually post higher or lower profit depending on exchange rate of RM and HK$ converted to US$ on that date. The exchange rate could fluctuate depending on changes in political and economic environments without notice.

 

XML 33 R24.htm IDEA: XBRL DOCUMENT v3.20.2
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

18. COMMITMENTS AND CONTINGENCIES

 

Lease commitments

 

On April 1, 2020, the Company adopted ASC 842 for ASL’s office space lease and sales and training center as the lease commencement date upon the acquisition of ASL. The Company recognized lease liabilities of approximately $466,000, with a corresponding right-of-use (“ROU”) asset in the same amount based on the present value of the future minimum rental payments of the lease, using an effective interest rate of 5.5%, which was determined using the Company’s estimated incremental borrowing rate. The weighted remaining term of the lease is approximately 3.04 years.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

The five-year maturity of the Company’s operating lease liabilities is as follow:

 

 

Twelve Months Ending
June 30,
  Operating lease liabilities 
     
2021  $155,316 
2022   158,236 
2023   149,337 
2024   8,064 
Total lease payments   470,953 
Less: interest   (37,853)
Present value of lease liabilities  $433,100 

 

The Company also leases two distribution centers and one employee apartment with an expiring term of twelve months or fewer, which were classified as operating leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company selected not to recognize lease assets and liabilities on these leases. As of June 30, 2020, the Company’s commitment for minimum lease payments under these operating leases within the next twelve months are $8,620.

 

Rent expense for the three months ended June 30, 2020 and 2019 was $52,672 and $13,391, respectively. Rent expense for the six months ended June 30, 2020 and 2019 was $66,180 and $26,766, respectively.

 

Purchase commitments

 

The total future minimum purchase commitment under a non-cancellable purchase contract as of June 30, 2020 for the next five years and thereafter is as follows:

 

 

Twelve months ending June 30, 

Minimum

purchase

 
2021  $693,900 
2022   693,900 
2023   693,900 
2024   693,900 
2025   693,900 
Thereafter   1,734,750 
Total minimum purchase commitments required  $5,204,250 

 

As of the date of this report, the Company’s vendor is not able to meet the Company’s minimum purchase commitment of the health and wellness products due to the manufacturing process was being delayed by its vendor.

 

Contingencies

 

Legal

 

From time to time, the Company is party to certain legal proceedings, as well as certain asserted and un-asserted claims. Amounts accrued, as well as the total amount of reasonably possible losses with respect to such matters, individually and in the aggregate, are not deemed to be material to the consolidated financial statements.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

COVID-19

 

On March 11, 2020, the World Health Organization or WHO declared the corona virus or COVID-19 a pandemic. In accordance with the recommendations of the WHO, Malaysia had imposed a nationwide lockdown via the government’s Movement Control Order (“MCO”) effective March 18, 2020. The MCO has resulted in quarantines, travel restrictions, and the temporary closure of stores and facilities in Malaysia. On May 4, 2020, the MCO was lessen to a Conditional Movement Control Order (“CMCO”) where most business sectors were allowed to operate under strict rules and Standard Operating Procedures mandated by the government of Malaysia.

 

Substantially all of the Company’s revenues are concentrated in Malaysia. Consequently, its results of operations will likely be adversely, and may be materially, affected, to the extent that the COVID-19 or any other epidemic harms the Malaysia and global economy in general. Any potential impact to its results will depend on, to a large extent, future developments and new information that may emerge regarding the duration and severity of the COVID-19 and the actions taken by government authorities and other entities to contain the COVID-19 or treat its impact, almost all of which are beyond its control. Potential impacts include, but are not limited to, the following:

 

  temporary closure of offices, travel restrictions, financial impact of the Company’s customers or suspension supplies may negatively affected, and could continue to negatively affect, the demand for the Company’s product;
  the Company may have to provide significant sales incentives to its customers during the outbreak, which may in turn materially adversely affect its financial condition and operating results; and

 

any disruption of the Company’s supply chain, logistics providers or customers could adversely impact its business and results of operations, including causing the Company or its suppliers to cease manufacturing for a period of time or materially delay delivery to its customers, which may also lead to loss of its customers.

 

Because of the uncertainty surrounding the COVID-19 outbreak, the financial impact related to the outbreak of and response to the COVID-19 cannot be reasonably estimated at this time. There is no guarantee that the Company’s total revenues will grow or remain at the similar level year over year in the remaining period of 2020.

XML 34 R25.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Basis of presentation

Basis of presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), and include all normal and recurring adjustments that management of the Company considers necessary for a fair presentation of its financial position and operation results. Interim results are not necessarily indicative of results to be expected for any other interim period or for the full year. The information included in this Form 10-Q should be read in conjunction with information included in the Company’s transition report on Form 10-K for the period ended December 31, 2019, filed with the Securities and Exchange Commission on March 27, 2020.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Principles of consolidation

Principles of consolidation

 

The unaudited condensed consolidated financial statements include the financial statements of the Company, its subsidiaries and its VIE over which the Company exercises control and, where applicable, entities for which the Company has a controlling financial interest or is the primary beneficiary. All transactions and balances among the Company, its subsidiaries and its VIE have been eliminated upon consolidation.

 

Subsidiaries are those entities in which the Company, directly or indirectly, controls more than one half of the voting power; or has the power to govern the financial and operating policies, to appoint or remove the majority of the members of the board of directors, or to cast a majority of votes at the meeting of directors.

 

A VIE is an entity that has either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support, or whose equity investors lack the characteristics of a controlling financial interest, such as through voting rights, right to receive the expected residual returns of the entity or obligation to absorb the expected losses of the entity. The variable interest holder, if any, that has a controlling financial interest in a VIE is deemed to be the primary beneficiary and must consolidate the VIE. 

 

Use of estimates

Use of estimates

 

The preparation of unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the periods presented. Significant accounting estimates reflected in the Company’s unaudited condensed consolidated financial statements include allowance for doubtful accounts, allowance for inventories obsolescence, useful lives of property and equipment, useful lives of intangible assets, impairment of long-lived assets, allowance for deferred tax assets, operating right-of-use assets, operating lease liabilities and uncertain tax position and impairment of investment in non-marketable securities. Actual results could differ from these estimates.

 

Cash and cash equivalents

Cash and cash equivalents

 

Cash and cash equivalents are carried at cost and represent cash on hand, time deposits placed with banks or other financial institutions and all highly liquid investments with an original maturity of three months or less.

 

Accounts receivable and accounts receivable – related party

Accounts receivable and accounts receivable – related party

 

Accounts receivable and accounts receivable – related party are recorded at the invoiced amount less an allowance for any uncollectible accounts and do not bear interest, which are due on credit term. Accounts receivable also include money due from a third-party e-commerce platform acting as a collection agent for the Company on the sales through their platform. Management reviews the adequacy of the allowance for doubtful accounts on an ongoing basis, using historical collection trends and aging of receivables. Management also periodically evaluates individual customer’s financial condition, credit history, and the current economic conditions to make adjustments in the allowance when it is considered necessary. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of June 30, 2020, and December 31, 2019, no valuation allowance was recorded.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Inventories

Inventories

 

Inventories consist of finished goods and are stated at the lower of cost or net realizable value using the first-in first-out method.

 

Prepaid taxes

Prepaid taxes

 

Prepaid taxes include (i) prepaid income taxes that will either be refundable or utilized to offset future income tax; and (ii) goods and service tax (“GST”) to be refundable.

 

Prepayments and deposits

Prepayments and deposits

 

Prepayments and deposits are mainly cash deposited or advanced to suppliers for future inventory purchases or service providers for future services. This amount is refundable and bears no interest. For any prepayments and deposits determined by management that such advances will not be in receipts of inventories, services, or refundable, the Company will recognize an allowance account to reserve such balances. Management reviews its prepayments and deposits on a regular basis to determine if the allowance is adequate, and adjusts the allowance when necessary. Delinquent account balances are written-off against allowance for doubtful accounts after management has determined that the likelihood of collection is not probable. The Company’s management continues to evaluate the reasonableness of the valuation allowance policy and update it if necessary. As of June 30, 2020, and December 31, 2019, there is no allowance for the doubtful accounts.

 

Property and equipment, net

Property and equipment, net

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:

 

    Useful Life 
      
Computer and office equipment   5-7 years  
Furniture & fixtures   6-7 years 
Leasehold improvements   Lease Term 
Vehicle   5 years 

 

The cost and related accumulated depreciation of assets sold or otherwise retired are eliminated from the accounts and any gain or loss is included in the consolidated statements of income and comprehensive income. Expenditures for maintenance and repairs are charged to earnings as incurred, while additions, renewals and betterments, which are expected to extend the useful life of assets, are capitalized. The Company also re-evaluates the periods of depreciation to determine whether subsequent events and circumstances warrant revised estimates of useful lives.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Intangible assets, net

Intangible assets, net

 

Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows:

 

 

Classification   Useful Life 
      
Computer software   5 years 

 

Impairment for long-lived assets

Impairment for long-lived assets

 

Long-lived assets, including property and equipment, and intangible assets with finite lives are reviewed for impairment whenever events or changes in circumstances (such as a significant adverse change to market conditions that will impact the future use of the assets) indicate that the carrying value of an asset may not be recoverable. The Company assesses the recoverability of the assets based on the undiscounted future cash flows the assets are expected to generate and recognize an impairment loss when estimated undiscounted future cash flows expected to result from the use of the asset plus net proceeds expected from disposition of the asset, if any, are less than the carrying value of the asset. If an impairment is identified, the Company would reduce the carrying amount of the asset to its estimated fair value based on a discounted cash flows approach or, when available and appropriate, to comparable market values. As of June 30, 2020, and December 31, 2019, no impairment of long-lived assets was recognized.

 

Deferred offering costs

Deferred offering costs

 

Deferred offering costs represents costs associated with the Company’s current offering which will be netted against the proceeds from the Company’s current offering.

 

Investment in marketable equity securities

Investment in marketable equity securities

 

Prior to July 1, 2019, marketable securities included in investment in marketable equity securities (non-current) are stated at the lower of cost or market in the aggregate. Other marketable securities (non-current) are stated at the lower of cost or market in the aggregate and investments other than marketable equity securities in other investments (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

 

On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Investments in marketable equity securities (non-current) are reported at fair value with changes in fair value recognized in the Company’s consolidated statements of operations and comprehensive loss in the caption of “unrealized holding losses on marketable securities” in each reporting period.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares) 

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Investment in non-marketable equity securities

Investment in non-marketable equity securities

 

Prior to July 1, 2019, investments in non-marketable equity securities (non-current) are stated at cost less any significant decline in fair value assessed to be other than temporary. Realized gains and losses on the sale of securities are based on the average cost of all the units of a particular security held at the time of sale.

 

On July 1, 2019, the Company adopted ASU 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities. Due to the Company’s non-marketable equity securities (non-current) does not qualify for the practical expedient to estimate fair value in accordance with ASC 820-10-35-59, the Company has selected to record its investments in non-marketable equity securities (non-current) at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issue.

 

At each reporting period, the Company will make a qualitative assessment considering impairment indicators to evaluate whether the investment is impaired. The qualitative assessment indicators include, but are not limited to: (1) A significant deterioration in the earnings performance, credit rating, asset quality, or business prospects of the investee; (ii) A significant adverse change in the regulatory, economic, or technological environment of the investee; (iii) A significant adverse change in the general market condition of either the geographical area or the industry in which the investee operates; (iv) A bona fide offer to purchase, an offer by the investee to sell, or a completed auction process for the same or similar investment for an amount less than the carrying amount of that investment; and (v) Factors that raise significant concerns about the investee’s ability to continue as a going concern, such as negative cash flows from operations, working capital deficiencies, or noncompliance with statutory capital requirements or debt covenants. If the qualitative assessment indicators indicated that the non-marketable equity securities (non-current) is deemed to be impaired, the Company would recognize the impairment loss equal to the difference between the fair value of the investment and its carrying amount.

 

Customer deposits

Customer deposits

 

Customer deposits represent amounts advanced by customers on product orders and discounted value of unapplied coupons. Customer deposits are reduced when the related sale is recognized in accordance with the Company’s revenue recognition policy.

 

Revenue recognition

Revenue recognition

 

On July 1, 2019, the Company adopted Accounting Standards Update (“ASU”) 2014-09, Revenue from Contracts with Customers (ASC Topic 606) using the modified retrospective method for contracts that were not completed as of June 30, 2019. This did not result in an adjustment to retained earnings upon adoption of this new guidance as the Company’s revenue was recognized based on the amount of consideration expected to receive in exchange for satisfying the performance obligations.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

The core principle underlying the revenue recognition of this ASU allows the Company to recognize - revenue that represents the transfer of goods and services to customers in an amount that reflects the consideration to which the Company expects to be entitled in such exchange. This will require the Company to identify contractual performance obligations and determine whether revenue should be recognized at a point in time or over time, based on when control of goods and services transfers to a customer. The Company’s revenue streams are recognized at a point in time for the Company’s sale of health and wellness products.

 

The ASU requires the use of a new five-step model to recognize revenue from customer contracts. The five-step model requires that the Company (i) identify the contract with the customer, (ii) identify the performance obligations in the contract, (iii) determine the transaction price, including variable consideration to the extent that it is probable that a significant future reversal will not occur, (iv) allocate the transaction price to the respective performance obligations in the contract, and (v) recognize revenue when (or as) the Company satisfies the performance obligation.

 

The Company accounts for a contract with a customer when the contract is committed in writing, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of substantially collection.

 

Prior to July 1, 2019, the Company recognizes revenue from sales of goods when the following four revenue criteria are met: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred; (3) selling price is fixed or determinable; and (4) collectability is reasonably assured. Revenue from supplies of health and wellness products is recognized when title and risk of loss are transferred and there are no continuing obligations to the customer. Title and the risks and rewards of ownership transfer to and accepted by the customer when the products are collected by the customer at the Company’s office. Revenue is recorded net of sales discounts, returns, allowances, and other adjustments that are based upon management’s best estimates and historical experience and are provided for in the same period as the related revenues are recorded.

 

The application of the five-step model to the revenue streams compared to the prior guidance did not result in significant changes in the way the Company records its revenue. Upon adoption on July 1, 2019, the Company evaluated its revenue recognition policy for all revenue streams within the scope of the ASU under previous standards and using the five-step model under the new guidance and confirmed that there were no differences in the pattern of revenue recognition.

 

Sales of Health and Wellness products

 

- Performance obligations satisfied at a point in time

 

On July 1, 2019, the Company derives its revenues from sales contracts with its customers with revenues being recognized when control of the health and wellness products are transferred to its customer at the Company’s office or shipment of the goods, which is generally similar to when its delivery has occurred prior to July 1, 2019 Such revenues are recognized at a point in time after all performance obligations are satisfied. The revenue is recorded net of estimated discounts and return allowances. Products are given 60 days for returns or exchanges from the date of purchase. Historically, there were insignificant sales returns.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

The Company also sells coupons to its customers for cash at a discounted price of the value of the coupons. Customers can apply the value of the coupons for a reduction in the transaction price paid by the customer are recorded as a reduction of sales. The cash proceeds resulted from the sale of coupons are recognized as customer deposits until the coupons to be applied as a reduction of the health and wellness products transaction price upon such sales transactions occurred. The Company’s coupons have a validity period of six months. If the Company’s customers did not utilize the coupons after six months, the Company would recognize the forfeiture of the originated sales value of the coupons as net revenues. For the three and six months ended June 30, 2020, the Company recognized $61,368 as forfeited coupon income.

 

As of June 30, 2020, the Company had contracts for the sales of health and wellness products amounting to $661,900 which it is expected to fulfill within 12 months from June 30, 2020.

 

Disaggregated information of revenues by products are as follows:

 

 

   For the three months ended   For the six months ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
                 
Ionized Cal-Mag  $611,160   $167   $611,160   $55,660 
Omega Blend   162,543    207    162,543    68,896 
Young Formula   349,738    353    349,738    117,332 
Organic Youth Care Cleansing Bar   28,805    53    28,805    17,728 
Trim+   223,497    133,319    223,497    198,614 
Lipomask   8,420    422    8,420    140,588 
Beta Maxx   11,434    123,470    11,434    123,470 
Energized Mineral Concentrate   22,606    138,481    22,606    138,481 
Survivor Select   35,994    -    35,994    - 
Vege-Fruit Fiber   6,106    -    6,106    - 
Mitogize   4,711    -    4,711    - 
Hyaluronic Acid Serum   55,721    -    55,721    - 
Mousse Facial Cleanser   3,127    -    3,127    - 
Total revenues  $1,523,862   $396,472   $1,523,862   $860,769 

 

Cost of revenue

Cost of revenue

 

Cost of revenue includes freight-in and the purchase cost of manufactured goods for sale to customers.

 

Shipping and handling

Shipping and handling

 

Shipping and handling charges amounted to $2,555 and $0 for the three months ended June 30, 2020 and 2019, respectively. Shipping and handling charges amounted to $2,555 and $0 for the six months ended June 30, 2020 and 2019, respectively. Shipping and handling charges are expensed as incurred and included in selling expenses.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Advertising costs

Advertising costs

 

Advertising costs amounted to $2,882 and $0 for the three months ended June 30, 2020 and 2019, respectively. Advertising costs amounted to $2,882 and $0 for the six months ended June 30, 2020 and 2019, respectively. Advertising costs are expensed as incurred and included in selling expenses.

 

Commission expenses

Commission expenses

 

Commission expenses are the Company’s most significant expenses. As with all companies in the network marketing industry, the Company’s sales channel is external to the Company. The Company’s “external sales force” is stratified into two levels based on priority recruitment. First, there are sales distributors. Second, all members recruited by a sales distributor, directly or indirectly, are referred to as “sales network members”. The Company pays commission to every sales distributor based on purchases made by its sales network members which includes the independent direct sales members. Top performing distributors with their own physical stores may also become stockists of the Company, whereby they enjoy benefits such as maintaining a certain amount of the Company’s inventory on their store premises. The stockists shall account to the Company for all products sales from their store premises as monitored through the Company’s centralized stock tracking system. The Company pays a separate commission to stockists based on revenue generated from the stockists’ physical stores. Commission expenses amounted to $382,498 and $0 for the three months ended June 30, 2020 and 2019, respectively. Commission expenses amounted to $382,498 and $0 for the six months ended June 30, 2020 and 2019, respectively.

 

Defined contribution plan

Defined contribution plan

 

The full-time employees of the Company are entitled to the government mandated defined contribution plan. The Company is required to accrue and pay for these benefits based on certain percentages of the employees’ respective salaries, subject to certain ceilings, in accordance with the relevant government regulations, and make cash contributions to the government mandated defined contribution plan. Total expenses for the plans were $23,710 and $0 for the three months ended June 30, 2020 and 2019, respectively. Total expenses for the plans were $23,710 and $0 for the six months ended June 30, 2020 and 2019, respectively.

 

The related contribution plans include:

 

  - Social Security Organization (“SOSCO”) – 1.75% based on employee’s monthly salary capped of RM 4,000;
  - Employees Provident Fund (“EPF”) – 12% based on employee’s monthly salary;
  - Employment Insurance System (“EIS”) – 0.2% based on employee’s monthly salary capped of RM 4,000;
  - Human Resource Development Fund (“HRDF”) – 1% based on employee’s monthly salary

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Income taxes

Income taxes

 

The Company accounts for income taxes in accordance with U.S. GAAP for income taxes. The charge for taxation is based on the results for the fiscal year as adjusted for items, which are non-assessable or disallowed. It is calculated using tax rates that have been enacted or substantively enacted by the balance sheet date.

 

Deferred taxes is accounted for using the asset and liability method in respect of temporary differences arising from differences between the carrying amount of assets and liabilities in the consolidated financial statements and the corresponding tax basis used in the computation of assessable tax profit. In principle, deferred tax liabilities are recognized for all taxable temporary differences. Deferred tax assets are recognized to the extent that it is probable that taxable profit will be available against which deductible temporary differences can be utilized. Deferred tax is calculated using tax rates that are expected to apply to the period when the asset is realized or the liability is settled. Deferred tax is charged or credited in the income statement, except when it is related to items credited or charged directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Current income taxes are provided for in accordance with the laws of the relevant taxing authorities.

 

An uncertain tax position is recognized as a benefit only if it is “more likely than not” that the tax position would be sustained in a tax examination, with a tax examination being presumed to occur. The amount recognized is the largest amount of tax benefit that is greater than 50% likely of being realized on examination. For tax positions not meeting the “more likely than not” test, no tax benefit is recorded. No penalties and interest incurred related to underpayment of income tax for the three and six months ended June 30, 2020 and 2019.

 

The Company conducts much of its business activities in Hong Kong and Malaysia and is subject to tax in each of their jurisdictions. As a result of its business activities, the Company will file separate tax returns that are subject to examination by the foreign tax authorities.

 

Comprehensive income (loss)

Comprehensive income (loss)

 

Comprehensive income (loss) consists of two components, net income (loss) and other comprehensive income (loss). Other comprehensive income (loss) refers to revenue, expenses, gains and losses that under GAAP are recorded as an element of stockholders’ equity but are excluded from net income. Other comprehensive income (loss) consists of a foreign currency translation adjustment resulting from the Company not using the U.S. dollar as its functional currencies.

 

Non-controlling interest

Non-controlling interest

 

Non-controlling interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals. The non-controlling interests are presented in the consolidated balance sheets, separately from equity attributable to the shareholders of the Company. Non-controlling interests in the results of the Company are presented on the face of the consolidated statements of operations as an allocation of the total income or loss for the periods between non-controlling interest holders and the shareholders of the Company. As of June 30, 2020, the non-controlling interest balance was $0 and therefore not presented in the accompanying unaudited condensed consolidated financial statements.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Earnings (loss) per share

Earnings (loss) per share

 

The Company computes earnings (loss) per share (“EPS”) in accordance with ASC 260, “Earnings per Share”. ASC 260 requires companies to present basic and diluted EPS. Basic EPS is measured as net income divided by the weighted average ordinary share outstanding for the period. Diluted EPS presents the dilutive effect on a per share basis of the potential ordinary shares (e.g., convertible securities, options and warrants) as if they had been converted at the beginning of the periods presented, or issuance date, if later. Potential ordinary shares that have an anti-dilutive effect (i.e., those that increase income per share or decrease loss per share) are excluded from the calculation of diluted EPS. For the three and six months ended June 30, 2020 and 2019, there were no dilutive shares.

 

Foreign currencies translation and transaction

Foreign currencies translation and transaction

 

Transactions denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting exchange differences are recorded in the Unaudited Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

 

The reporting currency of the Company is United States Dollars (“US$”) and the accompanying financial statements have been expressed in US$. The Company’s subsidiary in Labuan maintains its books and record in United States Dollars (“US$”) albeit its functional currency being the primary currency of the economic environment in which the entity operates, which is the Malaysian Ringgit (“MYR” or “RM”). The Company’s subsidiary in Hong Kong maintains its books and record in Hong Kong Dollars (“HK$”), similar to its functional currency. The Company’s subsidiary and VIE in Malaysia conducts its businesses and maintains its books and record in the local currency, Malaysian Ringgit (“MYR” or “RM”), as its functional currency.

 

In general, for consolidation purposes, assets and liabilities of its subsidiaries whose functional currency is not US$ are translated into US$, in accordance with ASC Topic 830-30, “Translation of Financial Statement”, using the exchange rate on the balance sheet date. Revenues and expenses are translated at average rates prevailing during the period. The gains and losses resulting from translation of financial statements of foreign subsidiary are recorded as a separate component of accumulated other comprehensive income within the statements of stockholders’ equity. Cash flows are also translated at average translation rates for the periods, therefore, amounts reported on the statement of cash flows will not necessarily agree with changes in the corresponding balances on the consolidated balance sheets.

 

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

 

 

   As of 
   June 30, 2020   December 31, 2019 
         
Period-end MYR : US$1 exchange rate   4.28    4.09 
Period-end HKD : US$1 exchange rate   7.75    7.79 

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

   For the three months ended   For the six months ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
                 
Period-average MYR : US$1 exchange rate   4.32    4.15    4.25    4.12 
Period-average HKD : US$1 exchange rate   7.75    7.84    7.76    7.84 

 

Related parties

Related parties

 

Parties, which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control the other party or exercise significant influence over the other party in making financial and operating decisions. Companies are also considered to be related if they are subject to common control or common significant influence.

 

Fair value of financial instruments

Fair value of financial instruments

 

The accounting standard regarding fair value of financial instruments and related fair value measurements defines financial instruments and requires disclosure of the fair value of financial instruments held by the Company.

 

The accounting standards define fair value, establish a three-level valuation hierarchy for disclosures of fair value measurement and enhance disclosure requirements for fair value measures. The three levels are defined as follow:

 

  Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
  Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.
  Level 3 inputs to the valuation methodology are unobservable and significant to the fair value.

 

Financial instruments included in current assets and current liabilities are reported in the consolidated balance sheets at face value or cost, which approximate fair value because of the short period of time between the origination of such instruments and their expected realization and their current market rates of interest.

 

Leases

Leases

 

Effective July 1, 2019, the Company adopted ASU 2016-02, “Leases” (Topic 842), and elected the practical expedients that does not require the Company to reassess: (1) whether any expired or existing contracts are, or contain, leases, (2) lease classification for any expired or existing leases and (3) initial direct costs for any expired or existing leases. For lease terms of twelve months or fewer, a lessee is permitted to make an accounting policy election not to recognize lease assets and liabilities. The Company also adopted the practical expedient that allows lessees to treat the lease and non-lease components of a lease as a single lease component. There is no impact from the adoption of ASC 842 as of July 1, 2019, as the Company did not have any existing leases with a lease term in excess of twelve months on July 1, 2019.

  

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

Operating lease right-of-use (“ROU”) assets and lease liabilities are recognized at the adoption date of July 1, 2019 or the commencement date, whichever is earlier, based on the present value of lease payments over the lease term. Since the implicit rate for the Company’s leases is not readily determinable, the Company use its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The incremental borrowing rate is the rate of interest that the Company would have to pay to borrow, on a collateralized basis, an amount equal to the lease payments, in a similar economic environment and over a similar term.

 

Lease terms used to calculate the present value of lease payments generally do not include any options to extend, renew, or terminate the lease, as the Company does not have reasonable certainty at lease inception that these options will be exercised. The Company generally considers the economic life of its operating lease ROU assets to be comparable to the useful life of similar owned assets. The Company has elected the short-term lease exception, therefore operating lease ROU assets and liabilities do not include leases with a lease term of twelve months or less. Its leases generally do not provide a residual guarantee. The operating lease ROU asset also excludes lease incentives. Lease expense is recognized on a straight-line basis over the lease term.

 

The Company reviews the impairment of its ROU assets consistent with the approach applied for its other long-lived assets. The Company reviews the recoverability of its long-lived assets when events or changes in circumstances occur that indicate that the carrying value of the asset may not be recoverable. The assessment of possible impairment is based on its ability to recover the carrying value of the asset from the expected undiscounted future pre-tax cash flows of the related operations. The Company has elected to include the carrying amount of operating lease liabilities in any tested asset group and includes the associated operating lease payments in the undiscounted future pre-tax cash flows.

 

Recent accounting pronouncements

Recent accounting pronouncements

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption of such any pronouncements may be expected to cause a material impact on its financial condition or the results of its operations, as follow:

 

In May 2019, the FASB issued ASU 2019-05, which is an update to ASU Update No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which introduced the expected credit losses methodology for the measurement of credit losses on financial assets measured at amortized cost basis, replacing the previous incurred loss methodology. The amendments in Update 2016-13 added Topic 326, Financial Instruments—Credit Losses, and made several consequential amendments to the Codification. Update 2016-13 also modified the accounting for available-for-sale debt securities, which must be individually assessed for credit losses when fair value is less than the amortized cost basis, in accordance with Subtopic 326-30, Financial Instruments— Credit Losses—Available-for-Sale Debt Securities. The amendments in this Update address those stakeholders’ concerns by providing an option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. For those entities, the targeted transition relief will increase comparability of financial statement information by providing an option to align measurement methodologies for similar financial assets. Furthermore, the targeted transition relief also may reduce the costs for some entities to comply with the amendments in Update 2016-13 while still providing financial statement users with decision-useful information. In November 2019, the FASB issued ASU No. 2019-10, which to update the effective date of ASU No. 2016-13 for private companies, not-for-profit organizations and certain smaller reporting companies applying for credit losses, leases, and hedging standard. The new effective date for these preparers is for fiscal years beginning after December 15, 2022. ASU 2019-05 is effective for the Company for annual and interim reporting periods beginning January 1, 2023 as the Company is qualified as a smaller reporting company. The Company is currently evaluating the impact ASU 2019-05 may have on its unaudited condensed consolidated financial statements.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

In January 2020, the FASB issued ASU 2020-01 to clarify the interaction of the accounting for equity securities under ASC 321 and investments accounted for under the equity method of accounting in ASC 323 and the accounting for certain forward contracts and purchased options accounted for under ASC 815. With respect to the interactions between ASC 321 and ASC 323, the amendments clarify that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting when applying the measurement alternative in ASC 321, immediately before applying or upon discontinuing the equity method of accounting. With respect to forward contracts or purchased options to purchase securities, the amendments clarify that when applying the guidance in ASC 815-10-15-141(a), an entity should not consider whether upon the settlement of the forward contract or exercise of the purchased option, individually or with existing investments, the underlying securities would be accounted for under the equity method in ASC 323 or the fair value option in accordance with ASC 825. The ASU is effective for interim and annual reporting periods beginning after December 15, 2020. Early adoption is permitted, including adoption in any interim period. The Company does not expect the adoption of this standard to have a material impact on its unaudited condensed consolidated financial statements.

 

Reclassification

Reclassification

 

Certain prior period amounts have been reclassified to conform to the current period presentation for the three and six months ended June 30, 2019. These reclassifications have no effect on the unaudited condensed consolidated statements of operations and comprehensive income (loss).

XML 35 R26.htm IDEA: XBRL DOCUMENT v3.20.2
ORGANIZATION AND BUSINESS BACKGROUND (Tables)
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Schedule of Subsidiaries and Associates

Details of the Company’s subsidiaries:

 

 

   

Subsidiary company

name

 

Place and

date of

incorporation

  Particulars of issued capital  Principal activities 

Proportional of ownership

interest and

voting power

held

 
                  
1.    Agape ATP Corporation  Labuan,
March 6, 2017
  100 shares of ordinary share of US$1 each  Investment holding   100%
                   
2.    Agape ATP International Holding Limited  Hong Kong,
June 1, 2017
  1,000,000 shares of ordinary share of HK$1 each  Health and wellness products and health solution advisory services   100%
                   
3.   Agape Superior Living Sdn. Bhd.  Malaysia,
August 8, 2003
  9,590,598 shares of ordinary share of RM1 each  Health and wellness products and health solution advisory services   99.99%
                   
4.   Agape S.E.A. Sdn. Bhd.  Malaysia,
March 4, 2004
  2 shares of ordinary share of RM1 each  VIE of Agape Superior Living Sdn. Bhd.   VIE 
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT

Property and equipment are stated at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets with no residual value. The estimated useful lives are as follows:

 

    Useful Life 
      
Computer and office equipment   5-7 years  
Furniture & fixtures   6-7 years 
Leasehold improvements   Lease Term 
Vehicle   5 years 
SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET

Intangible assets, net, are stated at cost, less accumulated amortization. Amortization expense is recognized on the straight-line basis over the estimated useful lives of the assets as follows:

 

 

Classification   Useful Life 
      
Computer software   5 years 
SCHEDULE OF DISAGGREGATED INFORMATION OF REVENUES

Disaggregated information of revenues by products are as follows:

 

 

   For the three months ended   For the six months ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
                 
Ionized Cal-Mag  $611,160   $167   $611,160   $55,660 
Omega Blend   162,543    207    162,543    68,896 
Young Formula   349,738    353    349,738    117,332 
Organic Youth Care Cleansing Bar   28,805    53    28,805    17,728 
Trim+   223,497    133,319    223,497    198,614 
Lipomask   8,420    422    8,420    140,588 
Beta Maxx   11,434    123,470    11,434    123,470 
Energized Mineral Concentrate   22,606    138,481    22,606    138,481 
Survivor Select   35,994    -    35,994    - 
Vege-Fruit Fiber   6,106    -    6,106    - 
Mitogize   4,711    -    4,711    - 
Hyaluronic Acid Serum   55,721    -    55,721    - 
Mousse Facial Cleanser   3,127    -    3,127    - 
Total revenues  $1,523,862   $396,472   $1,523,862   $860,769 
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES

Translation of foreign currencies into US$1 have been made at the following exchange rates for the respective periods:

 

 

   As of 
   June 30, 2020   December 31, 2019 
         
Period-end MYR : US$1 exchange rate   4.28    4.09 
Period-end HKD : US$1 exchange rate   7.75    7.79 

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)

 

   For the three months ended   For the six months ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
                 
Period-average MYR : US$1 exchange rate   4.32    4.15    4.25    4.12 
Period-average HKD : US$1 exchange rate   7.75    7.84    7.76    7.84 
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.20.2
VARIABLE INTEREST ENTITY (“VIE”) (Tables)
6 Months Ended
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF VARIABLE INTEREST ENTITY

The carrying amount of the VIE’s assets and liabilities were as follows:

 

 

   June 30, 2020 
     
Current assets  $290,630 
Current liabilities   (289,911)
Net assets  $719 

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

3. VARIABLE INTEREST ENTITY (“VIE”) (Continued)

 

   June 30, 2020 
Current asset:     
Cash and cash equivalents  $18,680 
Accounts receivable – intercompany   260,438 
Prepaid taxes   3,113 
Prepayments and deposits   8,399 
Total current assets   290,630 
      
Current liabilities:     
Accounts payable – intercompany  $286,820 
Other payables and accrued liabilities   2,741 
Other payables – intercompany   350 
Total current liabilities  $289,911 

 

The summarized operating results of the VIE’s are as follows:

 

  

For the Three Months Ended

June 30, 2020

  

For the Six

Months Ended

June 30, 2020

 
         
Operating revenues  $129,492   $129,492 
Gross profit  $1,373   $1,373 
Loss from operations  $(3,749)  $(3,749)
Net loss  $(18,139)  $(18,139)
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.20.2
BUSNINESS COMBINATION (Tables)
6 Months Ended
Jun. 30, 2020
Business Combinations [Abstract]  
Summary of Assets Acquired and Liabilities Assumed

The following table summarizes the carry value of the identifiable assets acquired and liabilities assumed on the acquisition date, which represents the net purchase price allocation on the date of the acquisition of ASL.

  

 

   Carry Value 
ASSETS     
Current assets     
Cash  $1,206,493 
Other receivables   33,210 
Other receivables - related parties   219,121 
Inventories   616,880 
Prepaid taxes   1,206,821 
Prepayments and other assets   318,267 
Total current assets   3,600,792 
      
Other assets     
Property and equipment, net   325,648 
Intangible assets, net   6,686 
Deferred taxes asset, net   172,250 
Total other assets   504,584 
      
Total assets  $4,105,376 
      
LIABILITIES AND SHAREHOLDERS’ EQUITY     
Current liabilities     
Accounts payable - related party  $491,628 
Customer deposits   1,600,606 
Other payables and accrued liabilities   209,096 
Total current liabilities   2,301,330 
      
Total liabilities   2,301,330 
      
Total net assets acquired   1,804,046 
Schedule of Pro Forma Busniness Combination

The following unaudited pro forma combined results of operations presents the Company’s financial results as if the acquisition of ASL had been completed on January 1, 2019. The unaudited pro forma results do not reflect operating efficiencies or potential cost savings which may result from the consolidation of operations. Accordingly, the unaudited pro forma financial information is not necessarily indicative of the results of operations that the Company would have recognized had we completed the transaction on January 1, 2019. Future results may vary significantly from the results in this pro forma information because of future events and transactions, as well as other factors.

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

  

   For the Three Months Ended   For the Six Months Ended   For the Six Months Ended 
   June 30, 2019   June 30, 2020   June 30, 2019 
Revenue  $684,112   $2,765,114   $1,914,362 
Cost of revenue   (108,478)   (571,407)   (309,999)
Gross profit   575,634    2,193,707    1,604,363 
Total operating expenses   (1,269,443)   (2,055,016)   (2,613,015)
Income (loss) from operations   (693,809)   138,691    (1,008,652)
Other income (expense), net   (281,239)   110,912    (237,655)
Income (loss) before income taxes   (975,048)   249,603    (1,246,307)
Benefit of (Provision for) income taxes   137,983    (184,900)   202,180 
Net income (loss)  $(837,065)  $64,703   $(1,044,127)
Net income (loss) per common share - basic and diluted   (0.00)   0.00    (0.00)
Weighted average number of common shares outstanding - basic and diluted  $376,452,047   $376,452,047   $376,452,047 
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.20.2
ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE – RELATED PARTY (Tables)
6 Months Ended
Jun. 30, 2020
Receivables [Abstract]  
Schedule of Accounts Receivables - Related Party

 

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
Accounts receivable  $325,426   $- 
Accounts receivable – related party   8,694    520,786 
Allowance for doubtful accounts   -    - 
Total accounts receivable and accounts receivable – related party  $334,120   $520,786 

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

XML 40 R31.htm IDEA: XBRL DOCUMENT v3.20.2
INVENTORIES (Tables)
6 Months Ended
Jun. 30, 2020
Inventory Disclosure [Abstract]  
Schedule of Inventories

Inventories consist of the following:

 

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
Finished goods  $416,627   $            - 
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.20.2
PREPAYMENTS AND DEPOSITS (Tables)
6 Months Ended
Jun. 30, 2020
Prepayments And Deposits  
Schedule of Prepaid Expenses and Deposits

 

 

   As of
June 30, 2020
   As of
December 31, 2019
 
Prepaid expenses  $8,399   $2,641 
Receivables from sales distributors   33,956    - 
Deposits to suppliers   465,634    266,552 
Total prepaid expenses and deposits  $507,989   $269,193 
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.20.2
PROPERTY AND EQUIPMENT, NET (Tables)
6 Months Ended
Jun. 30, 2020
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment. Net

Property and equipment, net consist of the following:

 

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
Computer and office equipment  $71,785   $- 
Furniture & fixtures   119,166    - 
Leasehold improvements   197,564    - 
Vehicle   96,263    - 
Subtotal   484,778    - 
Less: accumulated depreciation   (172,919)   - 
Total  $311,859   $- 

 

Depreciation expense for the three months ended June 30, 2020 and 2019 amounted to $17,716 and $0, respectively. Depreciation expense for the six months ended June 30, 2020 and 2019 amounted to $17,716 and $0, respectively.

 

XML 43 R34.htm IDEA: XBRL DOCUMENT v3.20.2
INTANGIBLE ASSETS, NET (Tables)
6 Months Ended
Jun. 30, 2020
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Intangible Assets, Net

Intangible assets, net, consist of the following:

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
         
Computer software  $33,426   $- 
Less: accumulated amortization   (27,143)             - 
Total  $6,283   $- 
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.20.2
INVESTMENT IN MARKETABLE SECURITIES (Tables)
6 Months Ended
Jun. 30, 2020
Investment In Marketable Securities  
SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
Cost of investment  $66,484   $134,166 
Unrealized holding gain (loss)   126,666    (68,391)
Exchange rate effect   513    709 
Investment in marketable securities  $193,663   $66,484 
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.20.2
INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)
6 Months Ended
Jun. 30, 2020
Investment In Non-marketable Securities  
SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES

 

Unreserved Sdn Bhd  As of
June 30, 2020
   As of
December 31, 2019
 
Investment in non-marketable securities  $730,637   $730,637 
Less: Sale of investment in non-marketable securities   (730,637)   - 
Investment in non-marketable securities  $-   $730,637 
           
Phoenix Plus Corporation          
Cost of investment  $1,500   $1,500 
           
Total investment in non-marketable securities  $1,500   $732,137 
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.20.2
OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)
6 Months Ended
Jun. 30, 2020
Other Liabilities Disclosure [Abstract]  
SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES

 

  

As of

June 30, 2020

  


As of

December 31, 2019

 
Accrued professional fees  $322,661   $58,594 
Accrued promotion expenses   59,474    - 
Accrued payroll   22,180    - 
Others   63,252    18,652 
Total other payables and accrued liabilities  $467,567   $77,246 
XML 47 R38.htm IDEA: XBRL DOCUMENT v3.20.2
RELATED PARTY BALANCES AND TRANSACTIONS (Tables)
6 Months Ended
Jun. 30, 2020
Related Party Transactions [Abstract]  
SCHEDULE OF RELATED PARTIES RELATIONSHIPS

Accounts receivable – related party

 

 

Name of Related Party  Relationship  Nature  

As of

June 30, 2020

  

As of

December 31, 2019

 
                  
SEA  VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA   Sales of products   $-   $520,786 
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL   Sales of products    8,694    - 
Total          $8,694   $520,786 

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Amount due from related parties

 

Name of Related Party  Relationship  Nature 

As of

June 30, 2020

  

As of
December 31, 2019

 
                
Agape ATP (Asia) Limited (“AATP Asia”)  Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia  Expenses paid for AATP Asia  $2,228   $2,217 
Redboy Picture Sdn Bhd “Redboy”  Mr. How Kok Choong, the CEO and director of the Company is also the director of Redboy  Paid advance to Redboy for business operational expenses   3,361    - 
Total        $5,589   $2,217 

 

Prepayments and Deposits - related party

 

Name of Related Party  Relationship  Nature 

As of

June 30, 2020

   As of
December 31, 2019
 
                
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL  Prepayment for Printing Label  $2,784   $      - 
Total        $2,784   $- 

 

Amount due to a Related Party

 

Name of Related Party  Relationship  Nature 

As of

June 30, 2020

   As of
December 31, 2019
 
                
Mr. How Kok Choong  CEO and director of the Company  Acquisition payment of ASL and expenses paid for the Company  $90,043(1)  $3,952 
Total        $90,043   $3,952 

 

(1)On July 1, the Company issued additional 13,853 shares of the Company’s common stock valued at $90,043 based on the Company’s closing price of $6.50 at March 31, 2020 to settle the acquisition payment of ASL (See Note 15).

 

 

AGAPE ATP CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

Related party transactions

  

Revenue

 

Name of Related Party  Relationship  Nature  

For the Three Months Ended

June 30, 2020

  

For the Three Months Ended

June 30, 2019

 
                 
SEA  VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA   Sales of products   $-   $390,661 
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL   Sales of products    13,654    5,811 
Total          $13,654   $396,472 

 

Name of Related Party  Relationship  Nature  

For the Six Months Ended

June 30, 2020

  

For the Six Months Ended

June 30, 2019

 
                 
SEA  VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA   Sales of products   $-   $839,308 
Agape Superior Living Pty Ltd (“ASLPL”)  Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL   Sales of products    13,654    21,461 
Total          $13,654   $860,769 
XML 48 R39.htm IDEA: XBRL DOCUMENT v3.20.2
INCOME TAXES (Tables)
6 Months Ended
Jun. 30, 2020
Income Tax Disclosure [Abstract]  
SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX

The United States and foreign components of income (loss) before income taxes were comprised of the following:

 

 

   For the three months ended   For the six months ended 
   June 30,   June 30, 
   2020   2019   2020   2019 
             
Tax jurisdictions from:                    
Local  $(161,751)  $(27,608)  $(304,170)  $(42,332)
- Foreign – Malaysia   369,367    (16,875)   313,780    42,799 
- Foreign – Hong Kong   13,691    (403,928)   (20,053)   (384,628)
Income (loss) before income tax  $221,307   $(448,411)  $(10,443)  $(384,161)
SCHEDULE OF PROVISION FOR INCOME TAX

The (provision for) benefit of income taxes consisted of the following:

 

 

  

For the Three Months Ended

June 30, 2020

  

For the Three Months Ended

June 30, 2019

  

For the Six Months Ended

June 30, 2020

  

For the Six Months Ended

June 30, 2019

 
                          
Current:                    
- Local  $-   $-   $-   $- 
- Foreign   -    -    -    6,965 
                     
Deferred:                    
- Local   -    -    -    - 
- Foreign   (134,067)   -    (134,067)   - 
                     
(Provision for) benefit of income taxes  $(134,067)  $-   $(134,067)  $6,965 
SCHEDULE OF DEFERRED TAX ASSETS

The following table sets forth the significant components of the aggregate deferred tax assets of the Company as of:

 

 

  

As of

June 30, 2020

  

As of

December 31, 2019

 
           
Deferred tax assets:          
Net operating loss carry forwards in U.S.  $107,285   $43,410 
Net operating loss carry forwards in Malaysia   98,649    - 
Less: valuation allowance   (107,285)   (43,410)
Deferred tax liabilities:          
Depreciation   (64,218)   - 
Deferred tax assets, net  $34,431   $- 
XML 49 R40.htm IDEA: XBRL DOCUMENT v3.20.2
COMMITMENTS AND CONTINGENCIES (Tables)
6 Months Ended
Jun. 30, 2020
Commitments and Contingencies Disclosure [Abstract]  
SCHEDULE OF FUTURE MINIMUM OPERATING LEASE LIABILITIES

The five-year maturity of the Company’s operating lease liabilities is as follow:

 

 

Twelve Months Ending
June 30,
  Operating lease liabilities 
     
2021  $155,316 
2022   158,236 
2023   149,337 
2024   8,064 
Total lease payments   470,953 
Less: interest   (37,853)
Present value of lease liabilities  $433,100 
SCHEDULE OF FUTURE MINIMUM PURCHASE COMMITMENT

The total future minimum purchase commitment under a non-cancellable purchase contract as of June 30, 2020 for the next five years and thereafter is as follows:

 

 

Twelve months ending June 30, 

Minimum

purchase

 
2021  $693,900 
2022   693,900 
2023   693,900 
2024   693,900 
2025   693,900 
Thereafter   1,734,750 
Total minimum purchase commitments required  $5,204,250 
XML 50 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Schedule of Subsidiaries and Associates (Details)
6 Months Ended
Jun. 30, 2020
Condensed Cash Flow Statements, Captions [Line Items]  
Proportional of ownership interest and voting power held 100.00%
Subsidiary Company [Member]  
Condensed Cash Flow Statements, Captions [Line Items]  
Subsidiary company name Agape ATP Corporation
Place and date of incorporation Labuan, March 6, 2017
Particulars of issued capital 100 shares of ordinary share of US$1 each
Principal activities Investment holding
Proportional of ownership interest and voting power held 100.00%
Subsidiary Company One [Member]  
Condensed Cash Flow Statements, Captions [Line Items]  
Subsidiary company name Agape ATP International Holding Limited
Place and date of incorporation Hong Kong, June 1, 2017
Particulars of issued capital 1,000,000 shares of ordinary share of HK$1 each
Principal activities Health and wellness products and health solution advisory services
Proportional of ownership interest and voting power held 100.00%
Subsidiary Company Two [Member]  
Condensed Cash Flow Statements, Captions [Line Items]  
Subsidiary company name Agape Superior Living Sdn. Bhd.
Place and date of incorporation Malaysia, August 8, 2003
Particulars of issued capital 9,590,598 shares of ordinary share of RM1 each
Principal activities Health and wellness products and health solution advisory services
Proportional of ownership interest and voting power held 99.99%
Subsidiary Company Three [Member]  
Condensed Cash Flow Statements, Captions [Line Items]  
Subsidiary company name Agape S.E.A. Sdn. Bhd.
Place and date of incorporation Malaysia, March 4, 2004
Particulars of issued capital 2 shares of ordinary share of RM1 each
Principal activities VIE of Agape Superior Living Sdn. Bhd.
XML 51 R42.htm IDEA: XBRL DOCUMENT v3.20.2
ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) - shares
May 08, 2020
Jun. 30, 2020
Condensed Cash Flow Statements, Captions [Line Items]    
Ownership interest percentage   100.00%
Share Exchange Agreement [Member] | Mr. How Kok Choong [Member]    
Condensed Cash Flow Statements, Captions [Line Items]    
Ownership interest percentage 99.99%  
Stock issued during period acquisitions, shares 9,590,596  
Agape ATP International Holding Limited [Member]    
Condensed Cash Flow Statements, Captions [Line Items]    
Ownership interest percentage   100.00%
Subsidiary Company Two [Member]    
Condensed Cash Flow Statements, Captions [Line Items]    
Ownership interest percentage   99.99%
XML 52 R43.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)
6 Months Ended
Jun. 30, 2020
Computer and Office Equipment [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated Useful Life of Property and Equipment 5 years
Computer and Office Equipment [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated Useful Life of Property and Equipment 7 years
Furniture and Fixtures [Member] | Minimum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated Useful Life of Property and Equipment 6 years
Furniture and Fixtures [Member] | Maximum [Member]  
Property, Plant and Equipment [Line Items]  
Estimated Useful Life of Property and Equipment 7 years
Leasehold Improvements [Member]  
Property, Plant and Equipment [Line Items]  
Estimated Useful Lives of Property and Equipment Lease Term
Vehicles [Member]  
Property, Plant and Equipment [Line Items]  
Estimated Useful Life of Property and Equipment 5 years
XML 53 R44.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)
6 Months Ended
Jun. 30, 2020
Computer Software, Intangible Asset [Member]  
Acquired Finite-Lived Intangible Assets [Line Items]  
Estimated useful lives of intangible assets 5 years
XML 54 R45.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF DISAGGREGATED INFORMATION OF REVENUES (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Product Information [Line Items]        
Total revenues $ 1,523,862 $ 396,472 $ 1,523,862 $ 860,769
Ionized Cal-Mag [Member]        
Product Information [Line Items]        
Total revenues 611,160 167 611,160 55,660
Omega Blend [Member]        
Product Information [Line Items]        
Total revenues 162,543 207 162,543 68,896
Young Formula [Member]        
Product Information [Line Items]        
Total revenues 349,738 353 349,738 117,332
Organic Youth Care Cleansing Bar [Member]        
Product Information [Line Items]        
Total revenues 28,805 53 28,805 17,728
Trim+ [Member]        
Product Information [Line Items]        
Total revenues 223,497 133,319 223,497 198,614
Lipomask [Member]        
Product Information [Line Items]        
Total revenues 8,420 422 8,420 140,588
Beta Maxx [Member]        
Product Information [Line Items]        
Total revenues 11,434 123,470 11,434 123,470
Energized Mineral Concentrate [Member]        
Product Information [Line Items]        
Total revenues 22,606 138,481 22,606 138,481
Survivor Select [Member]        
Product Information [Line Items]        
Total revenues 35,994 35,994
Vege-Fruit Fiber [Member]        
Product Information [Line Items]        
Total revenues 6,106 6,106
Mitogize [Member]        
Product Information [Line Items]        
Total revenues 4,711 4,711
Hyaluronic Acid Serum [Member]        
Product Information [Line Items]        
Total revenues 55,721 55,721
Mousse Facial Cleanser [Member]        
Product Information [Line Items]        
Total revenues $ 3,127 $ 3,127
XML 55 R46.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Dec. 31, 2019
MYR Currency [Member]          
Derivative [Line Items]          
Exchange rate $ 1 $ 1 $ 1 $ 1  
HKD Currency [Member]          
Derivative [Line Items]          
Exchange rate $ 1 $ 1 $ 1 $ 1  
Period-end MYR [Member]          
Derivative [Line Items]          
Foreign Currency Exchange Rate, Translation 4.28   4.28   4.09
Period-end HKD [Member]          
Derivative [Line Items]          
Foreign Currency Exchange Rate, Translation 7.75   7.75   7.79
Period-average MYR [Member]          
Derivative [Line Items]          
Foreign currency exchange rate period average 4.32 4.15 4.25 4.12  
Period-average HKD [Member]          
Derivative [Line Items]          
Foreign currency exchange rate period average 7.75 7.84 7.76 7.84  
XML 56 R47.htm IDEA: XBRL DOCUMENT v3.20.2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Product Information [Line Items]          
Accounts Receivable, Allowance for Credit Loss         $ 0
Allowance for doubtful accounts $ 0   $ 0   0
Impairment of long-lived assets     0   $ 0
Forfeited coupon income     61,368    
Revenue 1,510,208 1,510,208  
Selling expenses 108,894 6,504 109,356 7,846  
Advertising costs 2,882 0 2,882 0  
Commission expenses 382,498 0 382,498 0  
Defined contribution plan expense 23,710 0 $ 23,710 0  
Income tax examination, likelihood of unfavorable settlement     greater than 50%    
Penalties and interest incurred     $ 0 0  
Noncontrolling interest, description     Non-controlling interest mainly consists of approximately 0.01% (2 ordinary shares out of 9,590,598 shares) of the equity interests of ASL held by two individuals.    
Non-controlling interest 0   $ 0    
Potentially dilutive securities outstanding     0   0
Social Security Organization [Member]          
Product Information [Line Items]          
Salary percentage     1.75%    
Social Security Organization [Member] | MYR Currency [Member]          
Product Information [Line Items]          
Monthly salary     $ 4,000    
Employees Provident Fund [Member]          
Product Information [Line Items]          
Salary percentage     12.00%    
Employment Insurance System [Member]          
Product Information [Line Items]          
Salary percentage     0.20%    
Employment Insurance System [Member] | MYR Currency [Member]          
Product Information [Line Items]          
Monthly salary     $ 4,000    
Human Resource Development Fund [Member]          
Product Information [Line Items]          
Salary percentage     1.00%    
Health And Wellness Products [Member]          
Product Information [Line Items]          
Revenue     $ 661,900    
Shipping and Handling [Member]          
Product Information [Line Items]          
Selling expenses $ 2,555 $ 0 $ 2,555 $ 0  
XML 57 R48.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF VARIABLE INTEREST ENTITY (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Trading Activity, Gains and Losses, Net [Line Items]              
Total current assets $ 5,908,808       $ 5,908,808   $ 3,536,653
Current liabilities (1,594,037)       (1,594,037)   (83,988)
Net assets 7,092,375       7,092,375   4,335,274
Cash and cash equivalents 3,427,664       3,427,664   2,744,457
Accounts receivable - intercompany 8,694       8,694   520,786
Prepaid taxes 1,214,035       1,214,035  
Prepayments and Deposits 507,989       507,989   269,193
Total current liabilities 1,594,037       1,594,037   $ 83,988
Revenue 1,510,208     1,510,208  
Gross profit 1,052,308   (700)   1,052,308 43,419  
Loss from operations 46,192   (59,938)   (113,324) (48,205)  
Net loss 87,240 $ (231,750) $ (448,411) $ 71,215 (144,510) $ (377,196)  
Variable Income Interest Rate [Member]              
Trading Activity, Gains and Losses, Net [Line Items]              
Total current assets 290,630       290,630    
Current liabilities (289,911)       (289,911)    
Net assets 719       719    
Cash and cash equivalents 18,680       18,680    
Accounts receivable - intercompany 260,438       260,438    
Prepaid taxes 3,113       3,113    
Prepayments and Deposits 8,399       8,399    
Accounts payable &nbsp intercompany 286,820       286,820    
Other payables and accrued liabilities 2,741       2,741    
Other payables &nbsp intercompany 350       350    
Total current liabilities 289,911       289,911    
Revenue 129,492       129,492    
Gross profit 1,373       1,373    
Loss from operations (3,749)       (3,749)    
Net loss $ (18,139)       $ (18,139)    
XML 58 R49.htm IDEA: XBRL DOCUMENT v3.20.2
VARIABLE INTEREST ENTITY (“VIE”) (Details Narrative)
Jun. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Ownership interest percentage 100.00%
XML 59 R50.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Assets Acquired and Liabilities Assumed (Details)
Mar. 31, 2020
USD ($)
Current assets  
Cash $ 1,206,493
Other receivables 33,210
Other receivables - related parties 219,121
Inventories 616,880
Prepaid taxes 1,206,821
Prepayments and other assets 318,267
Total current assets 3,600,792
Other assets  
Property and equipment, net 325,648
Intangible assets, net 6,686
Deferred taxes asset, net 172,250
Total other assets 504,584
Total assets 4,105,376
Current liabilities  
Accounts payable - related party 491,628
Customer deposits 1,600,606
Other payables and accrued liabilities 209,096
Total current liabilities 2,301,330
Total liabilities 2,301,330
Total net assets acquired $ 1,804,046
XML 60 R51.htm IDEA: XBRL DOCUMENT v3.20.2
Schedule of Pro Forma Busniness Combination (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Business Combinations [Abstract]      
Revenue $ 684,112 $ 2,765,114 $ 1,914,362
Cost of revenue (108,478) (571,407) (309,999)
Gross profit 575,634 2,193,707 1,604,363
Total operating expenses (1,269,443) (2,055,016) (2,613,015)
Income (loss) from operations (693,809) 138,691 (1,008,652)
Other income (expense), net (281,239) 110,912 (237,655)
Income (loss) before income taxes (975,048) 249,603 (1,246,307)
Benefit of (Provision for) income taxes 137,983 (184,900) 202,180
Net income (loss) $ (837,065) $ 64,703 $ (1,044,127)
Net income (loss) per common share - basic and diluted $ (0.00) $ 0.00 $ (0.00)
Weighted average number of common shares outstanding - basic and diluted 376,452,047 376,452,047 376,452,047
XML 61 R52.htm IDEA: XBRL DOCUMENT v3.20.2
BUSNINESS COMBINATION (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jul. 01, 2020
May 08, 2020
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2020
Jul. 31, 2020
Dec. 31, 2019
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Ownership interest percentage     100.00%   100.00%    
Common stock par value     $ 0.0001   $ 0.0001   $ 0.0001
Stock issued during period, value, acquisitions     $ 1,057,508        
Mr. How Kok Choong [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Purchased price per shares       $ 6.50      
Mr. How Kok Choong [Member] | Subsequent Event [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Stock issued during period acquisitions, shares 13,853            
Stock issued during period, value, acquisitions $ 90,043            
Purchased price per shares           $ 6.50  
Share Exchange Agreement [Member] | Mr. How Kok Choong [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Stock issued during period acquisitions, shares   9,590,596          
Ownership interest percentage   99.99%          
Share Exchange Agreement [Member] | Mr. How Kok Choong [Member] | Agape Superior Living Sdn Bhd [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Stock issued during period acquisitions, shares       176,547      
Ordinary shares no par value   $ 0          
Ownership interest percentage   99.99%          
Loan payable       $ 656,495      
Common stock par value       $ 0.0001      
Percentage of common stock issued and outstanding       0.0469%      
Stock issued during period, value, acquisitions       $ 1,147,551      
Issuance of common stock shares         162,294    
Share Exchange Agreement [Member] | Mr. How Kok Choong [Member] | Agape Superior Living Sdn Bhd [Member] | Subsequent Event [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Purchase consideration value $ 1,804,046            
Issuance of common stock shares 13,853            
XML 62 R53.htm IDEA: XBRL DOCUMENT v3.20.2
CASH AND CASH EQUIVALENTS (Details Narrative) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]    
Cash and cash equivalents $ 3,427,664 $ 2,744,457
Cash in bank 917,458 238,937
Time deposits $ 2,483,915 $ 2,505,520
Minimum [Member]    
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]    
Percentage of Interest rate for time deposits 2.95%  
Maximum [Member]    
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]    
Percentage of Interest rate for time deposits 3.25%  
XML 63 R54.htm IDEA: XBRL DOCUMENT v3.20.2
Schedule of Accounts Receivables - Related Party (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Receivables [Abstract]    
Accounts receivable $ 325,426
Accounts receivable – related party 8,694 520,786
Allowance for doubtful accounts
Total accounts receivable and accounts receivable – related party $ 334,120 $ 520,786
XML 64 R55.htm IDEA: XBRL DOCUMENT v3.20.2
Schedule of Inventories (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Inventory Disclosure [Abstract]    
Finished goods $ 416,627
XML 65 R56.htm IDEA: XBRL DOCUMENT v3.20.2
Schedule of Prepaid Expenses and Deposits (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Prepayments And Deposits    
Prepaid expenses $ 8,399 $ 2,641
Receivables from sales distributors 33,956
Deposits to suppliers 465,634 266,552
Total prepaid expenses and deposits $ 507,989 $ 269,193
XML 66 R57.htm IDEA: XBRL DOCUMENT v3.20.2
Schedule of Property and Equipment. Net (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Property, Plant and Equipment [Line Items]    
Subtotal $ 484,778
Less: accumulated depreciation (172,919)
Total 311,859
Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Subtotal 71,785
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Subtotal 119,166
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Subtotal 197,564
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Subtotal $ 96,263
XML 67 R58.htm IDEA: XBRL DOCUMENT v3.20.2
PROPERTY AND EQUIPMENT, NET (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Property, Plant and Equipment [Abstract]        
Depreciation expense $ 17,716 $ 0 $ 17,716 $ 0
XML 68 R59.htm IDEA: XBRL DOCUMENT v3.20.2
Schedule of Intangible Assets, Net (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Goodwill and Intangible Assets Disclosure [Abstract]    
Computer software $ 33,426
Less: accumulated amortization (27,143)
Total $ 6,283
XML 69 R60.htm IDEA: XBRL DOCUMENT v3.20.2
INTANGIBLE ASSETS, NET (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]        
Amortization expense $ 482 $ 0 $ 482 $ 0
XML 70 R61.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Investment In Marketable Securities    
Cost of investment $ 66,484 $ 134,166
Unrealized holding gain (loss) 126,666 (68,391)
Exchange rate effect 513 709
Investment in marketable securities $ 193,663 $ 66,484
XML 71 R62.htm IDEA: XBRL DOCUMENT v3.20.2
INVESTMENT IN MARKETABLE SECURITIES (Details Narrative) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Oct. 16, 2018
May 17, 2018
Entity Listings [Line Items]        
Investment amount $ 66,484 $ 134,166    
Greenpro Capital Corp. [Member]        
Entity Listings [Line Items]        
Investment in securities, shares     33,333 83,333
Investment amount     $ 1,000 $ 500,000
Purchased price per shares     $ 0.03 $ 6
XML 72 R63.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Apr. 03, 2019
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]      
Cost of investment $ 66,484 $ 134,166  
Total investment in non-marketable securities 1,500 732,137  
Phoenix Plus Corporation [Member]      
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]      
Cost of investment 1,500 1,500 $ 1,500
Total investment in non-marketable securities 1,500 732,137  
Directors of Unreserved Investments [Member]      
Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]      
Investment in non-marketable securities 730,637 730,637  
Less: Sale of investment in non-marketable securities (730,637)  
Investment in non-marketable securities $ 730,637  
XML 73 R64.htm IDEA: XBRL DOCUMENT v3.20.2
INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative) - USD ($)
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Mar. 31, 2020
Mar. 02, 2020
Dec. 31, 2019
Apr. 03, 2019
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]            
Investment amount $ 66,484       $ 134,166  
Equity interest percentage 100.00%          
Ordinary shares authorized 1,000,000,000       1,000,000,000  
Proceeds from investments $ 70,173        
Phoenix Plus Corporation [Member]            
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]            
Investment amount $ 1,500       $ 1,500 $ 1,500
Equity interest percentage           5.00%
Share purchased price per share           $ 0.0001
Phoenix Plus Corporation [Member] | Common Stock [Member]            
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]            
Shares purchased during period           15,000,000
Maximum [Member]            
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]            
Equity interest percentage 20.00%          
Minimum [Member]            
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]            
Equity interest percentage 17.86%          
Director [Member]            
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]            
Investment amount $ 863,592          
Equity interest percentage 20.00%          
Director [Member] | MYR Currency [Member]            
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]            
Investment amount $ 3,500,000          
Mr. How Kok Choong [Member]            
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]            
Investment amount         $ 730,637  
Ordinary shares authorized 2,500,000          
Amount due from director     $ 660,464      
Unreserved Sdn Bhd [Member]            
SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]            
Equity interest percentage       17.86%    
XML 74 R65.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Other Liabilities Disclosure [Abstract]    
Accrued professional fees $ 322,661 $ 58,594
Accrued promotion expenses 59,474
Accrued payroll 22,180
Others 63,252 18,652
Total other payables and accrued liabilities $ 467,567 $ 77,246
XML 75 R66.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF RELATED PARTIES RELATIONSHIPS (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jul. 01, 2020
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Dec. 31, 2020
Jul. 31, 2020
Mar. 31, 2020
Related Party Transaction [Line Items]                  
Accounts Receivable - related party   $ 8,694   $ 8,694   $ 520,786      
Amount due from related parties   5,589   5,589   2,217      
Prepayments and Deposits - related party   2,784   2,784        
Amount due to a Related Party   90,043   90,043   $ 3,952      
Issuance of common stock in acquisition, value   1,057,508              
Revenue   $ 13,654 $ 396,472 $ 13,654 $ 860,769        
SEA [Member]                  
Related Party Transaction [Line Items]                  
Related parties relationship, description   VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA VIE of ASL, Mr. How Kok Choong, the CEO and director of the Company is the sole shareholder and director of SEA      
Related parties nature, description   Sales of products Sales of products Sales of products Sales of products Sales of products      
Accounts Receivable - related party       $ 520,786      
Revenue   $ 390,661 $ 839,308        
Agape Superior Living Pty Ltd ASLPL [Member]                  
Related Party Transaction [Line Items]                  
Related parties relationship, description   Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL      
Related parties nature, description   Sales of products Sales of products Sales of products Sales of products Sales of products      
Accounts Receivable - related party   $ 8,694   $ 8,694        
Revenue   13,654 $ 5,811 $ 13,654 $ 21,461        
Agape A T P Asia Limited A A T P Asia [Member]                  
Related Party Transaction [Line Items]                  
Related parties relationship, description       Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia   Mr. How Kok Choong, the CEO and director of the Company is also the sole shareholder and director of AATP Asia      
Related parties nature, description       Expenses paid for AATP Asia   Expenses paid for AATP Asia      
Amount due from related parties   2,228   $ 2,228   $ 2,217      
Redboy Picture Sdn Bhd Redboy [Member]                  
Related Party Transaction [Line Items]                  
Related parties relationship, description       Mr. How Kok Choong, the CEO and director of the Company is also the director of Redboy   Mr. How Kok Choong, the CEO and director of the Company is also the director of Redboy      
Related parties nature, description       Paid advance to Redboy for business operational expenses   Paid advance to Redboy for business operational expenses      
Amount due from related parties   3,361   $ 3,361        
Agape Superior Living Pty Ltd A S L P L One [Member]                  
Related Party Transaction [Line Items]                  
Related parties relationship, description       Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL   Mr. How Kok Choong, the CEO and director of the Company is a 51% shareholder and a director of ASLPL      
Related parties nature, description       Prepayment for Printing Label   Prepayment for Printing Label      
Prepayments and Deposits - related party   2,784   $ 2,784        
Mr. How Kok Choong [Member]                  
Related Party Transaction [Line Items]                  
Related parties relationship, description       CEO and director of the Company   CEO and director of the Company      
Related parties nature, description       Acquisition payment of ASL and expenses paid for the Company   Acquisition payment of ASL and expenses paid for the Company      
Amount due to a Related Party   $ 90,043 [1]   $ 90,043 [1]   $ 3,952      
shares issued price per share                 $ 6.50
Mr. How Kok Choong [Member] | Subsequent Event [Member]                  
Related Party Transaction [Line Items]                  
Issuance of common stock in acquisition, shares 13,853                
Issuance of common stock in acquisition, value $ 90,043                
shares issued price per share               $ 6.50  
[1] On July 1, the Company issued additional 13,853 shares of the Company’s common stock valued at $90,043 based on the Company’s closing price of $6.50 at March 31, 2020 to settle the acquisition payment of ASL (See Note 15).
XML 76 R67.htm IDEA: XBRL DOCUMENT v3.20.2
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jul. 01, 2020
Jun. 30, 2020
May 31, 2020
Jun. 30, 2020
Jun. 30, 2020
Dec. 31, 2019
Mar. 31, 2020
Acquired Indefinite-lived Intangible Assets [Line Items]              
Preferred stock, shares authorized   200,000,000   200,000,000 200,000,000 200,000,000  
Preferred stock, shares issued   0   0 0 0  
Preferred stock, shares outstanding   0   0 0 0  
Common stock, shares authorized   1,000,000,000   1,000,000,000 1,000,000,000 1,000,000,000  
Common stock, shares issued   376,438,194   376,438,194 376,438,194 376,275,500  
Common stock, shares outstanding   376,438,194   376,438,194 376,438,194 376,275,500  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets             $ 4,105,376
Potentially dilutive securities outstanding         0 0  
ASL [Member]              
Acquired Indefinite-lived Intangible Assets [Line Items]              
Stock issued during period acquisitions, shares   13,853 162,694        
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets   $ 90,043   $ 90,043 $ 90,043    
Business acquisition percentage of voting interests   99.99%   99.99% 99.99%    
Non controlling interests       $ 0 $ 0    
ASL [Member] | Subsequent Event [Member]              
Acquired Indefinite-lived Intangible Assets [Line Items]              
Stock issued during period acquisitions, shares 13,853            
XML 77 R68.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Local $ (161,751) $ (27,608) $ (304,170) $ (42,332)
Loss before income tax 221,307 (448,411) (10,443) (384,161)
MALAYSIA        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Foreign 369,367 (16,875) 313,780 42,799
HONG KONG        
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]        
Foreign $ 13,691 $ (403,928) $ (20,053) $ (384,628)
XML 78 R69.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF PROVISION FOR INCOME TAX (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Income Tax Disclosure [Abstract]        
- Local
- Foreign 6,965
- Local
- Foreign (134,067) (134,067)
(Provision for) benefit of income taxes $ (134,067) $ (134,067) $ 6,965
XML 79 R70.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Less: valuation allowance $ (107,285) $ (43,410)
Depreciation (64,218)
Deferred tax assets, net 34,431
UNITED STATES    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Net operating loss carry forwards 107,285 43,410
MALAYSIA    
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]    
Net operating loss carry forwards $ 98,649
XML 80 R71.htm IDEA: XBRL DOCUMENT v3.20.2
INCOME TAXES (Details Narrative) - USD ($)
6 Months Ended
Jan. 02, 2019
Jun. 30, 2020
Dec. 31, 2019
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Cumulative net operating loss   $ 10,000  
UNITED STATES      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Cumulative net operating loss   $ 511,000  
Operating loss carryforwards expire year, description   2027  
Valuation allowance   $ 107,000 $ 43,000
UNITED STATES | If Unutilized [Member]      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Cumulative net operating loss   $ 24,000  
Operating loss carryforwards expire year, description   2028  
Labuan [Member]      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Tax percentage 3.00%    
Statutory income tax rate 24.00%    
MALAYSIA      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Statutory income tax rate   17.00%  
Income tax examination, description   The tax rate for small and medium sized companies (generally companies incorporated in Malaysia with paid-in capital of RM 2,500,000 or less) is 17% for the first RM 600,000 (or approximately $150,000) for the three and six months ended June 30, 2020 and RM 500,000 (or approximately $125,000) income for the three and six months ended June 30, 2019, with the remaining balance being taxed at the 24% rate.  
HONG KONG      
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]      
Statutory income tax rate   16.50%  
XML 81 R72.htm IDEA: XBRL DOCUMENT v3.20.2
CONCENTRATIONS OF RISKS (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Concentration Risk [Line Items]          
Commission expense, percentage 10.00%   10.00%    
Cash in bank $ 917,458   $ 917,458   $ 238,937
Deposit for insurance $ 384,652   $ 384,652   $ 0
Accounts Receivable [Member] | E-commerce [Member]          
Concentration Risk [Line Items]          
Concentrations of risk percentage     97.40%    
No Customer [Member] | Revenue from Contract with Customer Benchmark [Member] | Maximum [Member]          
Concentration Risk [Line Items]          
Concentrations of risk percentage     10.00%    
One Customer [Member] | Revenue from Contract with Customer Benchmark [Member]          
Concentration Risk [Line Items]          
Concentrations of risk percentage   98.50%   97.50%  
One Customer [Member] | Accounts Receivable [Member]          
Concentration Risk [Line Items]          
Concentrations of risk percentage         100.00%
Vendor One [Member]          
Concentration Risk [Line Items]          
Concentrations of risk percentage 100.00% 66.80% 100.00% 60.70%  
Vendor Two [Member]          
Concentration Risk [Line Items]          
Concentrations of risk percentage   33.20%   39.30%  
One Vendor [Member] | Accounts Payable [Member]          
Concentration Risk [Line Items]          
Concentrations of risk percentage     0.00%   100.00%
XML 82 R73.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF FUTURE MINIMUM OPERATING LEASE LIABILITIES (Details)
Jun. 30, 2020
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2021 $ 155,316
2022 158,236
2023 149,337
2024 8,064
Total lease payments 470,953
Less: interest (37,853)
Present value of lease liabilities $ 433,100
XML 83 R74.htm IDEA: XBRL DOCUMENT v3.20.2
SCHEDULE OF FUTURE MINIMUM PURCHASE COMMITMENT (Details)
Jun. 30, 2020
USD ($)
Commitments and Contingencies Disclosure [Abstract]  
2021 $ 693,900
2022 693,900
2023 693,900
2024 693,900
2025 693,900
Thereafter 1,734,750
Total minimum purchase commitments required $ 5,204,250
XML 84 R75.htm IDEA: XBRL DOCUMENT v3.20.2
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Apr. 02, 2020
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Acquired Indefinite-lived Intangible Assets [Line Items]          
Operating lease liability   $ 433,100   $ 433,100  
Operating lease payments       8,620  
Operating lease, rent expenses   $ 52,672 $ 13,391 $ 66,180 $ 26,766
ASL [Member]          
Acquired Indefinite-lived Intangible Assets [Line Items]          
Operating lease liability $ 466,000        
Operating lease effective interest rate 5.50%        
Operating lease, weighted average remaining lease term 3 years 14 days        
EXCEL 85 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 87 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 88 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 256 412 1 true 73 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://agapeatp.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://agapeatp.com/role/BalanceSheets Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://agapeatp.com/role/BalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) Sheet http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Sheet http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://agapeatp.com/role/StatementsOfCashFlows Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND Sheet http://agapeatp.com/role/OrganizationAndBusinessBackground ORGANIZATION AND BUSINESS BACKGROUND Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - VARIABLE INTEREST ENTITY (???VIE???) Sheet http://agapeatp.com/role/VariableInterestEntityVie VARIABLE INTEREST ENTITY (???VIE???) Notes 9 false false R10.htm 00000010 - Disclosure - BUSNINESS COMBINATION Sheet http://agapeatp.com/role/BusninessCombination BUSNINESS COMBINATION Notes 10 false false R11.htm 00000011 - Disclosure - CASH AND CASH EQUIVALENTS Sheet http://agapeatp.com/role/CashAndCashEquivalents CASH AND CASH EQUIVALENTS Notes 11 false false R12.htm 00000012 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE ??? RELATED PARTY Sheet http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE ??? RELATED PARTY Notes 12 false false R13.htm 00000013 - Disclosure - INVENTORIES Sheet http://agapeatp.com/role/Inventories INVENTORIES Notes 13 false false R14.htm 00000014 - Disclosure - PREPAYMENTS AND DEPOSITS Sheet http://agapeatp.com/role/PrepaymentsAndDeposits PREPAYMENTS AND DEPOSITS Notes 14 false false R15.htm 00000015 - Disclosure - PROPERTY AND EQUIPMENT, NET Sheet http://agapeatp.com/role/PropertyAndEquipmentNet PROPERTY AND EQUIPMENT, NET Notes 15 false false R16.htm 00000016 - Disclosure - INTANGIBLE ASSETS, NET Sheet http://agapeatp.com/role/IntangibleAssetsNet INTANGIBLE ASSETS, NET Notes 16 false false R17.htm 00000017 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES Sheet http://agapeatp.com/role/InvestmentInMarketableSecurities INVESTMENT IN MARKETABLE SECURITIES Notes 17 false false R18.htm 00000018 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES Sheet http://agapeatp.com/role/InvestmentInNon-marketableSecurities INVESTMENT IN NON-MARKETABLE SECURITIES Notes 18 false false R19.htm 00000019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES Sheet http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities OTHER PAYABLES AND ACCRUED LIABILITIES Notes 19 false false R20.htm 00000020 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS Sheet http://agapeatp.com/role/RelatedPartyBalancesAndTransactions RELATED PARTY BALANCES AND TRANSACTIONS Notes 20 false false R21.htm 00000021 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://agapeatp.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 21 false false R22.htm 00000022 - Disclosure - INCOME TAXES Sheet http://agapeatp.com/role/IncomeTaxes INCOME TAXES Notes 22 false false R23.htm 00000023 - Disclosure - CONCENTRATIONS OF RISKS Sheet http://agapeatp.com/role/ConcentrationsOfRisks CONCENTRATIONS OF RISKS Notes 23 false false R24.htm 00000024 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://agapeatp.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 24 false false R25.htm 00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 25 false false R26.htm 00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables) Sheet http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables ORGANIZATION AND BUSINESS BACKGROUND (Tables) Tables http://agapeatp.com/role/OrganizationAndBusinessBackground 26 false false R27.htm 00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies 27 false false R28.htm 00000028 - Disclosure - VARIABLE INTEREST ENTITY (???VIE???) (Tables) Sheet http://agapeatp.com/role/VariableInterestEntityVieTables VARIABLE INTEREST ENTITY (???VIE???) (Tables) Tables http://agapeatp.com/role/VariableInterestEntityVie 28 false false R29.htm 00000029 - Disclosure - BUSNINESS COMBINATION (Tables) Sheet http://agapeatp.com/role/BusninessCombinationTables BUSNINESS COMBINATION (Tables) Tables http://agapeatp.com/role/BusninessCombination 29 false false R30.htm 00000030 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE ??? RELATED PARTY (Tables) Sheet http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedPartyTables ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE ??? RELATED PARTY (Tables) Tables http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty 30 false false R31.htm 00000031 - Disclosure - INVENTORIES (Tables) Sheet http://agapeatp.com/role/InventoriesTables INVENTORIES (Tables) Tables http://agapeatp.com/role/Inventories 31 false false R32.htm 00000032 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables) Sheet http://agapeatp.com/role/PrepaymentsAndDepositsTables PREPAYMENTS AND DEPOSITS (Tables) Tables http://agapeatp.com/role/PrepaymentsAndDeposits 32 false false R33.htm 00000033 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables) Sheet http://agapeatp.com/role/PropertyAndEquipmentNetTables PROPERTY AND EQUIPMENT, NET (Tables) Tables http://agapeatp.com/role/PropertyAndEquipmentNet 33 false false R34.htm 00000034 - Disclosure - INTANGIBLE ASSETS, NET (Tables) Sheet http://agapeatp.com/role/IntangibleAssetsNetTables INTANGIBLE ASSETS, NET (Tables) Tables http://agapeatp.com/role/IntangibleAssetsNet 34 false false R35.htm 00000035 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables) Sheet http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables INVESTMENT IN MARKETABLE SECURITIES (Tables) Tables http://agapeatp.com/role/InvestmentInMarketableSecurities 35 false false R36.htm 00000036 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables) Sheet http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables INVESTMENT IN NON-MARKETABLE SECURITIES (Tables) Tables http://agapeatp.com/role/InvestmentInNon-marketableSecurities 36 false false R37.htm 00000037 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) Sheet http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables OTHER PAYABLES AND ACCRUED LIABILITIES (Tables) Tables http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities 37 false false R38.htm 00000038 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables) Sheet http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables RELATED PARTY BALANCES AND TRANSACTIONS (Tables) Tables http://agapeatp.com/role/RelatedPartyBalancesAndTransactions 38 false false R39.htm 00000039 - Disclosure - INCOME TAXES (Tables) Sheet http://agapeatp.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://agapeatp.com/role/IncomeTaxes 39 false false R40.htm 00000040 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://agapeatp.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://agapeatp.com/role/CommitmentsAndContingencies 40 false false R41.htm 00000041 - Disclosure - Schedule of Subsidiaries and Associates (Details) Sheet http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails Schedule of Subsidiaries and Associates (Details) Details 41 false false R42.htm 00000042 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) Sheet http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative) Details http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables 42 false false R43.htm 00000043 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details) Sheet http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details) Details 43 false false R44.htm 00000044 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details) Sheet http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details) Details 44 false false R45.htm 00000045 - Disclosure - SCHEDULE OF DISAGGREGATED INFORMATION OF REVENUES (Details) Sheet http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails SCHEDULE OF DISAGGREGATED INFORMATION OF REVENUES (Details) Details 45 false false R46.htm 00000046 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details) Sheet http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details) Details 46 false false R47.htm 00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables 47 false false R48.htm 00000048 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details) Sheet http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails SCHEDULE OF VARIABLE INTEREST ENTITY (Details) Details 48 false false R49.htm 00000049 - Disclosure - VARIABLE INTEREST ENTITY (???VIE???) (Details Narrative) Sheet http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative VARIABLE INTEREST ENTITY (???VIE???) (Details Narrative) Details http://agapeatp.com/role/VariableInterestEntityVieTables 49 false false R50.htm 00000050 - Disclosure - Summary of Assets Acquired and Liabilities Assumed (Details) Sheet http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails Summary of Assets Acquired and Liabilities Assumed (Details) Details 50 false false R51.htm 00000051 - Disclosure - Schedule of Pro Forma Busniness Combination (Details) Sheet http://agapeatp.com/role/ScheduleOfProFormaBusninessCombinationDetails Schedule of Pro Forma Busniness Combination (Details) Details 51 false false R52.htm 00000052 - Disclosure - BUSNINESS COMBINATION (Details Narrative) Sheet http://agapeatp.com/role/BusninessCombinationDetailsNarrative BUSNINESS COMBINATION (Details Narrative) Details http://agapeatp.com/role/BusninessCombinationTables 52 false false R53.htm 00000053 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative) Sheet http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative CASH AND CASH EQUIVALENTS (Details Narrative) Details http://agapeatp.com/role/CashAndCashEquivalents 53 false false R54.htm 00000054 - Disclosure - Schedule of Accounts Receivables - Related Party (Details) Sheet http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails Schedule of Accounts Receivables - Related Party (Details) Details 54 false false R55.htm 00000055 - Disclosure - Schedule of Inventories (Details) Sheet http://agapeatp.com/role/ScheduleOfInventoriesDetails Schedule of Inventories (Details) Details 55 false false R56.htm 00000056 - Disclosure - Schedule of Prepaid Expenses and Deposits (Details) Sheet http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails Schedule of Prepaid Expenses and Deposits (Details) Details 56 false false R57.htm 00000057 - Disclosure - Schedule of Property and Equipment. Net (Details) Sheet http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails Schedule of Property and Equipment. Net (Details) Details 57 false false R58.htm 00000058 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative) Sheet http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative PROPERTY AND EQUIPMENT, NET (Details Narrative) Details http://agapeatp.com/role/PropertyAndEquipmentNetTables 58 false false R59.htm 00000059 - Disclosure - Schedule of Intangible Assets, Net (Details) Sheet http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails Schedule of Intangible Assets, Net (Details) Details 59 false false R60.htm 00000060 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative) Sheet http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative INTANGIBLE ASSETS, NET (Details Narrative) Details http://agapeatp.com/role/IntangibleAssetsNetTables 60 false false R61.htm 00000061 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details) Sheet http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details) Details 61 false false R62.htm 00000062 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative) Sheet http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative INVESTMENT IN MARKETABLE SECURITIES (Details Narrative) Details http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables 62 false false R63.htm 00000063 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details) Sheet http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details) Details 63 false false R64.htm 00000064 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative) Sheet http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative) Details http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables 64 false false R65.htm 00000065 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) Sheet http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details) Details 65 false false R66.htm 00000066 - Disclosure - SCHEDULE OF RELATED PARTIES RELATIONSHIPS (Details) Sheet http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails SCHEDULE OF RELATED PARTIES RELATIONSHIPS (Details) Details 66 false false R67.htm 00000067 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://agapeatp.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://agapeatp.com/role/StockholdersEquity 67 false false R68.htm 00000068 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details) Sheet http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details) Details 68 false false R69.htm 00000069 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAX (Details) Sheet http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails SCHEDULE OF PROVISION FOR INCOME TAX (Details) Details 69 false false R70.htm 00000070 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details) Sheet http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails SCHEDULE OF DEFERRED TAX ASSETS (Details) Details 70 false false R71.htm 00000071 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://agapeatp.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://agapeatp.com/role/IncomeTaxesTables 71 false false R72.htm 00000072 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative) Sheet http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative CONCENTRATIONS OF RISKS (Details Narrative) Details http://agapeatp.com/role/ConcentrationsOfRisks 72 false false R73.htm 00000073 - Disclosure - SCHEDULE OF FUTURE MINIMUM OPERATING LEASE LIABILITIES (Details) Sheet http://agapeatp.com/role/ScheduleOfFutureMinimumOperatingLeaseLiabilitiesDetails SCHEDULE OF FUTURE MINIMUM OPERATING LEASE LIABILITIES (Details) Details 73 false false R74.htm 00000074 - Disclosure - SCHEDULE OF FUTURE MINIMUM PURCHASE COMMITMENT (Details) Sheet http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails SCHEDULE OF FUTURE MINIMUM PURCHASE COMMITMENT (Details) Details 74 false false R75.htm 00000075 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://agapeatp.com/role/CommitmentsAndContingenciesTables 75 false false All Reports Book All Reports form10-q.htm aatp-20200630.xsd aatp-20200630_cal.xml aatp-20200630_def.xml aatp-20200630_lab.xml aatp-20200630_pre.xml ex31-1.htm ex32-1.htm http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 http://xbrl.sec.gov/dei/2020-01-31 true true JSON 90 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-q.htm": { "axisCustom": 0, "axisStandard": 20, "contextCount": 256, "dts": { "calculationLink": { "local": [ "aatp-20200630_cal.xml" ] }, "definitionLink": { "local": [ "aatp-20200630_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "form10-q.htm" ] }, "labelLink": { "local": [ "aatp-20200630_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "aatp-20200630_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml", "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "aatp-20200630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 558, "entityCount": 1, "hidden": { "http://agapeatp.com/20200630": 26, "http://fasb.org/us-gaap/2020-01-31": 117, "http://xbrl.sec.gov/dei/2020-01-31": 5, "total": 148 }, "keyCustom": 79, "keyStandard": 333, "memberCustom": 51, "memberStandard": 21, "nsprefix": "AATP", "nsuri": "http://agapeatp.com/20200630", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://agapeatp.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - BUSNINESS COMBINATION", "role": "http://agapeatp.com/role/BusninessCombination", "shortName": "BUSNINESS COMBINATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - CASH AND CASH EQUIVALENTS", "role": "http://agapeatp.com/role/CashAndCashEquivalents", "shortName": "CASH AND CASH EQUIVALENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE \u2013 RELATED PARTY", "role": "http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty", "shortName": "ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE \u2013 RELATED PARTY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - INVENTORIES", "role": "http://agapeatp.com/role/Inventories", "shortName": "INVENTORIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:PrepaymentsAndDepositsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - PREPAYMENTS AND DEPOSITS", "role": "http://agapeatp.com/role/PrepaymentsAndDeposits", "shortName": "PREPAYMENTS AND DEPOSITS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:PrepaymentsAndDepositsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - PROPERTY AND EQUIPMENT, NET", "role": "http://agapeatp.com/role/PropertyAndEquipmentNet", "shortName": "PROPERTY AND EQUIPMENT, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - INTANGIBLE ASSETS, NET", "role": "http://agapeatp.com/role/IntangibleAssetsNet", "shortName": "INTANGIBLE ASSETS, NET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:InvestmentInMarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES", "role": "http://agapeatp.com/role/InvestmentInMarketableSecurities", "shortName": "INVESTMENT IN MARKETABLE SECURITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:InvestmentInMarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:InvestmentInNonMarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES", "role": "http://agapeatp.com/role/InvestmentInNon-marketableSecurities", "shortName": "INVESTMENT IN NON-MARKETABLE SECURITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:InvestmentInNonMarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES", "role": "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities", "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Consolidated Balance Sheets (Unaudited)", "role": "http://agapeatp.com/role/BalanceSheets", "shortName": "Condensed Consolidated Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS", "role": "http://agapeatp.com/role/RelatedPartyBalancesAndTransactions", "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "role": "http://agapeatp.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - INCOME TAXES", "role": "http://agapeatp.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - CONCENTRATIONS OF RISKS", "role": "http://agapeatp.com/role/ConcentrationsOfRisks", "shortName": "CONCENTRATIONS OF RISKS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://agapeatp.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Tables)", "role": "http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Tables)", "role": "http://agapeatp.com/role/VariableInterestEntityVieTables", "shortName": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - BUSNINESS COMBINATION (Tables)", "role": "http://agapeatp.com/role/BusninessCombinationTables", "shortName": "BUSNINESS COMBINATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "role": "http://agapeatp.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "AATP:VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE \u2013 RELATED PARTY (Tables)", "role": "http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedPartyTables", "shortName": "ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE \u2013 RELATED PARTY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - INVENTORIES (Tables)", "role": "http://agapeatp.com/role/InventoriesTables", "shortName": "INVENTORIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "AATP:PrepaymentsAndDepositsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - PREPAYMENTS AND DEPOSITS (Tables)", "role": "http://agapeatp.com/role/PrepaymentsAndDepositsTables", "shortName": "PREPAYMENTS AND DEPOSITS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "AATP:PrepaymentsAndDepositsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - PROPERTY AND EQUIPMENT, NET (Tables)", "role": "http://agapeatp.com/role/PropertyAndEquipmentNetTables", "shortName": "PROPERTY AND EQUIPMENT, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - INTANGIBLE ASSETS, NET (Tables)", "role": "http://agapeatp.com/role/IntangibleAssetsNetTables", "shortName": "INTANGIBLE ASSETS, NET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Tables)", "role": "http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables", "shortName": "INVESTMENT IN MARKETABLE SECURITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "AATP:InvestmentInNonMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:NonMarketableSecuritiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)", "role": "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables", "shortName": "INVESTMENT IN NON-MARKETABLE SECURITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "AATP:InvestmentInNonMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:NonMarketableSecuritiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)", "role": "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables", "shortName": "OTHER PAYABLES AND ACCRUED LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - RELATED PARTY BALANCES AND TRANSACTIONS (Tables)", "role": "http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables", "shortName": "RELATED PARTY BALANCES AND TRANSACTIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - INCOME TAXES (Tables)", "role": "http://agapeatp.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-012020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited)", "role": "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss", "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-012020-06-30", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromRelatedParties", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "role": "http://agapeatp.com/role/CommitmentsAndContingenciesTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - Schedule of Subsidiaries and Associates (Details)", "role": "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails", "shortName": "Schedule of Subsidiaries and Associates (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-012020-06-30_custom_SubsidiaryCompanyMember", "decimals": null, "lang": "en-US", "name": "AATP:NameOftheCompany", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)", "role": "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30_custom_AgapeATPInternationalHoldingLimitedMember", "decimals": "INF", "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-012020-06-30_custom_ComputerAndOfficeEquipmentMember_srt_MinimumMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)", "role": "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "shortName": "SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AATP:ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock", "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-012020-06-30_custom_ComputerAndOfficeEquipmentMember_srt_MinimumMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AATP:ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-012020-06-30_us-gaap_ComputerSoftwareIntangibleAssetMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)", "role": "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails", "shortName": "SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AATP:ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock", "us-gaap:IntangibleAssetsFiniteLivedPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-012020-06-30_us-gaap_ComputerSoftwareIntangibleAssetMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-012020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - SCHEDULE OF DISAGGREGATED INFORMATION OF REVENUES (Details)", "role": "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails", "shortName": "SCHEDULE OF DISAGGREGATED INFORMATION OF REVENUES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueRecognitionPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-012020-06-30_custom_IonizedCalMagMember", "decimals": "0", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-012020-06-30_custom_MYRCurrencyMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EffectOfExchangeRateOnCash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)", "role": "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails", "shortName": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-012020-06-30_custom_MYRCurrencyMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EffectOfExchangeRateOnCash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2019-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:TradeAndOtherAccountsReceivablePolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2019-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - SCHEDULE OF VARIABLE INTEREST ENTITY (Details)", "role": "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails", "shortName": "SCHEDULE OF VARIABLE INTEREST ENTITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfVariableInterestEntitiesTextBlock", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-012020-06-30_us-gaap_VariableIncomeInterestRateMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Details Narrative)", "role": "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative", "shortName": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d) (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2018-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "role": "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity", "shortName": "Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2019-01-012019-03-31_us-gaap_RetainedEarningsMember", "decimals": "0", "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - Summary of Assets Acquired and Liabilities Assumed (Details)", "role": "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails", "shortName": "Summary of Assets Acquired and Liabilities Assumed (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2019-04-012019-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - Schedule of Pro Forma Busniness Combination (Details)", "role": "http://agapeatp.com/role/ScheduleOfProFormaBusninessCombinationDetails", "shortName": "Schedule of Pro Forma Busniness Combination (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2019-04-012019-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:VariableInterestEntityDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - BUSNINESS COMBINATION (Details Narrative)", "role": "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "shortName": "BUSNINESS COMBINATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-012020-03-31_custom_ShareExchangeAgreementMember_custom_MrHowKokChoongMember_custom_AgapeSuperiorLivingSdnBhdMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - CASH AND CASH EQUIVALENTS (Details Narrative)", "role": "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "shortName": "CASH AND CASH EQUIVALENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "lang": null, "name": "us-gaap:TimeDeposits", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - Schedule of Accounts Receivables - Related Party (Details)", "role": "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails", "shortName": "Schedule of Accounts Receivables - Related Party (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - Schedule of Inventories (Details)", "role": "http://agapeatp.com/role/ScheduleOfInventoriesDetails", "shortName": "Schedule of Inventories (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryFinishedGoods", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock", "AATP:PrepaymentsAndDepositsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - Schedule of Prepaid Expenses and Deposits (Details)", "role": "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails", "shortName": "Schedule of Prepaid Expenses and Deposits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "AATP:ScheduleOfPrepaidExpensesAndDepositsTableTextBlock", "AATP:PrepaymentsAndDepositsTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - Schedule of Property and Equipment. Net (Details)", "role": "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails", "shortName": "Schedule of Property and Equipment. Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-012020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - PROPERTY AND EQUIPMENT, NET (Details Narrative)", "role": "http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative", "shortName": "PROPERTY AND EQUIPMENT, NET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-012020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CapitalizedComputerSoftwareGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - Schedule of Intangible Assets, Net (Details)", "role": "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails", "shortName": "Schedule of Intangible Assets, Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CapitalizedComputerSoftwareGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "role": "http://agapeatp.com/role/StatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": "0", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-012020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - INTANGIBLE ASSETS, NET (Details Narrative)", "role": "http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative", "shortName": "INTANGIBLE ASSETS, NET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-012020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)", "role": "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails", "shortName": "SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "lang": null, "name": "AATP:MarketableSecuritiesUnrealizedHoldingLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)", "role": "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "shortName": "INVESTMENT IN MARKETABLE SECURITIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2018-10-16_custom_GreenproCapitalCorpMember", "decimals": "INF", "lang": null, "name": "us-gaap:InvestmentOwnedBalanceShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)", "role": "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails", "shortName": "SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "AATP:NonMarketableSecuritiesTableTextBlock", "AATP:InvestmentInNonMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30_custom_PhoenixPlusCorpMember", "decimals": "0", "lang": null, "name": "AATP:InvestmentInNonMarketableSecuritiesNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "AATP:InvestmentInMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InvestmentOwnedAtCost", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)", "role": "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "shortName": "INVESTMENT IN NON-MARKETABLE SECURITIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "AATP:InvestmentInNonMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2019-04-03_custom_PhoenixPlusCorpMember", "decimals": "INF", "lang": null, "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedProfessionalFeesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)", "role": "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails", "shortName": "SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "AATP:ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccruedProfessionalFeesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableRelatedPartiesCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - SCHEDULE OF RELATED PARTIES RELATIONSHIPS (Details)", "role": "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails", "shortName": "SCHEDULE OF RELATED PARTIES RELATIONSHIPS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-012020-06-30", "decimals": "0", "lang": null, "name": "AATP:RevenuesFromRelatedParty", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "role": "http://agapeatp.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-06-012020-06-30_custom_AgapeSuperiorLivingMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesAcquisitions", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-012020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)", "role": "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails", "shortName": "SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-04-012020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2019-01-012019-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentForeignTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000069 - Disclosure - SCHEDULE OF PROVISION FOR INCOME TAX (Details)", "role": "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails", "shortName": "SCHEDULE OF PROVISION FOR INCOME TAX (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2019-01-012019-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentForeignTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - ORGANIZATION AND BUSINESS BACKGROUND", "role": "http://agapeatp.com/role/OrganizationAndBusinessBackground", "shortName": "ORGANIZATION AND BUSINESS BACKGROUND", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsValuationAllowanceCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000070 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS (Details)", "role": "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsValuationAllowanceCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000071 - Disclosure - INCOME TAXES (Details Narrative)", "role": "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "INF", "first": true, "lang": null, "name": "AATP:CommissionExpensePercentage", "reportCount": 1, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000072 - Disclosure - CONCENTRATIONS OF RISKS (Details Narrative)", "role": "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative", "shortName": "CONCENTRATIONS OF RISKS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2019-12-31", "decimals": "0", "lang": null, "name": "AATP:DepositForInsurance", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000073 - Disclosure - SCHEDULE OF FUTURE MINIMUM OPERATING LEASE LIABILITIES (Details)", "role": "http://agapeatp.com/role/ScheduleOfFutureMinimumOperatingLeaseLiabilitiesDetails", "shortName": "SCHEDULE OF FUTURE MINIMUM OPERATING LEASE LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "AATP:ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000074 - Disclosure - SCHEDULE OF FUTURE MINIMUM PURCHASE COMMITMENT (Details)", "role": "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails", "shortName": "SCHEDULE OF FUTURE MINIMUM PURCHASE COMMITMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "AATP:ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "AsOf2020-06-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000075 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "role": "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": "0", "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - VARIABLE INTEREST ENTITY (\u201cVIE\u201d)", "role": "http://agapeatp.com/role/VariableInterestEntityVie", "shortName": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-q.htm", "contextRef": "From2020-01-01to2020-06-30", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:VariableInterestEntityDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 73, "tag": { "AATP_AccountsReceivableAndAccountsReceivableRelatedParties": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Accounts receivable and accounts receivable related parties.", "label": "Accounts receivable and accounts receivable related parties", "totalLabel": "Total accounts receivable and accounts receivable \u2013 related party" } } }, "localname": "AccountsReceivableAndAccountsReceivableRelatedParties", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "AATP_AccruedPromotionExpenses": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accrued promotion expenses.", "label": "Accrued promotion expenses" } } }, "localname": "AccruedPromotionExpenses", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_AgapeATPAsiaLimitedAATPAsiaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Agape A T P Asia Limited A A T P Asia [Member]" } } }, "localname": "AgapeATPAsiaLimitedAATPAsiaMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "domainItemType" }, "AATP_AgapeATPInternationalHoldingLimitedMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Agape ATP International Holding Limited [Member]", "label": "Agape ATP International Holding Limited [Member]" } } }, "localname": "AgapeATPInternationalHoldingLimitedMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_AgapeSuperiorLivingMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ASL [Member]", "label": "ASL [Member]" } } }, "localname": "AgapeSuperiorLivingMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_AgapeSuperiorLivingPtyLtdASLPLMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Agape Superior Living Pty Ltd ASLPL [Member]", "label": "Agape Superior Living Pty Ltd ASLPL [Member]" } } }, "localname": "AgapeSuperiorLivingPtyLtdASLPLMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "domainItemType" }, "AATP_AgapeSuperiorLivingPtyLtdASLPLOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Agape Superior Living Pty Ltd A S L P L One [Member]" } } }, "localname": "AgapeSuperiorLivingPtyLtdASLPLOneMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "domainItemType" }, "AATP_AgapeSuperiorLivingSdnBhdMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Agape Superior Living Sdn Bhd [Member]", "label": "Agape Superior Living Sdn Bhd [Member]" } } }, "localname": "AgapeSuperiorLivingSdnBhdMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_AllowanceForDoubtfulAccountsReceivablesCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Allowance for doubtful accounts,", "label": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivablesCurrent", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AATP_AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount transferred from investment in investee company to investment in non-marketable securities.", "label": "Amount transferred from investment in investee company to investment in non-marketable securities" } } }, "localname": "AmountTransferredFromInvestmentInInvesteeCompanyToInvestmentInNonmarketableSecurities", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_BetaMaxxmMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Beta Maxx [Member]", "label": "Beta Maxx [Member]" } } }, "localname": "BetaMaxxmMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_BusinessAcquisitionProFormaEarningsPerShareBasicDiluted": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net income (loss) per common share - basic and diluted" } } }, "localname": "BusinessAcquisitionProFormaEarningsPerShareBasicDiluted", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusninessCombinationDetails" ], "xbrltype": "perShareItemType" }, "AATP_BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted average number of common shares outstanding - basic and diluted" } } }, "localname": "BusinessAcquisitionProFormaWeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusninessCombinationDetails" ], "xbrltype": "sharesItemType" }, "AATP_BusinessAcquisitionsProFormaCostOfRevenue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "label": "BusinessAcquisitionsProFormaCostOfRevenue", "verboseLabel": "Cost of revenue" } } }, "localname": "BusinessAcquisitionsProFormaCostOfRevenue", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusninessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "AATP_BusinessAcquisitionsProFormaGrossProfit": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "label": "BusinessAcquisitionsProFormaGrossProfit", "verboseLabel": "Gross profit" } } }, "localname": "BusinessAcquisitionsProFormaGrossProfit", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusninessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "AATP_BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "label": "Income (loss) before income taxes" } } }, "localname": "BusinessAcquisitionsProFormaIncomeLossBeforeIncomeTaxes", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusninessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "AATP_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "label": "Benefit of (Provision for) income taxes" } } }, "localname": "BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusninessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "AATP_BusinessAcquisitionsProFormaOperatingExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "label": "Total operating expenses" } } }, "localname": "BusinessAcquisitionsProFormaOperatingExpenses", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusninessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "AATP_BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "label": "Other income (expense), net" } } }, "localname": "BusinessAcquisitionsProFormaOtherOperatingIncomeExpenseNet", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusninessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes", "verboseLabel": "Prepaid taxes" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidTaxes", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "AATP_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "label": "Other receivables - related parties" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivablesRelatedParties", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "AATP_CommissionExpensePercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission expense, percentage.", "label": "Commission expense, percentage" } } }, "localname": "CommissionExpensePercentage", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "percentItemType" }, "AATP_ComputerAndOfficeEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Computer and Office Equipment [Member]", "label": "Computer and Office Equipment [Member]" } } }, "localname": "ComputerAndOfficeEquipmentMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "AATP_CustomerDepositcurrent": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Customer deposits.", "label": "Customer deposits" } } }, "localname": "CustomerDepositcurrent", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "AATP_CustomerDepositsPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Customer Deposits [Policy Text Block]", "label": "Customer Deposits [Policy Text Block]", "verboseLabel": "Customer deposits" } } }, "localname": "CustomerDepositsPolicyTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_DeferredOfferingCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Deferred offering costs [Policy Text Block]", "label": "Deferred offering costs [Policy Text Block]", "verboseLabel": "Deferred offering costs" } } }, "localname": "DeferredOfferingCostsPolicyTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_DeferredTaxAssetsDepreciation": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Deferred Tax Assets,Depreciation,", "label": "DeferredTaxAssetsDepreciation", "verboseLabel": "Depreciation" } } }, "localname": "DeferredTaxAssetsDepreciation", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "AATP_DefinedContributionPlanPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Defined Contribution Plan [Policy Text Block]", "label": "Defined contribution plan" } } }, "localname": "DefinedContributionPlanPolicyTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_DepositForInsurance": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Deposit for insurance.", "label": "Deposit for insurance" } } }, "localname": "DepositForInsurance", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AATP_DepositsToSupplier": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": 3.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Deposits to supplier.", "label": "Deposits to suppliers" } } }, "localname": "DepositsToSupplier", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "AATP_DirectorsOfUnreservedInvestmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Directors of Unreserved Investments [Member]", "label": "Directors of Unreserved Investments [Member]" } } }, "localname": "DirectorsOfUnreservedInvestmentMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "AATP_DisclosureInvestmentInMarketableSecuritiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investment In Marketable Securities", "verboseLabel": "Schedule Of Investment In Marketable Securities" } } }, "localname": "DisclosureInvestmentInMarketableSecuritiesAbstract", "nsuri": "http://agapeatp.com/20200630", "xbrltype": "stringItemType" }, "AATP_DisclosureInvestmentInNonmarketableSecuritiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investment In Non-marketable Securities" } } }, "localname": "DisclosureInvestmentInNonmarketableSecuritiesAbstract", "nsuri": "http://agapeatp.com/20200630", "xbrltype": "stringItemType" }, "AATP_DisclosurePrepaymentsAndDepositsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Prepayments And Deposits", "verboseLabel": "Schedule Of Prepaid Expenses And Deposits" } } }, "localname": "DisclosurePrepaymentsAndDepositsAbstract", "nsuri": "http://agapeatp.com/20200630", "xbrltype": "stringItemType" }, "AATP_ECommerceCompanyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "E-commerce [Member].", "label": "E-commerce [Member]" } } }, "localname": "ECommerceCompanyMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_EmployeesProvidentFundMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Employees Provident Fund [Member]", "label": "Employees Provident Fund [Member]" } } }, "localname": "EmployeesProvidentFundMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_EmploymentInsuranceSystemMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Employment Insurance System [Member]", "label": "Employment Insurance System [Member]" } } }, "localname": "EmploymentInsuranceSystemMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_EnergizedMineralConcentrateMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Energized Mineral Concentrate [Member]", "label": "Energized Mineral Concentrate [Member]" } } }, "localname": "EnergizedMineralConcentrateMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_ExchangeRateEffectOnInvestmentInMarketableSecurites": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": { "order": 3.0, "parentTag": "us-gaap_MarketableSecuritiesNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Exchange rate effect.", "label": "Exchange rate effect" } } }, "localname": "ExchangeRateEffectOnInvestmentInMarketableSecurites", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_ForeignCurrencyExchangeRatePeriodAverage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign currency exchange rate period average.", "label": "Foreign currency exchange rate period average" } } }, "localname": "ForeignCurrencyExchangeRatePeriodAverage", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "pureItemType" }, "AATP_ForfeitedCouponIncome": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Forfeited coupon income.", "label": "Forfeited coupon income" } } }, "localname": "ForfeitedCouponIncome", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AATP_GreenproCapitalCorpMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Greenpro Capital Corp. [Member]", "label": "Greenpro Capital Corp. [Member]" } } }, "localname": "GreenproCapitalCorpMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_HKDCurrencyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "HKD Currency [Member]", "label": "HKD Currency [Member]" } } }, "localname": "HKDCurrencyMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "AATP_HealthAndWellnessProductsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health And Wellness Products [Member]", "label": "Health And Wellness Products [Member]" } } }, "localname": "HealthAndWellnessProductsMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_HumanResourceDevelopmentFundMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Human Resource Development Fund [Member]", "label": "Human Resource Development Fund [Member]" } } }, "localname": "HumanResourceDevelopmentFundMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_HyaluronicAcidSerumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Hyaluronic Acid Serum [Member]", "label": "Hyaluronic Acid Serum [Member]" } } }, "localname": "HyaluronicAcidSerumMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_IfUnutilizedMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "If Unutilized [Member]", "label": "If Unutilized [Member]" } } }, "localname": "IfUnutilizedMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_ImpairmentLossInEquityInvestment": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Impairment loss in equity investment.", "label": "Impairment loss in equity investment", "negatedLabel": "Impairment loss in equity investment" } } }, "localname": "ImpairmentLossInEquityInvestment", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "AATP_IncreaseDecreasePrepaymentsAndDepositsRelatedParty": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Increase decrease in prepayments and deposits \u2013 related party.", "label": "IncreaseDecreasePrepaymentsAndDepositsRelatedParty", "negatedLabel": "Prepayments and deposits \u2013 related party" } } }, "localname": "IncreaseDecreasePrepaymentsAndDepositsRelatedParty", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Initial recognition of right-of-use assets and lease liabilities.", "label": "Initial recognition of right-of-use assets and lease liabilities" } } }, "localname": "InitialRecognitionOfRightofuseAssetsAndLeaseLiabilities", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_InvestmentInMarketableSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Investment in Marketable Securities [Text Block]", "label": "INVESTMENT IN MARKETABLE SECURITIES" } } }, "localname": "InvestmentInMarketableSecuritiesTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/InvestmentInMarketableSecurities" ], "xbrltype": "textBlockItemType" }, "AATP_InvestmentInNonMarketableSecuritiesGross": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Investment in non-marketable securities.", "label": "Investment in non-marketable securities [Default Label]", "verboseLabel": "Investment in non-marketable securities" } } }, "localname": "InvestmentInNonMarketableSecuritiesGross", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_InvestmentInNonMarketableSecuritiesNoncurrent": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Investment in non-marketable securities.", "label": "Investment in non-marketable securities", "verboseLabel": "Total investment in non-marketable securities" } } }, "localname": "InvestmentInNonMarketableSecuritiesNoncurrent", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_InvestmentInNonMarketableSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Investment In Non- Marketable Securities [Text Block]", "label": "INVESTMENT IN NON-MARKETABLE SECURITIES" } } }, "localname": "InvestmentInNonMarketableSecuritiesTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecurities" ], "xbrltype": "textBlockItemType" }, "AATP_InvestmentInNonmarketableSecuritiesNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Investment in non-marketable securities, net.", "label": "Investment in non-marketable securities, net", "verboseLabel": "Investment in non-marketable securities" } } }, "localname": "InvestmentInNonmarketableSecuritiesNet", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_IonizedCalMagMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Ionized Cal-Mag [Member]", "label": "Ionized Cal-Mag [Member]" } } }, "localname": "IonizedCalMagMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAsl": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Issuance of common stock in exchange for acquisition payment of ASL.", "label": "Issuance of common stock in exchange for acquisition payment of ASL" } } }, "localname": "IssuanceOfCommonStockInExchangeForAcquisitionPaymentOfAsl", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_LabuanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Labuan [Member]", "label": "Labuan [Member]" } } }, "localname": "LabuanMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_LipomaskMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lipomask [Member]", "label": "Lipomask [Member]" } } }, "localname": "LipomaskMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_MYRCurrencyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "MYR Currency [Member]", "label": "MYR Currency [Member]" } } }, "localname": "MYRCurrencyMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_MarketableSecuritiesUnrealizedGainLoss1": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in marketable security.", "label": "MarketableSecuritiesUnrealizedGainLoss1", "negatedLabel": "Unrealized holding gain on marketable securities" } } }, "localname": "MarketableSecuritiesUnrealizedGainLoss1", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_MarketableSecuritiesUnrealizedHoldingLoss": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": { "order": 2.0, "parentTag": "us-gaap_MarketableSecuritiesNoncurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Unrealized holding loss.", "label": "Unrealized holding gain (loss)" } } }, "localname": "MarketableSecuritiesUnrealizedHoldingLoss", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_MitogizeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Mitogize [Member]", "label": "Mitogize [Member]" } } }, "localname": "MitogizeMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_MonthlySalary": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Monthly salary.", "label": "Monthly salary" } } }, "localname": "MonthlySalary", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AATP_MousseFacialCleanserMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Mousse Facial Cleanser [Member]", "label": "Mousse Facial Cleanser [Member]" } } }, "localname": "MousseFacialCleanserMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_MrHowKokChoongMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Mr. How Kok Choong [Member]", "label": "Mr. How Kok Choong [Member]" } } }, "localname": "MrHowKokChoongMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "domainItemType" }, "AATP_NameOftheCompany": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the company name.", "label": "Subsidiary company name" } } }, "localname": "NameOftheCompany", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "stringItemType" }, "AATP_NoCustomerMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "No Customer [Member].", "label": "No Customer [Member]" } } }, "localname": "NoCustomerMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_NonMarketableSecuritiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Investment in non-marketable securities [Policy Text Block]", "label": "Investment in non-marketable equity securities" } } }, "localname": "NonMarketableSecuritiesPolicyTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_NonMarketableSecuritiesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of Non-marketable securities.", "label": "SCHEDULE OF INVESTMENT IN NON MARKETABLE SECURITIES" } } }, "localname": "NonMarketableSecuritiesTableTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "AATP_NoncontrollingInterestPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Non-controlling Interest [Policy Text Block]", "label": "Non-controlling interest" } } }, "localname": "NoncontrollingInterestPolicyTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_OmegaBlendMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Omega Blend [Member]", "label": "Omega Blend [Member]" } } }, "localname": "OmegaBlendMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_OneCustomersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "One Customer [Member]", "label": "One Customer [Member]" } } }, "localname": "OneCustomersMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_OneVendorMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "One Vendor [Member]", "label": "One Vendor [Member]" } } }, "localname": "OneVendorMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_OperatingLeaseEffectiveInterestRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Operating Lease effective interest rate.", "label": "Operating lease effective interest rate" } } }, "localname": "OperatingLeaseEffectiveInterestRate", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "AATP_OperatingLossCarryforwardsExpireYearDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Operating loss carryforwards expire year, description.", "label": "Operating loss carryforwards expire year, description" } } }, "localname": "OperatingLossCarryforwardsExpireYearDescription", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "AATP_OrganicYouthCareCleansingBarMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Organic Youth Care Cleansing Bar [Member]", "label": "Organic Youth Care Cleansing Bar [Member]" } } }, "localname": "OrganicYouthCareCleansingBarMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_OtherPayablesRelatedPartyCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Other payables - related party.", "label": "Other payables &nbsp intercompany" } } }, "localname": "OtherPayablesRelatedPartyCurrent", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "AATP_ParticularsOfIssuedCapital": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Particulars of issued capital.", "label": "Particulars of issued capital" } } }, "localname": "ParticularsOfIssuedCapital", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "stringItemType" }, "AATP_PaymentsToAcquireNonMarketableSecurities": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Investment in non-marketable securities.", "label": "PaymentsToAcquireNonMarketableSecurities", "negatedLabel": "Investment in non-marketable securities" } } }, "localname": "PaymentsToAcquireNonMarketableSecurities", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_PercentageOfCommonStockIssuedAndOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of common stock issued and outstanding.", "label": "Percentage of common stock issued and outstanding" } } }, "localname": "PercentageOfCommonStockIssuedAndOutstanding", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative" ], "xbrltype": "percentItemType" }, "AATP_PeriodAverageHKDMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period-average HKD [Member]", "label": "Period-average HKD [Member]" } } }, "localname": "PeriodAverageHKDMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "AATP_PeriodAverageMYRMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period-average MYR [Member]", "label": "Period-average MYR [Member]" } } }, "localname": "PeriodAverageMYRMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "AATP_PeriodEndHKDMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period-end HKD [Member]", "label": "Period-end HKD [Member]" } } }, "localname": "PeriodEndHKDMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "AATP_PeriodEndMYRMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period-end MYR [Member]", "label": "Period-end MYR [Member]" } } }, "localname": "PeriodEndMYRMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "AATP_PhoenixPlusCorpMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Phoenix Plus Corporation [Member]", "label": "Phoenix Plus Corporation [Member]" } } }, "localname": "PhoenixPlusCorpMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "AATP_PlaceAndDateOfIncorporation": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Place and date of incorporation.", "label": "Place and date of incorporation" } } }, "localname": "PlaceAndDateOfIncorporation", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "stringItemType" }, "AATP_PrepaidExpenseAndOtherAssetCurrent": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepayments and Deposits - related party" } } }, "localname": "PrepaidExpenseAndOtherAssetCurrent", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "monetaryItemType" }, "AATP_PrepaidTaxesPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Prepaid Taxes [Policy Text Block]", "label": "Prepaid taxes" } } }, "localname": "PrepaidTaxesPolicyTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_PrepaymentsAndDepositsPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Prepayments and deposits [Policy Text Block]", "label": "Prepayments and deposits" } } }, "localname": "PrepaymentsAndDepositsPolicyTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_PrepaymentsAndDepositsRelatedParty": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 8.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Prepayments and deposits \u2013 related party.", "label": "Prepayments and deposits \u2013 related party" } } }, "localname": "PrepaymentsAndDepositsRelatedParty", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "AATP_PrepaymentsAndDepositsTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "PREPAYMENTS AND DEPOSITS" } } }, "localname": "PrepaymentsAndDepositsTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/PrepaymentsAndDeposits" ], "xbrltype": "textBlockItemType" }, "AATP_PrincipalActivities": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Principal activities.", "label": "Principal activities" } } }, "localname": "PrincipalActivities", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "stringItemType" }, "AATP_ProceedsFromDeferredOfferingCosts": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Proceeds from deferred offering costs", "label": "ProceedsFromDeferredOfferingCosts", "verboseLabel": "Deferred offering costs" } } }, "localname": "ProceedsFromDeferredOfferingCosts", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_ProceedsFromRelatedPartyDebts": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount due to a related party.", "label": "Amount due to a related party [Default Label]", "verboseLabel": "Amount due to a related party" } } }, "localname": "ProceedsFromRelatedPartyDebts", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Proceeds from sale of non-marketable securities to a related party.", "label": "Proceeds from sale of non-marketable securities to a related party", "verboseLabel": "Proceeds from investments" } } }, "localname": "ProceedsFromSaleOfNonmarketableSecuritiesToRelatedParty", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_ReceivablesFromSalesDistributors": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": 2.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Receivables from sales distributors.", "label": "Receivables from sales distributors" } } }, "localname": "ReceivablesFromSalesDistributors", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "AATP_RedboyPictureSdnBhdRedboyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Redboy Picture Sdn Bhd Redboy [Member]" } } }, "localname": "RedboyPictureSdnBhdRedboyMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "domainItemType" }, "AATP_RelatedPartiesNatureDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Related parties nature, description.", "label": "Related parties nature, description" } } }, "localname": "RelatedPartiesNatureDescription", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "stringItemType" }, "AATP_RelatedPartiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Related Parties [Policy Text Block]", "label": "Related parties" } } }, "localname": "RelatedPartiesPolicyTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_RelatedPartiesRelationshipsDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Related parties, relationships, description.", "label": "Related parties relationship, description" } } }, "localname": "RelatedPartiesRelationshipsDescription", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "stringItemType" }, "AATP_RepaymentsOfRelatedPartyDebts": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Repayments from related parties.", "label": "Repayments from related parties", "negatedLabel": "Repayments from related parties" } } }, "localname": "RepaymentsOfRelatedPartyDebts", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_RevenuesFromRelatedParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Revenues from related party.", "label": "RevenuesFromRelatedParty", "verboseLabel": "Revenue" } } }, "localname": "RevenuesFromRelatedParty", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "monetaryItemType" }, "AATP_SalaryPercentage": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Salary percentage.", "label": "Salary percentage" } } }, "localname": "SalaryPercentage", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "AATP_SaleOfInvestmentInNonmarketableSecurities": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sale of investment in non-marketable securities.", "label": "Less: Sale of investment in non-marketable securities" } } }, "localname": "SaleOfInvestmentInNonmarketableSecurities", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "AATP_SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAsl": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sale of non-marketable securities to a related party in exchange for ASL.", "label": "Sale of non-marketable securities to a related party in exchange for ASL" } } }, "localname": "SaleOfNonmarketableSecuritiesToRelatedPartyInExchangeForAsl", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_SalesCommissionsAndFees1": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).", "label": "Commission expenses [Default Label]", "verboseLabel": "Commission expenses" } } }, "localname": "SalesCommissionsAndFees1", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "AATP_ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Estimated Useful Lives of Intangible Assets, Net [Table Text Block]", "label": "SCHEDULE OF ESTIMATED USEFUL LIVES OF INTANGIBLE ASSETS, NET" } } }, "localname": "ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetTableTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "AATP_ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Estimated Useful Lives of Property and Equipment [Table Text Block]", "label": "SCHEDULE OF ESTIMATED USEFUL LIVES OF PROPERTY AND EQUIPMENT" } } }, "localname": "ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentTableTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "AATP_ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule Of Future Minimum Purchase Commitments [Table Text Block]", "label": "SCHEDULE OF FUTURE MINIMUM PURCHASE COMMITMENT" } } }, "localname": "ScheduleOfFutureMinimumPurchaseCommitmentsTableTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "AATP_ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Other Payables and Accrued Liabilities [Table Text Block]", "label": "SCHEDULE OF OTHER PAYABLES AND ACCRUED LIABILITIES" } } }, "localname": "ScheduleOfOtherPayablesAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "AATP_ScheduleOfPrepaidExpensesAndDepositsTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Prepaid Expenses and Deposits [Table Text Block]", "label": "Schedule of Prepaid Expenses and Deposits" } } }, "localname": "ScheduleOfPrepaidExpensesAndDepositsTableTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/PrepaymentsAndDepositsTables" ], "xbrltype": "textBlockItemType" }, "AATP_SeaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "SEA [Member]", "label": "SEA [Member]" } } }, "localname": "SeaMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "domainItemType" }, "AATP_ShareExchangeAgreementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share Exchange Agreement [Member]", "label": "Share Exchange Agreement [Member]" } } }, "localname": "ShareExchangeAgreementMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_ShippingAndHandlingPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Shipping and handling [Policy Text Block]", "label": "Shipping and handling" } } }, "localname": "ShippingAndHandlingPolicyTextBlock", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "AATP_SocialSecurityOrganizationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Social Security Organization [Member]", "label": "Social Security Organization [Member]" } } }, "localname": "SocialSecurityOrganizationMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_SubsidiaryCompanyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Subsidiary Company [Member]", "label": "Subsidiary Company [Member]" } } }, "localname": "SubsidiaryCompanyMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "domainItemType" }, "AATP_SubsidiaryCompanyOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Subsidiary Company One [Member]", "label": "Subsidiary Company One [Member]" } } }, "localname": "SubsidiaryCompanyOneMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "domainItemType" }, "AATP_SubsidiaryCompanyThreeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Subsidiary Company Three [Member]", "label": "Subsidiary Company Three [Member]" } } }, "localname": "SubsidiaryCompanyThreeMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "domainItemType" }, "AATP_SubsidiaryCompanyTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Subsidiary Company Two [Member]", "label": "Subsidiary Company Two [Member]" } } }, "localname": "SubsidiaryCompanyTwoMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "domainItemType" }, "AATP_SurvivorSelectMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Survivor Select [Member]", "label": "Survivor Select [Member]" } } }, "localname": "SurvivorSelectMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_TrimPlusMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trim+ [Member]", "label": "Trim+ [Member]" } } }, "localname": "TrimPlusMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_UnpaidAccruedLiabilitiesOnDeferredOfferingCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Unpaid accrued liabilities on deferred offering costs.", "label": "Unpaid accrued liabilities on deferred offering costs" } } }, "localname": "UnpaidAccruedLiabilitiesOnDeferredOfferingCosts", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_UnpaidBalanceDueToRelatedPartyInConnectionWithAcquisitionPaymentOfAsl": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Unpaid balance due to a related party in connection with acquisition payment of ASL.", "label": "Unpaid balance due to a related party in connection with acquisition payment of ASL" } } }, "localname": "UnpaidBalanceDueToRelatedPartyInConnectionWithAcquisitionPaymentOfAsl", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "AATP_UnreservedSdnBhdMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Unreserved Sdn Bhd [Member]", "label": "Unreserved Sdn Bhd [Member]" } } }, "localname": "UnreservedSdnBhdMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "VIE consolidated amount of cash and cash equivalents.", "label": "VIE consolidated amount of cash and cash equivalents" } } }, "localname": "VariableInterestEntityConsolidatedAmountOfCashAndCashEquivalents", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "AATP_VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "VIE consolidated amount of other payables and accrued liabilities.", "label": "VIE consolidated amount of other payables and accrued liabilities" } } }, "localname": "VariableInterestEntityConsolidatedAmountOfOtherPayablesAndAccruedLiabilities", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "AATP_VariableInterestEntityConsolidatedAmountOfPrepaidTaxes": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "VIE consolidated amount of Prepaid taxes .", "label": "VIE consolidated amount of prepaid taxes" } } }, "localname": "VariableInterestEntityConsolidatedAmountOfPrepaidTaxes", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "AATP_VariableInterestEntityConsolidatedAmountOfPrepaymentsAndDeposits": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "VIE consolidated amount of prepayments and deposits.", "label": "VIE consolidated amount of prepayments and deposits" } } }, "localname": "VariableInterestEntityConsolidatedAmountOfPrepaymentsAndDeposits", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "AATP_VegeFruitFiberMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Vege-Fruit Fiber [Member]", "label": "Vege-Fruit Fiber [Member]" } } }, "localname": "VegeFruitFiberMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "AATP_VendorOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Vendor One [Member]", "label": "Vendor One [Member]" } } }, "localname": "VendorOneMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_VendorTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Vendor Two [Member]", "label": "Vendor Two [Member]" } } }, "localname": "VendorTwoMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "AATP_YoungFormulaMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Young Formula [Member]", "label": "Young Formula [Member]" } } }, "localname": "YoungFormulaMember", "nsuri": "http://agapeatp.com/20200630", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails" ], "xbrltype": "domainItemType" }, "country_HK": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "HONG KONG" } } }, "localname": "HK", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" ], "xbrltype": "domainItemType" }, "country_MY": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "MALAYSIA" } } }, "localname": "MY", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails", "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r459" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r459" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r458" ], "lang": { "en-US": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r456", "r458", "r459" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r457" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r465" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r458" ], "lang": { "en-US": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r458" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r460" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r448" ], "lang": { "en-US": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r451" ], "lang": { "en-US": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r461" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative", "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r461" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r464" ], "lang": { "en-US": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r461" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r462" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityListingsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Listings [Line Items]" } } }, "localname": "EntityListingsLineItems", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r459" ], "lang": { "en-US": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r461" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r461" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r461" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r461" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative", "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r458" ], "lang": { "en-US": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r452" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r453" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r447" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r450" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r449" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r454" ], "lang": { "en-US": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r455" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r463" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://agapeatp.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_CondensedCashFlowStatementsCaptionsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Condensed Cash Flow Statements, Captions [Line Items]" } } }, "localname": "CondensedCashFlowStatementsCaptionsLineItems", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesAxis": { "auth_ref": [ "r300", "r301", "r306", "r307", "r445" ], "lang": { "en-US": { "role": { "label": "Consolidated Entities [Axis]" } } }, "localname": "ConsolidatedEntitiesAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidatedEntitiesDomain": { "auth_ref": [ "r300", "r301", "r306", "r307" ], "localname": "ConsolidatedEntitiesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails" ], "xbrltype": "domainItemType" }, "srt_DirectorMember": { "auth_ref": [ "r157" ], "lang": { "en-US": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r156", "r220", "r223", "r416" ], "lang": { "en-US": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r230", "r233", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r413", "r417" ], "lang": { "en-US": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r230", "r233", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r413", "r417" ], "lang": { "en-US": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_MortgageLoansOnRealEstateLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items]" } } }, "localname": "MortgageLoansOnRealEstateLineItems", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails", "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "stringItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r156", "r220", "r223", "r416" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r153", "r220", "r221", "r369", "r412", "r414" ], "lang": { "en-US": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r153", "r220", "r221", "r369", "r412", "r414" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r227", "r230", "r233", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r413", "r417" ], "lang": { "en-US": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r227", "r230", "r233", "r359", "r360", "r361", "r362", "r363", "r364", "r365", "r413", "r417" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r231" ], "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r154", "r155", "r220", "r222", "r415", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443" ], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails", "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r154", "r155", "r220", "r222", "r415", "r431", "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r444" ], "lang": { "en-US": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails", "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r208", "r231", "r358" ], "lang": { "en-US": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "SEC Schedule, 12-18, Supplemental Information, Property-Casualty Insurance Underwriters [Line Items]" } } }, "localname": "SupplementalInformationForPropertyCasualtyInsuranceUnderwritersLineItems", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r157", "r353" ], "lang": { "en-US": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilities": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other.", "label": "Others" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.", "label": "Accounts Payable and Other Accrued Liabilities, Current", "verboseLabel": "Other payables and accrued liabilities" } } }, "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r42" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable &nbsp intercompany" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableMember": { "auth_ref": [ "r15" ], "lang": { "en-US": { "role": { "documentation": "Obligations incurred and payable to vendors for goods and services received.", "label": "Accounts Payable [Member]" } } }, "localname": "AccountsPayableMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r13", "r42" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableGrossCurrent": { "auth_ref": [ "r158", "r159" ], "calculation": { "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails": { "order": 1.0, "parentTag": "AATP_AccountsReceivableAndAccountsReceivableRelatedParties", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, before Allowance for Credit Loss, Current", "verboseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r5", "r24", "r158", "r159" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableRelatedPartiesCurrent": { "auth_ref": [ "r49", "r105", "r351", "r354" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails": { "order": 2.0, "parentTag": "AATP_AccountsReceivableAndAccountsReceivableRelatedParties", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of receivables arising from transactions with related parties due within one year or the normal operating cycle, if longer.", "label": "Accounts receivable \u2013 related party", "terseLabel": "Accounts Receivable - related party", "verboseLabel": "Accounts receivable - intercompany" } } }, "localname": "AccountsReceivableRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails", "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails", "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedPayrollTaxesCurrent": { "auth_ref": [ "r13", "r44" ], "calculation": { "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued payroll" } } }, "localname": "AccruedPayrollTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r12", "r13", "r44" ], "calculation": { "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherAccountsPayableAndAccruedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r41", "r198" ], "calculation": { "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less: accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r27", "r59", "r60", "r61", "r401", "r422", "r423" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive income" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r58", "r61", "r62", "r107", "r108", "r109", "r305", "r418", "r419" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcquiredIndefiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Indefinite-lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredIndefiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r25", "r241" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional paid in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r107", "r108", "r109", "r238", "r239", "r240" ], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r88", "r190" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r242" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r243" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising Expense", "verboseLabel": "Advertising costs" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r164", "r173", "r174", "r175" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable, Allowance for Credit Loss" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r31", "r164", "r173" ], "calculation": { "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails": { "order": 3.0, "parentTag": "AATP_AccountsReceivableAndAccountsReceivableRelatedParties", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "verboseLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfAccountsReceivables-RelatedPartyDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r88", "r184", "r190" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/IntangibleAssetsNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r121" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Potentially dilutive securities outstanding" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StockholdersEquityDetailsNarrative", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r98", "r142", "r145", "r151", "r171", "r300", "r306", "r325", "r386", "r400" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Net assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r9", "r11", "r56", "r98", "r171", "r300", "r306", "r325" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total current assets", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CURRENT ASSETS" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r235", "r237" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r229", "r232" ], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r229", "r232", "r284", "r285" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r281" ], "lang": { "en-US": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business acquisition percentage of voting interests" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r282", "r283" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "Schedule of Pro Forma Busniness Combination" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax": { "auth_ref": [ "r282", "r283" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of pro forma income from continuing operations as if the business combination had been completed at the beginning of a period.", "label": "Income (loss) from operations" } } }, "localname": "BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusninessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r282", "r283" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Net income (loss)" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusninessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r282", "r283" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Revenue" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProFormaBusninessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r292", "r293", "r294" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Purchase consideration value" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "auth_ref": [ "r291", "r292", "r293", "r295" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination.", "label": "Loan payable" } } }, "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r296" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "BUSNINESS COMBINATION" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombination" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "totalLabel": "Total assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StockholdersEquityDetailsNarrative", "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "verboseLabel": "ASSETS" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "auth_ref": [ "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "totalLabel": "Total current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Current assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Prepayments and other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Other receivables" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "auth_ref": [ "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "totalLabel": "Total current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Accounts payable - related party" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "auth_ref": [ "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue", "verboseLabel": "Customer deposits" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "verboseLabel": "Other payables and accrued liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets": { "auth_ref": [ "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax asset attributable to deductible temporary differences and carryforwards acquired at the acquisition date.", "label": "Deferred taxes asset, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "verboseLabel": "Intangible assets, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r286", "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "verboseLabel": "Inventories" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r286", "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net", "totalLabel": "Total net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": { "auth_ref": [ "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets", "totalLabel": "Total other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r286", "r287" ], "calculation": { "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "verboseLabel": "Property and equipment, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "auth_ref": [ "r2", "r106", "r136" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "ORGANIZATION AND BUSINESS BACKGROUND" } } }, "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/OrganizationAndBusinessBackground" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalizedComputerSoftwareGross": { "auth_ref": [ "r446" ], "calculation": { "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.", "label": "Computer software" } } }, "localname": "CapitalizedComputerSoftwareGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r37", "r425", "r426" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash in bank" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r82" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash and cash equivalent acquired through acquisition of Agape Superior Living Sdn Bhd" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r3", "r37", "r90" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents (Included $18,680 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of June 30, 2020)", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsDisclosureTextBlock": { "auth_ref": [ "r16" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for cash and cash equivalent footnotes, which may include the types of deposits and money market instruments, applicable carrying amounts, restricted amounts and compensating balance arrangements. Cash and equivalents include: (1) currency on hand (2) demand deposits with banks or financial institutions (3) other kinds of accounts that have the general characteristics of demand deposits (4) short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only investments maturing within three months from the date of acquisition qualify.", "label": "CASH AND CASH EQUIVALENTS" } } }, "localname": "CashAndCashEquivalentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalents" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r16", "r91", "r94" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r84", "r90", "r93" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "CASH AND CASH EQUIVALENTS, end of period", "periodStartLabel": "CASH AND CASH EQUIVALENTS, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r84", "r326" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommissionsExpensePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for commissions incurred in relation to revenue generating activities or operations.", "label": "Commission expenses" } } }, "localname": "CommissionsExpensePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r205", "r206", "r207", "r209" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r107", "r108" ], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockNoParValue": { "auth_ref": [ "r22" ], "lang": { "en-US": { "role": { "documentation": "Face amount per share of no-par value common stock.", "label": "Ordinary shares no par value" } } }, "localname": "CommonStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r22" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value", "verboseLabel": "Common stock par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical", "http://agapeatp.com/role/BusninessCombinationDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r22" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized", "verboseLabel": "Ordinary shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r22" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r22", "r211" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r22" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, par value $0.0001; 1,000,000,000 shares authorized, 376,438,194 and 376,275,500 issued and outstanding as of June 30, 2020 and December 31, 2019, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r64", "r66", "r72", "r298", "r313", "r394", "r408" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "COMPREHENSIVE INCOME (LOSS)" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive income (loss)" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "auth_ref": [ "r185", "r188", "r290" ], "lang": { "en-US": { "role": { "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks.", "label": "Computer Software, Intangible Asset [Member]" } } }, "localname": "ComputerSoftwareIntangibleAssetMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r130", "r131", "r156", "r322", "r323" ], "lang": { "en-US": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r130", "r131", "r156", "r322", "r323", "r424" ], "lang": { "en-US": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r136" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "CONCENTRATIONS OF RISKS" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisks" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r130", "r131", "r156", "r322", "r323" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentrations of risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r129", "r130", "r131", "r132", "r322", "r324" ], "lang": { "en-US": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r94", "r302" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r78", "r369" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "negatedLabel": "COST OF REVENUE" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesPolicyTextBlock": { "auth_ref": [ "r224" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.", "label": "Cost of revenue" } } }, "localname": "CostOfSalesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r104", "r264" ], "calculation": { "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": { "order": 2.0, "parentTag": "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "- Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r99", "r264", "r271" ], "calculation": { "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": { "order": 1.0, "parentTag": "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "- Local" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r47", "r102", "r212", "r213", "r214", "r215", "r336", "r337", "r338", "r398" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Schedule of Long-term Debt Instruments [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r99", "r265", "r271" ], "calculation": { "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": { "order": 4.0, "parentTag": "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense (Benefit)", "verboseLabel": "- Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r247", "r249" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred tax assets, net" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r88", "r99", "r265", "r271", "r272", "r273" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred tax expenses" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [ "r55", "r182" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.", "label": "Deferred offering costs" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r99", "r265", "r271" ], "calculation": { "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": { "order": 3.0, "parentTag": "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "verboseLabel": "- Local" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r258" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "verboseLabel": "Deferred tax assets, net" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r262", "r263" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carry forwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r257" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowanceCurrent": { "auth_ref": [ "r247", "r248", "r257" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of valuation allowance of deferred tax asset attributable to deductible temporary differences and carryforwards, classified as current.", "label": "Deferred Tax Assets, Valuation Allowance, Current", "negatedLabel": "Less: valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowanceCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.", "label": "Defined contribution plan expense" } } }, "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r88", "r196" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/PropertyAndEquipmentNetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r88", "r139" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r220" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "SCHEDULE OF DISAGGREGATED INFORMATION OF REVENUES" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DueFromOfficersOrStockholdersCurrent": { "auth_ref": [ "r49", "r105", "r351", "r353" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amounts due from owners or owners with a beneficial interest of more than 10 percent of the voting interests or officers of the company, which are usually due within 1 year (or 1 business cycle).", "label": "Amount due from director" } } }, "localname": "DueFromOfficersOrStockholdersCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueFromRelatedPartiesCurrent": { "auth_ref": [ "r6", "r17", "r23", "r100", "r351" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).", "label": "Amount due from related parties" } } }, "localname": "DueFromRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r42", "r105", "r351" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Amount due to a related party", "verboseLabel": "Amount due to a Related Party" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r120" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Basic and diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "EARNINGS (LOSS) PER SHARE" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING" } } }, "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r94", "r121", "r122" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings (loss) per share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCash": { "auth_ref": [ "r326" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of effect of exchange rate changes on cash balances held in foreign currencies. Excludes cash equivalents.", "label": "Exchange rate" } } }, "localname": "EffectOfExchangeRateOnCash", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r326" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "EFFECT OF EXCHANGE RATE ON CASH AND CASH EQUIVALENTS" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r251" ], "lang": { "en-US": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Tax percentage" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r251", "r275" ], "lang": { "en-US": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Statutory income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r107", "r108", "r109", "r111", "r116", "r118", "r124", "r172", "r211", "r216", "r238", "r239", "r240", "r267", "r268", "r327", "r328", "r329", "r330", "r331", "r332", "r418", "r419", "r420" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EquityMethodInvestmentOwnershipPercentage": { "auth_ref": [ "r170" ], "lang": { "en-US": { "role": { "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.", "label": "Proportional of ownership interest and voting power held", "terseLabel": "Equity interest percentage", "verboseLabel": "Ownership interest percentage" } } }, "localname": "EquityMethodInvestmentOwnershipPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails", "http://agapeatp.com/role/VariableInterestEntityVieDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ExtinguishmentOfDebtAxis": { "auth_ref": [ "r210" ], "lang": { "en-US": { "role": { "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.", "label": "Extinguishment of Debt [Axis]" } } }, "localname": "ExtinguishmentOfDebtAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ExtinguishmentOfDebtTypeDomain": { "auth_ref": [ "r210" ], "lang": { "en-US": { "role": { "documentation": "Type of debt extinguished." } } }, "localname": "ExtinguishmentOfDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r94", "r320", "r321" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair value of financial instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Estimated useful lives of intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r189" ], "calculation": { "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Less: accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r185", "r186", "r189", "r191", "r370", "r371" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r185", "r188" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r189", "r370" ], "calculation": { "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "totalLabel": "Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfIntangibleAssetsNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "auth_ref": [ "r333", "r334" ], "lang": { "en-US": { "role": { "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.", "label": "Foreign Currency Exchange Rate, Translation" } } }, "localname": "ForeignCurrencyExchangeRateTranslation1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r94", "r335" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign currencies translation and transaction" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee": { "auth_ref": [ "r74", "r75", "r88", "r391", "r409" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries or equity method investee.", "label": "Gain on deemed disposal of shares in Investee Company", "negatedLabel": "Gain on deemed disposal of shares in investee company" } } }, "localname": "GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r79" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "negatedLabel": "GENERAL AND ADMINISTRATIVE" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r77", "r98", "r142", "r144", "r147", "r150", "r152", "r171", "r325" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross profit", "totalLabel": "GROSS PROFIT (LOSS)" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "auth_ref": [ "r88", "r195" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.", "label": "Impairment of long-lived assets" } } }, "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r94", "r193", "r200" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment for long-lived assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r103", "r274" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Local" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r69", "r142", "r144", "r147", "r150", "r152", "r384", "r392", "r395", "r410" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Loss before income tax", "totalLabel": "INCOME (LOSS) BEFORE INCOME TAXES" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r103", "r274" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r70", "r88", "r140", "r169", "r390", "r406" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).", "label": "Loss from equity investment", "negatedLabel": "Loss from equity investment" } } }, "localname": "IncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r252", "r255", "r260", "r269", "r276", "r278", "r279", "r280" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationDescription": { "auth_ref": [ "r254" ], "lang": { "en-US": { "role": { "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.", "label": "Income tax examination, description" } } }, "localname": "IncomeTaxExaminationDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationLikelihoodOfUnfavorableSettlement": { "auth_ref": [ "r244", "r254" ], "lang": { "en-US": { "role": { "documentation": "Description of the likelihood that an uncertainty in income taxes will not be sustained as a result of the examination by the taxing authority.", "label": "Income tax examination, likelihood of unfavorable settlement" } } }, "localname": "IncomeTaxExaminationLikelihoodOfUnfavorableSettlement", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": { "auth_ref": [ "r253" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.", "label": "Penalties and interest incurred" } } }, "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r99", "r117", "r118", "r141", "r250", "r270", "r277", "r411" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedLabel": "(PROVISION FOR) BENEFIT OF INCOME TAXES" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r67", "r94", "r245", "r246", "r255", "r256", "r259", "r266", "r432" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r92" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r87" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": { "auth_ref": [ "r87" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Accounts payable \u2013 related party" } } }, "localname": "IncreaseDecreaseInAccountsPayableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r87" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivables" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivableRelatedParties": { "auth_ref": [ "r87" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount due to the reporting entity for good and services provided to the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management, an entity and its principal owners, management, member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Accounts Receivable, Related Parties", "negatedLabel": "Accounts receivables \u2013 related party" } } }, "localname": "IncreaseDecreaseInAccountsReceivableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r87" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Income taxes payable" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r87" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Increase (Decrease) in Contract with Customer, Liability", "verboseLabel": "Customer deposits" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDueFromRelatedPartiesCurrent": { "auth_ref": [ "r87" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate increase (decrease) during the reporting period in the amount due from the following types of related parties: a parent company and its subsidiaries; subsidiaries of a common parent; an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Increase (Decrease) in Due from Related Parties, Current", "negatedLabel": "Amount due from a related party" } } }, "localname": "IncreaseDecreaseInDueFromRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r87" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLiabilities": { "auth_ref": [ "r87" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities that result from activities that generate operating income.", "label": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r87" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid.", "label": "Other payables and accrued liabilities" } } }, "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r87" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepayments and deposits" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidTaxes": { "auth_ref": [ "r87" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Taxes", "negatedLabel": "Prepaid taxes" } } }, "localname": "IncreaseDecreaseInPrepaidTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r192" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "INTANGIBLE ASSETS, NET" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/IntangibleAssetsNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r94", "r188", "r366", "r367", "r368", "r370" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible Assets, Finite-Lived, Policy [Policy Text Block]", "verboseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r183", "r187" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r83", "r85", "r92" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r178" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "INVENTORIES" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r52" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r4", "r53" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r14", "r54", "r94", "r123", "r176", "r177", "r178" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory, Policy [Policy Text Block]", "verboseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentOwnedAtCost": { "auth_ref": [ "r427" ], "calculation": { "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": { "order": 1.0, "parentTag": "us-gaap_MarketableSecuritiesNoncurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Cost of the investment.", "label": "Cost of investment", "verboseLabel": "Investment amount" } } }, "localname": "InvestmentOwnedAtCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails", "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentOwnedBalanceShares": { "auth_ref": [ "r428", "r430" ], "lang": { "en-US": { "role": { "documentation": "Balance held at close of period in number of shares.", "label": "Investment in securities, shares", "verboseLabel": "Shares purchased during period" } } }, "localname": "InvestmentOwnedBalanceShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r197" ], "lang": { "en-US": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r343" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r346" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "SCHEDULE OF FUTURE MINIMUM OPERATING LEASE LIABILITIES" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r346" ], "calculation": { "http://agapeatp.com/role/ScheduleOfFutureMinimumOperatingLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfFutureMinimumOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour": { "auth_ref": [ "r346" ], "calculation": { "http://agapeatp.com/role/ScheduleOfFutureMinimumOperatingLeaseLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfFutureMinimumOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree": { "auth_ref": [ "r346" ], "calculation": { "http://agapeatp.com/role/ScheduleOfFutureMinimumOperatingLeaseLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfFutureMinimumOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo": { "auth_ref": [ "r346" ], "calculation": { "http://agapeatp.com/role/ScheduleOfFutureMinimumOperatingLeaseLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfFutureMinimumOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths": { "auth_ref": [ "r346" ], "calculation": { "http://agapeatp.com/role/ScheduleOfFutureMinimumOperatingLeaseLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.", "label": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfFutureMinimumOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r346" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfFutureMinimumOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r43", "r98", "r146", "r171", "r301", "r306", "r307", "r325" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r30", "r98", "r171", "r325", "r388", "r404" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r46", "r98", "r171", "r301", "r306", "r307", "r325" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Total current liabilities", "negatedLabel": "Current liabilities", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CURRENT LIABILITIES" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "OTHER LIABILITIES" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "auth_ref": [ "r167" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.", "label": "ACCOUNTS RECEIVABLE AND ACCOUNTS RECEIVABLE \u2013 RELATED PARTY" } } }, "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedParty" ], "xbrltype": "textBlockItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MarketableSecuritiesNoncurrent": { "auth_ref": [ "r38" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 }, "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in marketable security, classified as noncurrent.", "label": "Investment in marketable securities", "totalLabel": "Investment in marketable securities" } } }, "localname": "MarketableSecuritiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfInvestmentInMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r396" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Investment in marketable equity securities" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.", "label": "SCHEDULE OF INVESTMENT IN MARKETABLE SECURITIES" } } }, "localname": "MarketableSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInMarketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "auth_ref": [ "r73" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in marketable security.", "label": "Unrealized holding gain on marketable securities" } } }, "localname": "MarketableSecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r51", "r98", "r171", "r325", "r387", "r403" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "verboseLabel": "Non-controlling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Description of noncontrolling interest which might include background information, terms of the ownership arrangement, and type and terms of equity interest owned by the noncontrolling interest holders.", "label": "Noncontrolling interest, description" } } }, "localname": "MinorityInterestDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r84" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r84" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash provided by (used in) investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r84", "r86", "r89" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r63", "r65", "r71", "r89", "r98", "r110", "r112", "r113", "r114", "r115", "r117", "r118", "r119", "r142", "r144", "r147", "r150", "r152", "r171", "r325", "r393", "r407" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net income", "totalLabel": "NET INCOME (LOSS)", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails", "http://agapeatp.com/role/StatementsOfCashFlows", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent accounting pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "SUPPLEMENTAL NON-CASH FLOWS INFORMATION" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": { "auth_ref": [ "r217", "r288", "r303" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in noncontrolling interest from a business combination.", "label": "Non controlling interests" } } }, "localname": "NoncontrollingInterestIncreaseFromBusinessCombination", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r80" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "TOTAL OTHER INCOME (EXPENSES), NET" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "OTHER INCOME (EXPENSES)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "negatedTotalLabel": "TOTAL OPERATING EXPENSES" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r142", "r144", "r147", "r150", "r152" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "INCOME (LOSS) FROM OPERATIONS", "verboseLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r341" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating lease, rent expenses" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r340" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of lease liabilities", "verboseLabel": "Operating lease liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfFutureMinimumOperatingLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r340" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease liabilities - current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r340" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease liabilities \u2013 non-current" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r342", "r344" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating lease payments" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r339" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r88" ], "calculation": { "http://agapeatp.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Amortization of operating right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r345", "r347" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating lease, weighted average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r261" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Cumulative net operating loss" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherAccountsPayableAndAccruedLiabilities": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received classified as other, and expenses incurred but not yet paid, payable within one year or the operating cycle, if longer.", "label": "Other payables and accrued liabilities\u00a0($2,741 are included in the consolidated VIE that are without recourse to the credit of Agape ATP Corporation as of June 30, 2020)", "totalLabel": "Total other payables and accrued liabilities" } } }, "localname": "OtherAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfOtherPayablesAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssets": { "auth_ref": [ "r20", "r385", "r399" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets classified as other.", "label": "Other Assets", "totalLabel": "Total Other Assets" } } }, "localname": "OtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "OTHER ASSETS" } } }, "localname": "OtherAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r298", "r299", "r304" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r57" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "verboseLabel": "Foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "OTHER COMPREHENSIVE INCOME" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r250" ], "calculation": { "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of other current and other deferred income tax expense (benefit) attributable to continuing operations.", "label": "Other Income Tax Expense (Benefit), Continuing Operations", "totalLabel": "(Provision for) benefit of income taxes" } } }, "localname": "OtherIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfProvisionForIncomeTaxDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Liabilities Disclosure [Abstract]" } } }, "localname": "OtherLiabilitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r45" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "OTHER PAYABLES AND ACCRUED LIABILITIES" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/OtherPayablesAndAccruedLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r81" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other income (expenses), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of interest-bearing domestic time deposit liabilities to total deposit liabilities.", "label": "Percentage of Interest rate for time deposits" } } }, "localname": "PercentageOfInterestBearingDomesticDepositsToDepositsTimeDeposits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r21" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r21" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r21" ], "lang": { "en-US": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r21" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheetsParenthetical", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r21" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.0001 par value; 200,000,000 shares authorized; None issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r9", "r35", "r36" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepayments and deposits\u00a0(Included $8,399 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of June 30, 2020)", "totalLabel": "Total prepaid expenses and deposits", "verboseLabel": "Prepayments and Deposits" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails", "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r7", "r10", "r180", "r181" ], "calculation": { "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails": { "order": 1.0, "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfPrepaidExpensesAndDepositsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidTaxes": { "auth_ref": [ "r8", "r10", "r179", "r181" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid taxes (Included $3,113 in the consolidated VIE that can be used only to settle obligations of the consolidated VIE as of June 30, 2020)", "verboseLabel": "Prepaid taxes" } } }, "localname": "PrepaidTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PriorPeriodReclassificationAdjustmentDescription": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.", "label": "Reclassification" } } }, "localname": "PriorPeriodReclassificationAdjustmentDescription", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r41", "r199" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r201", "r433", "r434", "r435" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT, NET" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/PropertyAndEquipmentNet" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": { "auth_ref": [ "r94", "r194" ], "lang": { "en-US": { "role": { "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).", "label": "Estimated Useful Lives of Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r40", "r197" ], "calculation": { "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Subtotal" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r18", "r19", "r199", "r405" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_OtherAssets", "weight": 1.0 }, "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net", "totalLabel": "Total" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r39", "r94", "r199", "r433", "r434" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "verboseLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r18", "r199" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule of Property and Equipment. Net" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/PropertyAndEquipmentNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r18", "r197" ], "lang": { "en-US": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Estimated Useful Life of Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails" ], "xbrltype": "durationItemType" }, "us-gaap_PurchaseObligation": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.", "label": "Purchase Obligation", "totalLabel": "Total minimum purchase commitments required" } } }, "localname": "PurchaseObligation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligationDueAfterFifthYear": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails": { "order": 6.0, "parentTag": "us-gaap_PurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of purchase arrangement to be paid after fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "PurchaseObligationDueAfterFifthYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligationDueInFifthYear": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails": { "order": 5.0, "parentTag": "us-gaap_PurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of purchase arrangement to be paid in fifth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "PurchaseObligationDueInFifthYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligationDueInFourthYear": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails": { "order": 4.0, "parentTag": "us-gaap_PurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of purchase arrangement to be paid in fourth fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Purchase Obligation, to be Paid, Year Four", "verboseLabel": "2024" } } }, "localname": "PurchaseObligationDueInFourthYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligationDueInNextTwelveMonths": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails": { "order": 1.0, "parentTag": "us-gaap_PurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Purchase Obligation, to be Paid, Year One", "verboseLabel": "2021" } } }, "localname": "PurchaseObligationDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligationDueInSecondYear": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails": { "order": 2.0, "parentTag": "us-gaap_PurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Purchase Obligation, to be Paid, Year Two", "verboseLabel": "2022" } } }, "localname": "PurchaseObligationDueInSecondYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligationDueInThirdYear": { "auth_ref": [], "calculation": { "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails": { "order": 3.0, "parentTag": "us-gaap_PurchaseObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Purchase Obligation, to be Paid, Year Three", "verboseLabel": "2023" } } }, "localname": "PurchaseObligationDueInThirdYear", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfFutureMinimumPurchaseCommitmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r228", "r350", "r351" ], "lang": { "en-US": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r228", "r350", "r354", "r372", "r373", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r382", "r383" ], "lang": { "en-US": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r348", "r349", "r351", "r355", "r356" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY BALANCES AND TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/RelatedPartyBalancesAndTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r26", "r216", "r241", "r402", "r421", "r423" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r107", "r108", "r109", "r111", "r116", "r118", "r172", "r238", "r239", "r240", "r267", "r268", "r418", "r420" ], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r137", "r138", "r143", "r148", "r149", "r153", "r154", "r156", "r219", "r220", "r369" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "REVENUE", "verboseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerMember": { "auth_ref": [ "r130", "r156" ], "lang": { "en-US": { "role": { "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue from Contract with Customer Benchmark [Member]" } } }, "localname": "RevenueFromContractWithCustomerMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ConcentrationsOfRisksDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromRelatedParties": { "auth_ref": [ "r76", "r429" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.", "label": "REVENUE \u2013 RELATED PARTY" } } }, "localname": "RevenueFromRelatedParties", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r95", "r96" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r68", "r98", "r137", "r138", "r143", "r148", "r149", "r153", "r154", "r156", "r171", "r325", "r395" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Total revenues", "totalLabel": "TOTAL REVENUE" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails", "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SalesCommissionsAndFees": { "auth_ref": [ "r79" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).", "label": "Sales Commissions and Fees", "negatedLabel": "COMMISSION" } } }, "localname": "SalesCommissionsAndFees", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r50" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "Schedule of Accounts Receivables - Related Party" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/AccountsReceivableAndAccountsReceivableRelatedPartyTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r297" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r266" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "SCHEDULE OF PROVISION FOR INCOME TAX" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r225", "r226" ], "lang": { "en-US": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfInvestmentInNonMarketableSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r258" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "SCHEDULE OF DEFERRED TAX ASSETS" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r185", "r188", "r370" ], "lang": { "en-US": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfIntangibleAssetsNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r185", "r188" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Intangible Assets, Net" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/IntangibleAssetsNetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock": { "auth_ref": [ "r315" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the presentation of foreign exchange contracts on the statement of financial position, including the fair value amounts and location of such amounts.", "label": "SCHEDULE OF FOREIGN CURRENCIES TRANSLATION EXCHANGE RATES" } } }, "localname": "ScheduleOfForeignExchangeContractsStatementOfFinancialPositionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r103" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "SCHEDULE OF COMPONENTS OF INCOME/(LOSS) BEFORE INCOME TAX" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r14", "r32", "r33", "r34" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule of Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfDisaggregatedInformationOfRevenuesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r41", "r199" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r289" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Summary of Assets Acquired and Liabilities Assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r101", "r352", "r354" ], "lang": { "en-US": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of related party transactions. Examples of related party transactions include, but are not limited to, transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners and (d) affiliates.", "label": "SCHEDULE OF RELATED PARTIES RELATIONSHIPS" } } }, "localname": "ScheduleOfRelatedPartyTransactionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/RelatedPartyBalancesAndTransactionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r202", "r203", "r204" ], "lang": { "en-US": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the key aspects of a subsidiary (partnership, corporation, or other entity) of the limited liability company or limited partnership.", "label": "Schedule of Subsidiaries and Associates" } } }, "localname": "ScheduleOfSubsidiaryOfLimitedLiabilityCompanyOrLimitedPartnershipDescriptionTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/OrganizationAndBusinessBackgroundTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": { "auth_ref": [ "r308", "r309", "r310", "r311", "r312" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.", "label": "SCHEDULE OF VARIABLE INTEREST ENTITY" } } }, "localname": "ScheduleOfVariableInterestEntitiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/VariableInterestEntityVieTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingExpense": { "auth_ref": [ "r79" ], "calculation": { "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Expenses recognized in the period that are directly related to the selling and distribution of products or services.", "label": "Selling expenses", "negatedLabel": "SELLING" } } }, "localname": "SellingExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r234", "r236" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails", "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Purchased price per shares", "terseLabel": "shares issued price per share", "verboseLabel": "Share purchased price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, shares", "periodStartLabel": "Beginning balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r221" ], "lang": { "en-US": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping and Handling [Member]" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r106" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r48", "r107", "r108", "r109", "r111", "r116", "r118", "r124", "r172", "r211", "r216", "r238", "r239", "r240", "r267", "r268", "r327", "r328", "r329", "r330", "r331", "r332", "r418", "r419", "r420" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r107", "r108", "r109", "r124", "r369" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative", "http://agapeatp.com/role/IncomeTaxesDetailsNarrative", "http://agapeatp.com/role/InvestmentInMarketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/InvestmentInNon-marketableSecuritiesDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfComponentsOfIncomelossBeforeIncomeTaxDetails", "http://agapeatp.com/role/ScheduleOfDeferredTaxAssetsDetails", "http://agapeatp.com/role/ScheduleOfSubsidiariesAndAssociatesDetails", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r21", "r22", "r216" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd, shares", "terseLabel": "Issuance of common stock in acquisition, shares", "verboseLabel": "Stock issued during period acquisitions, shares" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative", "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r21", "r22", "r211", "r216" ], "lang": { "en-US": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Issuance of common stock shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r48", "r211", "r216" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Issuance of common stock in connection with acquisition of Agape Superior Living Sdn Bhd", "terseLabel": "Issuance of common stock in acquisition, value", "verboseLabel": "Stock issued during period, value, acquisitions" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r22", "r28", "r29", "r98", "r166", "r171", "r325" ], "calculation": { "http://agapeatp.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value", "totalLabel": "TOTAL STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets", "http://agapeatp.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r97", "r216", "r218" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r333", "r357" ], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r333", "r357" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r333", "r357" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/ScheduleOfRelatedPartiesRelationshipsDetails", "http://agapeatp.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "SUPPLEMENTAL CASH FLOWS INFORMATION" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TimeDeposits": { "auth_ref": [ "r389", "r397" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of time deposit liabilities, including certificates of deposit.", "label": "Time deposits" } } }, "localname": "TimeDeposits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/CashAndCashEquivalentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r160", "r161", "r162", "r163", "r165", "r168" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts receivable and accounts receivable \u2013 related party" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TradingActivitiesGainLossByTypeTable": { "auth_ref": [ "r318", "r319" ], "lang": { "en-US": { "role": { "documentation": "Schedule of gains and losses on trading activities (including both derivative and nonderivative instruments) recognized in the statement of financial performance by statement location, separately by major types of items (such as fixed income/interest rates, foreign exchange, equity, commodity, and credit).", "label": "Trading Activities, Gain and Losses, by Type, by Income Statement Location [Table]" } } }, "localname": "TradingActivitiesGainLossByTypeTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TradingActivityByTypeAxis": { "auth_ref": [ "r316" ], "lang": { "en-US": { "role": { "documentation": "Information by type of trading activity.", "label": "Trading Activity [Axis]" } } }, "localname": "TradingActivityByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TradingActivityByTypeDomain": { "auth_ref": [ "r316" ], "lang": { "en-US": { "role": { "documentation": "Gains and losses on trading activities (including both derivative and nonderivative instruments) recognized in the statement of financial performance, separately by major types of items (such as fixed income/interest rates, foreign exchange, equity, commodity, and credit)." } } }, "localname": "TradingActivityByTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradingActivityGainsAndLossesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Trading Activity, Gains and Losses, Net [Line Items]" } } }, "localname": "TradingActivityGainsAndLossesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r297" ], "lang": { "en-US": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/BusninessCombinationDetailsNarrative", "http://agapeatp.com/role/OrganizationAndBusinessBackgroundDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r125", "r126", "r127", "r128", "r133", "r134", "r135" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableIncomeInterestRateMember": { "auth_ref": [ "r317" ], "lang": { "en-US": { "role": { "documentation": "Trading in a derivative or nonderivative instrument that provides a fluctuating return in the form of periodic payments of interest typically based on movement of a benchmark rate (for example, US Federal Funds Rate, LIBOR), and eventual return of principal at maturity.", "label": "Variable Income Interest Rate [Member]" } } }, "localname": "VariableIncomeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfVariableInterestEntityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableInterestEntityDisclosureTextBlock": { "auth_ref": [ "r314" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for a variable interest entity (VIE), including but not limited to, judgments and assumptions in determining whether to consolidate and in identifying the primary beneficiary, gain (loss) recognized on the initial consolidation of the VIE, terms of arrangements, amounts and classification of the VIE's assets and liabilities, and the entity's maximum exposure to loss.", "label": "VARIABLE INTEREST ENTITY (\u201cVIE\u201d)" } } }, "localname": "VariableInterestEntityDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/VariableInterestEntityVie" ], "xbrltype": "textBlockItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index." } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfForeignCurrenciesTranslationExchangeRatesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/ScheduleOfEstimatedUsefulLivesOfPropertyAndEquipmentDetails", "http://agapeatp.com/role/ScheduleOfPropertyAndEquipment.NetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "verboseLabel": "Basic and diluted" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://agapeatp.com/role/StatementsOfOperationsAndComprehensiveIncomeLoss" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r106": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r136": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(19)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e4975-111524" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5212-111524" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5093-111524" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r167": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/subtopic&trid=2196772" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(11))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r178": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.A)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=27011391&loc=d3e105025-122735" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r192": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=68071081&loc=d3e1205-110223" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2611-110228" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r201": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "http://asc.fasb.org/topic&trid=2155823" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308" }, "r207": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r209": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r218": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r224": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "705", "URI": "http://asc.fasb.org/topic&trid=2122478" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "http://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=65877542&loc=d3e27249-109313" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31928-109318" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6405-128476" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(3)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479" }, "r296": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5728-111685" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6759159-111685" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5747-111685" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=SL6228884-111685" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r314": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624186-113959" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624186-113959" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "4F", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624186-113959" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "184", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5634876-113961" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521" }, "r335": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "http://asc.fasb.org/topic&trid=2175825" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r356": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "http://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.12)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.12)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(f))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(g))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(24))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120252992&loc=d3e62652-112803" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(10))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(20))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(b)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "210", "Subparagraph": "(c)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=99383244&loc=d3e12121-115841" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.1(c))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611197-123010" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 4))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r447": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r448": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r449": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r451": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r452": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r453": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r454": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r455": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r456": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r457": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r458": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r459": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r461": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r462": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r463": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r464": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r465": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.8)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(12))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(22))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1(e))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" } }, "version": "2.1" } ZIP 91 0001493152-20-015471-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-20-015471-xbrl.zip M4$L#!!0 ( #%F#5'7:(4$5!< 'G^ 1 86%T<"TR,#(P,#8S,"YX MMSVSB2_WQ7=?\#SU=UEZE:Q8],,I/7;LD2;;.BUXJR9[)?MF@2DE"A M2 U RO;\]=< 28DD2!"2G26SU'R8R$0WT-T_/!IH/#[][7'E:AM$*/:]SR?G MK\].-.39OH.]Q>>36[/3-7N&<:+][:__]9\:_/?IOSL=[0HCU_F@]7V[8WAS M_Z,VLE;H@W:-/$2LP">_[&>O#)-_K:]M6R,P,K".DVK[/'L_@_ M-?8AIO:6^?V[X9K^\CC%OR^0]VO8M[P'^IOUAX[N)^__?/N/7WOHVW+SV^7# MO?/MC\T3]>]^OUJ]>^I[Y[^,+[XZ?]>C(C]1>XE6E@9(>/3S24J[AS>O?;(X MO3@[.S_]?3@P.=U)1/CAT<7>MR+R\_?OWY_RU(14H'R\)VZ2]9M3EGQO4;3- M&5*QA!Y[-+ \.T/O!%N&-/';TR@Q0XH+2=]%I#@A=5".CB+[]<+?G$("T%^< M=<[..V_.$_*0=A:6M=ZRS"UZS[..$PI8* E$ZYU6!,-F6+PD[-\.LT3I[((*7+&WE_Y[S5!%/BX] /X$#/& M)"5,MN7:H;L?STZ40I;X0V*E@^QV:;FL29I+A (:V2_[26['"S >ZQG1UI"> M@SR0D/VBOHL=2'.T.$LMRE-[=>M9H8,AY:>CT2<6 ;V6*, @;0$"V70Y'&^> M"X?V*E-<.^'96I".Y^,U\TV@--KU'.:/$+0$B^(-,L#=6:&!3^-FLS>7',J? MU:#?>>CC&9&%Y^$\N%_1]ER'%'J+TTK*_+8@?>DX$3369'*9?F/\&4RK7 MIR%!\,=X>MT=&?_HSHSQ2.N.^MKEK6F,=-/4+KN]+]?3\>VHWTI S'"ULLC3 M>&[BA0VP<8!S-4G4*-MC)(&HT8KA^;7/#3F[7#8G7[5QE>::5R/ MC"NCUQW-M&ZO!Z#,C-&U-AD/C)ZAFZT$Z,XBV+IWP3,($*@5Z&#LX.D.HPB3 M\F0Y#._S,-QUIT;WN/AI3'B/54K[ZY@T?!/@/_>^WQEUW +6]G1U,W(/3*;(1 M6!3Z$K"P^'&*7.;:P/PO\7H/890C=9%'*AX$3&VJ]W1 B?5/#+BB[ZQS.C__ M")\&W9G>UR;=Z>QK*Q$UO VHXI/MP)W^($?@31X!8W0'+6,\;>OP.R%H;3UQ M5QYJ=Q^M?8J3WJ@D36[AG_,6GDSU2??KD/4_O&[W]_9L8=H2"Q=W&BW.!O18./)SKT#=S:K/>?,./_11OILU;:'%Q'RUM@UG]3 MB@*ZM7=1@MS6[\3N8]8=71N\WS9-?6:VVR#OK*W]>MK.(]_KK)00*:64 MHR+,>;.HC,:CSA&9[1)1L$1D8CTQ"]/(HR0A<@8PS<5N"A<%.CDJPA1X/+O1 MI^ W?F4PF(FC.;T%9W( G)I]: M_?*1.TNMG5.QZ-C,>MP-"[L/FLE"MA\9L-Y4%'-@"OCYJ[>J]6LCDD#"+6KCE0IC]JH=;M%=)&>U< M\*\,0LZXZZD8L8R)Y6@)\V>5N*7V*LJ[G2BIM98T5'MQR/$2IMO[M*XVHU8: MMDP#544DQT:8=.\3X6PW.D4!S30PDG0Y)L*4NS#LV6[C'Q!62V-S.+L4NC?" MM/S9L;EVPYR*R:7A$S_+81'F[:F 7;L-7!R=2]M:2B$WNS"G+XOBM1V#PHA= M%@09B1P%8>(O">VU&XB"4%ZVURE+E@,@K 4Q_O:;GMY2"_?_2O0RE$1YOP* M0< C1%4QOC*8*NCE4!4$S)4B@^V&JSKTEUF:4:660R7N*5<*%[8;*85P8!HJ M=7(Y5L+<7S&&V&ZP4B&M;&>7_RPWOC#)3\>[VFUA2:PE;?%J,BD"/PMS=6E@ MIMV0L-L/G-!%X[D9WE/L8(O-O=DP0:EO8^B.:!^&=NPFJ\?J]'*0Q(A[G#,[ M,I;.FY_5W.6NO8KS;R=>E8&6V#HCB[ @\@8IQF<$-CEZP@* 6J0F+D7;%M-. M$'>-2*>@.P"1T/"]:%"AIA?MG( =66%,P>S=Z_Q:\[_&5!JZY M,>2.Q*VI7]T.P-$#=YVE%*\\M+RM5J%4L.RP%\H2?CG(PKJ%&LAEJQM'D#E( M8%%KL2!HP8!BMQN1%9=V/)^B#?+"TI%4G5$.J[C9(05KWS"[U]=3_9I#:XRN MQM-AU%NS_4'ZG3ZZ9;[0$4L.R95/$%YXO9"0V/%D<[!(8OW1YK<.3"7.T=[\ M(P_U2#+=UJTNNV5[F>O;0O04B6T'#F) MT7/=IQ*E'"=AD:=DN]JQBXQ6MPMOYRA&1Y%6CH]X\*/L9H\C1D+/)^X)I)UT M_*VD]U-EDR,G+L"D>L"D""U5!HOA1:5HO)B6=X,[/%(;!DL0*Z"0@R,NHZ3 M2>5VQ&#K$:"UA1W]<NKJ20FTS'=X;)0IZ TA&D@AVP:(X(00Z8.UI!*=OP6D8G M!><7<>-'>G^K?J5/IS!\,4"BM9:6XY(ZN%;FZY<3R)$HN'8C?<;M."[%Q]T* M+G,LV0^@1"H'15@!*;D'\HB/N-T[#,!D0RAP%:[B9P*]Q0!9%%7/K?9CEF,H M7?NXNIW=@GODKD*^YU4[>U*>5&%H>GLJW"VM7TG??O;0M+JQH_%G^Y> MBX__SK\H_PD4]TF@><+3]*)2V*,!NXSD1*,P1JZL@6_SK"0L[*].PM=AGSKG M%YTWYZ\?J;.3=!\A=F;83XB$[P A>&X4V:\7_@9 Q:>L4G3.SB&+8BEH&1/[ MT=EQJPHPM^@]5R>DG85EK2L%2,HO9#Q%;D"3+\^4AK4>^D+B\+P.D"<#N!.0 M4Y;1J>=['2]<(8)MM:J2YAQ%C*RNO&=UY?S=,X4Y3)"#I,5A5.M&C$@UH.]>N#XZ\L[!D!6C$RL$5X3V%D"1GI-?'#]>>3*"\H M;273SEQ:!"5GFKL+@GAZ5J$*FMIU&)(;_^&+_ZVW]'UOD96])*UVF;=WY#RQ MR(7E/_)S5913-D[]"^ 9+/O90A?!IBN;)/P._MTJ#+$WM.C"I0N@=8:X_ MGL^QC;:;GK-Z*-#5KLL-LMR '0?[#;DN.[(W(;X3V@'-JE)-5KLFAN_A/Y$# M4[&AE>M&BY-JEWB\0@OKTD5>;@@N^%Z[K%_!$UNPL[$PS^ ]%QD>11\F$N+Y*RM0EF[/C."5Q,WS#5+X6OM<@[P&K*BW[)R"E]K ME_,2!=;0>GQ<9045/]XALF#=UQ##+\O=A>MRPZ8*8>W:F"'9X(U/3$BQ M\YYZ<5KM,M^A!;HB(0ZN,$B4E;DDK7:9ASCP667(S2?R7VN7\^;)D@TM=I5O[" ME.;(>_.E7R)O.J4A\G8WX&8M4(F-"U)KEQN,6-Q'%B74+FW&CB4UHR"U=KGY M$KH9\B+) &]@+FDZWN6R:*5=2E:[)M<$(6]-_)ZUQ@&;49!U5@<90>W2WWIL MMP79(*?(_*6IMD+ZN%*G'M M6IDHM]R5_E"[= 5=R"1X&@1.UQQ,!I7=31%M,W2"'UV*K3C@V(W_+(Y4R@AK MUV:*G'O_:8)MMJLSZFBB3UE=JLEJUT1>?X0PE#IY$S6KU*4YTAO0@P*7RU?^ MLF&/HI3:Y1U8]Z&56U_(?:M=QI'?"VG@K_*K.07?:Y<5FE(B5"XZ4)A2N[PZ MVRV-8/9<&'HO3:U=[COD.3X1^CGQU3@L\U7 M"H+M,+,G4T-U3[K*&+&RPNMA=L=V5XWGQ M?<#;7N/Y^304<'7-XFL]^6G5_>V2X_[WL(;0P1UHEZ)\?G@+5=]XL[^UE/)L M:F=D@"^'"?LV\"DUO.AZDMW L1U*JNGV\ 3^M3H6C7ML;6,U-CPHP**HCZ)_U7VD@S@;:X<)\6V$''I%_)5IL4.\X.\4ODON%SN, MA[(?;I'OVU-.8BQG?OP82HE;N+6 .OT/40F2.T;&<_@7>XN>3W<#I IA4X&= M;IMIYD*PISZZWRE81?1#0%BJ71514Z&+_ C^%&!4YY@"Z:E;]!LE"R\S/S>O M*^J1M@NDWRGSQE85@YU^M=PILOU%=!"6W9NR6 ;^/*3Q%<[LF:G<11R[\>]0 M]L9:9(^1R]@^0WGEDRYUMZ&U9V716,L8E(:L('[-&^3+[^G+*L!&/NER.HSMDX+*M$%U#=AZ&Y^)8,XFH05S(W&N62 MN:L4: 6>)F"=7LGF;TX_%7=*I22-44+H-F7J*! W0;'"(;U$+T7:)JA5TC9* M%%.F;H)JN:!BF4[59$U0QEQB=N_3 MK)C>4Y;O(NO:B/$F435.+77"%^H1_! M]YQ_ MYN>9M2HVZ":BPBSP3U76;^)/Q4WJB4B)N@6/:=@A*%JHB:H,CN2E = M,E@Q>6\IFH?N (/C4/PLXHQ)+;:WE\CI1S!)P2-JAUE$):-F&:3\6=,J"^S! MV025RUSE0BU5B9N@V#X/YE1A>D .S3)!Q2W(E0;8F[\)ZH] B?$\(+CHV-6%VLB-(;(&=70_$S[#M M@M(2BMK%AWQLO+;*1 +$QL;9& 12,J'"\&%#YQ5"NTU;DO2FQOU!9,AH MPHY4@%.[:V %W_-QI8./N8:O M0-?4IGX94LRN_H/Z?X^CFV'C#0Q_(L=@UY/@.=_,&N]?B+9R.6P?P\[OA+1P M!1U"I&U$F>KPLA/SQ&BUE-S07R&X%M(C*'(?JB'SO/ZOHK_AMC^593,RTF_^A"R \YY=8L=G.M++;./G"$KLA M?"?\=B5G+Y::9V_BZD6T[IS[6.S@'\K<4+\Q-:U(#O70/J916-@GJ9,2E70- MU7 ;(O+-<+UV<>IFIZ*4AFHA/X.7/'H"P[3:H;TL0U.G\>FE5'T^1W8P]J2; M#G?-]##6AH*OL/^.3U_VV*^7T#=4X^A\Q1['>O9A:&IU5Y ^-951IFXHQ'&@ M%YRFE<^8\Y-627I3 7:E/ M$5G=BF3WCS"WE$WY^3)?;NU;B;*A#2M>MQ..?>YP*DUO['P^V00,4^]H519\ M-X)LG GC5Q$U%*_=6^@P)/#I^;2>22&E_?V)G=R#G&F^V]+LQC%NN8C+3F MZ?QT6'Q1>,'WVN]FVVW[DHS^53O&]F%MPF:Q\L$TO]=$B;+QS:J\/]ZG[SZ\ MPUXP=KX;X0748FL&21A56/A.G=ZMH*K?9?]T&KUC"S__'U!+ P04 " Q M9@U1PG^7(QX< !M@ $ %0 &%A=' M,C R,# V,S!?8V%L+GAM;.U=ZW/; M.)+_?E7W/_"\55N9JG4<)Y-D)IGF]J=26RBT=V_!OJ!UR__?%H[Q@/R ^RY7T[.7[\Y,9!K M>POLKKZ[/^8'!B!*'E+BS'<]&7$]<[^>=__ON_&?#/+_]Q>FI<8>0L M/AF7GGTZ<)?>9V-DK=$GXQJYR+="S_]L?+./+U)_TF:_^)@]_LG\J\[*T &*,L-/CT%^,M)KM?'=Z\]?W7V]LV; M\[/?;H8S^QZMK5/L$J79Z"1K1:C0VIW__///9_%OLT]+7S[=^4[6Q[NSC)TM M9?@MYGR?XR3 GX*8O:%G6V&,>64W!O,+\K?3[+-3\J/3\[>G[\Y?/P6+DTSY ML09]ST%3M#3(?P&[;:_6RMH@*]P 7NLS\LNSO@?6")S&S>Y]M/QR8L$'0!WH M?WCWAM#^6^&C\'D#5AE@8E0GQEG-?B\LA^AH=H]0&%3U3_VX!3XFEH_<\!Z% MV+8<*::H+9OAD P9M ;JP7@YWI Q#G84]-P%&=<^ND=N@!_0 &:1-1IZ0:4R MZ])K7IK^O>6N4#!P9Z%G?[_WG 7,3^:_(AP^RP@A0*8%WJW@_LKQ'J7476K4 M#%]C?V6Y^,\82,#Q(@JPBX+@PK*_KWPO.&/=N&CD+P@Q//P39&U8J5HM(,Y]\L'UMW#HR.$/DH"$WH*WS^AE$5LY4- M&YK-HL"-H8.Q?(?=&-#*>8S3IAFNB-F3^07^0X;E@^60X5#I=+BMFN$LM9=@ MBFP$/0! T&/YAU/DP"!>P"1?/3,=0+(9F0;N RC*\P6&$.739GB8^&AC/<>S M'DA_B39>@*L1Y[=JBC,/?%[X#!T0J]J0WD8HK&:-VZPIY"!N7&%B,D$ 084 M7YPFS5E3$!)Q!^Z-Y7]'(;'>&;(C'X>")B;2OGEN1YY[NCZ0XRH:#?EO"!S] MB?5,^@B2V<*/T&(('@,[0CR+4VB&X_SLE<;!I-NY;[F!9<+=,,T"QLLI#KY7NV9>HZ;X6J]QF/D"Z) $ M=<@5"0P%FG89QS8;S[83UU8F /-X9CDXCRB2Z1(%,0'JT&HYLQ!C7+!Y>UF& M&)O5+97%]6("'$RX\1A?C&]F@S;C?3'61-JV&ON+LBG0N+4\0!3EBH;=Y 3B M)BE.I;O\0)Y[,4I=Y0J"KEJ23F=Y@QC[TH0:C]A%S831H/4H68P_80(-Q6KV M/5I$#H( *[H+\ );Q",1\PL"S\8 :7 )HP@[U9&:-*6.(N6TUY'ED_3HH;(R M7)M@TXB808C79%#=!F@9.4/H"E([FMN3AJ@VZ6YDI+C-AD2LIMRTA)^G4Q.9YIV8"?/)CI?_ MIK7FCKJ4N\Q<92>4PZ@VC1T],94&2HA,RYFX+!#2A!JVJF3*Z=DPM_IH ;-L M+KB#WT5KM!#%H3[)INT)G,85F8!HE01IJY(@UE[E1-:L9&BTN7XKR[<7$%'FG5VV^9'*]I8>&$^;9 ;H'Q]I\98%235PHQ3 M"E-?UPD1!0FU6NN2';229)JW\L,C\ZYB<'8_PMJ6(-'&?,*KQM6:9"0(=E.9 ME >D'KTVT1EYS0,D1K.[&NPA.,G2;!JKZLJJ-%32))N6*1?80&?QWTB)]1YO MY(41I]76O@_IC%J80M-Z)UNR/3?9/)R4DATO""[0TO/1MK0LC4 =JBU$50^8 M'$:!!*R^)")4&J^PH27R(?N%GA(O+5]0JZ#0^%J%_'1:V;3%W4?2B:4,D<9K MDU$8^>@&NW@=K=/C%.YJB*P '3+CUR+;JFR3R+?OH?O=BM%A0E72:WV%3-[. MI$GQ9+ MQXX2YS>$OQ=:H*<0N0NT/7=!1!$]Q!7BD'RVAF)@EH \I_8+\*? P"RPXY:^?M'6I+.8X/U"VMX"X^51<%IRO+VIP1F,^0$P;93V+@ M3]^;QN>#Y'3EY/SK!_+MPMF5#[IF'YQ%I#",R%S"LBOL_9+ MWUOS])WJUJLC2AX7X.+$>$1X=1_&W"O$L5QM'*&PV@ZYK<10>ZL4-1&YCP"L M8LY3 S<& 3$(WVD&(5<;VJ%Y&:$KD%L20GXK,=Q^5(J;B-S:@94M;3SG#D*5 MP2E^)0;&>Z5@T.323OGI$DWAE$I9^<6OQ)3_0:GR:7+IJOQT?0PBG;AH*!BP M"C46@^JC#E"):*%!!"GG!'KSR1_TG>VTD[\Y1$A+D89B:/RD!@U1(30=2SFC M88^9PD=*!WZR1#MQR$8O^OEDVHCGM5*=T%$ * WT:JFULRO*^J[Y9#L1N?[I MVO,6C]AQ>%&+2&O565TU=#):T ["8BUV2E@:+V^#1!3.9,%OICJ/JP9-2&[M MT*(M:H\\UZZ*AZK:J<[?JO$2D[S]&$A@EP$7$$)$DH;J?(X#3@UI-!U9V1KF M> G_A6FA[P6\8(GQN>KLKWH<<>74%I7M F[I5A@V-+0VJE,^<7S8$FL'4E5B MPL,K+B&8F&Z&4QNQ;^RDD/[5H.ED'3SVMRW%DAX^8/: M2/6H8(/!6/?@B-Y^^-6/@A#F13\MO_#C+-;'J@=PMIXK!T=5 M.]6II/#X$%. ?KC%#J,XMKDWKK$JAT(D5">:XFC*JD4[8"\C-/?D5WF9;52G MH<+050NN'59"PZS&0.HD;&# P,%+-_4SIFZ1RII 4XW"#3G7=01E&_:5EF6H M:-^J7>!.4OV8KXJ-B]2/5<\!G/M$2ZO8+%&ULRBR*]IS13 I?ZEZI L#PA)2 M.S1ZBP4F>NC%>%7GYH\1A9[3>J"A+_*";QKC/#6QJ[[@S+71B% M#HVD1^,5Z?,'3;J'8CXL#1A=4.GFL?YJ^) M[RUYN4;A(]5CA\(Q'05]E4YV#HV79(-K'(P@_P';*)A!F,$KF;#;J!X5U9!4 M2TP!Z523TG9VT9Q *7OWJ=ZI'-E/A^T$Y53[M1OG,H5X5L1LH'I\"P/#EU@[A)*'LAVR.+U88Q<'87)G1^7(J6RHNF0J MBIB@!K1#;N2Y7B9BDHE58L9IHGH/20UIJMJIGLLK1:)M&JENI)L=[NH.).9/ M*D0W*+SW%KN]_9P97["YZOE?%DPIK6B'*>T8QJWK(\O!?Z+%M87=?)U)[,00 MK;UJ'R&+JIQ>M(,U8W#LDC!EO(Q+NP-W^V;,\]@O6RKB!0%U":I>EI,%_D#- M=7"R;+VQL$]F%<+FP$VXV5S50OL0DC)2:.IB.SZ"Z2V_0BD'A7 M?]^[D!0%YA,$JJ!^[(+Y#4"%\4$Y4BOUXMPP>VA#U/4VW*D.58ORD@BG;I'_ M6'7HV($YL#;Q49:1M%S-[%Y%QQ>:CU H,@3V/E-M_%2NN>%U.^CKAN96EM3L M+I"+N&L6S :JQZXXPDQI]:N54Q;CL^T\\+=DM7+B^;&2P]#'=U&<2,P]6;?= M>$>J!WQ+FMN?OJE&I]L@9^T.*[[-]YQ[VC5[Z#4%;/&_41+K9BJD:B[9NU)1 M6^N.#=434C<6J 1;G39IY3/G)"%'X^PO*^Q?>E]G_U+:BX%=(]_/WZV- M%WPVDNX*.Y>ZV<5%[EV^+4F@R-_P^TY<,P28".TJ5>(IAPR2/8F#P-N7%0.K/VUF3V M3-Z:9F,FUEJU SL82ADE:8?PSC&"*Q6#E=-$^:+$H5A6JD,[ +GWZ>4EJ%X4 MEJ:D?"GB4+CK*D\[*]!I);G%!8U#\3YT:;EVG82Q]"2V*'I. 8XT%VZM^G:\ M^KA)B:EK>>O8UH[;NX;OX '<_&)RTT-:\6IR>_>T'S:(#UA>5CQZ2Q=#BJXA M5#840_1G#1$5E5#?:,DG =\E2OX[<,MO"W&#)8'6@A6*-_JB*Z,E_8:M"/>B M1\KJT!+$7^,257T-'H,UU'N-2Y:.H!5H7-VJI[ECL(#L*2S)H5]H)HBOQA4O M(;T< YQBCX95M1,$5..:EIAFC@C1RL)E=4M!5/6N7 EIIXL,=X^5VJ^3U2$D MB*2NM:SZNCN& ;MW;6^=@'K;5!!HC6M5POHYHOPXY?SPQ(E!2!!U':M<=44^ M&AN@72:SO;)6Q@8J" G:@,9UL9JZ.P(;2*]AS^T-KS?7LX@(;@8YMJH97V=' M@'L#CQ4<1%30+HZJFG;\+QU09-INJ*AI$M3V@N@?516-IRGM@&;(GRS?';8? ME4I#Y5D4X+%G_RO"/EJ0,F?\YP#SM\1Q&VFZ5Y4#WO[U6]4J:?^4-K!O([2( M-^XD:_\CSUU3MH84GB!A/XQ>DYJFNU4%P#Q([,Y03HLAE7/&+(?X5=R[4/\RA4&FU-1:+/U^Z/OH/>L>W<5W!@84TO7;UW MR\!HNJVKCI?YJ>P2W3'QJ6BCZ=0OB(V00CI8/KQTL<;+S ]_8<^V.O"F^M"9 M%G:N Q BXZ?;2Q+&_LIRTQ-[P/A%%& 7!<&%97]?@3#N[KKXPIT!'XU3@PCI M>$'D(_C+>'K=&PW^ISOU?KZ?CV]%EF]<=$$/T MG\?+&5ZY>(EMRPW3=8+X,@T'V_D)K"#+3_NRS&YO;GK3WXWQE3$;7(\&5X-^ M;S0W>OT^2#$?C*Z-R7@XZ _,68L2?;-\3"H3V2T?)D@2/G_#B"[$S_M"?.M- M![V+H6D,1G-S:L[FA@F\SW\W7OW];S^]??OF\[>!&?_I_'.;]U" 0;FQ1?6] M]1VXE$(%-"_!^9M]"<""1HD)]<\M2DW;:UN0YMV^-(/1-T!B/&UWP-+WI=%9_'&? MQ,/G]4+:!>6]T/8@->38SY[/V68"WR6_2FQW-B>ZA3\:X)9^->?QL)N9_=OI8-ZN3>>%&$&41UOWH M2/.YN/^KU_'PTMS.HM]T,?/\434LO/9[DBBLUERI8,11"^F,>_]UJI)]#TP M C=,,XWQZ>#V:_MXS#SEDV@_;*I' >SZ%T MZ4JN5R0U-%XE)%N]$D\(.IYH)>\L US[ C)31IY,)4^-Q7/+TK!RN&_:I MR1R/_U(8P$GINC&44F['8[\4$= SO*Y,G)?J\<0HQ0(""5_7,K$R/YY%DM 2!1ZYN1<$E3 C884A4SM=3@N3V MZ#Q)PW(7QHZH\2HEJS3!27D867[R/"==QE((();JI,2-+?5N<#2#$*_)_' ; MH&7D#*'C8+RD10Y<8$MQPZS_U;R\A5D N/3]9P"<[')-'W+FB METL7.=$O![/>]?74O([%'XRNQM.;9"B0DI()\?PMF;LZE;?XV@&9A7;%!3!.2?P-"F&DZ/\?><9C(;O[6_PJXF\84U-*1^$*5#K$Y[J": MAZ*9CEX(X2)#^D^8O1?@ MJF%T6UO'Q558>MU8\B5[OUJ+72K<(=BH5,D^$D9:U2>E7]=[JU@UT;Q-? M-SAJM\&U-37OJM JIH1"[ZIWMA^U*5=@VO[AL2ZDJ;Q"B7"B@A'5YP@Z,UU5 M"OX+3,O9.AGG6JB6NE-].N"8)]X2:D<\TU;"NR_TE'M](>K,5L:Q^S7.M,O<\9YR:,_-2JAVZ';[O?%JE3X&9:.V7A)TS#;D-N?DJNA_HO- M(5DDE>[Z5&7P)39>DE_4Q. 94/_%##[.?%69>=KY2\K^-#'N JPOVJ0[#P!K MO"=R'(&(:IO]2YAK[FJFEM>>T$M;#4&L*RQ;3-I??)&B&ZV*C?)39==][L[( M3'SOBAS^HEVOP3U;P3W8"52-F*RQI6OD"'=R8(8C$?^LS/O2>4[&U2&='HJA M7TLI)E#YJB?6-97*SFJ5[T,)3HMW^G-LL7P2,V>+&64C1YH<:D^(&S'U T_Y M,+;HR5_\PM[/7).6PBBBS-RU[\%H3.(@=E!0U4Z9CS\ !JK#$5.0=M%AE;0U M &804!9WM(\T5V7Z0>XXWB.Y1@1\^J47W87+R"G+5 V\'!EE99+&X:^C/DWC MQ=P]7ER77+XA(.>2@N#$T?\<75YKRP?]"L!O3-#*B\5'BC*P6YX=Y MVV$K1ZU08X634Y$_27'41Q4R6J;.+ESYNW@N;AM59V]C!C!40A_?14"#_6)< M53/558<:B(@)UA4RV]L+O5FTV3B8NNY!OJ1]J'J-HJ;VV3+K]-I*H?Q2NG;I M=<7%0^_+=[$42R\QQ=@+[6@:0%037\38<5=175;R4KSWI7NFBGE?1BR]?ND?VKBE M*^R"Y9.; $N');B.J:J=TH=F-SBT'+)\U??6FRA$_LQ;AH^6CRJ<4W5+U>Y) M#*Z]J4A4(=JY*(ZTN>DU/XW6,E@F+=5NIQ;:]96FE8MA3\!\]_*A=/E=Q<6C MW7L6_G7I/#?SH;SZG+NG4>CN= U\#DWJW=D&]A"N:J=PIMJ!.GYT872%?2_@ M2,+X7+5W$0-F;[[ABMY^M8?&\ZWKH\3???4<\D#MD.[V"0&)]JK=@1P\DL() MN8 F "N_6#QVN7,B%*GT^&J?2Q'#E_*NC>##*8HPKGY-A0LQ]T9YT:=5-(CIDF6*XMDR M[B.CY:!(@H3:LBEA9^)[2Q0$8$J6[4!X8NE::DG8]AZ!ATY\:5]PD.*UD9UF-?4<&+K0T<( M]Z3-E"#L B1(J+ZVM0& Y;2E4RR_"W^*&P'COP']X!YO^'$/]TF9_,-K),") M_TZ>6OLZF'3TA$SI66ZQ\+6\18'Y3+>RB)6L 7@N.45!,A3RKAQP&UR@I>>C M[3MS7/"XK\7TQS>3\2@^5!%G*>0!NK-7P_%L]H-Q89+7@G*OTG6^#=)[P"0X MN?)\,5'+ZWHY42?3\;?!C)R) ;'H4BF.R+="I@' !7+1$H?)PWP1=E?C#4H? M3:\(S*4HJ5S]2[SD+(1IB9Q1@YZ<$M><)4"QYEI$ZS7 W5\9E%&6=@%'RGWZ MQID\R.R&6L3^C<%;I2#M@,VN["C8)4,=;)3EJ&B1,!P.>1W5:8M_:KBUD:]J MKT4.T1SF8NK2,X\H76W)B\H^EA^XR[_#:5Z9TRFD#R022U;\.RJ";]]H%DH6 M/I86\XNO-7=[S-IS;7 5J:%!7H>#[X)BE)9D^N-1'^+_:9*SQ0G=8/:KNA+] M510"8S?8Q>MHG8XF=S5$5H $R_0?N2LQ5[?S6\AJ;@:CPJ'R(88(BNA^>)]1R_WGW)NQ1-G()")R+*Y CL:NHYT/]J_HB35^3(LY,J+.)WT_Y7$GI".G$S2#;/Z!!Y9B*/[QR\JMBO M3_M6Y7G'$CNQ^9$81RQJ%":@.CID@[1_[E%.)=K-V S^9\CVW 694*3!S#=5 M'<$="F-9#<<"X/P>^_7PR[54'6 ="E])"<>"'O'BX7TM^/)-50= A^)75L/1 M (B7=?';M53]!.[!\.TKX3C0ZRU#Y-<%<+^QZE==#\.0K@J=\HI=XD#VG2?K M12ODVJ)[[3^6]I[OTH5DLWE_/")U;'/4Y^ZP3\4F_[H#-<)/_@]02P,$% M @ ,68-433*JF$8,P 6P4# !4 !A871P+3(P,C P-C,P7V1E9BYX;6SM M?6MSVSC2[O=3=?X#3[9J:[9J/8ESS\S.>8N6Z805W5:2/9OS1463D,0-16AX M<:SY]0<@)9L4B1M%$J!&6UN[C@V W?TT@$9WH_&O_WE<>]H#"$(7^K^]N/SY MU0L-^#9T7'_YVXO;Z84^[9GF"RV,+-^Q/.B#WU[X\,7__-___;\T])]__9^+ M"^W&!9[SBW8-[0O37\!?M:&U!K]HGX$/ BN"P:_:G>7%^#?PQO5 H/7@>N.! M"* _I!_^17OW\UM+N[C@&/8.^ X,;B?FT["K*-K\\O+ECQ\_?O;A@_4#!M_# MGVW(-]PTLJ(X?!KKU>.KW7_2[O_R7/_[+_A_[JT0:$A8?OC+8^C^]B+SU1]O M?H;!\N7K5Z\N7_YGT)_:*["V+EP?"\T&+_:]\"AE_2X_??KT,OGKOFFAY>-] MX.V_\>;EGIRGD=%?G>BI0[;QNY?I'[--7KGYO>RO*7(#3]:03M[ROH.6@I M,_Z(W6@KP@3', W0;H6K&P_^$!)WH5,]=(V"I>6[?R9 (AROXM#U01A>6?;W M90!CWV'1R#U 37*,UVLKV(X64W?INPLT9?Q(MVWTH0AMF6/HN;8+V((5&J4> MRN^LP+7N/30[(A" ,#+0MZ+MG0M8Q#([UK2:Q:&?0(?F\KWK)X RUS%*GWJH MPFJ/UQ?T?WA:/E@>G@[,38?:JQ[*=OH23H -T!<00.B+Q5].@(?;* M=,20]?!D^@](4##@F$(E3>NA81R C;5-5CW$_378P-!E(T[O51=E$.UYT19] M &O5!G]M""(V:=1N=2&'[,:EBU4F#)%1P4$7I4M]VA1&F%W3'UC!=Q!A[9T" M.P[/K73^T0^A?K(REFC5'3_HT,QV!L;?$WPG2U"&+@]-&.X7I<-/./ M4 _%V=5K9P?CS\X"RP\M.S$H620+#%&7]29N9#9K3Z8V]LQZY%'*0M.:]F:( M!.]'NU/ :#%QP^_LK9G6J2ZZUFLWVN\%Z(/8J ,^CV'(T;5-.[9>>[89NY9Y M )@E*\O1YXC\,&VBP,= E;$:/EGP$<[9O;E3!A^9[)[2['H^!HX>N'8;GX]N M8H0 96?!^ZCFOA'0FK M7QA"VT60AM=H%KD>VU(3'JDE2WGWU:$5X./1 ],S7'G NA$QPLA=XTEU&X)% M[/71I]#1KFS;$X:H\M#M\%BR;=;$(GODNCF\=D-KN0S $M."@_3!.E$M=$@' MR 2,*TPPX2'KYND&!@"=QWIQ$.R6)KS,>PD1QJ.=A/\FE=:.JB.W>7(575". M&[5N[,H/IL) <0W3\$E<% CA@6K6JG3)T6VTM@; 0:MLQKA#?XO7P.'%H?J0 M=>L3VC1N\ )4YDD0UBJ!P9KSG(BJE<@83<9O1>D6&Z5NO2GZ:,*+["%"6'<$ M!ZR;GXQ#1YATT+QQE189@0';\4R* U)MO";1&<+Z M >(;LST?[#$XB8Y9-U9LSZHP5,)#ULU3QK!!'TO^A5VL*W4 MVCUL8 $"=/I%7TIW:7&'&F.$VF,5XLLILVN#V4?"!TN106KW3<91'("!Z[OK M>+V[3N$O^\ *P3$K?J5A&^5M' ?V"GW^.6)T'%/,\1J/D(GKF?!0-!ZLP-ZS M4=8X2POA1MC^8AJ^"O8N(7&%A@CL^!Y<..X:7^3!J?R[#V7E]#2*ZT[= 6(4)AV: MI\N'D2Y*VKY/JSH)%E;L1965(^ [X.G:%1Z0 M]PYGY$:X\>X&[J5V@:_KQGC50C_N6C9%2/D]S1Q!KQ$53U?B$HK0^'X('/Q3 M"#W7P8<#;3>2E@ZE_73K6['CHK_\HR7JRR]TYEAYUG_ W_]$.RJ(W1W,2>%=% KNO:*ZO9;_S M=VL#PU^U]',YWG><[WGWH)UCV,-WR6%0NJPER]'""N^3-2D.+Y:6M7F)S9B7 MP(O"_6\2P^;BU>7N\OC?=K^>/Q&.I Q,]..3)GC6/?"2;\]WC*S!%,Y^%"E7@D(G?EE"0]U ;0W>8]="X]%,&&2!.(;N2!B?P),38_![BQ( K#0=%X[=OE# M*0$7^BR!;)K57.QTQTGD9GECRW5,OV=MW,CR6*A0NS4PO6J'B,T $2^Y@$VP MO\T'CF$%ONLO0Q92Y>WG9:NX8A!1*"?N39(GDVW'ZSB)\25QRY(C)G-B\0XQ M+UO"%4-0C!GB7B475/(!NI09DDJ(=NKH@(89WB&$%YR(08(:'Y5D4TT]7@*#B+0W053P(G)$#?2064 M9.K@525_ZVJ;N;2[O\*;YH3ISG_C-*L/+4JCQ45Y4&V2;IU?M, M;.;E@4 0N=_;B-L4ZFCFHC3O*T5IT)A:,F@[<2C^FILYWC[@@*X;8H=^' #T MC]'DLSXT_Y\^,T=#31]>:U>W4W-H3*?:E=[[^GDRNAU>-QA-$RO"F6/EXR$K MT]O!0)]\TT8WVM3\/#1OS)X^G&EZKX>8F)G#S]IXU#=[IC%MCB%VH;C3)Z9^U3__^WCZ]>O?KTSC>2GRU^;#&73:GIF M&;A\=<@ 4I]AJC^]T>#*'":*U6#N KW*9X[6RT-:>_KT2Z+SR0_&OV_-.[V/ MY-V@?AQ3WC/'S.M#9G9J/M4F1L] C& EPKR5_1YKT.7EK^A7?7UF7&MC?3+[ MUAS3975"<\R\.63&'-XA'$:31N.4C^%H>-$R+P(527.<%#;4T>R+,4$+W#=,^G2_(DYNT:K71SNMV6^8$9$Z MI5E.7A=VUMQBC:RSOC[L[3B:3?3A5._AK;9!5CBSG%X7]MGI;-3[^F74OS8F MTV3K^?!KL@0UN^?8A8JG.2H+&Z@Y1!:+H+ );X_SQ%EK-L538 MGD5.B2TPQ5&6-<=/89,N/32V0/CQY5BS?+TI;-E'G\E:D &YM&N.M\*FGCFB MM4 E5Y77',&%_9UT8FN%>I[BKSGR"YL_Y0#7BI:P2L/FJ"_8 >7GN9;46Z!, M;(Z+@@7 <;QKF27.VK$YMDH.VURGO198$RXKFV.LZ-SF.ORUP)=XO=D<8P4# M@/,LV(HRVH0*M3D."EM^]K35 IF4DPR%[+>%'9UZGFG#/A:O6YMCJ'@VWPV( M8UC9(9/;5L^#:C_MAJWQ>E$81)F ,/K783 8_6K^%'S;!^V>PVX]:Y/,G#[E MLA$:0FP$%2ZW=.X*DK"4"7D+REQ,XE7-IVAP)-TWXI$P'8QV[QFUC(>2-XSJPJR9FT4E+\[HL_'\:6-/.8]\\F6%4I*?.K1^N>1X<>=I)RY)3IYTD\[>-RQPU%]3T3)?6TR1KD/L!]23)OZ]9\D-KCKI#0=]?XKB+5>\/=7WDGL1 G MLMS&1[@PN^N]NX'M-LACXP6NC(!O:7R0I!+SA):*[H1D\GNFXO0TUE MHI[)Q.DO0S2-GW^3S:MB%HL2'4A.44HZ./ XEMJQ'CJ#L9)V1_-ZT&Y(&EV//)QE]!4 MT2V03' K3M]JPO_=C5;9!]!F,+U.1#MM"0_2_I&8#@0%,#YY*'%(EH&EDMM: M"T%]2M[&RIJUO7T=,'\C!"G'+DGMH:#54]N[$0V7O M&DC'Z& UP&["+,8?AQ^LU5IN3Y=@C#!RU]CO=!N"1>SU7:2PY2^E4V_%%"Y; M3GM?C.O;OH$OC1O3F3E(;EO=3HV;V[[6-^^,I/I"^97,)J[*"$^!O0C&'KY MGY%#03&*NL_35^;LSC[?6DXH*W[*/8+\R*H )N4375!:4J*M]:GWU18[2.C. M6:[.\LZIHH!!<>9:"=[6!RHFG/5=G.:Y;$4@XP2Q*1#GG;=-H*GF:;0/Q M5L^U.$871R! I(P6"]<&3P11S[BL;I+>'Q*93U",&S67U)LX0")%-BTB_<9] MQ#\Q@R7D/K(>O*D &Q\OB@:;DW?:<:$]<[T)X$-ZLF/!1NG4^KVFHW%C,4," MKO)%IWJ NP,KU_;84RS?KG47PM'PE-!/0N1=^T&J21)((P:F,G_NG)&?)Y^X M?,D1.5'K]U1+RJ H%1HL)TVA$)&(3)4TAOGEWN(SFURB'R"YK>,U3?BY)A*R M'LNT%I*I4V>I&%B/3-EFF\@(C3&$6R!/T7 7<6_9>\L7%"!6225.:FRK4(J3+[9%*MBI0&PK"4\& M !WHD<0!%HMS*)2"EI0]$BLRBA+Q+@JIW!$O]AC*Q+RJX$R,?O'*KAOQ+PHW M5]N!]5\8]#PK)%U&W#O'1 91X*C,#2&LSJ:B;EPR"\\,X'HIK+B*\$!R(F95 M(.,&G28QY:)HLI!7TJ$@2SM:=$\(*\@^-C6%B^B'%8 #?EB>:*[NDJ)U5>

.AD9BV7 5CB !^S"CG77RC*'.XNS:G^N?/$^-SCR2"M]H)?CC+NC.$MKEFNP(D. M'=J=V(XR_','!M M2I2QO*4"IRB6["&#A5:V21$P\+W+'874.B.4YNT')*FR+4! 9E&)2&5=0"AY MZ*@!K%8S]DSHNW_BJR'>P*)?1"MI*2&0R59QR"2Y[C6)(-K1&MEI5QZR]*AR M/6PFHZRTD%1+"2;)M.Y:TM]@["]OT%X4>Q95K,6&,JI1"@F60#))M!_KUM>D MR+'[FM&8!>YZ[,7D MY$#<*M]H?BFA,KJ0E,OH)4JT[F+H?7>#" N_4R6:;S1'8Z@MT3)ZR;9>S1*] M I$UL!X?R>DYN-E!J_EKU3>X4H*)0JU[AS-\$"RQV3) !^3 \IZ? *<_F<#L M-W^M^@;(R0(1BKIWQ&F,*'Z R)#W@,VH-E32=/Y&]5V/3#7Q_%'W/G<'EN F MB-WHQD4?I\JXK.G\C>I['IEJHHSKWOD&;@3QO*(7&LDU0D:]XG(MHY=X"JE[ MY_NRM;PX0,=+6[==3"PE115W(+:?OU5]-V203A1YW?OB ,9A"&XLVT4;0V*= M,Y8+:CU;B>3W2/&R0/2 M_310:/RG]T4??C:TB3Y3)%9X#0+W(7F)HH!R43=+&TN<3=?@'NEI&*$EEUVF MI+2Q,O$_"@X'LXW"=#>R+>^LP,54X[E&3ZDLMI06\:-)'3*(KMN?7C\,K'2W MLK9R[G84%(F'T6Y(8O< MNMVP*^B]F[W54EEFUN6NK5;'O[;9.?%V](]W(?M9)7N:G2"0Q;#1&=XW4&? MK]=&>+WM@IQ MPA'ZD/%,PV(![&BTR-(^\G&Q>S* Y#X=P(Q%?$L^$(KJY Y@A%62M[O*@(CS MP7'\:35Z&*_75K =+::(!7?AVK@,CFW#V(_P*P_0_)^ ^%R.'M8*!/ MON' X=3\/#1OS)X^G&EZKS>Z'<[,X6=M/.J;212QT8?CSQ<,SQ<,RXX)YPN& MYPN&"MYK.U\P5 0()?T@7;M@^ 587K1"-/P./,\'8;@GBWZ$IO=2_HX<#_VU MNRWJ\E^ZFPTR_A#Q7RS?0>.3[X4^N1D(760\=\:-$Q?Q))".*E0>[CD,@?WS M$CZ\=("; H1^.,0%_6K>!TO+2Y]7)&SQJ%6A47=V]S+JFP@4"0N>\:HJ:B+U M^5N*W""!PD;VZ8;EJN1&+"S[=A],ASAU? KL.$ $I+=;_TPF(/T:$Z-;^YYL MD@)#4:+K=T:3+O"M-Q[< H#W_ ?706_X$A# . M;' -'H 'D\K93&5G=YQ?MGTWA$/ZO&03 ?AP3C!JTH842S=Z<\X1.:<;G=.- M5% E):W[<[I1<>,N9M]TZ$-_F=2XANH!N-9[J]@"3 M\Y@6P(WP7A)OH&_Z-EQ3DI:*;;N (-X-8])N\(+-XCO'L1UH.SH=S=:]>(P M0I0'QJ/MQ0X.W2 50O]U9M8C>4)5&*P+P![+'3$**?=4 SPTYM)XQ,8=+4,I MUZY#>)413HPURC4JG0<01&[( T>Q;8<@(1%/@N5]S1$;"]LV<+UV0WQTQ?'K M&P#"LBST).A!:-X%@;/I)\G\@^1Z+$B*>/M$"ZQ['V,>\1ER%PP)B5T/W(=UXOQ_;1=NAE:"5+?"G!2WPM^/G+W)I]A!3XZ3(;( MRDJ"4:QC0"W#=PC[&ODE*DS&=R*G*NN^8M'39I&F&=%*L'ZDE6"]TR>F?H5^ M-H5$[20G[XTM> Z@%$]EJQLKE1/+:L13Y??FGZT??)3> MVT 3VEM&NZZLGI)JT_+,J_+ROS1&U%P[T\P,PH2Z7( 0D0 MN;.ICQ3)]9(MFXE*L6TGH2&PH?*$85K=NX<3-$0F4JHEG)W+_H%-@ M'\DG\4@O]TS_.8!)];:%2UEM,XTZB=DA_40LY)[Q1QN BP/[R]27BGDC8U+2 MN)/8D/@@8B3WN#X$$0\ZN6:=Q*7( 1&1S F[S224\M23.Q?PU?/^=)B&0DX] M^?O?/KY^_>K7.]-(?KK\]1^E%;V?I5 SIT]ES--#F6[_$;L!<#"6ST8@^EN\ M!@XM]>;=JT+J33JR!A=:.K:V'URS?$?+#*_MQL\DXC3';[8XS@W.M[J*0]_% MA49[<'V_RU6E+EK_8H21>UK8(F["GY]WU(FPZL)O2/6V:\;JXYDC:$/H)WIF1]&QEAY;TH-WZ MR/@&P?ZM)GT9@(0H>FUD2A=)V6A59QKDYZJ5Y9?K68\9MO)'"]-WT&G=B2V/ M_-H-H>D)[Z%DIHF+JWP L5\XB0A@ME;N9@89=>'+N&0-TOYC.G0@*(#QR:/I M?5)9+)7<%YO#N]T:H,$7^.,K_-Y;04AY\"4I:B1U.WVI@R$JU!/L2 MAG["R1 B:XYU/[2L^0E#3.97S7@\OMH:;0<@6D'']!] &"7/ M3/SP08!]@=0ZOKLQN(DW?QG>4G%JTI&3Z*/K%X'Y/-FAEU&3Z2E=BV^2QI'863Y^(8( MP2\I,,(IPEI%!"1LY=Z1)QQH$M4\ZEA8&.$4]:"*"$AZ(/?^?7J"37D8!Z[- ML:03NYPRTE2>2=!6O6#?@NMG"'XD?ZKJ]WGJ?\J@\PN I &9V_QMWH,LKX#% M=YGLS>%ELIX^_:+IP^OT!^/?M^:=WC>&LVFS%\JXDO*F\6:3NN(M+U.'_08& MXP!N *ZY8(6QY>%R^X@=_-3J+9)C\"-P(W3 +VA /ENOOM&E+@/(YDQ4GW'I MZZ"=_ M;M2) F.%ELI%RR8I+W2=)RCHQ"3SS9WE!Z7*1PC(B6W&L\@N6&+G: M4RWI0E*IT& Y:>V$>VN7J9(A7'ZYMQB>Y1+] ,EM':]IPL\U:3W\2E!;2"&/ MJ-GMKQ8#ZY$IWFR3>9D*R!5O@3RB]LJ- M*&A43"0_+()VU&NP@:%+J_B=;76"&!784S,BG'52[XLA70$+.S&NX1K]P[7W M7,S@TT]< !\]] EJ13TRX0@DRWG1K5AS.[S(9873RBZ]I95=VH^L989&37:# M:\GH[9:7PCD@/IJ5+@BI;+VCL949I.WB6-G"S=@7NMM4L4:0[\P4P*3<52DHK6Y4BB+RPO/2(%=G!6[G M< )V6(*?6S*J'13(_'+<\N#J+.=.C@@DG&!VX*9.TV@JZ?IM W&5[_0,+'N% M-J0@9VFQ;O90.DFJ%B4R[Z (+VHNO#=Q@ 2*C%Q$](W[B']B5FHC]Y%U)ZLZ M: Q>VHD@"*/6!U8(5M!SS/4F@ ]I%@L+-DHG6;7%J^/&8H8$W%NYP-V!E6M[ M["F6;S=_WS5X2N@G(?)>4>ZA@IF2])M?2BIQ4?FPR,./FH$?W;;C=9QX M_Z[!)@"VNZN#OO% (FO?T=O+B-?]>.A>W<\&8V-R>Q;DK.*TU7' V,X^Z% M1T;,X4P??C;QTRKZ=&K,II+AV=_[-?V!%7Q'1" >I\".@^22'@VK]\5G17I? MC.M;Q-GH!O%Y9TQG6/_0C]I GWPU9LF#,E.C=SLQ9Z8Q;0&1'A MKHX<\7"_J(; _GD)'UXZP$VW!O3#X8Z ?C4WDG*8?3?$KTE1L[U1:V+C<_)V MA7@'3:#E 0YIN=C":M4'2\M+N2-$*%"K0B-%4[++2&W"MJLX>8D>YB<%DQ04 MH,@-$BALQ,/?L%R5=,\+R[[5,IN? P#\30![UL:-+*\'@PVUV".Q?=M>6A].[TEM\Y!V5UJOU?&[AS91)O9K>GP.R]:@'0\JQO;1Y MY\#)D*WF!*KUCKCRZ-!)5\QS4GZ&'4+Q8VSAVB_Y&#L4R,(38NGI4?-D M:EQ9(4X%WNXOX)K;S=?&>-F30D_<]>\^9W;944B#,='#*C M"Z5M6\_MY@@MD DE:G75?8(@5@X?&BF1%/?G[2[K(:\F/0#"_-<=@""]>FZ5 M.$?7)901,.7N?ZJ@B@F@;H..;Z*6D5.>[UFBIH3.IXJG /=-V&B*Q A/$%PF MOT3CI/5-%-?GQ:\>E*;I<^XDSV.<(IC5A$!"^*VN*Z%BJJ#OD^;$*K M*YQOT[WP4"D++7D-RIZH)QQ 2E^S;[NN0CW!."(KQ--"S6)_#@%.'?]JY5 % M7]Y81LG0&D1/888D_'=R4WWU'U;@L"NO'313U&0K)U9-K]9S5);@3@BOMH7( M;<+9,WN^@V]\#ZTULRQ7,U^34Y6M'-Z2G.Z&I*M3#MLU@!R7+[;1"0Y9#!/MUUKWE/,+40V]K7U^(>K\0M1?[H4H MT2>,U'LAJD >4;,EO! E^@"7>B]$%<@C:N\Y6[>-VAMOVY3R.3-6!;DJN>>= M>F;LIZYDQGZBO3LMN6+ ?M7#Y?RB+3Z303^Y:D!U*S*Z*;J(\Q%/=/A*!>J M5I:SA]!*$IXDN. M/XT^3R /U42GV*L3R!^^E' <;CC3C,(H"4H55L>)\5F5U30LWZ3'B)W#_?,Y2IJZSAYU.$6@FNT3SI^:S60!M )SP M!O&>7BLB7$"9P>SKHJ336[713@K@H^702GQ%O(17## WH\7"M1'[HR#17?Q M#/I7CWAS9'\O@Z/W26F!,-]-N!B5K--Y@BBS^573TU!K$>B]WN36N-;ZIGYE]EM[0.&9W\P>BGC+YH/2&2T^L9UA=&+T]1GB:JQ/$HZ2 M?YNCX?2+.5:CJF;6=)@AY0XM>R=75J5,=D\EJE\2R ROMKF_\!:D%!I._D4V M;JS*UZYCI"CE+EM=^G_ &#V\(3*& N6EJF )*S.LIGLA2R?+_5[65DYDI(+< MR< I'B,Y#B&5HR,-H-AJ*'X*+&KX_>GODAZ'IB@Y)%!9]R)%D)R.[4]TW@"! M"X.^^^#ZRW&T[4>./NV/^U2A\G25]4 PG\"Y.2!Z,9I Q,6NE;?7:/3G*/O M_LF&@M9/6G1/ @V_60KKF8<)L"YA]NQ:^-WO=,+=>FOJ"@P>LTOE9X,7-03 M$6AD)A"GYL@GYW*S)_93[_GE1Y41$>*"B,Q'Q:XVOV[;H28D8I<^90$'0:%P(N:7F/= MMF'L1TB3;. ^8+LHSPPSA85S@,[@684M-4W#79*-()ZT7ET#D1<+IQ8F*8J7< E\D=#^<3BIFU_"C,T("[&/=ISMT]H]!>&!(D:XZD)IW M1OAL)DB"_R0IOS63.I_>D^)[J.!#(/? MM^;L6[-O$U0XLR(V _Q,XTZ*H.\FKS9&EK]TT5$M,2AYGD87'TF1!- P"F(< M:$6K.K*B=SJ*;T&& FF?S$&42?:LBC@E^9-3@MU(^;R*0\1ZF#7:Z#$\8@ ]1Z&<*_>DI*M>WLG(C2^O9U3D0Y)Z+\E1)1)+U&64\> MBL)/DXR#W7N;@L5>Z/WFEY(JUM=T^N;AC@2HW,E61GGJEQ7#,NUSBCAF.5/S MN%U&]2B.0L2[@PPS,2 S'4\1S0)[:IJ<]1?4ZC:43-:(MHQ:,+*65D*'DX./ M9U&5FQ%3()EK1:7U.CD0N=?2OU">3,S]9+0W^(U^F72A.WSKN];75>AIB1"TC6Y63PZ M8L=QO1@G#CP7>30>;2]V@(.S+'#YYCA*Y#!:&%;@HUD5[O-=]#5.Q:9$\>L8 MONL:5:,02$I4-;.HL9C;<]W?T>(.1H@?)#6 %N'G&2,4B.,8K^MJ<@S7)+WX M)%4OAM#'_F$D2B]#NNG; ;#")/^_9+$EJT6EX;JN%4#0;1$4[L/+3\<(2/#\HP0OV514(F#)]\X M^JGP:@\KW>V@G?R,-D[9$@X>I8_[R$A1XU*^)WH_ [@,K,W*M2V/_.(KI;FB M[RG1B6[%$!;"4B[/PZ^M5ZNCDOG81F51(=RK4^DBHCVRU>R M:+]\G;==:JN":'=4$L_/E80;-%AY8<5.)3L,(%!YA\Z=)03 MY4M-!U&!"UP_*CF)ZIX'?^"W(]E%\+C'Z#; =+;J7AT)]]Q+CIR; -@N*>\% M=Z+VZ08F?&QP>#]4F&-#(#*;4.MN8,1B@&B8R?%-95WY/"6U/EP>^F^>W4Z9 MMU\;*:)U=MNWS=EM(]-M0SB8]*W[V/*I-;>R3>9M MOY(C(K]28DERK/PF3M/^+PF'A@K^+]K)X,,Y6ZT;V6IB)N+4!KX5N)##/,PW M[8!I6,9;PPX)/N'OZ+KUPPVPW84+'*HA0FXNT2PL%2[D(5HED[ F))0W":NB MU6K=4'-QZ\>1Z^&;V53CI=A02H")J>*023)Q+LAUDU8)+E%B+JT_:7Z,MX?% M1]W!(\)D()-A/&[< 'P#5L!^^T]PE(X@59FS5EQ#303^CHKX=01548;4C# 9 MBP6P<3,>4?HUO0BO+%$:52!F%<5,:WT0:?JFIT Q"IEH:/!3T(D*#).416[=MB="C4=KO2OG0-^V<]<3B!V[!3(7,R0 M,^7:VHQ)HV4)%VO9+4BCQ<0-OW-&IU\?1J=[HV'/&,XF^LP<#9,J%A-S^K7A M0'6%&H,9CC&[!5C+*@R2^T@MEWA %B-@36HO/W#-(>?2*4>7@+K!ZX'U7QCT MXC!""T80DMV29>VD^209PH94JELYE'#)?FBMP6B1HY'F#J,T;]\Q29$LY*%8 M(:]D73"HZI4\#JI679)#N/\XU2%YV$Q"0)JMVI!.;]W+$,FOY8,GZ*DR+39L M0)_K%2N!9*)D:Q;M'3)O88"(H,KUH%7K3Y.("K6,7N)1H1&)SGY #HD^M9(1 MD:X@T3R])(E6CDV3IW_Z>=;>:M;K8NR>R_;ZV3 T>]NM&(>)W;]N;JW?&Y:KDRBPL^U8C*P9^OP^_AX,?#['\+=4? M6-ZX=3N:I*N0BU*B9"4G+#[B+-K8#5=8C7 AS?N([@4D]U!\%6?23XPK*(?0 M;'OXE#L?3ME^WA\RMK8B7J!<\\NVK\G7EOI7X(*$6LTV'K:%W!"O M+L;C!BTSX)D0@J%'Z=$!^7-Q0)PQ+%:XH\P+]M0/R+U!;=R2!6 AP T,W M2LKIAW% N+"5ULTKM.R 7*F43WA?,:6\T&)BS@3&A[COIY;$E M\&V7MW;@N^+MC#W]4TT?7N/;&AA'8]@SFRXF6,'XK/8,;9E=*CJ2S,*#3]H] M 6$4Q#92<00[4H )\*P((#T(HY!5E5!D$&5N?M3T\' %"4JY)"*L&B7O;-/= M5\0.\DK:5,"&^=AXBY=+:L$L57.F@X2CJQR_%@L"-F"E$E#.L]4D=BK[MVK& MM]5@BXZMJ&F,5B07!FC[0(L+-=Y";"\IXXQ_MD!.)M1<%\M/*5ORC")T:+W> M8+VV"HVKEEQ7>1(R10K2%_X(11SRA6F(/;L*CPA[79A@OP-WN4+FE?Z ?KL$ M$X"%N/_C# 1KBJM8=*2N8GX,NW6[WYK0@;&U37P)O$COVY\4GCFF.!QZTE'; M^=9Y0=LU/RG,LCR1('O+]L'N?H__YQZ-BG[S_P%02P,$% @ ,68-43F[ M!+.F@ K0P' !4 !A871P+3(P,C P-C,P7VQA8BYX;6SDO7MSXT:2+_K_ MC;C?H8[GQ(8=1[*[V[LSX_'N.4%15#>O)9)+LMOC,['A@,"BB&T0X."A%N?3 MWZK"@P#J"3ZJ4CT;NVLUD9GX)>I76>^L?_\_+]L0/>,D#>+H/[YY^_V;;Q". M_'@51$__\/M+L09 M)@^*%_\%_=OW_^JAZVL#LY]PM(J3C_-Q;7:39;N__/##ER]?OH_B9^]+G'Q. MO_=C,W.+S,ORM+;UYN5-^3^%^K^'0?3Y+_3_/7HI1N1C1>E?7M+@/[YIO/7+ MC]_'R=,/[]Z\>?O#7Q_N%_X&;[WK(*(?SUJ)/''RHXM67R-%#(-Y"DP5]2!N\^]KV,E;GV-4@J0?]U78E=TY^NW[Z[ M_O'M]R_IZIOJX[,OF,0AGN,U8F[^)=OO"(_2@-+@F_*W38+78C!ADOQ ]7^( M\).7X15]T4_T16__2%_TA_+G>^\1A]\@*DG8(?7KIY:M4ND'VV!G. GBU2@Z M#G57VQ%\4G>2[ 0'FOK675C&F1<>!;ZI:1WV!!_WQ0]Z]K\T"?+XN"_=T+P( M[(R'W/OSBK]K2'^\)W^U(.*7C#1?>%6!I"84$9B]@34,I>W:>NRW[(8TFL>) MT'=F=Z.V'_WY@<<9FGURS7]Y?K-VS)\_Z'\^7?:0.(MCK+1 MW_,@V].VF_0"HBP=O 1I]4+F[7]\8ZCS0]<;JCU(*I>\Q-=\EU+B!S\FK=HN MNPZ+$BC4UTF\-892?L384.'W\+%^3_'E"12)0RVQ!*=QGOBX5\$WO>KSA4N4 MVY!HT6X M"^1L\DD*L\DA3@@,;V3(NEPIY! 31'\K1($09;!:!;3GZH4S+UB-HZ&W"TB# MK"2-1LW93K,-3FA+G. -CM+@ M&8\C/]YB=10SU[<:T?JZU8INILI@*-D7,1?UIL,Q&F19$CSFF?<88I3%)/XE MI$=V6;ZF2=;@*OE7EZ?D)])!B-(X#%;4O5&4D?B,13U]M:@-]IF I413R3GG ME $XOF=V$$>5_)EZ\IZ7%<'KS1]_?,,H,1@L9[\/GKP=)G^,HPPGD5<%T/4@2X@H;)"NF*B2R-MM/)=QF6RD4=$XT$W1\$ N)=IP0/CT3?AUTD!>M M6O]F32S*-AX9&[24+AKQ%AO2'H]>_ W%,7A*, ,C#W)J>6MQS01V'N2A(T.TI<-*P_)A_C++_'GX2:.HR=Y.!'+60LC*IAU^! ).6> #EF7 M 0_)]Z0O\P41:52(GRU0R%J6_#$-5H&7L#E[+]HOO\2*=D4A;:]5T4(^M"E2 M41C4T.+CVI-: 94:B*A8)TD/AKBGARDW0!.C+RML,V(:B><*M=+N>,%!EE.C M%@7*CBX^ X(0%?MM"Q'O0Y.6O,/VA8>M:&$.PD#)PB,T:66H$K!YE5D2[W"2 M[6<$?#:(5G1#P8Z.KF[V=/"OF&4QTK0YY]+#E>8,C(&:7'1U1ZN<93@C6Z7H=^+A&+ ]A>AUK8:::D?.&>#" W7D&5> M%J19X'LA>L!>FB?E[-OE-IH9E?9#$ 7;?"N,(X+GMDI="*LJ^=9#$*4O0L3- MJ!0R &KX@_>B+O/V\3,(&8'VJD?-DVPB-?9%R_! MG0^@.PEDHFOY=)"Y.YT30WI%,(SM@U8Z,50I7W&,!3!XG"7Q*O>S:;+ R7/@ MRV:*Q&*VAI(JD-6(4B3CG$<:8%W*E*)L,%!*7W8F^@/VPFQ#1BN_XC",<)J6 M",3=,#,5:_/0AN#K:6B-O'.R] #9)4ZAA8@:JO10I7CIQ=AQ' 7_P*NA%SYX MBJU>0C%K7%& K/DAD('!"3FP+@]*241$KXGLI8M^NL5/WDV((\6Q"%[&6J'+ MX-4EWA6 4=P25-VR9F*(R5VZG'^+\^CI+D[H:3!Y28NDK)6U'&)=VKP(C/*6 MXNJ6.!-$I>3%ZW;RY$6!3]Z9;8:D]SH,L1>E0?1TXR6*VFZ@9:_^&[MPB A: M%1B<,<;)18U"$3%-1%51K8N(\J5IM4R"[2S,%1W,KH0UNHBAU=1H/X9! R$F M;O<_$?I?ER[7^V 7;[U4G-)$*&&M7,70ZG)M/X91KD),W+Q^*73IHKW!F??@ MO;R(5YC%(M8*5P*N+MW. M98F7*?;4&BA9(X&Q S4MM!HPB&(*D\N 5>FA4A$U-"^_.SMY#I[C9(%#[*O. MD@KE+.[&EL-L[,+FA6!00X&,WW5=B*)"]M+E_PD_X;LD#[*[@+Q%7OYB.6OE MKX)9E[]("$;Y*Y#QB[M/^)K)(B9\:0(\!%E,HX^\Z+L2]DY\"J$=SGJV'L,H M:"$F?C=B(73IHOVP]\(\B.6 M!&IY1!40T[AXS8_S-,5WGA^0O@J;5E U "II>Q%!"_D0':2B,"BBQ<=%#:: M"@U4J0#; [38!+M=$#T-HM4'+UH1^^)5)@-YJ_EX=;!;N7AEPLZ)98J0ST]2 MR+.U[$KCK,Q**VJEV/_^*7[^886#@E7DCRZ9R$^_W^,G+V2)Q/:"70Y""1N$ M44"C%!$\=DX*.29^[RF1*K*W[2^!E^\9*4Y%=R1L9JS5 2OE9>T*>"< M-"I47,X^*H.HT(63&?TV'^9)@B-?D9Y$(&2O"RL#>.BY=B6<%[02%M=/_6V. M*L&+3X9O=V&\QYANO'H.5CC*[G+5_A:UO+TI< /8A]EOA3 ,9A@@Y.:\*Q54 MZR"J9(!&3K'%Y'QCF+-,"XY9I2#,W98NTE MN[;U_7JDAR4/-"(I:X%%#K$.)+R(\R)7X^+.?3#!:[J3EW9U+]S:U+ ^_')K M4.@-*?N%SD'D"[T6 5;H75R*0B>B=@I]\(P3[PD;U'9>TG+ARZ!V"- 5@T0" M"38)$;Q"VD8$('S3SV@(A.SU)F4 #YW'K@2,@I?!XKJ&I,;;FM%HD=$@YO.2 M;JJ^+O9WQ6 P0(E-4_7/V0Z TF\LV&YNKN1B'ZIP0C4ME.F#H M9@A4.FXM]%"E6(YC0<6U.6;WVLV\)-N3VA*EGD_7%M.;??.)(M#U,6#W0LR^ MCK4OR335!D/6WI#YRS29&&)R%NZ76^0[VNHG]R0T1T^+572ST=TJIU*Q>Y>< M'GS[!CFYO',"]0 IOBVN4D.%'B**B&@"BW0TY3K^>TYO4'\F_T_3?Y-*6]TZ MIX;I-2"G$PQ-)CY%,@EQIL8^_Y$]U+>D[O M$XRC71(/O5V0T7.0R4[>9U((6^LM:0'7_22II'.6&,'K$J221Z4"HAK? \AT M=QLDV"?VA+P1"=C*;B<&5N6U:S]US@DII"X/*J%+1X:/$7$-)\]XI1M*R22M MQ00UU#H@B,66Y<"!^&SCXUD2QV;&$?!"TV)HFXB)(+V%CI40 _K'"(I M&$100>-6.0I91(59<\"NMC[C3GX)&ZH0E$[7!RJ.HV><9NK+E@P5K;&EER,U M>XRT8+"I#U190Y/2"XX;(>>@?O$4F NL2(O7>&CO-%$7T.'8$ :5^ZX+AQO- MC@:7+CS!%. LV]]GJ\'B?G;?:V96H.=R>E;JAFJ.EE."090>2,UF:XDV(NJ( MZ5OA&/ECD ;>?; -,KP:E/_4$$RM9)==)@ZTJ:72 ,0K YAB4@W0$LT0%4:E M,OFI\>.%:37'J\=X/PM\>FU0T2$O?I*32JMBC5*&X&M":>1AT,D,)+\$2450 MJ58/ELJ?G;9_RNNWC56!M(+RB[D-]6"0K!_8GLTA6J![$K[NSWJ/]WG6#F[R M-*"I[0?^W_,@#>@04K&4*96VN6:@@=Q<+Y"(.J><&3XN>64IC1KBUC=7](I< M$&*5>70"'H_4$6AQO@[W\>L!] I?=A7>>QP_)=YN0R_SE5Q_HY"UM4J@A5LM M&$@%G9/%!!VWG-00.^-.""YYD!_G49;L"]J4_^BRIOSY]X??.HXU']C@ P^$ M%O[A5^$7,&590^'.LDPG M[]$OY/\Y+TR"1HR=/K!9F <@S<+\N !3F#44;LUN,EZ.;M%B.5B.%@ :YX6/ M(X_T*W0-J,L@LDUR$TAYTS0(>-FXDN1RW;BQ^N/49X%((M3D2W-\N$;,5U.< JJ/,2SFF@A,7=3EO*7#:< M3^+J/?+JS'4U[PHX+V,5JFX13V)T*&50$[F'RTB".)H'Z>>;_0V. M_,W62SXK9G3U:G:OP#9SHGW[M5K'.;]Z N7OO&ZH(:J':C50YUCF^!E'.;XC M)4HP$\!^]FN0;931JJ>NW5.?/=QI'_@T4 3#RCYH^356IHOHAT.5-OH2T%L0 MJRC9X.IEN[S3"->-M+QE%$G9NSQ3"O%P628GXIPI:ES<99@1AMI$#GPV59/. ML8^#9WJL7AF3Y.)6DTUK0+?R3DMDG5/($""WJ%6*HX/\Q3//#N,M8:Z/R7]W M7J38]2.3M)=G5@GUD%Y6*.:<$GIL7#+9:[^4OOQM:]$J3I3;=#@1BW>L"<$U MKE=K/8=1T&)0_*5J5.JLNV24);S\$NM*N"%BN80Y<)T2KI]#*N$N*$D)$S$+ MW<'B9\B#=T-69Z?H6 M/V:*B1&YN,W>GPYTL_NB< M S)$_*SI,UN(*:7<%/=M[.?;,D61P(_V8UN%+0)5E77S&8BB%@#BSJJ6(BRQ MDY-B'I#7K]CM%:'W)'"B\]Q600MA527=>@BBJ$6(N&A>R2 JY+:P;W'J)\&. MKLJHO&F)62]Z 4B. 0T96$3@@BN8(K!)Y&TW!DK8 MW=9!* R".B8(I>U'4PG56D[9-(BBW OG>!2#"?A7DL-3M(V.R10NP3IB('BB!B;E":U. 2FL/3-[*2@ MEBJ\J/4AB00L-SSIR(%BBP2".%)V4.TT"E"C3RL$2YMZ039>AR0]XEA3C8*A;5PF")U$5HR*4BRS'5<\JG MXBH?TA5/=$SB)&US2 *URYZ.&"C>B+%)&5.((R8/A2JC:&5$E%K.#4TZ,,4D M*84 4J2-3$<0(NV>'G=!ZGMA@>B._-9=]=7(VJ:)%&Z7*IP@*+K(T$DI4RA4 MS&$J &CS&_82,](T)-U0AH,J)DPM!I N76PZLE!YAU0I;IQL8)>W07)1:PN] M&K#UFJ]$#@1=-.#X4WE,O$47IVW2*,J";'\7A'B2"_:+B$5L,40&KF)&]SD( M1DA <1N*F!BBL?)V66&!&:;&ATA0-P0(Y.0HQ1&3!H1<8?TF"7! MUDOVB\#7-!Z\H%V"R("V&=*5 D01"30)1TIIM!@/W;SK1NX?K"T;8QHAAD?)J&*_D/1>- MEEUJ&;G0)IA2!1#-3'!*R-92O2KVO* X0:4!1"TXY-U@M4IH5&P]!4$&$B#^J7,RV%$)N"IOR-<&>)#JT'ULK:@&HNJ0;SV 4- ^( M*V=6QXF,NTI]']/]6)LXDF\]X$5LE;<,7%7FW><@RET"BDL3'K-];53.Z7S^ M2X:C5!S0&\^LM?A=.'4#7ST 4<9=-()$-<5S)V7Z:Q)DY/TTDUX>E6M&HIV* M$CE;9:V$696[4 @$!U3(NGPH95%;V DY%G$8^ '-H_1 !JM)X(E\$PG9HH4< M8,4)7@($(:2PN$M>:D%423JAPBS!+-LF*0YV3!%'*YQ,UVMA+T E;(L:>L 5 M1>22(*BBA=>E#%$H%!"J.B"0%+Z$3)P^15#*0 M6FH5BNX9ML!^3MK-_=MWC\L@"T7#4%[$6BLE 5>W49WG(!@B =5E!'M&LRN^ M???MXW>HTG)"@DF\3+P5:2H7^^UC'$KR:0FE;%%! ;%B@T $!"'DN 37W)2B MJ)!UEV^K!5G@5.>Y+1H(854$:#T$4?0B1%P@:)6XTT9@].)O"#0L.1HA%K/= M&(A =AN$I@P((BB <0.74A15LNZ.1AR:LB=]Y^#)6>?@2=,Y>(+8.7@R[1P\ M.>X<5"\O$IV02#5]#(,G3Y* 42EMFQH*R%V6"$1!$4:.3QH_:A5TT'&3NY,E MWNR]' ;F_-D0B#()4)0LD&':IT M_9EJH4JMG#]SR*=/<9A'F9>P\^^)*$I)Y.SR1P*SS9N.$""^B)%)>%(+HT+: MY7'R(OM%W06C(5"8R$8M;OEPN1)TYXRY4!807T$&B& MZ4T:P3.^]3*O1"CU6B9N^]BG"G3WO*=(%A"1E "E)SQK'9KPQJN8Y3CQ33(D M';&G6+%3O2-E/_T-!Y'/@%.+ "*)")I( MV66$$&*;$2T10(P0X9(P@HFB2M8A(T9;G#R19N]]$G_)-F566JF'$FF[#%%" M;C-%* J(,2I\$N94*JC0J1()NZ30RR&Q>I%/4NZO0-0R>:1@.\SAY"#11@9. MQIF79N[[0L/M;2O%78%%'SU:>8F(,BIAZS>O2 %S]Z]PDB"(HX4GOXNEUD"5 MBA/N3+,-3IIC.P9EG.&M](2%7L46CTS!5VS2R8/@E"%([MYBJM8><#-%1#7= MYV!J)O67=_5:0I9[R * G0YR0P($4Z2P9-WCYAT)+G, YH]AX-^%L2>??VG) M6,[\Q\/K)/T[" #B 8]*ENJ/"2(FZ9 %-U[T. MI;1E)?#D,^9*)J1[ MSDH3Z&_4"&)6SG(+?,7,M9<^,C?S]/K)\W8%/7&8I=4O79Z6/_]>;T.9KNN] M*;.XF >I+JSO?*Q^JC98>HPSE*1]])QS] BPW"[(2I7NHCUL1:JTT=\J?2#D M'*0ISE(-#;M"-@DG!MBD5EL"#(F$L+B]:XO%:+F 1(6R$VG$"$[6/C$D<'E^ M= 2!T42,CDLI\W$^'TV6"!)KAEZZ&40K^I_1W_/@V0MI SW(AEZ2[$GW\),7 MYMT#'#UU;;*JESM-EADI@F%='[0<"XD2(GU_Y-,_\$$=?4NZ96&^(EVR__GV MSU=__/,;%$0HVV!$/GP:A\&*==<^C4?D1R\C^A%ZQ"A/R8]Q%.Y1%B-2&=@1 ME/KD0$H;4J$-CSWZ__((HQ_?7"'*S^]@U(ERM8(,\'U,/LYCB"<3I5;W-\1PJZ#S_5*C9):0*^ MR425/!CZ&8#D.+>EE$.K'"/Z@5H\(\HPF#:.Z!WF<;(G<5WB>EO$)I-$X)K, M:3X'PQ0!J"XS*A$P+)@E>.<%JZ7W@KL[2\4B-ED@ M=D0?,Y&!8(0 ER#%$1 ME%&9YAC@QZNW;W_\)QT"E!]E]++#48K)4(MM.&D-]M5?7*WI@+I-_^4/;__XYN=&9?CSU8\__?3J*H/G907%W_SQ MQS>,X(/!&[?S=OEA- >UA#%+XATF 6U&<&8D8M(9\1V-@O*QI%K%;N],#[[=+9/+ M@V&3 4B^[2I46,.%*_DK%.&S;(@[QPQ%1O &CR$NJ@EQ9?1">X?TZ%4#PP+>X#E9T8J5=(MI[J B#@E]<2C&T;OL9?B>?"T MR:;KCVGAI"R\JW6L-I8F\%O-IDH!#-E,4')-::6#$BI_':^OR>"Q9!P,LCUX MR6>.AJSF811'UQ?AXIE60>GF MY 2O6+9]>MPC3KGT@AI9J^N>*KBM!4^1H'..F:#C-I:7LB@NA9%/I6'1A^YY MW^*E]U+W1C6>BQ1<$$D.7,0F7AH X'#G(U^5L?9C)AF)@S6 ME"D/3#QA6AP_AS1=JN2!"PK(2Q]BP:O+?+H24J2Z8MJ@G8.Z&TO'@9GP_7HY'"S28W*+% M%RH5FGH9Y MFI'N?E)NI%!,,=,T&/C0DLI7.]4@1%8VG/Y5<# M-9INY?C52-_^=$ /M_C) @-E."SMB5B@E%0[595;E.EDE^";!/G&3V&1#PG=2*+"XT$KP*6^V#PY.TP(A$=# 4P P7)3[P4FZ M*LZ3U+EB9/5GB%GVB$9KS(]&B=F-1.:!&0KZ5E' M!@S?),"X]8,BMW')M)IA%>=^1F\KGHFY=H5^_-,?K_[UQS]?O?WI7QG7Z+_? M_>G?KOZ-B(LI*)H#8S*WV,?TV@GTXUOZZ]N?KA!YVPZSZ_Q"(!,9@]6*)3+U MPID7K,;1T-L%I/95#^O)%&#M/U7,V4GU('%.D.TVLF]"^_XE>RC^^0E =V0P"XIQVDV M*B^F.>PQ*!9RIVMQ=FK1;K'3;5K;FW>9 D@QV7),$\P\]KX;)!:4\'B73/K)@SF0N>T9X/+')QYR31AUZBMV-+-#"?LTDFCE46YLKL%6YU# M\C5 ZJA72H&G6@FA*L6(C %QZR6_I-M9R333)/=V& M*J II[^I6\8[R!N?>G;SC#0=;8_JT\$S4 -#1G.LAONJP)'0L%.GU'!$.I/N MG$(<(LD,.W)M<@'MQ7%N*;MP4FFGY))WWB2B<$FE[+8)"06IS\:YH^^PJ56< MTDK355/)PR68OI,F9!FX'EJQ.8JU]%O]65.IM-V[")20V]RZ;)T2<,C-[11L038X>8.*O'F1U 1A6:BGZ[I M#4)L&R=.G@,?IXLXE \/Y0IVN_(ZX.V.O$S:#H%^*@@4X2<:+E04TB+E^O+3 MQ1)-[V#1ZGT2I^DLB=?206#6X?QI/Q8CD?+,>?@'1OZF16I1O2%+:\G)-49%V8PM1CE9 +"BVUE]E( M4(J'6-/9B-)E\AZ-_CH;3190K\;4HZX0X/5@QB8>1HY-F[V M>D(:MU'99T9W\^E#1:'I! AU)G$4M_TI:X)F6<1 SR:MC-UHDDRK!(9RIDC% M*3DK&E9!"\CPC9T)D'HFJWP:)>LIV[4.<'G:I1I@Z&8$4YR1O4@8@;[%97OZ M':#+ _QFLZQ%^?)'W"VB5>'NU9E#:>AKOU%84-W^"5BC2(8,O9!RUT!1K00 M_6KL#'2V)_2L5&!04G0S\,P6-&7>$]% \84N'#_3S$CIU#2B,SS3-=L;-(X6^6,:K (OV4\3 MOGIBZ8S)L=:LSJ2Z92V(L@M Z&:W MF"T&5F?]C7KK9WZCN]'513Z=?$QVUM?!JFJ7=U0]"WLSNIO.1U6M70[^"F42 MOW:X##TW.,+R?2Y2:?MU1 J9YSB*0 KIHF@=;E"^@2H%8E@L,(D=_ L3FA@ M'F19$CSF;&YB&<\\@XO:SF;=^K3^^3X)-_]_NFGG [3+^"->O2)59C8??2!] MZ_&GJMV&77?N2/(J**Q?]_3+QHI1X23]"M&+_"EE/9[#Z[[P8D!I\JYXE M<"$,$.KA13^O26V]" #P=?J27G=K?OFN\N)Q?X^R@WWDU2^ $08$WZKR?!R5 M!\*$GZ#7P/KL;[%\0/H2GZASIOJV2Q548_VWVR#UPSC-:;*ADZ*B MW!H@:NI<[D%9F:G70F4-_B[%?QV-WW^@A\8'GT;SP?L1FGQ\N"&1=7I'Q]T/ MTTD18Q=H^G&Y6 XFMV!.>OU*!@@;VFP\X\1[PI.XQ2K^L0G>?%*0GV=]V9)N_.2#]$5LGO5F0A@^YJS MI@28,"J$Q1UM/:0=8F) <@[5L.Z#"+/U4)V3#4$G[." "AE22\%C21>:@BE4 M%#%9)5TN^MF/O'_PG=4/O\-)$*_(ETLR59Q7X.2B.'X*(MH[0H\>>>#C*TA) M64WS&CI.9FB4P=!MVD)3YABF+130IMB#ZJC^]EP*MUMK5>%2C(M;"<<9O'ME MB^RIMWE"9U(9O5@2Z(%/(D[*KAB7-[*FZM;OH.WA%-1F$/1;G^6"F6Y^.?Q.T2:F+>GF!71(01Z$_.AA+C")U1BLY2FZ=DHTT>@Q MX0WE7$P#Z I "E+W_2$U3_4L47'3]UT8?]$MSZE5G$SF*< +I_4$\H"Z55J0 M\JD^TC>B2HAI@8UI*08A;GBSC\P29R[S*9ABZY,=J M\OP2[P$3RB[H7+>J-5Z%LA@EU&[3W M=MG;5(5!OT-]NHL3 \XIY-V$;0EL<>SM"(.AE XA%P4;(C!X5$?R>^RE>$XW M>4W7),C3.Y6R)EQ-HLC>9IRDP>WII#!'KJ$-,!P]$KB*NG0L?FB:$VKR.EY? MDU8;>=2JJZ7\"^=HM#13US=_@BELB^D:):F_S++XO>UXVT_56B*PGL[4^< , M]:!P[0C,E\R_>,'H 2#[(+@(&E:O?YT_R!*=M^<%]O MQK];O,9)0JDBM5P'1+S7#R _%""V7>"ZJRGL.@&W$D MH3WL6US\MS%+-O1V0>:%^KNOC0U8SCO6T[%.U]I0&PPU>T/F5G8VY%]%6]:8 MP60C(W;J*0R\QR"$-)O)NSSP_3@GPX3%+D;SCH/:B%N&FSBH9K?* GQF&Z 7S+T24J-5CHOY.N]U M4)F.)B/RMC[QN:7CEJ@"^&I>-A3@TY 'RXWT#Q)0&39+\,X+5BQOM;'G;26W M'!,YH"994P,^RP1HNS0K1>B('CS1U(N@>C409%,L=% V7D]3I90O;W0(]AUWC[9B[U:$ M5!<>+\V/6TL^3Q\#, _2BSAJK@WK;I7>N$5GMK5G1$%3M]AD>X:<$$I# *AL MX*@!I156P(3@HZ'KQ$4<9JGP$KRB&QH::?$D7TFI8?6" M+#WTUF57!4$LUCH%Y'.]J4M<6T$YVM5]2.M..9',71M? $&DU&<>9-5C)BETM]R[BLO<1+T6D[X2"VGD]K=/Z*L9A M]^C;Q0A#CKOG M"&-=&0(WPAB1!MW/INO1B\\2 3H@7V]7PW6GXJOM/AC>/@R@SR"M M_E?HL;[S.%ZCPB-'24[_J7@*\&HU)_[W8"J.5F8P.,"^LK@T; M1^LXV187.&JN=#/5MGJ[6S^76A>]F:F"&>+UP\M=__9Q-KL?/1!N#NY18QEN M/+F;SA\&R_%T H.DK=-0P6J"%%FQ M>R)H;;_M7CI!E\D#.QMTI6G#B'4OI/7T332W%KG62 M']$]S93%!&(G.=O((G:4'1BUXC3P?">'66-W;9;FZ-!><%U7D93^W.=_);3N M<9AC'%53\O1ZO53XS4XR9XW>9W"ZIO@)MF#0_'0'N&[3$0=ZV,TUI7&TCA,T M6-Q?*I*G:4[Z@,1ITIQMXZB\1:GIVN&(77FH9+J6$/X$8_:B^:D.'^+YL99@ M4/U4^%Q,+^U1LOO,(DJI28[,S3.;Y:91=G;S8AS_&-&Q](T74GBW.>[6XV$< M1=BG>&B*JQY\/Y-A:]P_ZX>HZ\%9K,*H$^=TA;]JD.62?BR,2[:[TLKBUR]! M7\A;7-47/I70-#(^Y=';A.4ZT-NY#MN-]2'QNB]H"8,%>:**>Q,O2 M%YFR"*I9' :^_@2=2L'JK>1:X*UKR:72SGEH#%&2(942JM) ?ZMT_@L&O6[R M-(APFM[BU$^"'5L]C$@[D@;I=#TCGY"N,=)?E_@ENR% /DN^SC&&;-+Q>$>; M-.UO!0Q]CX;.93>;OQ],QO^7S9FS#0\W'Q?CR6BQ0#>#X2_OY]./DUL8Y%X$ M3U&P#GPOROC*JR.TJ;+5+0Z]'&KM<##2!$/67G#Y]9Z'A\'\-[K1?#%^/QG? MC8>#R1(-AD-"39;W:3:]'P_'(R![2*?)DQ<%_V"5C_334^+FRBOK9[-B3M?E MLI<7+L@ON+@'0=T;.)-MFR0_Z^=HUH&S& 931<[I#1?B&[:O4,LZF]9NVJ#F?H3&D^5H/EHLT8BT"ZZ MD"B4M$D\!=0FQ01B8,@DQ\;GE*HEP06V^]B+TDF"MZ]0J[4:4!V3S( M'6G+)N].'N*>BY=:UB(G6!YJ/AB 1$.IJF,5+T>W4IX'QT/UB. M;M%L,%_^!J,B5%>Q-R8/-$%4J6'W+)$6>OM5\C#X8P:2 MH\U\-!O\1H\S+EBWZW8TFR[&4(:DLX3>'9;M9R%=NX]6=-B]HRYJ^E8&>C:; M/F,WFNV?5LDY[?HB%5SYPO2N$--D4WFU+KC.E]1+\\Y8/Q,@&&K86>NC#Y^W MYIVYV7PZ&Y%!*(N==$9O1D/I%9J,EC!8^SZ.5U^","3NC:.,0 _H#;GL3*'Q M2+6G#9N\/VB4P/#57.L_$AY.9B\'[,9P<5B1).?G2&N:@?-S3P&HKO"S(;/YE8<#*3[ MNB@84IN:<,[#TW K;H0;1^A@ "TNGVQ"#5PY]NZA;#&A1$^'&BDD##5AD*\O M7-&,X6)).Y8TA_'#8/[+:,G60Q:CX<UAAR'1D-'-=%1 M8P4&1T^!KHZ1DW;&!ZMQ4G+;IW&HU.L[B9:F;@D#IDX9!A^/0*P.FS15VT5" MYYF.[= %],:19./!N8FBU0,WQHZT3M-HM9S3LC=4[AP,540-3;W)^1:]F=^NBF1/M?8QJ'3 \- 3*[W L%B P MTS!>]E 'SU?S^-G:BHAN!O>#R;",H\OY8+*@UT]/)T "*%W@RO::<-D5LGH= MH!!@ZVJ^E@08(@EA<5?6,2%P(8UEO-O$X0HG:0&1;NTU#V@]]*VFM^CK5BO# MA:DRE&N'CP7.I;M83H>_?)C>WX[F"[;=^D\_LW5M./NLR[LE>NRS5F@XN=?# M=)^U5!Q,V--CE%SY050@CWX%?NF7EE4JCGFF64R6RT-FFG[^;SA]&*'EX*]@ M!K!!^IENSOQ(RC#)O"!2+)L8ZE@=()C ;PT)5 I@J&6"DNOV4QVV/,L9&JU>/&/9QIG30VT /#QAY@N?/%4S+VG)!A)QMRTHQE M\_'B%R"QCV;7#K)J>_J0W87XA"._SUI'3QMVN7F$>VV2]C B*W]47.T/=@H MLCDTK4#N)1HYKP^S_8R ([4F]/:Q\+IHK0_'#P_CY>%H#0G/-%_D: (G6629 ML+63%7-?_']MBB9#9:LIFGHYU$K19*0)AJ&]X'(IFJ@RNT2XD7H1!B-;Z2'- M>*A6L=Q!U8+O=$RE\F"89@"2/]@5D%BYHPE+V"TH#0,P6/8QQ=/U*,V"K9=Q M][')A&PR20RPR9VV!!BV"&%Q-RBD['H<7(G!((4XO9-A##+3=9^\=,3_%XE0VI=G 2#N'56%+/@*1=WDI_&($3*9*&M!FMPRI(@ M76YS/DM2$:R6W@O6M*QZ<;OI0M2@VZE"Q++.(Y0A0&%FF6"%,JIB-9V,*4/T MBHY3RQBQ1J<%B#^&4%4YBFBSMCI3CJ(+)_@P:\7,U4$D]C!HY4QUH;5Z/7'+ MTM(PBN)*]PI%.(-!U.Z)^KL@"C)\'SSCE7),8*#G,O>!U U5Y@-."1H930'S M?;$Z(T=Q!3PD FY)AR!A-[TFMT%*@K@73M?WS['V7**DU/<+;% MW"/L.&_RSP">(W9MBEV#'1(;UR$U4O+\4D?913>\&G0PS?3L'53OX<;A7+J! M$I2XV1=PEUZWD._?%1UC5C;9*@6;05 /O!GJY-)@ IH6HB*I01"A1D(#7)SJ M2"^=UT!R"MX@A)EJ6@MB_5RIPYB9FG.*]<>JYEK43J!ABV_#/,WB+4YZ3,9H M5:PQS!!\32V-/*C&T0PKM]95:@&;=)GC9QSE>([]^(D,C(PW?1CHV3T[:^A& M^\2L1LEY*.N+E#_8S?3HLE6E"(-VM$,Y72^\4-> FBC8W6*D ][>8"23!D,M M+41^NW":T=TC2<&M"[5^BTVPVY'1PR!:??"B55COL%,V@"9:UMI 3V M=CA*<9]]W\;:UH\JF+O$G5'0JX*A8C^\PM,V3!OA M0ON",ZY!A-GIB21XS%FOD4 QFW,UTK0YZ]K#E>:\JX&:8NP1L2+X-G M7,#KV68:JEMN-'LYU6DUC73!4+ G8$&[>5!'04'0;\,X3;^[W(0_BZ=Q2 DVBW9:+:LYY8,419EN)=H00D6GI! M\LD+,HS9)\>S@'*:MC9KI6HV ?=UH1ST31.?>.0+4S\)=O1'R3?K;\;N MT;/CG&P?0>MG PR=CP0NH'-+%P9]%_X&K_*0]%X6^6,:K (OV4_7]\$V(/WC MZAJ:/9TQ]:+]-"D?T,YVA)-T$^P:CNM"]H7>9343_24_5RMK_25>!*9*7=([ M;I]0^2[:Q:[?1B<-Z$3!($UCTN4^0^(BV>:SVM,JD]+J8XK7>4@/6Z73=75" MM7FV=4DWAZLWIYW!JKW-:V?[!(?-;2>;=%X5SNL'1_KAA]'MQ_L1S1P\6BS' M#^QFFX^+T=W'>W0__C1B.85G\^EL1"^[H3DMZ=40,YKBTE%-Z)ZNG> S5 0# MHV#J@?$',*X&6HNOHQ:8NG%<);C,U?3GZ9W=!JGW])3@)]9CG*[+3?C*>M%3 MUV;OJ9<[S=Z0D:)S,A^#5L79V_%B\/[]?/2>\78\N9O.'UA">)8/?O1I-/D( M)?OPH0J7JS.C%W]#_,)L$YKG9^DB(_6:G3H_S)/.Z.DEVH4SX?-Y7^%FT'"^ MCR,>*YQN'TPENH!3JKI&ZM9H_'Z"AA_G\R*M=W'IWWU1X49_'7X@K<0(S4E= M!%?G/I$!#76XVJXRBC+EY>A'67!38XQ=$U<(K3I OIMB5M'YTV ^9I>CD][- M:$XZ/XAT[,'<_';PM3R&^ ^\&J](30[6096!9."3 4]"_A6M&KHN;&G#63R2N)6=Y!<":=$Z_N-J6;[=>LJ>S2H5)5-ED$TO-N^%+LS#J MWDV>!A%.BR]0-):S)"9M[-8;1VOZ'Y.IW-Y6K-X<<9R+K2LD^ID P_WC<*NF M3(DZ8OJ(V(Z8<32,MX^DQP5Q%:-*NTRO2DWO8X_M,2N[A]'3(7>S>>-QA$4W M#<71KHL;A=[FP%2"TWU058@ZL?=!/477J'7Q/;1:42>/+C9AJB=6^ZN[X;N9 M4V)RJW4!,MD(L(JVET\(?@!;IIDNC[0VDPOWF=$WM^)@"K^OBX(Y>U,3SMEX M&FYUYZ+(1U[98EWG6U!9C:09B'7ATT011/IH9%[ M-(&2L+L[H6YNR=&\>5]7)=/CIF; E FI ;# M;U&J11V3-3JNLZLJV:E4 ,-#$Y2J^>CQY--HP2Y0)7^BA\'\E]&2S4\O1L./ M\_'R#->H]LNUJN^(&BJZSK2JZ6X::3FG66^HYER;3.WR[1"QV:UA,V_/9@A( M?V3@^TF.F_/-?49#_:TY&!4=Z[)@=-37% P.GXQ?1>SI\L-HCF:#WRB3BXNH M!\/A_./H%MV/!S?C^[/P^OQ+?/7YS-;9W]YK>&9F7"W2]7%2M@IG8L,YST\$ MKB+X?'3/MCK-!G/*Y.+?X^ED\6$\ \?K(N_,#5['":YS(MV2_Z19X--IYF+; M2N^IUJ.LNIJ!/>$3R"9FCS )L$ZJB@RG#[/IA/1MRKVKY-^C'[Z]GRX6 MWZ&;$=W%5/Z(EH._0JLR]$!''-&S>]4'(A^EG/N[P1%>!WU7)HZPZ*:J'.VZ MN)KT-@>PBASK@ZIZS.;33^,%W;%'J@+@FE!=;4,\+C>D1,8#@Y.MN:D!1[DL M9G\O4P"9?PQ^Y4;QT=UH/B<=)\+T\A ##,(7F0JF.YQX] W2T-0'^][\#(Z MQ-\;D?TH2_;S3!SE*I]_HI<9, 0_'KMR9_;'Y4?2JWD83\8/'Q\0/;%&!@63 M]^A^-%B,SCGRU<[HW.7$!_P01,$VW\[(I]L0#UD69G8&O-=\3E];#F9SCG-7 M,)?3SY!S/I\#?0]&SS[.AQ\HE4EGY6&\/,<13&'T3I.L$;G)O[I1F_ST^S". M5K0#MAIZZ>8NC+_4IRS2HT\]GZJ]O@]+%.41KWU77.W",! M\PER2Q.(VD#4"#I8N4*5'?0W:@DQ4_]UJ?4;;TOJ8+;!938 XY6= ?F%((J(YH6*>A9Z/J;;B0C3BB%ALHL33Y U1R]N MC0 &H&LN*&1AT$(/D+MAG6JPS3(KHD,W%P1-K4LQA>9M]//02^C<09KF--KM M@LP3>Z60ML<3+>0#3:2B0%BBP\>1Y*# &,)4D%_H7(HB"2%BL//"@9\%SVQ< M+?1%)&:/%'*0!S;P,D!H( 7&E7\EB;Q:%,8$Q8C=P/J LTV\.ES5.OU2IAF: MX83FH/.><.<#'*%O-5%Z7[=:*=--E9W3\%C$/#]CTF#1]HI0E 2HN-*L4_BS M%NXY+K(0QE]P@C8X5)[H>_VE^P[*5;G'0^\6])0OV%VMY:@T%UGL?RY:T=N< MWG)?I!IDMP TS_&EHM(T5H97FOVA4QN!8:3QE![LO&,\WL7IF25,6XMBYQ&FB!(R;MB MQ,J#&GQ:F8#*[[*W=:V_\U4[5Z0U@/9UH7 MA!GH@:%K#[#R3D->=!K"JM,0'*CJ,:K"8&=K9F25^UDSYYCII)98S]ELELH- MZ3262 D,(TV1:M)D4$W44(75[O.N&75Q0-STA5OW%;^5M;A-]5V>"6]SB7% M!?0R53 D[(=7=KE\I8XJ?40-7*&&"1AD':W7V,^FZZ:?TXCNVY?MHE$H6-VC MI@7>VK8DE09#/"U$;GQ?42LADA?:!JNH#<5^F\$S3OC]C3UUK6V8[>M.O8O6 M5-$YFXY!*PMB?A7$<)-I]1ZIP@:,,#8(P_B+1PJ?8+^-\\=LG8=5INU#HFW9 ME+"ALM6Y^5X.M6;EC32=$_4HN/Q,/)=,_0K5%A$9^Z-A@E=!1D8C3B9F0 M3LR$;#WS/"M#\G[E&M-+N8=QOHNC(G^/I"LC$K398Y0#;78/>2GG%-%"$W3\ M"EGD,V%V&%-]7O?RD^5WY,?JTL9?@VPSS-.,@$I(KS;,5T'T1,E._I>FPU', MJ_K")II'$..U.1&MD[242TL ]) J2"$(AA E(/H5*)0DLC-SB=1#1S@1I MA(+'G-T02)"/MKLPWN.$=#?]!+.CL,F^*338TI&/=.'G-*-VU]G.\0':2W*G M6 33.I[%#7ZACQDELIC((50>J6:BF#4B8$HS5K MY WVMN65M/?!9QP&FSA>3=D8?7:-SWTUJ5O;'Q?19Q;(KM#JH MPF2:X2=PRRD3(D&9,M'@$S#G6D0=&&P91%FP"L*<;E<]W$M73-GC53&EO]WE M&8O-T_7(2R+B1$J&22R9D7+FY$RVK<[OGO-SM*:$SV$83/P\IS=<"$9CE7O(/W2ZB4HSK,T(RT],0BC"BT3CZUNU>D?WWM!1+?TW.R7Y-VJ0QYF MJC8K0!]GFOPVT0-#WQY@N4-%A2HZZ%XAJLWZGM0$_>%QCZ@=]DR3!,HF35P-73>%V1.6VR>8/-D M69=LFMF6'\%N/J$ H)5Y,2[Q:<5B5W-FL+_I@E^Z<5V3XG/S4K:^^4_%-X_P M$TT@H.JB*S!RBYKEEP\/*DZ)+FBT,COTS_PP8"KBL#M;&[/UG^O,-S>,4B1,?G=6!" M=+W%6>-18BAGS$DL8'>U:_M.!FI@"\4(M+"L]L6I?AKR;O$N3@,HIQ^J6CSS M]K0&BT_GZ(3M9FM3 19%YK8DG!Z-"IXTV.X*:?0OWG;W<_28[HPCKC-.U=7% M]Y,B9^[3X(J5)W&:SI)X'0@_>^,QH$D/$:KNAV8R:,>$''W;^J[J8@6"SN:*OK% #%Y/ M7P6R^^GI0T0_!8H+K3@"TJN_R=,@PBD]:?%8[G8BP_SX*0K^@5?C%5WU7 => MG>FWRN1+)_,/-94\R[?5(=K!8\J.VTD^VR5?:+-7=_D/UZP1EWL;M&IU<4^Y M =-B,5J>?)<]O-I8MKO6*Z7DO:^U;BH_XZ6JJ/"E8#H;MCR5+8=!2L%]UF]1 MK)0T5DEL%(#@I:^VKDH_X,4J*O?&K[.6RMP4+==]A16S&:0:.8ULQ\?6JU]M M)=5\3"MM:N.]7V>%53LKG@T[+,]>:@K5AHOMM6G1E*$+%-:F>=U]XGKBV#X$ MYW78K=_:ZHRNR;^8(MH5FE]?(TUO*(\(SN[!] N_Z[4VP]SGNE2[6[_H:YYI MZCK)GWHNGE]N=?)BP4>T2"J4&6O?XZ%UQK[,I%'T. MX8XTVR,1-9;7VI3V_MQ6AK@J(,[[RQ"\UVV_C%DO^JN=;&Y^+=NE\Y74=:OU MV6J=S>BF'%N=9Y&;IQY%>YV5DF;T<+1L*W_U:ZVJNH]YJ5HK>^]7V>AJG!7/ M3'VMU7>6T.U=V9ZF\I7>_U@JL_9R7JL'2%T,90+MP6G!C,)-G M?65<"5^A" -)(W3>^;W65?(IBV/+C1>]C^/5ER"T,\>HQ?!::[KQY[W<)+4& MP-=<\TV=YR>U*[VR1?]**_\M7F.:M7'IO5@;+@O>^5HKM_3S7:HR M,B\%&>&97#'97=34K[2B=@:RCZ>K6'RUSN_)?%4/,7U=<\Z6ZN7 MK[TVVJF#7WO-,ZAO7VM-:_YB;Q99^-;76@<5G_!2%5+PRJ^R\RKWDSLZ.Q[< MC._'R_%H@0:36[3X,)B//DSO;T?SQ;_\X<_OWO[I9S3ZSX_CY6]?7QTN%\;< M5&75RU]KC=9_T LOY?ZSU&^MNR>FNOQJZG,[+XZ;DNEB^(IJM_CS6JSD;0#_ M+'5=Z+4V4UG[D *0%&67_5+5Y%QYQ;23TN(P?#WU7_)Y[=7_#H"O>17)U'F^ MY2^N9$FB/ABX(N*X0@W<;*H>:Y>&Y=,+YX00X1K&:39=B[G45]EZ;@9CA[C\ M"EI-*$/ZHU!SF]6T -W@=)WBX(?[B=!R5:Z/T#MUH-7K)$B].5J0WG.S9?;>D7SM=+[V7 M(_HCEX,"I5-YZ8]MVDN]% [G%1J \_Q1-':C^;>%WY[YIXYC&B2Z'=&X( M*:,;/^UQLC48S9:1RV9MF-*4<_Z?![]X!2THB5RV;=^=Y:36$00^U-^BGA;_ MUB8![&T*!'4-G#7BK<(.?-+JP:N#[B/3J@A\ELQZ1_.6H"[KVPV.\!%C3ZD9 M0'R5.MF#JYR-U\)3&? N1\NG=!+D6V+AF5B+(T28^MU9F7KY(01I./A+TWIT MR#KZ4#KK0K=,>]@M9>?,/19QE[)$INX&L-!J+XQ6,$=>$I&>2SK#R6+C)?C& M2P/_-@CS#*\,ZZN9*9?AM(^SJI!J8L^7K(@#)GTVF>I1D!2;X T#Z8J7L"I2U1"^@[$7@*F)K)^ M0Q;[GR?QS$L^>:%T"YA$UF[=4,!MDUP@"(BM6_/-F0H3CK?=:IW3[*F5ZH/AYQ&@N32^!,_& M2S$903047REM&SN QT7.M>X _EQ&@5);\0&.)+O XFNDO]P-+N%03+H#Y4%& M506PTWJ21F>:+#*:%8$U/M7\G*8ME:G]_@[*!L1C0/,]O6+2@RJ?K[&5S# 2 M-#[I-'I/N)[%H>\=IVG.3A\T9G-$4T6]U*W- Q[A5#VUUT/7><0X$C#76-86 MFG-NC'X!LU)<''6PXRB -/RZS1."@P /XJ)6-9>EA/- AKKP0DEOY-WB731+ M-H35?8: R^BY/J M'IJA1Z"'V7X$"SG!] MA=$05>M*5^CMN^NW?[Y"S7>BQDNO4/7.Z^JEJ'XK:KX6XM2SEVYD@S?VR.K$ M<@-,:^Q+?G=..P$8;LA*'J$@0H]>]!E&\2Z#+;XM4Z])_&F+V"QN$;AFL3>? M@RE^ 2CN*!L1 9;PKCDZ'D[4'TS-&EZLE$PW#Z7)^J9ES$]%ERBW) M]],IV:2ZF0--'JLUH,T'&:&59B5.:BT@= O#^ OM+Y(>[&V)2#:,7_."\R>\^\ M1)!W[Q1#UI9*3G*T7C0YR@J,!%TGXY=-D?Q=$0;K!*WIYJJQ/+!.V&7#5@)N152P)IDNJA-?E7"6#GJB0Y>4Y5H-N M@]0/XS1/\"S!.V]?[7ZL.LBB&VEZ*<)9F#L.-C?35LZRH>D:,1/!"E698A Q MA&Y!#0M*B"5"=7],(FMUO*N"VQK#B@3!! $5.O[F^H)$Y\H?).D9'5I#E@-E MX9$_2&7(DN Q)S:$G2"]CK7^CBG\.C[I%)QSI0]*/E%CK5:DETFI(EHU-"]$ MH\-T"EM="+A[(Z12UJ@BAWAHO#@1&'20XN*OT2X$41:CM!2UW7\0!SNZ M9"CRX1I'<*':[S_"&&L< UD\O-AU@GUQ#A)8CZ%8&YP1^!G-?O7W/-C1;A*; MKI)^&;62W3Z$B0-M*JHTG(>&7C"Y_FK^R'@-@UQD;)YO+ M>)U]\1*LZD;IU>SN;C)SHKWS2:T#AEZ&0 6'?)@L2DMA&'RC$\D9O@^>\6H< M901PT+B2I&[$FBVBY+,<8\@F)X]WM,G2_E; \/9HZ/HNCM=0 D]K^7U-.B4@ M=)5TVM0:L#IM1E@!=]J:M81M(&NY(!MY:)2LCAR-'&B-!Y4:8**<$4QNRTE# MR:0[>/DU5;H8G&9T&#..'KSD,\[HG/T"^WE27 RF7UTU-0%VG;6W ZH5UX,Q M\BS!"RP'H]$M$VN.,7GZDV#(@D+6]_4(*M[O[@A,$$S94Z&2W406U MSH66S$2D_Q@EN!A\?(A#>C1;D$>YK[*U!;;>#M5AS5C3.:..@MNEV$$6;0IA M].0%T643*8]>?':+R9STZ4?K-?:S::2,P>(-D$>9L4;!$YRLR7B$#1BT/!YX MEZ"5I>)D V:V'$UNB^H:3<$G7T!6:T";X#9$R]]J47=X2.#8'CH\Z5D[/&G5 MXR%FOW^*GW]8X:#H[) _NGT<\M/OHR@+LOU]D-([9:0'FI62-H*% 51**868 M\RJOQ\;5:B:-*G& AW@[_;0;+Z0G!8JD &9=NXZ*P[ZR$+RBR]R2=\ZN'B#5 MH>D0CZX,TC/ 'E)Q9@5/A#SNM;7*3 HPLI.$K99$TC"^ZO M0;891ZO@.5CE7DCZ)V%.^\W5+1#T$$>]9WM&/D2"LR!AFN7=.NG-?AED(3L0 M6IDALN17XJ/X]6;9VN$"=Y/]'>[WX*LZ?-1@&H)7\ZFDTX3Q&E6ZJ*G<2K;] MA:!'A_=>H=H!Q#RX?F3IL"H?V#[-MA>HX1\Z0X+%[99#KT$7%'#@I4 MAOU>12XN5-E0X#*OL+N+YOP?I[T+YWSVP823"SC%[P+J7=DE-?FL(R7)]%QS MHH:,_T73 J(=0CUUK4W$]76GGGTS5832'3\&M'K$%,71]44F="3,HX>+:%O; M0]E:]SK[5!-/F--YW'T*+CBK3[42GO!RP4+#;R0W$ENJNDJ]FE< MD44^B1KDN*>&?(&HY[#U$J]!]->&,[%T G;QH;8S!)0+=MOI28)L_X"S3;QJ MSZ4EZ2;8'5)]B?KDQLJVCRJ2]RMG#?L#YU81F 52HF7RLUVMXOX>BF)>>I 3 M[Q*ZO"XJ.H4XG+K8!ZSNBB>O5G$12F=)[&.\JH^Q3]>2AF(9-]+Q[+F@>J0= M.$5Z%B_X)!&%O>*T_R'@ MGM=IMCZNETO0Y\$F#HO2F$R73/"_F7.NF(F:K5 M>9X>SK3F;PSTG(\GC@ KV&:;DZ9^E>."C:L@P3XA%HSUOM.68\%$D5YHN:GP MHD'8U;&GGK#*&**56H0&&3RR)ZZRX3[-.X%1@;5S**?\*IOHN,J<;NR5*HJY5 MAL3%7HBY>1,J[6HVLH+:\<"LK(R5H6U^[P]M6.ME(' M,274M,>VG[4?@]I3)OD.]YI]8GHUF^PV=:))9)T.&,X: N63T$HH:6,;53NE M/_L7K0R;8)?>XM1/@IT@R4TO38NIC?NXTDAP;*+FG&3]LCB.D9,\C" $YV8TFO.["$ MJM"V)_2%+;T7ZV 79_W(A9)-%#D@!;/31EK68L)YBXT5N5U*C B@S%.X2T, MC;,>=8+U'JRZ[)IT:Z> .BC(I>$MGQE@52Q 9S'RVH,?5ZN;JGO.!_[?\X"P MB79:A$->4V5H8;P_<.,KWH,(>0<#CL\42_S\Y(4Y/K)P.=U74K9RW$<7[3,U M^;IW)4 K.RW0;F&5>P@#IG+N'0G2@=4SCO+BYAO1GL!VEU\F:W$HI8;;&$.) M!:$TO28@^<$3$X&U/)GNO6:NO+\9N\O3QSG9 MGN;H9P,,N8\$SL]W%&;0P?;]@D=_D*<&0IL-X^QA$;+9V MCOWX*:*G$\8K,K@+UH'72%Q>>$>J?&,MF#S+M^1':2[C\[_%\O!819P+.M,HHUOQ&NZ.(S_!7LI.@@CBC>2+'FG+)OM/'^*>B[U">V4,/8 MA0F>)EF#W.1?76*3GWY_B)/LB52[^]B+TBEI'KUPE&8>[6*)^\NF2C:HVL\! MRDDS#>?DZP63&\F-AJ@:S5VAM^^NW_U$>R)>B I]EN/'BUB6R79>@>J5B+T3 M$;8VU2"F0/7C+:;)PVD]')*:%40YJ5A3TIP4VQMN\#JFUR=0.;;C^I;\D6:! M+ZGM)UFTFT#U9-?;!_J.-N>\LIS/!R[G"Z$ND&WW1SAW1_X9/,EZ(*<8!$[T MCN,G\KRT]IIIWG:AR_+RJ;.CQ[W=&;UDB1>7F1M8>R3NI)V) *:O S3Q8<-+ M/EB2,=TC,TOZ$M0NRKP7&-&SW VQH/T8.KM#XSKQNMSB4J8NE'Q+0UVKEXKV M<:>5S\5$$0R+^Z#MLO$: 6J\2T?*0-N3>'(M!Y33N2 @FTP%<T.'F"&;2; M]K,.MRI+'=Z-^-;/A(NLP7V<$V4%-M&'LL'@!.R@8V'E3UE[CJ.H3MD%../'%2U:Z M6P:,++B(N#U<$X5= W4P?=3^F+FU)TR(6BDA>GDF\JD:JO2 TI;NE2YN/ C# M^ O="ZW)A=C#@%/2:AU3R/Q64C? 3W19HTETP1BY.O/Y<:2&O4KO0 MCFH.\"W>)=@/1,OY)@K6]E8; 3_%.P88I;?@D'X<\ICP%8HPD/O_>G?@H/37^G7/7D%OK'?G:YAO.' 3)J3\4^/F<(^!FS2L;]CK1M>C+7!D+,W9"Z9(NDBFEWGXIJ>]!!*Y =A M,1H:9'=X17P+Z8)23H#L6\*]/E=/R^X)?=2GT#.]EUG@5> 87[@=R)5P8UX< MD>H$I)HT5@*\;;EC7]X3-M:RORM2ZP*_\TVJ H:69CCY"_)JHN&#'L ^[) 6 M;I05CZA':WAO#H<^'QK^B%:*DXY)@"O9%E#'B[/>)!* MIJ5TGT)"V7:^88MDZI'>Q!BP"W+*O1;\!:'->2VEN+4I10/0]?2A0M8Y7PP! M\ERI-*H+;*XN3Y0R0^1=G(RC-$\$$WAR,8OKJE*0C=543@8&$>3 !$NF5)+N M!R'#ME(61F-$MP!@?)C^IB>OJW09^UF9\W4)@AD$R:G&(1/[Z;CIQ.<6GOE%&^X("#YCZ^8 MY'?DZY[S4Q7VP%.\Z?;)#*?&7C?!&QX(^/VOKXO?)WX8F.P]A:RP#LGT1"V^ M7#"D6JBZ!>(5\/-CM I2=@\*7HU>?)KDCMV,<,Q'DML"PUR=N\8TEAF"=OS@ M%"?$)Q&JI&TPR"WQ3/(UI-)NM@,+(8OW K=$P33J:GR"^W%2FFF-W=5 9^.+ M: GNUM49^40;@FSZ& 9/Q?H[[9?0^1.#:35C;9NL,B,1K(EB*3[QE/ VB()MOD6[4HW=8QEDQ37!"2[N M"G&4?/@,4U'@+@/6 56>-0T^@.B[A2K>>-0=T#*SMYJ\X>-ID>#4@5P^@I]*2TAKS!%FK'25LE[PO4M1))7R[A&W^L@ M[(ZP7219?J(+'4C3]=!+ M-R2JT/^,_IX'SU[8[0>=Q2"L$CV3-UP^J?&(WKM9&T$>LT*WX/C$ (O![ ]\ M, 6<'JP)"5;LZJ832-$T\UJI(/"A!P%*[2)U.WH-I<[U.$XM?\[@JV:"S)L> MG-A)^F? V<&N.2 #32I-/\# ]Y,<-^^R/X$I>N.OE37&GO5@4$QMTE$\,\I( MY!5FF]L]W?3LMR3>)?3;T32BXX@VG]G^T&7E._,:!5CE;HB6Z[+7:D5:5-)O MQTR3_%6I.AJ(%3>-W^+BOT>,J_N; %:DQ^(7) EC!DA +_\@Q2P+]H &X[,D M]C%>LA6,#)=QIH)EJ/LP&+#:4[P4S&%-40_-TJ)/1J^I4-V ME,7(@\"(DK'+>."S%73)5 5/ 4-%8&7>#_5KFH\I>B'+Q(O2\EXU\JPY"57\ MC?$P)DU4M%_&G1DJ$?6Y8K_(6V!QY)(N=@E5O MEAY<5\2-H$2TH7TAWO- W MTN 1 *;B."+O]D*: ?:)_AE'T_6@-EFZQF%E%*37(,\ YFJ^T#5,<5,3Y& M=%KUQ@LI^-L<=ZO&,(XBNCK'$MB MB5^_!'TA;X%))GYB;AI5EXQ,U^2_0?0TC%/!A'A/?8@$Z0M>0@7!+"0B9;RJ M;CZ+2U.$$:FC">_%QDMP%2\'3PG&]/,\X.TC3OA^A4(85C$:(.5Z!E0%53JH M5D)_*]24N:(O53P/R8?XRR_QY^$FCJ,G2;&(A& 5AP)AMQ@>DN\1$49$&A7B M3@M@\.3M,/F#K6P4]QQXX8 E^VIZXDLL"WE245C%IL7)A;M: 94:B*@X+9:)MR4] M^6Q331IQA=$5@%4$$G3!$C';OB& ]5Q61W]PT_UW:3"-L6A-J45C%H,5I M4!.("K 19-O&H>H@S#PHN&1FH0IJ@2K>$Q+YE442M_R<%D2L]#S,5V7)B/L MZ9K>2Y7LXH0[[:N3A54B>J#+>IFY9D.BQ;Y#B=!G-P3)-'38A7=;)2C1[D\K/(P RL>*59J MJ-!#1!$13;?MN[_!JYPN/94;ELOS8,T=4.Q^NB5^R6["V/_,-_V]3< JTJ/Q M&6O"*J*^L-6;K X6T,$$J4]N:](<^SAX9GNRJ^V#Z6V0 M9DGP2.\KYOL=.@5816B(MEMR#;7#-L@4K1J:;F:"ZH _2K-@2UD M7<8I;09BTE!G>Q+_Z2[O'?TVQFW@L29AE?C9_%&UD;5I5-A&S'C1>A;F6:M9 MOP!(LZG[-F/R7:.G@" M=G--\*GLT5I\7>0Q=>JA2=#LV]4(OV2NNR^T*P"H-"3K! M-DTZQ7RX$]=-GRCV R\LN]3[:?+D1<$_F&NR"7^- K"R,$/+E0U3JT8:>]14 M=+M9AEZR$.X+[O"[9)I/816$"!JW+Z:0H<,%(N2D.HRVNS#>8TPCZ'.P(A[= MY9%L E,E#.OK&R#M%D:M@FH=1)6J^ MBC6SG\SB,/#W\O&K0A962>F!"E.J!2O$5-#?"B77HTCQ076C4M)I 2PO0\C& MR?" %*)PD[VN#$V48!5A#\3\FHWP\ "4 I2<%=<5H9D:K$+LA?G(4_)0BK63 M_4];GAIY6 5I!E::X_ 66 Q=;(+=C@0&TCA\(#&>/'[2%9=>!5:)&>/E#_D4 MBJSQVY2J4 J.A/8@HI/'4;$42(\=$O0&S9^!&JP"[(59T 129=341E0=2D'2 MG+446W&W?)44S: -U&O!*L8^D+ES$*3-:RBC2AM*(38.!AMT8)32L K-!"J_ M:Z$XPUPJ02FC<1P%_Z";<,,'3W8Z4B #JSSD +E.8R&)B.@UD74Z%3+=XB?O M)L32":NN *R/+D''I?JG8HC).?W:O\5Y]'07)]L\]"3?FQ>!]<6E^+K?G FB M4M+I5U\FP786YK)E\/9C6%];B(V[,XX(_2^W482M'?JDR+/-T$OP,,1>E)+N MP(V7R.**5@5621CCY6)/H8B8)J*JJ-9%1-EIP=T'NWCKI9\EA=1^#*M A-BZ M'[\22)ZS601$W:[TRG( M8EHM90F!6H]A?7(A-FZS4RGD=I/&W@OSA RY_8$?K!8XR67ML%02UJ?7P>1V M8M3RB"H@IN%XAU^>IOC.HQL0B[ZP-/C(16$5BA8GOQ&0*J!" U4J;K?%T!.\ MJU&T>OAM+BD.7@16,4CQ<3LHF. UG1 BHC ^^X=?;G6?O18!^MF[^!2?G8@Z M_>QW<8*#IVC(;L#S]U7&0'I3=X&RO/.8*PQ315A%U!.UX)P+54=^J7_(H\N& M$.SP?WVWLYN4&$TO=!&L*P:KK)08)56JNE8;1C0KL>LB6E<,<#$81K:J&%Q' MM]8%7!6&E)?JY@LZP)W)6 5A0P>U^$E M@:D2=#L@_.56\\4Y"5A?7 :/&_B1& 3BBP]\G][]DAZ2)A17!G9^;.]HX$KE M*"NP2NX4%[B\2Z4:O1^EU*ON3.1^;X8Y5ZFSWB<81[LD+E.M#>-D)ZE^4DE8 MA:F#V2VP2AZ5"HAJ?.]V(D:P\?ECE& OI(L%5;KH..4KH[$FK#+K"YN_$:"2 M19LR$S:]^M+-.<[&$&ZT7F,_FT;*A$2"F'J$#5@%>KP#W!I9:T"+F2WG6;0D MAQ/,$FGIE&&5Y!'(%:Q M&*POK\0HZO<4PB RN\XV,8Z"%[HS4C&.$$K!*@051&Z&L9!%5)B-'!$ $J0MH:W9 MAYDD%+IQP-, <6ET>TG1XG *9./.FI;%J4AG4&S%@X<5$[D&IF>[]I:D1>94 MV*Y$LK1S3(^V[IJ;)SI^8K3HG(1YYNBZ8!D/L[)O@X?VSJ_D'O!>IDKOL*I3 M5=$B_,7M& JD*H_[M$ZQ.ZZTLHY:(N%3%;);>)+CV]+1]6WG(-:"M(@=06DY MS1"\['1YQI7 H=;UK>7UCUO$OP! N4EVCEYH-^ ):HZV._""1EJ&&F\=M$QQ M?@.<@\O-FNW?I>YI(S*F#+3WG)>K(ME94VSYB=$B>1)FU[UX=3ZZD >F6G[! MXE9#F(D#=UT7;GZAQ<8^+*,C?3X+ND[J6\MU5-4%]^\11GE:+]\/[$@?8)F0 M\[?]%WR*^[F)8.XG)FX8X;[<>%"HM7;:(*YX88I)=Q MD,JWR8HM><;7&+(+9-8UFJMR1(8A6[C"-!7G8B4@JE?*\!XV3C%7"LD2O634 MT;ZH-BOA=<3L*:DVH#[/.'OF48&_8DNR9FF> M/01*P.2FJ)INA=4;L\+J_U9(PPJ_\4>>U3*?4MD97$C*,WOJ"PN MTT*%=S"V9'7T3U9)<6XY!M/H^'=788_(UM^SNDI$IW8%MS**T'KE3GS&%BR> MBNB27F_]!=/&&SWLHIZ@HGF&H?HJ*N(2O0U+P/V&DM+7&3^YH4\*\ #C.D"V]WVF];CLX,U +EF+XRL._ MZ?NG?/!--[]3?-/[X!QO&HJ%O;&:<8G$/8IT?Z?UINW@;..'>MLAW_2G?+M- MRK(]E!U(0SA0EA8#XT"-R/^-A#YK7H3.5*AR$%SD19/GRC+),V8NC87"ID M2B/3*EE')Y'#\W;!R@&@O%R6/'(=X!YOG TLRYTRM)CV!^Q>E M1=6,.9*$K MJQ0 >),N3'>.4EZVXSNZDUUP7O[#[*Z.@K1(&D%I9@=+ME&1I,^LP-5A*?K4 MJA7''-6U6$@FF3A&4-%[ED!CS$06:WQ:HFOL\KDC";_R)F6F.()(BO; .%\+ M,:@MJ9Y_*]E#GL>B&/I()RNNCD/6*(PC/NHO\30D*2MQT +/=C(W,RC9X",Y M' \*(_'(("F7^>[LEYM0 >+\)J83".2B^.1QRBM.8OB&,3P':0I+]Z'B? Q M>.?X2Y1DN"-FVJ:G'"U3G0;:?497MQ>M'T"(O<.=O_=,)%CO>OF:'KYA3EF@ M=^YJ&/;P0'*]!FO__%>=[ 8N3HP)T*+5$ZUEBBW$1,>7@JR1#!VF2DWT;]8X MLN;97043COX3VDS](T?\(EPT5>G.?ULEK7J1E8 MR^F+.4V<%M6SL!L?!*U$+,UBI:8))A;D:/&VR%>Z<+T?8,DK39,#U?33U#*FIV:HF][7N78O<"Q2]@O0HL&!SDP9:WI1A(F@AXM@ M7-'B/D64N2(HV8O1>O6#&(U0=Q]6JG2P]U^7'QZB:/>S]=[O#4"6GW_^_C-= MID=[XSW,ZDT/H;*'FI:% KW;SAUWV[OM_$SHW=I0F5G]FC*!7JW8-\,(H+PH M<4.S?[G!7>KGO\B\Z %PQOEMI^AO3!9F9Y4\;A%[[S#!@0\N#%#A3?TLB_W8 M&9.AV2F&H0[T%+$S*XL'(@F7-#?K+W@LB*U0IX)WT! ;/>[2A(CQ &F>B93B MA$L("5*T&$.Y4 .:_8C9.JK9BQ)B90RA+0A4R3H"@A84"<3&%RZR=&(4G'B; M9'BR':%KA=J.M;$R(D*('5^D1OQT*2?#^/0DF1(--8?5NZ2VD#W.0H08<6-S M;PCKHH'>^76>-;=>+S-8S@SU#6=A0AR,8S27T:T$DR+LG1)Z'X@6"<,X.+*1 MXBA*B)(QA&;\.<$!WLY1$NR=D@G%!^X&%'P#6(13'^*[YC!C 8SPK[3&(_K; MO,!=A>Y\_CX'XP+U%=23"H.4'GWV>=JK5D&(_T.US.8ET]33]&0\N'N_8% C MSA:AS@5K:F6J6F,1UJ^9Z:H#6=\?/'G85%RG4+NN<:OI9GVW@:5BQ]?D8U0F M*Y@.G"=I#:5M1C9/$R%;>F$#]DU&JV-*'Y,*T5*$RI)UE"Z84"LF3DIQJ%6& MP.;PK7(6^OE/,C2ZL1EK"E%RT>4AY!:K92S# 68O*^A]$65EM!(C6A:+?\DX M:&?Q?VKI=*E'0.=N[:O71*@7'[B!]CWDP<^#SLO:9$?HU"LZ?*=FUE;=_:Z< MHD]T^!%C%EPC9Z*??+C)?H%7/\ZY_/,R,]U.'#/_43E"G7X27,N:0 BQ=UK\ M/;JM-\G[6A6$270G9IROY8T1[ _G^[%?@!9,OR?UWS/S26Q.L[-TT":=R_@ MGIR#+NE8LL?S0GVK0RW*S%9CW/RLR@OOOMT1($VG#:QU1,CRIT(X MHU7U1U)MM">I]G2QNOI,5$&:5#_DGA1K92+ <..5NVC2XX3JK->\^A25FUL9 M:SG^^/R]Q!QMS?'S&4::<'HV^DL38GH&:.-$F%<,=3"M! ,FO$,]P/5[UA[> MM[J"W!)1WX?[_&SU5YT4W)%)T?C@^@I2^*4K="]ZZ8U((MSX M@9QT&Y+]@,X4U6G%KK"B8T>$&1G<+Y(LRE9SOV<6:?K?LR'0$[]GC:IPW[/& MH0M0XG]X"^(Q2KDXX<&H89A^!7\XR^+^@T[)6Q$DS5R/*9>LS[]6&W@K'"/F MR3!Z5F>YHR(@9&>!&FZXVH'BA;36CGX\B]-5RQ_1YQ5'C&E>UH4]A.]D84(C['3,7M<\40EK MM; ?X:+RMGNB\FSV^39/D]7S().NLH2(&X5HRW,O!. S)$38#_5G>&Y@#@@] MOWJ^!<05C%1-M$]-,GQ>YE5 #]9IER& M-H#9?5+QJ^01%H$"H[T3C@@18M0?J]DMM:1.SL.D\ L0HOO&L-B61W=6O299C?/:A MRZ3[90AU B>T6=%R:%W4W',4:K)JKU8%+.8[060&W,"GZB!$[6SHQNBWYS$E MX][+2&!2&>MH"^T)_K&&89J7.+PLDTSLUGQKXCA?QIC(8YU$S4Q8N2!@H/AN M/*)29"AOUJ0VTSA(183LY[#MVS4T$[FZ-:BG"=)W"(KM1H52U MB\;C_=@N7^(S]YIO4'4J6=+E,W^\6@G8:8#&NHSVH+6?P#C::]NAQ])>903L M]'AM/-*8JBH/&P;T-=^F<[_ST*;JK/A$S7:\O40D#?GX-ORW,5\"EGL")GM$6SU](PUH MG:=EE=?\X-MK4,6)6F&W9<=:A_%C[XOU#G@$P#(1SO>W17Z1%]M(YBFQ+)FF M21*PD9F 7=2/:J#&Y)U'UI\B]!19M<*=PV)$/[%/3AGP4F#P\:.P2 M!%B;"-3I'=.-@KGDZ[R P;67?_@3C*\)3"Y!:6@G&;_LRD.L3E% B>19N+TX M)T>VS*-M- Y3%$T(ACM?"Q5OTY>!=W)?-))BTA19GH<-U= 9V.IM+9"<\QW M2\2<$/Z>(]@\^'>N[80E"9N )=)_<[N4HV]EKH&64C+^$EG*9.<)MB=F.,?+[ M"E(9["?CM=U#E0HPE&"69Q^VC0Y6-DH"7S^PM75K:>M>+YP@1I30,;0SZ5RP M+$S'5 MR(^Z0P9JK(!6>1O&9<:WL H$^9?K0]:X")+CIEJ^B=$+FORGRA#YS MLV [[Y4*+7(/$?7HO#Z4D@=JK"K'T R&AR4)@9H9X]&AO6*I%'3[F %W;$RVME=(QO3HL'25.9&?B!=;%FEJ/0[QS+? M5HYR7QI:TEM[C[EOK*$F)P,N1] M5J6"12=^O-#1R1*PP"OM2\YNHR14:MG!5G[/8@Q.5V>P"MVC^.=PWU7*I%8FU88*0@;O8 MGVVL,UQ/44)\3T5L1"!3\JQ5T.W."_8GCPIVDX4:K1WMN^,@&R.V"32V0O0) MM&"=1]W]4TZ+NOM-4DQEKI&A3YP)=29OFX(3ZW07\/ZJS43J6B'ZW%FPSB,/ M%9'ASH\LTNQ,H_ ]02P,$% @ ,68-41QO M[WK[5@ K(D% !4 !A871P+3(P,C P-C,P7W!R92YX;6SM?6V3XKB2[O<; MGIGO^X-BJ*ZB:& !:IG>[],N(P G38VQR]5Q?GU5[(- M&&Q)*6.1@JZ-W9WJ*DE6YI.24JE\^<__][+R6D\DC&C@__V;=]]^]TV+^&XP MH_[B[]\\3-ZT)YU>[YM6%#O^S/$"G_S]&S_XYO_]W__]OUKL?_[S_[QYT[JC MQ)O]K74;N&]Z_CSXK35P5N1OK0_$)Z$3!^%OK4^.E_#?!'?4(V&K$ZS6'HD) M^T/VX;^U?OSV!Z?UY@U@V$_$GP7AP[BW&W89Q^N_O7W[_/S\K1\\.<]!^"7Z MU@U@PTUB)TZBW5C?O7R7_T_6_3\]ZG_Y&_]_CTY$6HQ9?O2WEXC^_9O"5Y^_ M_S8(%V_??_?=N[?_?=^?N$NR_%1JOJ]^_777]^F?]TV+;5\ M>0R][3>^?[N=SFYD]EN$Z>8*S_3$K;@_WJS;?:&_^K- MN_=OOG_W[4LT^V;+_)2#8>"1,9FW^'\9=KNO.@MG39QXS?!:O>5_?-L)F#2R MF:;=EB&9__T;AS5@H[/Q?_K^.S[V7PX:Q9LUD\J((RI4S/S&H8+QZ?_2H%D.-XD$?5)%-TX[I=%&"3^3#5' M\ -\3%9K9QP,YQ/Z,*G<[9D_+CMNNQ#,3L'1X%'74K4C-4:I9F9?W)"ZCQZ M;'7$)"11W&7?BC>?*%%-5MFQH=TLB?P4.K:6'ZF? JKF$X9LAJ:> M_\08%82 )531M)DYC$*R=C;IKL>HOR7K(*)JQ.6]FII9P,Z\>,,^P*5JS;\V M(+%Z:M)N32''],8%Y2(314RI ,Q+TJ4Y:8IB3F[/OW?"+R3FTCLA;A+2&"AB MD/[-SW80^&]6)\Y8-49#YS=3',.1L^'?B++=(DS(K,].#.J!Y@P?H9D9%W>O M7 _FGYV&CA\Y;JI0JJ:L,413VIN^DFE6G\QT[*GS A'*4M.&SN: ,=Z/\UO M<#ZFT1?UT2SKU-2\5BL:;\\"]D&NU!$?HA@"NIY3CVU6GS6CURHO --T9SGY M'G$XS#E1@!%09RS#-PO8Q('=S=TR8--4]T33ZV$$G#QPXSH^;-["#B;U?=C4 M('V-ZO[0:0(Z&[L'0%%6=#S/G0 NDO!1SG<_T)\];*1SW16 1[7F.&>[-\"F MKSU0XQH[5$P$'8QKR;#Y@0=H2%=SEV26>(0I6,EC1&?4X2<2%[\H"ES*((UN MV2JBGEI3TQ[I3)IR_M6!$_+KT9/2,EQ[P*81Z48Q7?%%]1"1>>+UV:?8U:[J MV-.&J/;0YZ&QXMALB$3UR$U3>$LC9[$(R8+/A;^\AZM4M-@EG3 5,*FQP+2' M;)JFNR D[#[62<(PWYKX-N^ED^B^N.GSW[C6WE%WY'/>7'4WE--&;1J[ZHNI M-E"@80S?Q'6!T!ZH8:G*MIRVR_;6D,S8+EM0[MC?DA6907&H/V33\L0.C3N^ M 559$K2E2F,P\BF:2HH-NQCZ;^XB75)U_K$P,A?:,&C] TW[E+ M=N!GSL.9*=D+HNB&S(.0[$S+V@C4&=6 5O5$>3 *NX#5IP0R2N,6-C(G(;O] MLB]EI[2^04TQ0N-O%?K;J;*K0>\C[8NESB"-VR:3. G)/?7I*EGEX13^HD^< MB)RRX]<:UBAMHR1TE^SS^Q>CTXA2CF?\A4Q?SK2'DM&P#DG$QDJEML]^<="% MO,3$GY%=X 6G!1K%%=.8-\X#Z]ZUWO HO(3/F_V8MF;-SJJ1VV.)Y9$OMR1R0[HN!ND(V'O0$LCE]ZAL4NC$^^4PBZ -G_/>;>(:46%8>V[R>.-R;K(%2P_[ ED.L_8'*]BC949O]7 MPB[F)/0V$'Z7&@-9_B,FRP44HG(]]3N@G$L0MI=; _G^$ZIR(J 1E?&3)?$\ M;A!Q?)#$5[4',O]G3.:+Z;2&_5W^*GG+#AXX H4N0!!^L06$$K6H.(Q(2(,9 M._9# *EQD#>_XK)>P&%%G"]Z\^@/-\U!=^:\%E^1!XJP^]HY#I>-J\[]KM( MSO2*YE#&H]Q7E61:P/S/Q G!K"\TAC(>Y0JK(!&%[9E3:V%*TGU&W!K*>)3+ MJXI(%,YGCIX\^=H@63WN#;.''"^W@G(:Y<(J(@J1PUN+A1_SY'(R+A^WA'(: MY9XJ(PZ1VYWTC(L-'(>5>UQ/JJK>1SGR4>ZR23'SF=]B/PW :/ O>OX6-H8Q'N<WH.#VAG$>\],H(Q3%:9C+ C1\B!Z>C)E NH]QS*\G!82Q'.R2. M6)0/6T#9BG)YK2(&A:O]@+^S+ -?:NDMMX)R%^46*B(*9T/FCM"1<#,H_!GL M8X>RW1Z3@<+,/T(:LWEP1_;$SRT^@GZ91 MAG1?&^20VU7MH*Q&N2B*"4/A\RA,XT@(4]933S,>.Q$.YW/1CBQK#^4[RCU1 M3:@-_.]%44)"710J>D&Q0+DR0HG&V7FRN.?-N_>/4QX/)-AW2JV@'$>Y+HJ( M0N'P()B&#B_<-MFL'@-/'/!2V1#*9Y3+H80T%%8?S*::R4=-H.Q%N156DH.Z M2VQSW8G]**I;0MF,\)R] >_)"S&C,DS'R MB=U1W_%==AW;EQT4\%[9"PH#3LPHD&C$1X0_B.?][@?/_H0X4>"3679!D+TC M"+M L4!\NU20BPC$I\!+&*_"U'DU%*P'05,HXQ'?+ 7D87J*9D[9NY,I*_HL MX[NH!Y3]B(^7ABPF=.G\BM$SOY/&4HB'I 44!\R)03BQP%$';8L;0( MY._V1PVA/$=TWZTD#9'5DY7C>=OZ"3)6'S6$LAK13[>2-$16=U_/G%# >UE[*/=1 TG%A*+P/\V#6M2TTBGUV)U/YGZA[@7% N6J"R4:\^0M MY#60'KP'[:!<1[S45A&&&1&6/'K4O?,"1ZK''S2#YX@3H#D4) M-?L2F T58/WGVQ)=??8+8[ED\W*:[.@C!3OZ04[9]ZTWK9VM/4TJR\;W(S+C M/T6!1V>KB^ M!)0TM^LUA49^4$)!*35'2Y$KYW 5# )2[4"CN@)9.^XX8;AA)^8GQTNJG#+R M_L#N:*EV04 $=4BR"<1RW;4!B<5:^98ITEYHZ7EK0 :AWU:D#DN_U !-, !: MHM]&\)-RQ0XH;Q-RQXC6Q$_>"RU5< W0(/3;@=2VMN.&[0IB9 Y;H24/KH%$ M%7UV<#XO4)E6S1%S_K 56N;@&IROHL\JSN>E09D^DYK,#VA3 B+OC)9&RVA7*V95J+Q7$KX. ](1W1<@WK0 $EQJ95!%PO]5:& M@43$=70OQ2)@D\\JL_4SLH4S3*<7!['CI2U1<2LL;[6%H;(Q7DYC'0.#A$X[ M%M"V5O+(!TV&$'@(<%$<=TL8R'\X3=<:H&IJH/7O[HVNB(2;<# MH@)%H#L29KYH?:6@3-REWVU54&FB9""=M/X3^;5@4ZA#SFY[J0_:,O 8GR-^ M\XLW:F,$? 2\C-6G^Z?H\LF.G;(P:[#[BJP/7MKKNC (4;3:QV7[O#QR-ER3 MY:EF"/BAO;(37MYL..NKG]@E/#!TV>HD4'FRM1DN(\.F M57%H+]G2MU$N#%4_O.3:==<&C!.6H)8JM(>+F>W=[#=APG2E/>DJ71XT!%ZZ M[MI8ZO+'#EAO$S(-]%V)A'WP,H#7!4[- 3N0*A.FH_QA)A&OBXR8XBNZKNV- MFEHZ?54WO$3FC:OU8J[8L1@%)S?D+070%2][NA82(&7&5J,]2&.IHY,82+?> M^/*ZEGVTCJ&K =.6@33OS4!\*0:MT5;8T@DK0GTJ&^,EAH>SNN0**J+9#E * M\R*&SGM]QUC2N+%BQ-;.).N#ED*^+ MC()V.P :D]BA/IEUG=#GB1C8/3]9)>DE\I;,>3D.,5:0OG@IZ>O"!N>('0@6 MYI?:;GAFF9 L>66@)Y*]G?>#B#^;#^=3YT5JL-<;""\??NTE68]7=@!=IE9' M.<3,JU\7+C'%EZ[PJ_3C^N_;F)G]&[_?27G3J R@)D09I5Q=DIBZ!?W@(#O* M]Z=F1VG]]> KK]E2X ^PGYR0\F>0-!\PB>)NGB9IS_?VBC^7#.?5J0\$3[6G M#WN!^56:(=SH>SM\>HKH7#U::P7Q6N6;= J]-B%:BJ]L!MN*8;'3NIP)92%# MT?%.;P'Y*W<$=0/0XP#D$]BY8LS+ 9S1=ERV#JV<3'4:ABF39JF1;43"-#4B MU-@K[H^=9>8$'U0]%MD(:Y;>LIW$RR"D_]KK[BHXR_VP\\XT!J.()?;"EY8$ MTH1NVP<[24W#L!VRPE[(Y)ET)0362:5KT/K8*'B&LNPV^IZF?PZ".F-GPCD! M20WF6(G8??*6)JDX]80?TW#I-PF7C@:>9-UY$6IVCSEPR MG29!@QUTYS;([\M\LLMJY@+(KK'<^%C]1EAMIO\!9J;??ZP5S%O[S[486UH' M'VQE7VS]E7_SWRU)=Y[-:4>$VF8O[(#J^?!$_"P%)\,FG<\?-%YN(X]VV6IX M@"W[WYGT[;S68,CF>P6*);>(VNRR8U\N$' 8)0%"];@+MGV^-GC5M%L%D1H1 M"TSGM0"X&H=EGBEE..>)O-(W>A(^49=$D\"3JJ3B/M@&<#TTU=3KX_MKAJ]/ M%GQYXB/\(60*QR@,YC(/P(-&V*9L/0PKZ+OT13DA'AMSD2?IE7A0'+7#-E[K M 5=-Y>4ON(GCD8A?EF@4Y5>/.R(["X4=L*W:FGC*Z;Y\8#\0G]WO//[H.5M1 MGW)N\)KBRG6J[(AM =?<<6%\N'S =Q&$.66R5 +EIMC&<#U0A;2>"N/4CC-U M1U_9\B-!L]@8VSQ>$\\*2Y<5=\1!X >'<]P6)5!:H0!=T:WC>FB!F6$'=JD3 MD'#.DG6EZ(=N'H?C4)%L1!G,]BEO)7LCL#MZ;OJZ M4&JQQPY$JW(3/_@A<3S^ /K!H;[\N(/V1T];7Q=3/0;9 >IV5D.?7ZR&\_3A MK>=/DL>(SJ@3;H9A63B)[!92=T#TU/=U83^1A:9RKJ_6#@WY-L+GUO.S*>PW MEPH$TWSDRF[H2>^U<8+19=.JK*'T-*#O&+/PU%U9.JK.19I@#[4 _E!*_801 MNW_BOR'S("2[G.8DZKXPCC'$J,]VEAY3^]-41?R)-4@-G5O?>JAJU?!'T=/Y MZ]V(S@# =<@H(SU?>S?$)])7'F$']&("=61#2/CE&QX')(:8J8Z:H5@,"N3AH"Y]--ZFQIL&^%SXT34Y>'M MU$MXS+/R- 8/@%XG0^^TU62,';N/8M*U4;2@Z(8N'EIH7A2*Z3YY2R/7"Z*$ M!WJ=ND;% Z+7[VATS:H89P?Z?Q!>KI9)]!,)G049)*M'$@[G*4&%>"/PTJX[ M'GJ]CU/1#!IAPXG'//O:8Q 1Y!1MQ8BPSM+Q%R3J^9)T= >!8#_6"03+O]*B M?JOXG7]SUD'T6RO[G"4A8(6 P'K)RT'=4;-MYC.<3K4#E):&D6U M"YY2ULU#BHH^3S8 PM8U2LTU835 ADL2-! MP#WA"I747G7<%#OPM X<0HKMN#P($O6KP%%TPPY0K0,4B!-V@': J654-@YULX%4PQ6^Q M4^834=^;IIYOW2G?P\[C )83LPQO^!GIXE3F/]_C9WHX06GFTV]$X>KZ%KA8 MGZ(T:P!I/M6QMMIL$$?4EUTG6MYYP;,@H>=/M=YQV9BM=%#[7FMW]&H]TE;T MPKWS\ F-PN"),M1O-@\,D)Z_RUW19N?+4U9 3IT4HL98]M3=$J)9OD;5Y)@= M*IW9R!9C89+UN6XRYL4:O6BO\T738$SI1PZ(G0:-K70S7\.V@S4F8R;! ML&,3N24,')>FT+"?/9+?0MHK[L+^K_3W8O&!]<8VK!E%,:C!$)L$8,\<=BN% MH2[I@FV3.R/42L;9@>^.L#YQ(C+FOJO#.:.9YR2/B]-69YS2'@G;J'=&::C+ M9CN$Q*H\5L9L=V<4A[J9K\X>9"](K /+\O2N0B1X=W!O;!/>.21"BR'X O&5 M9MPR9EP\XZ;37(XN6[8A[/Q>QM)[G&OCJ9$1[$)WG-M\UMJ9?)0=T?/?GO7^ M"N*B-5IKR+7M6Y+]MT!P[J0+JL(%'@,]I>YY%5A-WMHJ$VW7Y>76(\8O0I_D M@6NPWNCY>&N HT)7S*7+/QH@U$++G]49"SW7[UGD15E$[6JDY[:J:ESFS*-U MTLC'04\5;$!J()R[1HGA"K?/OJ:YM1QT0T]);$ >*OARC?"/0L*N8;,TLZH. M_H?]T#,<&Q" *LYB6R1QU-/9WX)KV0\50O9,W+ M?T>%XZW*J36UR]08R(;,PC61KTLROB"8OH&,G$W=*^FNJPW)BDW=+X[X<_G^ M74I23[^)"@:R(4NQ83&QN9!W>?)5->/[U'FDGC0:0GL@]"3!!H '\>Y*=XLP M*1CH2O9>,[N$G&>V[A!I$-G1'L>]"3-ZMO*N>4QH#&I#JMVFA4&; MI]8*Q\[EK*8<5/9'S\]K G()I^Q %^ZQ+D989PST?+QG?,K4Y^VEYV(74)RY M?303"R8="SWC;W/18 ">V;&#\,FGZ0>8K/(WED(J C&XTDY0%(U9&D^ )("3 MV0R( H,AF[M+R"SU LZ<\@:!OZKP!N6;H-)J6'LT*)3&3(>G0WD2_68QSJV8 MTR"7,3:I*H=?$:C@[E 4C=GY&D)1DU^7;_Z%\ZV)0:E!]57K;G?4 M=YB*W(CN)AT+*COFK+L!>':&8W_K4CN\>[@'286N<.0MC=9!Y'@? MPB!9I]6C(C>KU\Z.QUVY=K$,VC WJ&S;9/VS@6^V61-K4YYE1"T_P^3\*/(X MX[O<0'G.>4!EUWQ22;CLXF!UZ;NX'?NUG3NS^4R;9Y+NT_?@"\Z"__5)N$8R MV>^-&RFW'VW*[Y\^#<)4!KL[G"AT G-G,(KG2Y(X=JN>! MEQZ=L?NEU*FIU!8*E#D#MB;7JS)'59%O"SPQ81R- =@<-80"8ZX\SHG 5!)N M!RJ#P'<91?MW,7^VL\"D&L[A/R;-\V">&U(QQ_,PV*?Q3X.PA,U(:^!87?G&E;&\O .%.,"DW/9U]Q M/.XGN?!3OZ7A/,TQ&U/@7X$YEH"%H- M/Z:>OS7'\(RSD2> ]Z01H1 ;,]Z>!'$#S#2U@J,H842PV14*_Q[.8>^4F'M( M#>=BD$\8#PJQ.;_.DU;QJ8PT!/"#ST/8;QR/3^XV(<8>CJPVDRK@/#<-9.&X<+Q M\[S>C.2;)*(^B:(;Q_VR")F6N1OGL'[2SZTW+6Z<\X(H"0G[QW#\H3WH_4][ MVAL.6NW!;>OF8=(;=">3UDV[\_N'\?!A<(M8*2D/EN.U#@./NK#"(I(^B/?D M+42W)')#NMX"YT0T&LY'!=&8,E&X81/Y(B:QSEC(59+42![=FNOSRX+E.4E6 M*Y[U>#ZA3.&?4]?QXS('JM?H+\=K=/)P?]\>?VX-[UJ3WH=![Z[7:0^FK7:G MPU;GM#?XT!H-^[U.KSMY7:F-6/9EF %6)[3_I:U(/;Y8L H_.2'E%[&M_;3+ M9AQO/E%2O?!^/5YXG]KC7ONFWVWU!M/NN#N9MKILO4T_M_[Z;W_YY?W[[W[[ MU.NF/[W[#;.<8%$7V)=!S/;+XD8YG.>:D>/M"R2J5VE#PR,NZ&HYV$,-6-,: M0R OZT:EX6@'T&:D!9L TR/\5)%@E_9'1O%!Z&5Q_;_[[GC],UUXD"G#G>'] M36^0:LF("WVK$A4H :Q?>2\+-.+"Q+36)+0_\H*$H";0?6&>I_:?7;28JJSU02I%YNJ'W:8?FEJ6BM.8PCD M10?#KRI87X=#%JR\EOG]&0%[ $P:-5>Q*[+%C!59G(#U;F]\/=F Y&KOB5;!%F0KJ(7UB+08V3Y M:1#(#BN60[ F3*UCT^1:ZYK/N>@E>K >?BROA^&HRY2U=#'PN]>(KXW_: VZ M4\2S94O3R./&Y@)AZA,&T!7QG!'.3NO4 M7\12OS[A4ORIK-9-VX,/O?2>-9ETIQ/L5?@A"&;/U/,8\X^ITM'Y-(?!C3 0 M3 ^D# (Z(Z_%6HB6HQ&@3+)B.>X]J*6IW@[69LE/AE^Y)E-^-+(?6_?M\>_= M:6KYF'0[#^/>M.Y53*E!JN8/UB7A S7K/B[_JDJ_U.AOAZ:IB]>AF[@FLRQ; M7X/ ?R,-43A88R4_E\,U-A@.WB"M,X$7=ZVEIAS+U&H3I+;467#J(>Q;]OJ]]HW MO7[]9=>0@PNGM$"7CO()Z8NH<8JG!] X09VQW5' V!VIF1J MVE0]$9>B:'):2U)K$/0G-AB.1PNS!I\L6*!IL-8R\!A'(VY)$CR#OR]YITRF MP\[O'X?]V^YXDCYS__Q;:B=%?=_.*% ON.-VF%[5)0#XFZW6XM(8 GEI5>-S M[$^MRY&&DYV>_ZJXRR]2O?9*+BB]06=XWVU-V_^-_-*=3USOI5O2R88D-YK& M35DO])=N)3ZB5#=V'UJ=@.F1O-ID>L#RG '1%\':*3F)=(9,;QPPE3%5%WGP MT+@W^1U5;^2S9TKQ R,JC!WJPTH)*+IA>E06X>'3U'.F!/7&UA$AF!V[46JP MQ8I%MEK1>/O2WTGSUBV(+PS0>U_R*6&'U'UONO1+*=$XR MS6%0%R1@IJ"EJ3<.MK-S'9Q+B[8.ZRQ8OK!06VG([?N25PP\Y+;UU^W0F"& M5Q1]FT=X'\UND_U_2%00L/^E1=_J\<6.W( '\8=@!.6]@+@9R[&I#1R$"7; M]1"1X;P;Q73EQ+)R(\?MH-4!K8&DFE [0*@.0H(O'EAW<)T^6R#38HL=2!Z$ MHY1#LK*YBY$$=@=GA[8%22VVV('D+C "O S%/8!XF2M_KHN7BG@+R^2ESOMT MEJ6R5D*V<_<7]0!"9BPQ)1PR)2G-K"JM$!(- -1]@5 82R!9 PHH0^S8ZH1> M]^"M#SX"$$QC22&UMT)=YEQ^=<)C9^\[ZM.8].D3F:GT%T!7H 82QY9XRP$ MLN,*D%^Q4R1,TY>&V_HNPWD_\!V %H)Z#D"KR*^?H,[@1W5\<'3(LFFE M[;S -9[U1#V@<%E@!%'28A-&O!1B2)9LJ=,GDDU9?SL$C@#%T![;ABYWS%DZ M>+UO1BA7BW;E:J&&#DA?*#;VV#G@'+%CI76=T&=SC48DG"P91\ +3-D1BIT% MAA$H238!=Q>$A"[\3A(R5KB'H;QY"+J711"!(3UA2"C8]MA#3N:?H5VU$&@- M-ALK^D#!L<#V :#&JD7HT/"3XR6D4%>EYS/2DM7>45&RX&#=H?A98#/1(\PF M*/LDB@A)BS'#=TQI)RAL]EA, #RP ZP!>2X0%P8^^]$E!=D"(Z@_$A16>^PG M=;EE!]:CD 8A4\EH,!L3UW.B*(WW2MD]^T>2Y? JU(L48ZT_$MAAWAJLZW++ M@I@^977;:9KT;#?C@V"^4EY=2(W;UE^S(5^#^)I)]N(NR2SQV*$_21XC.J-I MA&:?KFB\SU"WX=8+Q]\,P_P/7,_S21@MZ;H@EY#$,&8^=VDA@D:Y;L&V OU ME>T-I;R^.H&^KSN$]*UX)WS;P+K90T3FB<<='].2S>4R!2E'E6_)#0Q\,2NY M*8+-N@4H)EB1 K\1I 'C7DYT<$,$VZ2?LYW562Q"LL@+S.:.1DKL\_[ [A<7 M;:S%%CN0W MF;ASMOKA+)HHD?=]EI$:[FL$%N\Z(^Q%RW0$(>+-?N;B09A-, MMD!+$U9=EREFI63P.K77;5#-7HNP@[>42@%1I*8O+1G (-B9KPT68J_!3 MV MAJI2[+)-H92IOK(@NPVK_\HJL^_%*W<2_Q>9]69,#-BE>QO$UG;9W2-D__*+ M)0?8WY(5F>EK U]Z/)JO1OBM1UZY)8?*0&9WL)NKTS=63D]?\[_ [3P:0^$ M?1&L(0DUF67!QEZC"+EDW_^^5!/AY%+D-IP1%UV3?+]+;6%-*VZGM;<9UKD& MXR_V\];:_6L,BIT8%UR?O '66;#$"U7*94NW5#ZA4*OHIWW6+FNLRQ8(T):DY+EENI8H*HO/EI:^^:ZISOY2)/E)4' M$I58#G^M@ ]D1[T\_6KH]9EFQ;*J+) N6U>E:@J2,NDV'&M?7[WT4Q*16; @ MX,05KKU1>H;HNN@W+[JLKD%YXLMIG/CN>M/5'!= MM@9+[M' LNMG7(<76W]=5#T<NQV[!:K[0P M>]%#HGJ:==Q-8".AOS+6*M%>EV,6+-]"D6C9,BVYAA5+1=NP%J^J9G3Q+8W/ M\(;,@Y#L9\O^$\74Y:_9F2=SG??'6@.C/TOJ5IYNB)5VN'?MB>%!A8'/7Y2V MA#%B\D>B&^*3.:WQ)EUC4&RWKU,$HC8/;1.&;89]-OW!27B7WEL0.]03;>,GM?5:$A'6P;0)9*FD2U.FJG6H,E036R$O4C:(_(*-8#:PZ%*(P+"+!_ M'7.?_8J7.I]Q13VM4'SG!<_[6+Z.DV94B=@B)3WVNZK*VFP(O1'L0*Q:WK8H M:1-5S&E^?OSR"$TRV\90ME^H&"M!Z\O!14! X;BU (+;8.70JD1N AJV[9%A MD'(8!,:6D+UNVZCRM\L/E6>#NB>K1Q**=#M1:S353<&T"AU-3K I'?OXJT.? MZ'&ZT $MO\7IS"Z1?2Y^3Y\#/7X7.J 5:C^=WR6RS\9OUEQ3P@^ZH)7W;H#G M9=)-55MP5NRB%B])_F610U&I&98=15L/++-;1+,A%H\\Q^4QS+=LDIDQ/EP' MH2-(*IN6>I?U0#XG3^(\@!6F0.!IW]W$,A/S-38>!G,]NZ8 MP^<\E>N(A"[G]4)B!=(8 @AE\Q5<3H12GU)K;++*)-BYZ73@A'P[?MK/_< T M6PH1AJ7#S@=O[49_M="^6FA?+;2O%MI7"^VKA?;50FO<0MOF^@#[(T/P2S@DY!06;!F8A^OVTN$?)@*W9_6^*,0G"%;15/G4'L@-!J30> M%ZK7)='0\R"O>;K-1MY>A"3]OGR'DW;!]LBM*8,'FQ^ )T:V/Y!F-N5W?FZ> MG=$G.DL<3ZP9"YK:L5B4:K%@]H5#$IOS?]!XF89=<7E:TO4T2$_6C4Q1UAX$ M7WN62IP,,!5I9K:T^_!C\/Q[\*6S# )_(=W*JIMB/B#4E+'B]B6CWPZMS4J# M]A7:LQFE68A)/^.?D*"4FB<2/@812=LB&TX#]TOV^'6;A-P"F9:V3(_E8LIL MB:*O,<2EOMCJ4VI$/O#\U^$ETZ0.[:4$D)/.Q^[M0[_+*P5V)]/>?9H4X&'2 MO7OHM_J]3]T)_TMUFLA7+W=3D8;B/(B*UQ7P"':HQ2?4EE(1:.9%1AM3X31+ M6YU&HL^^=:\QFI(+3?O9-_U"TQR>-QMN$)%;Y$"=KQO1(J5&'GR:0Y1/5'BY M5=%9[&P'HAJ2"\[*6R#2S/66&^23F(3LJ\/YG+ID]VWI55?=#3LZ4T/JBM== M*#_LN/K>):%/>>AH6@_DA?^DM(;+^F"7PJP!&H JFQ!+ [B7@3?KK=9A\)3= MSE2023NAA1NNIE]9Q.R T/]D'337%>,\4X_3Q1/@T4?BS M';I 7>WND!8C[[!P?@O%?3M+2]Y+#YE6S="&WCWK-L%\DU&PMHH6.TY!X4ZVM9C.)88S4&=;BZJ43$G0^UN9 M,Y9#664%KP%J]3#67@EKXRMCEP61(*K7C8H".]+'C5*%'=CCAJ@.S^OC!DZ) M'(MF7!I!ZL26YU1[$!77Z:/_2*UB+;D"40R MV9O-O?./(.QX3B2*8=D:Q'0&N1*TM6BVXW%$,N7]A'D2 ]5#B?9 =F!>0];A MH%<3;L($H(W[]IUA$LSC9X=8I<@9[$(R8)?J7K^/ A7Z1=XW8PGXB>*K*>E]1M;]+^\&'<_9#>I7J#N^'X/HNY9W\<=S]U!P\\H?7KY,"J#HN M8=5=[3AJ3_,%JZ;,DAM2>7Z "Y&TDQV0@<6R;+ 2DX88BI_/:QA.2/A$71'X^'Q[4EL](&I O:8[_^">3JC($5328\:WJ!3[]%_?&]^X= M>>1094O,]S^E>!1]IB1T&HJC'ZZ8ZG7C,>5-RM9R,\S?MPX7A*RJZ';=BF?G,1#DW>0M(=R&/^\4Q)M2G"#)(K(G>-2MN&G MVK5B"59G2CXS-Q\19]5*7%\/N)&&8 M%Y7E2;NR!#C;I%QC99G"GV0/=G?#<;?W8=#J/(S'>;G9Z;@]F/2S5[ON?W<^ MM@_KZ<-=I^(J&S(#!9+3=&>V:KP5L1J>?@+TQNRXWQWGOJ,[AQ M 6[H@O'LA#-UNJ:C9G8<:*=M@Y M9DP*]8$]4<0B4S;RWV]!D%2TP_/^.#,F0A[9<=0=&A@W19MBP=3X3KR%@@= M-@Q+C#K'81UZ++$#Q^Y\3MQX."_.=NCS3,IBZ&1]L&^7<+C4E!O:_21R'?L*B( +/0(LN>A)5FMG' SG$_8Q.F7A_KX] M_LS?6":]#X/>7:_3'DQ;[4YG^#"8]@8?6J-AOY<^N+R6'7T-C'H-C'H-C'H- MC+HH5%X#H[[*P*B/Q/'B)?O<'\3S>&WR[0SDEV!5KXL)[@'2;\?%:+*DZS4[ M&]ET/SK^C(TOCF7;F0:$7=!2XNI@I":C.8"B+4(1<;]=!$]O9X1FX+ ?CC%A MO_JS3Q:.UTVK=@E."=:JU.A"#X@J4IJPLVMSO2LOQ<>:=&VJLU?%MQ)GNV27E!V-W]* M@MFMI-G4BTFR2)>D&9B50HXI".4[[]@\!U.N1UZXR7[ -0U M+U1[!#1;7/C5(P#/4/CJ$:"[5?YPZ<_/QEP"&MIE/2]XYF?P71#>!LEC/$^\ MW)X=C8E+Z)/<2 _M?W%127J,,:2MP"8190)6]3C$1]$=!/OE60.K.N39M/IZ MJ[5#P[2$]KP?^(LTE66>ISBX(;!G-" M8WY6).O [_ENL)*X%52UQ?9LUUQ54HKM6#QYW.@=H[03^.E[ZQ\T7G:2*&9S M#;LOKI?,N/F5R0O[W]G4>1$OHUJ#00.=+<#T%#)+H#=1J1WC(D,\-N:B^\+5 M/9GCP5$[;.]5?9BK*;5CV;9G3"!B&D&0J&J+]@)47Y444HRYID0&=X*ZM'B1GCHN4%":-YK67M#-<-)4_BS'8Y\=D9!G M[1)[OY:;8<<'ZB_82CJ-9S#UM?5[Z@S @8J4VJ3T0%&^;+";UF&4'TO?4#[C#PW:2MX0=I'3-:1"C M*NV$'N6FCR" "7:B!8?(@N>?TW&YGHM!VX_IC'H)#WO)?8[89I'9@L@LLQ7Q M"EHIFX;SKA/Z["H;,=4K?2!3W0\:&A[/AZC^Q;])QMH0K;5S:]BFFM@=)YGS MB2P'WB^R''B?VN->FQ?X[0VFW7%W,FUU!]/>]+,5Z>Z*_G?L.A<%'IUE8N?/ M1@7VIG4G'3]UW6._R5Z1U9%;#0V/N(%,0RWPX&A4%(YV"Q@?+ D,.YSLAD^5JY=\N@1231C:WP[8=019^ U]JSB- M9;4E\J[JGM@N.P I%.1X5''#CJMNYG(B=K/:ZON'S9!]WO2.Z..K2Q7%=H#1 M9X)#O70C5R)2U=:RQ:*'BYAX?3O$K]FMSL_*$%M@ATAE3K6\\/W8&EA8=JTH MGJN'$<#_T_UG0I\<+[VNQ!TG##>,TD^.ET@N<,#NV!YP)\&FQ:(K, F6'&C' MQ..[Q,@)01LO> !L'[K3%K,>FRY?+D8A63N4NP7*BI$RY>%[1XV=6+INF#"AT[@5Z8^$[:/7)+A@QEGHG9M./*.53Q<$Y['UU]D#PR<&HD'1E5C=-?!DX"1T'_YJVQ 8@BL M1\W0?0Y/ K22YH:A/+<_6;47V2=*8 F_?SWV*!-[D?W;7WYY__Z[WS[UNNE/ M[W[[=\M2?K_ZF"D8Q*WN\>:>Q,M@UO.?F+2D:0&>?1)&2[J6QCOE8V@,@?QT M:]+-3)N1%[[)[$H,9/:[MLOH9Q3PC7=_%V%_2U9D)G-@_?&[D@-K-G(KF+>R ML5O;P5N./VL5AF_EXUOASGJ31)0G#>X$J\<\0@2P@\A[(6X,%1,;$S=8L/5# M9CV>SI'.TU,&@'_>I XS&OLF\M8#D8ZC'<4\ I>OLC;)H]QP@B&L@D]CN]2< M00+-B;P43CMNTXV2FWE2%+PHSB2Z%=_%]B0ZGQ@9%%\AGE%Y++(6R^ M!U_'=JVZ"CE68&LHK\0Y2#AT2A*\$6),!-OYZ^QRB\7H:]V0N0'#9_.LRLAB M ./"Y["]VJYARRVA9Z''A3$^*UPIC>X4M1PTC?GJ7=HZ;95>EKB:!6 MRZ>#[>-X#9N^-OK7I[4Z>,@=KSKVN<'@>_BF:K%7\?V M=;UH:[4*U.O;K4=AL"9AO.$I7N/-4YUMNG3\#T$P>Z:>=RYCC'(:Z)[45[) P(B_+I1#=Z*, U/GY9RZ M?L5GT;W,KV0A"!&]/K7GF,LX6KL%?OA7(KHB/%]OK,>WJ7/Z_5D0EG#1U]%7 M619QIOB;LQI>*C^,GKT9V:]5@L;UJ0ZY911- F7?APKB1;QVRJ3*N.'[:Q?I MPZP2:))]/ VH@%_2(Z4UCR7NI6E Q?V2GC)M$7ET!M5%\-+I67L;,; M6N#2?A%/G3AB_BK?\@<$)U5"B%*-=Z7$&_F8//,&&[65#MO:C=LJ#/R:<<,<.:G\1C2=V!9&(XD+1J!IT@BH=S,3;%@!A ?PO3/8!B?<"LL3@.K8H&>=9)%0?J MI*.TXM35(NPB@=UE<,O2-3S\^<'GD/2GW5?&+\84HR!X2;-',E4QN%6T\ 6Q# Y/-(A>M&^*3>OJ><"0+HYM/!%'(+ON5 V".:XTA+(SY M/>485B7$-KPPM]/H.J'/MOUH1,+)DK'AQHFH>TN])-Z;R-2+$S::A8&KN@M4 MAVWG!_,/0A=+-H,VN^XY"S)(>"GBX9S1NPK\=)[1,(FCV/%Y(O=TSDREJXWV MB9^S,?RSKCPTPOD*@3FWN5MBW)9GL__Q_;&5^^9A,N@-NI-)JS.\O^D-VM/> M<&!9VOHKLVSO'RLZ@LI\B1@6G:"IW"S7Q M+=6.4%HFZ-N"0684MS_,XLJG$\0VI':DQAK[8'LD *I M1!_7_-0EB;'1 MXZ4GTV3(G(PE74^#;EID[#98.=0'XJH:!!EQ,1!JP%2DF=D6[\./P?/OP9?. M,@C\A70[K&Z*M@W6X6%Y"Y31;X=INEA(N;@3W&R*?Y&KE#IC?"V;9@W6%+PQ M+!$(X>9909TE>V0-OBN!,[M'MKEM<9*L24B#L,^V&G\QF?DWRYETNU3VPG;P M$LM1<8,$$F_HA>#$XTFC2KNQ!W$8FT6SM^DDFB2/$?EGPDCN\FH!_!(H/W:$ M'>S8@LYVQ@CY4/"WL@M7U;DBZ6()MG)950/4T)%B!"&554G0'-O95"EG!^Z4510F:W2[F4Y9JM\X?0Y4CDN=C") M74(C8;T=8E0X/MGA.0PG,3=+I(?HUO43I'6(.V.'DIQ7!U$QT<( Q_UQN?/G MW.O;O.37WJ]38&33&@';\F92'K298=-6(+AEI6)\TJ6U8@3L4!:\2ZN0G9>O MHV;W\8SD44A=P DBZ8(=#G,.$5$QS.J-(9O]@#RG?ZIKRRKTQPZ?P;9DE5AI M0;Q$QXF6C'S^'W[K?G(\SA!8Q,3WQQ$3G?;D8ZL]N,U^Z/[70^]3N]\=3">6 M14U4$ZV.FU#U0UW#3"5-I541]7#4SHYW&Q@@I;5V2(J9> .0V]LD6:^]="Z. MU_/G/*"*,_ N"+>E[1AIB>/%FY[/UHKCN^2!+=+P.:0Q":7Q!6SXYD:W ^UJ M62UXR35'L)E8 )!,C%/W6J'S:N'/%X)*8<9&_/'A7!6^A&YG:8G?_"'3JAG: MD/][?8[>4Y^NDI6,IT=-T.S&QSPK<;22%CQ?]GOG1/^ M(M >X@[3-3=,!U>]K<*Z8SW#-WH>5ILW=?AW^68,3J=<&G#]V\^ MEWK=TI7 MY):L@XC*:O\=MD)[!3W$I\'N M)Q"Z#0R-J988%HG&&&^!Q6GO?[NMYC0F+F&G#KMU1&\._*9E2:E_D"6EWH[< M*@S-FN2#M]+1KDL+%-*ZB N& #;H?$4[*4\L>, ;WM>\,P/'W8PW0;)8SQ/O#(A:CCU MAL'V6-0 M0Y_+'3Y*,^9W>]4$BMP_J@Y%K9S(0#T$Z@[$7F["H-P%UN?B59: M<5"B=U1GT:,Z1^"8":Y38G:(VM6 M $R.-F0YX5;=9D8A63MTMDV#S[,CYI9 MX.C8SR7]^&;K(+']JF01\?[P[IAVC .HE.J.H#G68M)C<[4]0<8 0T'=A0.9 MY^V?..P'1D8$C2%2/]3=T.X,IP !(\TH('N+46J]HL(8^ZJ&:#K]J4P7 M4VW'%>UP:7)_8E[>("M8I[E3"3JC:>:-;UQ2[ER)$T^^K4P9"^=L"I*\"ES5M-J"7)>X53O=FH$^" .E\W MHD5*[4C>*Z8/D/@&U-D.1#4D%PJF=8EQ[AW& Y^$!TJ1*CV.M!/VNY.&=!ZA M!N"%'1>;NR3T:@.L8!/^S KNVZR2I)WWUO"6.P2YVLFM3:(RF?_5E[%80Q_5?Z M>R%I4K>8AKY@K?ZB$HBFF:QO]?LUL[CY9,$G@>]L)22QNA*P"@"=GJ&WRKR[M^XJ K!_.3;SCL;#47<\_9P&8?/XZ]%]=S#]C]:@.[4L M!/MJC;S%74Q,PV$K6T]SA96VBE2K7#)Z;$1_0;E35_I"I'HV^57NX+0=K)6- M]A_6O)APIYAGZGD,NV.2=;R?-(=!#>%:4[9WTW^162=8K9.8A)-@'C\S:5R(NQ%I:E$"\8>^S0L[EK5TSZ[$ J45S0#HM:H,1@5&,L;-VY"<3K\]!Z M&9"JO:I^V(JO86RO10L6']1R#?BG[XY/[-Y@VAY\Z-WTNZWV9-*=3FQ4?K^Z M\[JX\935,HF!1-'O"LYJ&&LL4ZNW*;E[_KT3?F%+BTUX0MPD3#/ARG3LG]Z5 M=.S.Q^[M UNOPSNV>C]U)U-^9V4_MN[;X]^[TS9?RY-NYV'SRKB MP/[/\(&0 POVV=5G[;@31(KXB(KF=GA"ZR)7$6H@9(4A%]RJ:3[X(0E3EH*WJ9XEO]HE;*8P[%WYC >E BNO+^_+U!:X G7J7 M>56%KB&#:J,+UTA*U6B+343<;Q?!T]L9H1DL[(=C--BO_NRFU9O[-(K9>2Y- MCLI:"QO;X8XISZHIFW\CGM#:O.^3A>-E2BAT&&_SW8.[ M5Q _RE?,KF3,'S1>]OP9?:*SA&E.+ZZ7<-MD*K$W3L032>TBWT=L@PI)3,.T MYPWQR9S&TN5M[E08*N#"*V5Z66Q(_K<6@ M:A;([ 0[A\4FOV+)I?<"A*QR=30+!F*AES)3A$5?!$U?):F>)(DYBE>@IC0A MSJTT?22O'[>DZVF@, !54:4:!+_0C705R !3D6;&F'3+)-+E2;:&<_Z$')$P M=:_;'OE2PQ*P+V8-B9I2>) H2X=#31@[OBY;]<5MMA+[^?M7^_D%V,]'RX#X M]&7D)9'2=BYHB^:> +";2\DSY D$,/2(XE%X?WAW9$=7$]>S(G:Z?+0PY3K/ MWEFR_%49#02RH-$?.V#%M#1HL_(\J[MJ!M7!*14B+>R,':%RYJ6M8.+EO]"< M]<'-6'(CDU*!Z&\-.&>D7IS LZJ&1V?S%3WM.;H;=/VL7N:8SI^,N#=5FQK, M ;14Q:STNO?&(B?0K^:=[]I<06N^7YGP!JUG56VZON*AN;6YT2TQ+JE*N3=' M\.N[BWFT7M\X;+#C6?S&41_)K9%?5J+^N,T%OVM44&/TOG$??@R>?P^^=)9! MX"^D%M?JIF@)4YMY0Y+1;XCE^[>JR!'8[)[60_G#X;"NP!T4_BS':M&>=IE5=+N$W0-&2<$LA8C2T=Q4MU5!<\M0D4G< M$4@"@JPHX<9FM0K\21RX7U25BBJ:0ORR4T V^IA9 M"=^59Q3()/F>Q,M@=DAJR(W-(Q*ZG+,+B1N$QA"8;T>&Y42;D?7SW[$1+9"< MPKZ6I6=H)XSVD.?B!&WFY4YHAD3ST@%@EH5.[8QTEY!9=,3/:F9EI&PH$JU1'0;2%[>Z;IB*<3 G4<2$Q_'N M"%$?^JI^R)&R<,3*A7 !_##D-+?_^"K@C.J^<#<*8:RJN#EV:*H^^^7TV*0[ M;6?I;!@_O*GSHK%:JOI@N^VYVDD=SUT%78PCL,-+:Z&JSZ:++@NPUV(+!AA%7]-^6JZX_R537 M<;??GC(]==0>ISIJ^N_><##YV!O9H;$6[513=L&)F&1PNM7ZJKJG%9E?1=.\ MV1S\!9J,56LX.YZBH1 +LZ%JT6Q)@E+!G$LW=K!<]ZT+&CU%Q(^P5M-L)FZT ML>WJD%2Y5X_.&%\-U)74&XE8/0ESE4]055L[,-277 EP9AT6)\21.BD6_HYM M/Q#+QD&"JF."3)EEN'XY2=8DI %3OI^HOQC%FWX\:T_ZH[Z4I["N:$\G6NS6 M88-))/A4(NKTZ8JR2;?S?ZIAD/=#]V73 '" 4,(C,GL,=B,J!NS:U$6UIK] M2LI_92\H]Y&7 )!ZE'UHZ(MCI=3+M] ;BL6O%JP$.#V,&0QBW3:80 M:,@VD#Q&Y)\)]\U^XF[SRIAV80<[-,LF;P="4BT)AR]/3QG3+NYB"7QR<50# M9%6YG8R'J*D&3PW(F#4MBL8[<&'#8#] MG*\+I2Y]I[X.VA$TD;OL:@J!O!?VRW]-Y"&L,+2;CD*R=N@L]_/9>1Q$$8G% M6&0>^^J.V$_U=?94.$/LV%:9[!S$1 7D;"/3890O26D8,,5>(?SF(;,Y_DV M";FQA1M>9GD4E?O/A$8T5<@DMP+X$&C>XZ<)@C:3+OT<%1#\R?$27U M 'Z7E1-_Z0$]A7C$+#X>5A;CYY(3Y'38^?WCL'_;'4_^[2^_O'_W\V^M[G\] M]*:?&ZN$T60Z!;6WXW$[2WP;V702_L;(3@MV"<@EDB>\B#0\&I6#V&$HKX9* MXK6HI,L27\7T< ]YL=89F5.?QJ1/T]JML>,O*/>_YO)-$;$Y14>F7OT8*.UP+E$("[7!'K)I>)GS*MTA 5SM 5 @E + C MLLPX*E9X=NAZMJ"GKX7SL*R-*NFWP_AWS0X7];:X5S>+5S>+RW&S,&8\M-54_9#^,NE>4(P!AW+$7R.1CLV([:C( 9 M]1+^]+M/F=Q]<;UD1F;\99W7:4@RW(;SKA/Z;/E%6\>(]HK['TO>P)H9'MN? MI"%A:I39=LA/A:E\GZQ_./\4Q(P"QB?"$-LO#ZU7&=!XV/XK#6\W]=AIAT@, M M\-_)BG%RQ,MN>[(7&BU&N]8E,52T3-X?"J=#4K$2=QLT(@\)*Z[MTU,Z.!RD %*(B;D;=EV!% M3(,P7K#SH1\X?C1D^JGC=2,^O=+>]I*[CB2M/2YI?"!X2"HPX#L%0((OC*0E?TCD-XN;(*,@97 9#3$@#[^>E MTK5I2&JXR?#(_W$,1_[K/^\_5_ ^_R/_&VIY$I6X;%EOA);/WXNYBM M_&]HMZ4:;-W38L?U)E,5^DQUS2[L[$[O)TPU'ZY)F"4W.%)I2<3H8SH[=<5: MT4F#(I:/A*L>I>(\)W/Q8L7ACOV3+B17WE/&Q"P2>4YI.&+BQ0I#]X7=,A@H M[.8>;E(>5=_X&Y46^$4YQT8;#*LC(*@R?*R]ZP10&SI/PJLZ2,QL-/ MO4EO.&C=#<>O1A.3+_I9OH%4F>=/1NQ+O"1+GDGBAOAD3B5D ;LCNROJVU:T MV&+'SI]/.3^5]#$4=\1V5:P-GXH7=@!WNW.\*PC;CF8HBGJC8#LMZD-:ATN7 M[X.QI3J7Y-I2H>J/[?Y87QY@G+E\24@S.@FHK-(OQ3*A/Q*VBZ6^=-3E5OWT M&E95K]HN#D9[]L8K4\5__DZFBM]V[[KCEJJO2PE^?+E^? M+E^?+E^?+E^?+E^?+N%O; \3\1L;_QNF(5[WC6U/"_K394,OPLW?E=!?A)N[ MS^X4TUP%]Q?<5MYQPG S#\)G)YQ)+C!:@USBTV0-+ED*+\]6F;':\X)GQW>) M.L^OQA@7^=2HSR3]6^FOV8W0)PN>@,1 VL>*&R:;FDM%KM2\DZ+/93WT 0BZ M%M-3BQ:]6B Y/7]^=VPDVK_*=B>69?%\M0V] MVH9>;4.OMJ%7V]"K;>C5-O1J&U)=9I@NECB^-%?H81.TU (ZW"M/^[H,;,W' MVJ,;V%Y#+LX3JI*@(@I@(,]FR>_,'/XFIQ]/(2(^^JH:H;R JZ2@>@&(J[;"8 MUWG_N+;G#O.O&X(E(/YP]V5-0_*9.*&Z2J_V*)?U:E&+1)N6&."]Y:37J$M[ MN="AS"86=3'#,R]7Q?=<:XR"<+?2;9#"Y/=.>[[/3.F![?$<9R MQ^,Z5<(FLCEHK(NZYN!H3M#-BT,MMMHA)P6?;F>5YYJ2']''#Q&BCIB)'DZ, M,U6RPX)84;8%\21R^>8SG(]I] 7X]/C^^.FQ,QQTNH/IN#WM#0=ILJUQ;_*[ M;:^0*85M?_; " _9O/PT$:?R'5+1#37[ MT^3 69'A_&!.,E.BI#F^*5$L1 7V2R@P8T<0,394=9TO(\M[-452=5][04-H%@*@$\)L^*HJ5C\D3\A&P3I/%K M]Q\T7BJUR>W]'=8=.WD15$J/,-1BCAW;:-M-G7>B,7$)?>(;C I"<0_LC",U M45.Q ,^9:>SX"U&9;?;WPI\MW?I$YH;"S L/P%K56IT23M"U?P+A\7Y6)U-0*B)LB:'+9"97,6W$FK,?Q-](;L:@QFOI08E+Y*BPGT Y5KOO"G;T2&BVYYRK/)_88RV_" MXAZ7M'LHB2DX 5@&SY1]5'7O5?6S RJ5\ ' *A)EQ5UW>S$8.1N=B]%1UV['>EW6%?\O"=AAGIH!=RSFNU+X#*:E3! T/F;WXBTHBGC\\S M=>X_+3CXI3VL,_D(6:\DQ:I%XD1+R6)(_XJ=5UI?Z@M$&9+N6[(.(AJGE1&B M)!3XFV?Y9"I:8J=FUI-F";$6."'N,^3>)7$2DGOJ\YOY/KR!5S0ME,V6ILW] M7I8V]^YA^C#NMNY[@][]PWUK..IR;\7!AU:_VYYT6_U>^Z;7[TU[73NRZ::; M4,P/=>X2E[F++XCO7K!LG$7)!*#P E#XNN/2))1Y.AE"<;I M<\$J4'B!PV#Q.AAW/G( M+1&=X?U];WK?'4Q?#1$8!&\Q'CYZ=)'%[W(]AE^-808'\ !78%C09-;EI]X6 M$#SA ?PSKN1JRT6QZS68$\ UZ#%0'*'SML1)6S;<]C$M8%]+CS-=SO-;AD*ZPZ M*%['/5S,@T8-=^?/;"1F#2B_T8_E_$;;._FDU1[<\GQ'W'>@.^CTK*NU\M5= MV/>VFC%ATTG<. G97-FLQ\3CYK].$,61JEB+SB!VN.4VL0-HD6U)4J6V^\^$ MLOVHQ[:$.?4I3\KVQ/\9._Z"LIEFV3/[ZE1+^B/9@7P-B2^Y .M2;B97DS;X M-TG$YA1%*0$13?DNC8,0=K@6*(4$&LGQU A@F? IHR, 7>T 42&4 ,".R#(3 MR=7FFM(D69.0!B%;[TS.I,%5?D'H8LE.YW;3(B< M!1D3ON=L_S@EX4H2I:0_$O9;@)&%#&>AC0*P=7:"PKQOCVW,-P+F,3MLA"R/ MYH(BMFN.;7(W M@1,[1<;O*_\/_WR(9BO_G_4$L#!!0 ( #%F#5&,V-M\ M8 @ +@] * 97@S,2TQ+FAT;>U;;5/C.!+^GJK\!QU5.P55#H%AV:L* MV50%DEFRPQ&.2=W>?E3L=J+#MCR2G$SNUU^W9">&A)?9,5-D+GP ;$NM1^K6 MTR^RVY>C?UQUZK7V9;_;P[^,?MJCP>BJWVDWW5]\VLP?M\^'O3_9I]&?5_U? M]T*9F!8[/DH-&XD8-+N&.;N5,4\\=\-CGT")< \[8M>;HI^!+Z;!(S%)6LR' MQ( Z8S%7$Y$TC$Q;[&AY.9;&R!CO['7>)6.=GK6;-YVRJ)="*"1:X>7QE9A, MS5ZG_6%X/2H+;80\%M&B]9Q8VU:+_X)#@9+.._U_7P[.!Z-Z[>3X\+C=/,>% M)/$=!_ZYE?C:*3VQ9M7-JEC]1^;QS6IPDZ]8#Q?]V]'@P^"B.QH,KY_40V5K MOGE69=NM=-G^DVDCPD65ZS;PZK7+X1_LX_ CN[@<#J]_\W >BH9A9LI-Z_6, MX!5F\]IV^PJ0CP_KM0&;\ADP!3,!;)XI^S5 0ZN&#W. M13-( @CJM=^S!-C)D'[T_VJ[5VT*%OT>%GW.-:D9MQ0MVE\AY!,$$O$?T M'DB4GTC#?!3%1<)0I2Q+C,J :<,-Q,@[9! <9X$]!8]8R'V\I9B,A6%&NG:E M!O6:;9& #UISM: V,;\#:QY+H1KO!8@+QXS(<=(@U, 7RL]B;)9@=X02H"W- MI\*?,IW1KU7_.2C(A= ,8J$CX(%()O7:7)@I3E&GX%N()#A%<#+ BFY2)!I8L='(O&C#&F& MC*BD3 ]-5)"1IV@"9+]DUQ':Y=*$<]/0#\;&31 (DNQ1BRS"!FB5$BW'CJ%R2J8"&T4QY$XW73 $:97,CQ=K^5PUO!NER:WT/A^MGZ0QU;O MJ$9CR*MGR>D?=\81<*>L: C.&&R^,HF2D4@/YH)C1Y.8<" MFT)BA5%2MHKSRIY60<0M#^7!U(I*O-P+TT.!#A,!:1F)@!N+=JQ%(+@2- OA M8C[K^]$!2C=\IBD6LVX>8SH,W*QSE!H0E4%O3#U33ILEBSAY=9R@1;**Z;"' M"Q%+3I5&&P,U1+>+_2&X9\3XZ_9M;-TWNEG?**SO[6-VIO)]88VWE\A?',RM M\?E:SQ>Q-[5"QI^) !P*!5S+A%-PRS42.J70Q-108"85(87C M$TC)05"3+#&.IM&1B!1#V16>T1&IV=)M@1WX*!-N5[65*)%[@0L]4-@,P&[,GGD MOF"1N(,H/S,K.N7MO6]>K+-\^,UTW[25U&I?BLFM*[\I,)$A@2>_I)6^*;.% M9Q*GARP_F@^*W>(Y-TT>FD*'LIVNG#59VD-]UVN/IYIK!;NEU? L$$8JOFT?31F#$$WG9/B7:H?%3H3/F< )V V7 M);X]2SMXC:.'[VM?NX.'W<'#MAP\=*.\0$,E)1&B >!FI -%7P!R1I[*+&O_ M<^!WE):X0HY-3&PQRK[W49R';Z*BQ_VTK=#G_D?!9I?' ^RM8>GQ'J6NO(2% M79!_<(MX+D'2N (ZBY$6<.IV1GG,L0141"3+HXU=\O.#P-HE/V]/)_^/)P/= M) _R0X4!E8>\!_85)F1.^YI:3K&>RPY$,I/1#"A%2/@D?]U.Y6\]09Q&<@'X M=#Z5+ECD]P@<"?>))*K@NAZ4YP2X\JXH74A[0F<[R;?'CP]/4?,T+ M__DL3H]^JC3Q1^-N.;#=;()[BQV?N%=_G]R[5@,_L&Q%^8P,]_KW0&[4&GJ9L.^*6:@L_-D.UAE6)?# M/QR.U?<:.Q/Y(6!]B^NN9 E6:SVX/[6!96/LW[D67HA:QM@L. MOE=M_E6^E"Q6?>T3283^MT:#?1 0!2UV@\G.&X%\%N ??2/Y"4>)S81BB6F4"Y66ZA_T+[[2:N1;$LI<5LTFJZ%5N91XD"'WPTVJ0OK]VG MV/3%]O\ 4$L#!!0 ( #%F#5%^EOL5204 &0< * 97@S,BTQ+FAT M;>U96W/:1A1^UXS^PRDS\=@S8,".W0149@3(@89:Q"AM\KA(*]A&["J[JV#Z MZWM6%XQS3XHS=6O& ][;V>]<]NA\*V<4_#;IV98S\MPA_H+Y.,$XF'@]IUG\ MXFBS'';Z_O US(+7$^^76BRX[D"[E6H(V(HJN*1KN!(KPNM%1QUF5+*XA@MQ MZ;1:MR)RP7@'6K7> 9^KM.LTI[W="5\KN M;45W0]%HW2,(6V)1LL=2UGG/A M7P:[0ALQ6;%DT_F2V'RN8G_1 @5*ZO>\5Z-Q?QS8UNG)<=MI]M$\1GRO /\/ MX>\3:V73_:&[;=R0$.ZW4TI/V-;3UCGX%Q", M/)BY5WWWTILU_%<3[S6X@\",G+1:)__G _YGIC2+-_N$/.:V%0K.::B9X+!F M>@EZ2>%%1B2Z.MG %4V%U"!B &4Q@(B9TD7W)HIA\DT=M,= =BE1*^ M.9!YZPAP^$+(%>[5>(%[RUSTVT(T4![1"'[-.,74W:JC=T]:0!3$+,'^+9(9 M#3/)-$.U"(_ NPZ7A"\H8EBMF%(& OZ9F1'1%)944L2ZBZK0H *%)L&A##>7 M"JV*6YDE\PW:@4HT+S/F2C.I,L(U: 'M)U#FC .%9NH6*<,@)9%(-0K8G5W. M,;&,,'(%B)P33E7#OT[H!MPP-Z:)Y3J.$UTWRW"B;QDZ$\C\/0\W6M]<=@^LBT3,.4QB+,$ST2(<9Z8B-Q& MJ:1O,R;I"D$HXT)5'JCVZ2'!GCKG'Z@[-_ MO+-/2F0WS(Z:,),G6)%FJD@@S*3'5%)EG%XWPR1)4 -,;HPD&!(J MQ2A0]7Q5S#CAH>E'@1'+19NCC;.R)/>\2&F14I5ME7%2YM/C_T L!&Y_XL' MFTQF4WFFFMAYU82XD9O5&*)*$I H!5?\9 MHN,$5]\N_IUY)(0DJ-N=!:K%#R\5FJ"\M\DQ9G MK4?[=,00([%3@'6S!3H:LU'QF-TZ)QC>G3:G>U6FO^E\%G7I^PIT/R'AFP(Z M*)&PZ#L4>/SS7C5PQKVF:A; 1V(-S\4;&"R%X NG.>[M*H=?5W<;L5]_0W!G M>>%C3GR M84U\O\H<#SWG\-@Y/N7SQY"Y '6+JS!$DE!@<2[QHI2LW<4_#AF M2&3J,,7*@IDZJ0Y#K$Q#+>1# #W NE7O3B7#FC0ER2>BZ.AC$=/,2[G]W@O? M7TJR3\BN;957$D(RW!/)0DX$&!)-I(N:ML[K MAFP*) \2(A%F^52289N;(ZNQL*L#ED;E]4+>K!:LF:*VE5]J8'].0 PA23D)+KD131")%)R%)DD4ES.?U&!)%,PI=J52O&/F M,D@+V]KA/3E!6C,D57/#L$L:AOI^SYPXDYRI9;[+YRZ6;&OW9DD"0T*/F.,8 MLA1[C-FITGNE9'<>]HCOIT8#+AA-H@Y,R8)V40 JPD-<>(*1[:Q]:W.BS-;V]ZF:_\#.WO=3,U4Z WC.S)VWB(?$&:..FLSABX70*A,$ YAH M?OW;S4%100%!P?1^]K/'*(?5JZ]U[-6KO_Z_^40DGH&B"K+T[P7UB;P@@,3) MO""-_KV8:<-T\>+_7;U_]W6LP>O@M9+Z[\58TZ:7GS^_O+Q\>LE\DI719ZI4 M*GV>HVLNC(LNYX[7T21)??YUU^AR8S!ATX*D:JS$@>5-HB ]NC\?_;J\=*"( MPMJEZ!OK)9G/6X^&O_*K&^P7YS\;/ZY=JCE>FC,NU:Q+!57.TE1A%QW&%Q#\^]-(?M[[G&(Z0UG/V9J<]9&BGP>LNN0X#S;8;;T3_@#OH,DT2=F>KH"A MZ\/SG^&OUH4S-3UBV>GRXB&K#O0+S1\=_^F]9OX.29I"D+9V:9/SK0IRK:]GC@EPZ7,DRO MO;R6';%3P&K33YP\T:\E\QGR0I=QP/+P7P+]YZLF:"*X^OK9^!?^.@$:2Z!G MI,'33'C^]Z(L2QJ0M'0/CNF"X(R__KW0P%S[;*B"S^B^S^9CO_XGG29J A#Y M2Z(+M"]$DYV 2V+.S[\0]8K^H4_2U_W[[C]TY89AVO ?1%Z?FRD*U$D+(IWV M^IA,M8_&W+>/M6^-U<=SLGGC+HJD@MR>J_0!1#L<"/QO58*L7)0ACQ16K$L\ MF'\'BSX)'UZ@,C3EZ[DEVW.9"9!X^/]:361'_2$KJL#/HXJV1U5D;J8_25 Y M5FQ#D,I\#7ZG]G_0?IZ9=WWF;\ JQA,1._T\D[(]LZPCPO;(JL176 WTC9\; M77)^)Y"O=S_^_=?'*_((>Y4^U3=UMO$P^)6?9]#][IA5 !Q?7S=1QD-4_3L_ MSZD@6MKFLS);)!WV\%*_/5- /VM_RA1^X^<9N7[GKD_"_S%O&LC\@E"UA0C^ MO1A"77!)4.14(WK"!-+6!"]$1YZP4LKX(@4?K A#7>OPPK-U'R^H4Y%=7!)0 MK0+]1V%^B=0'4'2]I/\I\#R03#6%OH#7-@V%:NB@N=9!IJ2FR!-+$Y*4)AN? M\VFHZP@)#@B^#0B7CD)Y<;62RJ^?UUYQV'L-Z_KO!;3(EP,9VAU6TN753M&: M.%]^Z( 3^WPLH0[2 MI _ZE+D+8B8)QK50M*'1ADZ$($)+JLP@C19Q%AV>J*M+SY .65E HGQ1D\]& M0$U; 5-6X'OL'*C^J"F$2 WR" Q2%@B!*@-1 *:R*J!)%"$>^#:K: M?!!;" M)'#%+GD*("5MD94T2&45^EM31++?R2SF(X$6#*Q& @0\HZI 4R%1U3DGSE#( M>"/+_(L@BOZH+$5 90MR$ 8RTJ@!8$S2$49CK36\5PV:?9%7HB,@KP*& *H* MOC6$_T(JR[*J^1(-Z)%&2%9=@@XS@/*ZG&)_M$6A1"R%VV872-OV%.@6[-"W M*T.P01Q5#%NGE&>J!MFEF-J$\V\$*#H*D*W+0$-@!X*(O)T@]$5AI%SH:\I2 M$!9FHV A-!>&1'0UF7M\8,49\$54+@HI[0!HW&< .3\H!D<7_12TL07#I39& MP@O_B^SNA8/;!(DFL]!M,CXYR0H=B2"'2#ZUA_PH[%^7%8%:EB<3045)4^1& MU,"F7^.9PYDH..R3Q#UTLNFEX.I^)$\$>0!")TWT0A[?#J4V2HS (=ZSR"#1DW;L F@!!$X!Z+RF M%857P-^P@H2&$Y3)4;B9AU&\1_ *41@/BZ:6A+1$:Z@;MKK4G0U4@1=89=%2 MMK$"0$!1+$0ABB$.P0-N"E$(9\BSL%=<"V&*J^[TUB0$D'CJ$L&N2O5 M$A0PH7OG00G=R],B&9G6ABY/=3X%D@JN@02&@B.1'K!;B@*[,!I*^>6\?.26RI*/]#DP&0-DD.9.-PMLXA&2&YP7T2%9LLP*4Q#([%316=",_ MBH300>1SW&PRT]-;+6T,%#@#4P6,(;:$9V \U6TH41A,0]&IZ@SPE1G*?!AI M9V.A@^&@;*HZM\,'5LZN68SWA1/%NG!5][QD!0@CJ6RN8/;0$KOQ$.B2ZW^) M^FH[P_^=&=H(3G5KZ"GB\3G\?!3:*A9C]R>@^2B-)0Z\;*!W:+4%RU%UA])#Q%%IH>2GB*['!1CR1%5@%PZ)R@#P1^%H$Y/F8B M*YKPJG\?;*$X6XQBE77%;#@]81 9B6;95>9I)]I<3@M*>Q2^4*0%&ME2F$*L M+Z1ZJW6@ K(XDAS,D9?9LZ70Z]6C6KW.D5$8NZWZ86^KV+NAD8ND"A&2J""= M40'&OW5I>T='0'JIB H#-NBM@MKT+4" =BWM]P"*2O-0V[=;^%"%H56*. MBD@E;Q#JOG7%,Z6AUG8;2F+^;6KR3'D5$ZBYY9FE_0&(S4;BM>XE=%[_ M)J&9UFWCXN)5^!KMX[HWPX\CARM$SMPD$UQR15!B5676L!^S0^B%*;,%[ M0#)#S3>8>]]D#@!>=S<-?Z@I2Q,'KZXGAZ [334Y#\IVJ// MPRR'&D[8]F\"!48/![,N&L6_E[C]?,N'&MOHTL%,D,W74U&&$"-:5E&8X="B MT!%EN%AIT9/M/[JHV:"LSY/A5W/#IPFL"$,?>23I5JLUU+,I\G!F9E.0:[FV M42^P!(>BV8X_2ME_WN3'D6GF6E"T0X2\ZY\6*HNL22\NBQM%D\B:W"U:<*;(D< PG\%V@S"9N1)]"T)S9ZYWH2-(N =$KSZ";56,YZ(>5 M46LHU57F,J>0.1Z-2 R$\?'8H*=5E: M]QM7?%IFVM2*H&J*,)A!6OV1%TF"PK7!E"X[N^A;5E+@YT?= MQA#%8DX(8W@ 8X$375D?26NDX&1OTQ>)'EX5\'FI&W(=CK^1'!4@_IJ*470D MRWMF(1PJ8$&9NYD&E*X\U%Y8!?A'0B0+2\BR:: A/*-5N_7.>S:0N-=G[:,Y M"J]]!\U^9ST7>IK-2!7Z3L]N*"_3_:T(4#:146\-42D4='[U,5O/=E9IF5 % MS7-9('C2@3?L;=R+M!]3&1;05\OB0R$TD9ND49NU!D4=27>0(X MQ)E<)$6;6[ZZA_(@9R!T >LRV9$T]3F,\C6A9%#7]^YLBDKI%:B%4%F]MFAH M/--MM!LN@RI&$5-[+]%R5B\=P _D15O@D&_:Y:7K,6]\Y3R(<'<5KOKE"KPI M?=!^ZW7+8)#-T\66F8S75XCY7N^X0W&VKC MMD 44SXI+D;AEIJ3W=4@N6AA4^98T5.]ZMX>5E0NDG+\P 3O;1,%"8XBNCV( MPWN6P"')441=!_%XYSH?)#B2JC.SL[VQ?R8T_$8H<'Y(]8+<*,*7@%S=B]E2 ME"7W:Z#U47_O 0^E*/39H71[ $0 M,1*% CF,XMT\SD?2^%_W@EWH1$VZ!6D&?7:S"-MS)Z9MVJ.4R.5Q!:M:<;02 MR"K*8B@K+ZRR>V6H;QZUUK_[O45WJ$N7NM.\1;0]S>LG!,E'DL';(L]GWBX? M-+N!OK8=\82H5! M0.* :EV$CAJ\5/4S).'S"?U@R,NQ@E[%LMHT;1W5]FFN M\A?FS^CDO7\O5&$R19L=/MO?M_$"XYVJ/%-LKT2C$BY-!NB#W:'.S9N6MP'] ME*GEM\OO!1[],A2 0NBC 8YG-);KW]=/I-J\>?6ZSX[O,]^F1]_\-A6J!J,U M=![2U6HXUI-6OVW=!HQ#E*Y6XUZ]GE^[Q?I^C0#K2Y.E[GQ>9:>*:2IIO#6. M(=6N5@-8OL+\)6PF)1" ZTRR(RD*)BU55E*99 T@&B:Y1@7)8M>F4LO&2ZFY M>DS)Y;(U&%]I<^*R;P,=+9=-M5K<*.O8[K=S*JZO& E&: W3]H/Y M$P^)F4]%@1/,!4Z"%R:H2PTZ%'W5JPGR#-UO]&! ]0*RI.^YG@OJQ=4R>[0Y M[J^?'5]A)^^S,WT'6XIBE);"9=YW]QIZ&QC8R8,WA@>7GDMO PC.@W]C"/#> MC>YM@,(S/]X&3A+FC1V+20'._'@;XG-R!RL4?SQC T[T48^/1LAO T2Q\M"2 M#BCLXIW$F'$/81$^(CQAQH*]<2^TIQ\)76O>4CE'-C5R?6KLZ) M\8 ]E9-[*J?6"-C12(:C<1J<)#H9=:S=4MBMBI5;%7UQYN:\8[D0PNY/0MR?A (M86FIF'-YU2 )>Z1Q\$C7>SY%77>('R8:(J&O0.)%46!1Y- M?A61+0 3'<8YT5YY<*[06$4MN3196'XJ+@]6';,*J,ZY,2N- #-2@"YOQN"M M:^Z46_GEN_Q8'LNR-$HV9BR=T5M,06O(* H:-WJ.#32[>+(?)UZ1VQ,TXZAY M7G@6^!DKVBAPXOBIHR2$']]1$H+:4:(D"\ZS@2KP JOHQH*5%KT7.=F ]:#D MW =]_EK-Y;CH38Z\/0S$0VG$]K0XC)88H"6VZJ(E)3R""H*!Y:"QT@BB-#!F ML.K #B=6'8>A9PRCS3>(G]6P,8)_KEN'81"?9, PHC M\:WA4. 2N%/;2B%S.S?"9(PF4W. YMM18:LU!9M$7(9#GLYX.L%@JT-)_MX M$QY:.[HLZ&]&?Z[Q&RO:" #-SC&@CPEH.[\QH+T!VEI&KLT42=!F"H#35A/F MZ)/ZII6S=;$[8[!F3B*0WYQ2/B60L48.#N0&8%4PED6^/IDJ\K,>P)Q)?9 MHFA]Z!@X_H!C^?1=>:B]L JH2QK4],) !(RJ NT\ M\%2#;I<&&L(SX#?&IUXO[MB_LE(6676[('T_9S#<]AV\F<33W3?/.@AR\.9: MB[WCYC!N 2MJ8Z@W?P)1E("J0GW*S[BD^QC([S1'TE*Z0'D6.'MV8L^HL:1Z MV^9F8J@N2\(KX,NL>,L6M6H<+[+NR!R,8H3ZU%$N:)8(Q@7V2?+X(Q@KV1?=X( MQ@CV1_;Y(U4)*".TE^I.@)]8L2Q+'&2 BDX:]3L'?>I=4W"?!:,HQCB*(%^ M#<91#'&40-\'XRB&.$J@?]2=00X_RY#3(N 2WMYK#W2(TU%/KEH3Y+1@MV&_Q M[K=@M&"_Q;O?@M&"_1;O?LN=H,DH?W76.%D?Y*GU2<)\%8P0[)_L]D\P0K!/ MLMLGP0C!?LAN/^1VP8HS198$CN$$'C(WZ2>E[3L-PFV\I]8L"?-.,&YB@)L$ M^BP8-S' 30(]&8R;&. F@?[-G3Q355!C.8$5C28W9YZ;!/@Y&3BR0DT O!R,G%LA)DI]C'=C;'0O3J2"-&(F_925>A!_/%3G62;RN M0SZUUDF*IX.Q$R_L),G7P=B)%W:2Y.U@[,0+.['V=USV%,C(9>P";J; 01OM MC%]9#+[QDQ5CZA F@9DOWNE&>* B1N@9'EABPO M[[9C,'L;S?Y9"K*"P!4:'R>=>C49DD_?] =K[M&BX$3 M #B(#W5)G2FLQ('N0M5 PA?7]F''=< 8/F'"YPW9T(-QA4WH::%\.YNP4@>H M\DSA0 4\ U&>3L["Y!".)B@:2LB2.08+7OCW7^6&0X)!P;TD?!@E> MS=[GDQC>&?,,%'8$WD9PN3G84ZN5A#DH&#$GUS$)\U8P8DZN8Q+FNF#$G%S' M),R/N?U>.7]G=VN0IU8K"7-=,$BPM[)_.1Z#!#LH>YM"8)!@G\17;N5M+/-M M#O;4:B5A#@I&S,EU3,*\%8R8D^N8A+DN&#$GUS$Q\V,V*M&L/;(62^L2)T_@ M_VI :J&&'P>D.DI+(_VPW*:\ SIOEZLW-]-5+FQX-A .E;)VMZ>'Q@;L<-& M(ES?'>T<,*1B#ZF8>3HKNY5+D\7E]NHQJX#JG!NST@@P(P4 Q(F-;6'*K?SR M77XLCV79:H-@_<:,V"GHSG22E :<*VG4Y:7K<<+WXBQA"%'7&C**@MB#GF/? MCKV#=?NQYX4*U*:B)V@B)*$N\9"Y_(P5[>4\#A,3SINM\7> "!'(MR%Z%U D M)97ET'YS]7IA_\5&TAX\G-8%0,"/V@7(I^F2\:D Y?](8K;JU#(;J.!I!I]= M?5Z^ LA%D)_0NB'N@W(;=MI1TR>VC@C,?5MG LVBQZ]OY>Q[7_!9AIKB%AI MB!BZSAG;5J6H7&X2JZ3+2U1^5*28#29& M40*U<(0-JRZ=ZK ]P/;@?.U!8M*;NDS"^>[?"9(P.8?SASJZ6.C(0'^NC>M< M%]6,B 0@XJA-GBQ$U&:*)&@S!4!.U(0Y^J2^04"X ML^&-:0B,A]CBX23ZH0%8%8QED:]/IHK\K,>.;Q$0._CPQC0$1D2,$7$2'?$ MQ@(GODD[L3[T-Z8)\+R??-Z/(>]4$55W404KEWZC "!!E5=FIX+&BF59F28; M >[-P5V'>L(9-VDQG79^-HN>"*H !.D\_@U%V752GTT_H@ MS]MR[YC=LVO1&/*T^_$@8MD5\D1(.\-BDFB6N9,^VYDT25NS?2\I0 7*,^#/ MH;ABWWP[C_:T,XYFXR@Q();O4WN%1\KT9/!LQV"VCU$F:O85:GX63S_0RS5>6)Q-9ZFHR]X@Q$'PKE\9J^AH!RBMJ"\C4 MJ2RA)8/UQ.(6L\\;B9OQ@A6>P1]7[E5=>@:JEOQ2E7TFQ]/@SSNBV/0O,1[B MBX>3'$J'?9(W(OEXIL]/IO?N\@%LLN":CCG&\=08)V_,?< 3_F:]"(>]G6UMT=!XIMMH-]XH*KPP!?L>OGP/C+,$ MXBPQ'@M&5T+0=?22"ZR$$@^34WM'D$F,*K -82) ]C'FGV\9+;LX@OTB_WX1 M1EA2$)8LCPCC*LZX.FW.!P,D00 Y;8ZH _B!O&@+'-K9;Y3O&E^]4:#LX0?V M@'QY0!A=B4%78KP?C*E88^JTG@\&1T+ $>>5L99T)N=;A9PO7/(%>T$AKH]A MM,48;8GQBC#&$H6Q&.2',%B2!Y;3>DWGM.LUT8=1)-P?PCB*(8X2X^DX,:Y$ M%L@LG"L;I^'BP[WPX5Z'^5,Q.[?5>P\:7?%EXZ!E?; M)Z3:/N&:">,L@3B+K3Y;2TEB"Q@O"Q@D^7A"Q&#-E%#-%$N<(2N;6WI:N=UK MM>$$XH?&)9R.0K"XKA@Y.;^^$C MSR1-6?3O?B<5**AC][*1_PV01PH['0NM-_AE'O&D'CS:6(77^+V^YE#XO;[J;5$TGP)#(G(M432? D,BY>G-64R_H'H)AUAU958@<\ VD&T/UE^#R%Y;2?@C;>N!KR MMW_'SH7);))\4W#'_I45:X"JS09L,BDYB0\C[C#2B.S*--@CVV>L?_K:XME2P)+8 41M+,4JVVF)%RP MWN RF/O>/0QY#/DS6]-Q=:8L8#.<[E&J'< !X9D=B&!]-T>U+$\@R=H-\9X:M47RRH_]RP)1@@VCKL#?(P0' ][ M04CO13Y[A"S'B!'B*V."=4@B/-63(P3KD+>.$'=/%4J6P4"7"+W-+LX_/+=S M(-S8O#K7!&DT$]0Q(KLUK("!YAR3KS$:.]-^,TT8Q!C$\HZFHR>GDDQD&\<+!I 3-^2RWQVS"E!=7V$R0;\H\#L@?6V7]_!PVGD' MWJ)[FS-HZ%A-=C!=/GBP2:/34VTOK0!)G@C2OM?NY\OF>YT>;/V^Q@4/#&W# MU^R9LBG\&'C".G>N3S<.,;_S_FAA?JF@WL2H3?%8F!)#J P[8*A"ME!=J403O! =><)**>.+%-&%,CK\0DQ8 M921(:4V>7A+D\L^!K$&%K7^#9#;-BL)(NB30$AS2UO_W7RI/?OGZ>7IUV&NW M7O 7&@IAN$#\,)_]GW2:J E Y"^)SDP$Z38[ D0Z??45#MMZ[8O :V/T7O*? MB[4?!K("N60,[EIDN4YS7Z(F?,L>;ZJSIE);_O6O$*W1T"T;[(*^XG[^O@ZKY9[U4K M[]]U>TROVOWZ>7 59VJ[U?)]I]ZK5[OOWS'-"E']5;YEFC=5HMRZNZMWN_56 M\W1#H#T-X2<+%9LTTF0I]?Y=Y5/Y$T&3N6SI=&2?!8QKKIM>C:&SX.F M19(EW7<0.,)TV:#)VDRR:?(J'W)!2"SRQ%&ID?U]%U<4F?ZAFZO5,U=3C6<] M*'EPUC?G.[LQWS]FT)T'BKCH@*FL:,Y3K\[4^M-O.7<3?.:'LC)AM7\OA+EV M.9!E$KTB/9]IWO/ M-'M$KT5 ?=B#.H^@,D2K0U"Y#_S'KP.%^ SO:]6(WFV56&G,E;)DRCT"_DR5 M,ED,P(, 6).5]^]Z8T LIY5HZU$?495XP!.; ,UM -2XN&H$D,[P5*[__)UI MI8>;UB 4?/)HRQ.\;\RSBP6 $8WD!-,UPBZNOLTD0&3(%(&>BG59%%"2%;%)E&H2LNT'H=9AF MMZZK?6P1XD6>91$T:!&TY<021B)0SX40_?7_$)J\^16>@(,F -7S"RK*3+]_ M5Q-$0$ !0@GK3?5P;:H'8T< NM*XT%DMS*O*=2X_;OXHC$*(#S;?>7&5R632 M-(W28-BZ1A$?KMVI/YH'G&P4TE\2,^BL*:(@@8LM*T*NP:0#1H**)%MKPLET MADJQ^O*7+E[_K12".VR;4%E_[\45<\.TJ^_?,;TV46YUH!%@>GKJPP4Z\4?0 MA^J]\?8#LM9 M,#2T<@X?+8KP>TZ01O]>P#E'?T]9GK?^]CT$6P)XF6NL&7S5^(]ELI5,'F_EC(^/L:T#9TC]1^XKY-2FO M2U U3$WMH/>(*!O=(,HR[R+T]X-*%N3__AW?L6&XC6D5<&@Q4@-317Y&0K$> MIGF@\^*J"9Y9GO5B3S1^>R)]3Q,=[BQMB(X3B;[V%D*7<2 %V2?#I;S!2+Q;Q'",'_4:)5+C[X'AL3\$$7S-4J ML:P0,HP/%.+O3!%47M"/=(4F;\U(+)>48S,,P:YKUD>CC%A)>-5_L%OB0]7* M<75)(J%5_]3YU/VTFHWJ9"K*"U12$VLLK>N;%85-^=,6@"RE\EEWFJ[B[]S% MACQH>J@"F7O_+DW ?XLIH@&>@0@_I[9BX>*:26)X7D%E7,8_#1@64<[FZ.E& M8/,_;EL_G\70S)'#RR^N>O(+5)BTBQW:'D]ISWAHY_'T^_[^I_RMX;TZP<5X9@R%U??6!'26P$J2URS M8W8DN'F>*2L?V6,GYAT>1]N6H4LL_A&F[GYXH?%WSGQ[:OR8_@U[N&MOO[C* M%6&@Y3+$K>%4G(93AA];"D2!Y#R6X8_[<98;,#]*(.RQK%Y].:,PF MTYEW-%X[#LAL"N@XFOISJZQIK)K5^- B)+-)GUM\M$[6Q=4='.A"=07FIWAG M2,S1O'\G#XFI OTQ8*&[!I.^ M-1]R-]77NE@(0>KM[X,8RI,?O:HL2\(;,@S+VFC,NR+3QMU]IYFK_+ANAJ%W M-]]Y<465:#I#DJ423H_O*HL,Z(]+//+%89 Z6!#<&'"/Z$V/Q,L8Z)$J6LZR M)60_4!^),:L20T$$/,&*(OP1+5VJ\-^GF:# +S69& #S OC,+C"B7"J# D9] M41(E>=%SX4\P#M8$2%]USHU17\GW[QA.0[^CY4B"AS]#Z4+73A7 5W6*)K0 M:QA4X@-\(#0+A#KCQH0ZEE$^V%IPT\:LMDG\"[M.)J+1N-DLQ!,? M:&.4 VA:X 6#OW ,Z ;]6G@7(L-\$%K'574J="I952-*),%#6_,IOI,>-2@5 M8336@@X#+LKU9YP6#7&*YPO]6L7%DA87$&$KP1- T*/1 A)*LR!)*-XH+ LGZ%+KV M\!?97%4R$UV ^ D&A"IH )KY(;QPD2)@"*TLB#HR!RR'W*[W[RJLQA+Z2O.& M^EN]TO8.Z&2K,T04O :5RA-9,H=T'?0T9L:^!Z*;[A$?5%-ETAGZDWF)-A;T M):\I6O(R]:)1:[!2C-H+$*$O:%.. 72B0?B2ZJ7* ^I'K-!"4FBEC16G): 0 MG$S]XE**(*M@.A-K?WX'KU#:7DER>O]NA49@C78RC085 4N(D!1 L!P'-1I2 M5[PNHS F@00X?4O 64P[_J!.H"J$;U$L@_;^'6>TPTPAAPT^#_HX:-PC8J3( M+]J8,'_^!.D'.G$\& J27NZD(EV%PB6:_.)&HOXS]<6ZS/4"9#;U*[8HM"A8 M/@II*_-B%V*M*P7)T+P4/4C3EA]J.9\$]#W?L)([E+X&FG#DP*\F%)E&Q=(0 M!+'CI]UI:?WB,KQO)+OEF#*-!?7 E'-C*CS5N/;:BZOFA@SI/[O%U):&[+JA M=VO(Y;4AZ_=9VZJ=A_S]>3AOO6JC.AOI]@4'>O9M78@O2*NF?GC_;EU![ &@ M==N-?I/9+]AI5BX(>#DBR;B/L&XDC#L)\];HY\N1XN3.6]R57WV(4@=NMA+E M"@TC3ZS;>&'H%+#H80I4,)*LQPHSU;"SD%R@;RW9JB]^_PYE(-#+Q 5Z^XL MWXU0+4%Z9:1\G@55-[ 2*W$"*R*[C%+CZ&+4 (-G%5XE4,&1P&]$*JL$S@?V MHZ/)W-Y\EUD7GOFJTMW87.))9JX;U??O6LW&;[0?J=[MWE<[ M7:+>?&@U'JH5^(&X9IK?._?M7OEW;(?2[K3*U6JEWKSIOG]7N>_ #_KFJ7:G M6M:_)FKUARKQN\ITNI>Q'<69Z?[U12?>W$&GZJ&_QR4H%5J&E,,ZU/MW#@M1 MA'T=2IT-5/AL8#A$>LH#T24,9F8!)Z&NGJ!O*(&&:HIJ8J ^&PK*Q* #+1'/ ME"A3#(=I^039H&/D'6,N@!$H;&L_4=52W5B]':[>D+HP*D9T1:$W$B/DF::' M72C^@M\"EAM;'JNQY\FJ.2$XD555H"=6H=,[D1$M,O>80INBS#M$^!Y5@]$; MRN)S^@8CM-,_<=[N>>R-,K:D1+P]*N1]LPAC(>X*,J=K.51]D$G9#10N:ULK M03>H9C6"F8V@_, G6#TUHMM+8W $PAXR9*3(T#=!T)>52^*_9>CDUFH'[+2) M;N/41H!I=4XQW;0%#/![*%7D'%Z6"V5AGKWO_7K,A[ 0L/G."WV3N;5SH6NH MXO^1GU"S58A[A7AFQ1G8ERD*:=-='#;%' T%Z_LTC5G0^6\T'+4)FHF+(D7V MIX*PF5:*>13V1R=(K,%"UT6@4[PPGMG N-N M@["0^V]N6:6]'3B7'3M/VG\SBDE?YRXB_ N\'@7:'.*(,0I=+VVSU+5+Z59; MS[SN>ZR<2[LSN>ELKK]CVTO<\";M\T<:KUD:;8=MK>L<%<%0OX/?0%$F\\^* M7TB4MZ_([KUB\QE('5C*P.J8N\G9*9R ]$ ![&-Z *"J@J-BQ1=VH:XW3C7X MN436$B]3S=X7=^TE=I >BL]M4.[MZWJVJFIPU3,C^!H,WIN]:K-WPCZN;RKP M.\AQ=M0-)KGDIWQ.D*)T[98OHM![;%HBW!$E)>!SBYF6;"K ^0A;;I$6##/P MVP[PE-'@ TUF4W2FF*)SN8]A _:@T3.=GD%-W37M$"DP66*L(._ZO\]]&+@= M,I1:O!#W3>:^@CJX(]-?J3:[QJ=NJU&O,.CK%33U#N]WR#NX3!8LWZ!Z MW&']8FBKU\&JU- M /&A(:OJQZ0!EL8J-%'8S?O&;EDO6%%1_:.>DQ[+(HR-5',%F:@^S01MD338 M9K">C3]6"_ZQRJICHB;*+XDS_%FL1T\3(!4#D]^4-?BS)A-[05I;[HM8P359 M@5(MK7=[@XHS0H,?+\VY"N+I$P3QA^I/E34R3W=,D[G18W/38'>)2KU;OM\A0@GFNG7?(^Z8 MSO=JC^C4N]]/I&,I*G;IJ+BJUFP"52OT&JC,Q15:$.VT&ET=DOJFC@I"8;*T M(O46X_?U%:(8+!%1V8-J0'NWU0Y>'DJB^J.2J?UR%U>-Z@WT$FU[V1*F]]ZV M.T@QR01>_N(*^75=HL:4>ZT.!EWL-1R=3*"AU&.S4[VI=WO53K5"=)E&50]_ MJS_NZ[W?]I,.D?MWWZVB'TUUF#!8HBTB;U@79I*)T.+%5:5:8_2TS'V[U820 M;-9;'1LR,0KCKARSR81>Z>+JKMZL0J58JT)=:$O!8,@E2/'E$HD^FKQPBG@Q M[N*MZO+)!!MU<57]=5N_KO>2IMLBK"2+K6Y+6+'#8 -L],55MW[39'HK4QK: MGOEC0,XQEQS%#M%#^T- SEMPV-K,M'O3(/V%:$WU0KY+]'BS]<\7X@%MRX8_ MXSV%FSL&G?;3V?<9VKEM\?D+T5M,(8&,P@X$[@N!3J8VYJ(I(P[3:SO^K+OT M7;-O;K_B\GV12$-T0HMVWEN[8\QW'KB:4R?V;Y9)2*N:R+E.A\!UP[FC/A%! M=XK$>"/ID60BS".@S0T2)K',#=.NOG_']-K+MEN1RT((G8(L_+Q_MP:@:Z8! M 50ENK?5:LRW(,-1?%@*Q,?8DVJ?$P18,X!^"[4(7JS#UG$PX^Z3=@NK\MJ'),AR3Y%4?W7 MVFC\_/JH%A4E WVRV032O- ON5P5?1)I;[N6B _+DM*/ 3:F>W,%-S:F\X(Z M%=G%)3K* _CI].26<;"Z="&?T:#;R9=<=QIW1FG[;E[.2;94M35L8EX>[ZG: M](62'B^<'F6VC?3ZYNW+0Z2;@713)8K.0$#==MBYR!:XW]>"1[H]OW,K&["W MR9S+:_1@X@4@2M!-(N_"1P@5)&3_7F0N7&]U5FW?9A(@,F3JX#?3?M]< 1S0 MU5F&\OGV"/GKVOS.*]OWAZ(>V6.TEHN&7#H*3)]3Q73N/P M]2AZU_6V@2P5$#J:=::F1RP[3:<9Z QH*C- +9(YK2]<]U^'ZF.+OFX+K:>5 M+O5N*3SF#3=XSW2[NL\7AJ:-I?J/2K>O9I7>FE7S&+;5Y)(4G-XG\5N[^WWX MO^R__N#YQM-M[_FZ,(A&HIW<0-,+S9/_.+F$^B8^ MM$V:0Q_ :B3$A[I^)#;TE_^WV;XQVP<<# ?D23K]P"H"\N'UDP>!JEE=%5?N M-C-!A].TALX,,_L[(N=Q.B6GJY-C'NI5U'YQY;6S^G/TWLEN-%^XM'MD8&1^ M>2BE;MT@MP^Q<.T&B1+(<*J!_FG9%?*^6[FXHHJI?)%TZP:)HD34'7J-(8A# M^C&@')R< 4!'"Z&S3\6%?O8GT" ;"7D )YM='N?G^ RC^;3E^^EM;#^ZI';I M?W9+N!7Q.$+M?RX/I?(;EUN]Y1WGTA3 2T_R%\Z$RBY.1NNCYU*Y8BG9?Z%RXUY=(JF]OMPAPE977J&XY"5!?0[-HW9\_?O@TZN0*FY8QDS='"00<_) M9<;.F"@L4);*I_*TR_3&2#8\>F+Y;)B>6-Z&T+8"IJS ]]@Y4#<0>EO_\9)E MQ>?Y7>GH"M\DB] 07;LR/TR0S,_:H /D>Z9VZD+*\=AIBM9J9%(4VHL8L\3. M:?10^%S?R*)!(Y--D9G58I"X^7(0JJ4]*@D(.\.3BWG2RFJY&2;0PA*+%7C M+)>V &RQH69'O^G68^&E5/Y5/+(?Z%I XJ9R=^?A=E9^[%[8V%^)XA6+_IZT M$ZVZ0MX_G5%(.9TJ%+UF^%P*;3RO/25PNCPZ4X4=SI0'K@7(NV]Z4STHYYHA MYTC>U5JV_[H8">W':I;Y]AI$WCVX59[%O"=KK$B8Y!(&\6> CMV)Y\@-=*I$ M%E-%LHC%-YH).M0+R*1RF7PJG]OO!QRH(PZVY<>OEHJ/ QE6"5?!IIYM7N9& M;5[G1VXZ[W6D+%4XCDZVVBS@(KU09[BMR%,X;8NVR$H:]-=0Z?[G-HE+WK8%%8HJ0@';JN,R=?9$4=%!4JIB+?S#KT=\L MYL-,WN76%KHT5AH) Q$8Z@O.1W6.\EX0;#>RS+\(HKB![V()S.G\X)L\.FGV M;D4YP>JDQP#F7K@9!=SS*;KHXG4D$.RE,,'.V,VT<9Z3-&H 5@4=1%9K>*\: MD[6!2! MNT1'M0QSQRJ/0-\%VP7<3!%0/493EKC-%1@=W3/U9G2;>U*>Z"!.2H@Z_!FH MFK['5I#0?F%S!(2Z',)IX;Z;J9$L/)8RJ7P^_G@/F6V'QM[Y?"KKEM@\U%FR M$O KM-8E.!I? L>HY>NG^7= 3XYO3M:E#+(G'2-)TW/AOC@;S7)_CG3:,Y, MF0N'@8?*7P&::2H315F>/0U> 4, A\"WAO!?"/RRK&KJAJ0M[G_FRT_/V7)V M=$K39I%*R":MD.GJJ;TW1_Y%LLQ$9A +8R]1WKPV"K6["L]K*S@@VCA-ML?. MEX'C!JQ+]!^V +Y]RWS/Q&4Q=PEQC9T[Q>#GNI#@/F>1I+*RJ6R&PFL^ARW9 M4N2.2MS0EFQ)YS4!VX(MDN7E@FVSV?[]NS%3I6]'V<7M3[J--5Q]%&]D!=[FMTAJT7&NJ M:%TUWSS4J4G[Z7>Y=:2..5XT,VUJYE:/:6PL\.YXKLM3?.L!_3Z"EVB"_M3 MARXSZ8EOV!0DPA0T!'8@B'JVC)'XKB9SCV,XHT!14;V"MEAKJO;2>*DHMR*G M74>TA.()68TZ^WK4:EVNF:1X>;AY]AE!R DJHS2IS[L95Z MDQ_"SRS/=(-D(/WW8[-A $]R2)EFJXU$FUV@-'I/87FPM9GM!\GW7QLW2D/\ M4?]Y/\O'HKG)U* X(-.W+/P!*1=TV%UZYT$H84/&$_6>VH;@4ZXCN;,K"@" MB1))I7+Y+ M1#E+ARJ*(M0419>(]H0E(SN\!KQD&-F2X:K ?F,]Z+X&1J2FYFX>@W2,];X> M9&S\QZM!X<^R2[+,:;>/;IOO6E6Z,9_*8_9OM$[_AD8Y/#MI]>%"NX0V\I1' M-A7>:DT.+"G<-Z^1[(THP6G-NOB7237L(K_ 9<[V@BHV*)3M$% MKTNG"5&@<9F>,PV)L)8.7TO;]S'N*I;4@Z *F#&2(OT952+J&K1-/ZZ%C+P6 MLJV8>R'U^=\XJ915_O1?&[??R-IP<)N_.^:^U;\S51.&"[WAL+E)5444IAR/ M('493IM56DI70SEG?61MH'3'K +LR\J"L%Q4WGK5E%6(9_TTPZO-E]*!7FJ> M,>_YI?M:97MX;0@6O-ZLK1N)MOYDUS7TPPGT:D&9TTM]3.;F:T-' M61"$>2'J(&191,%939'&__N&UA;C(<0&"O%Y:\Z9/7->5]49G&^ACB:ZS\LV MN+U2DV^=8D^4.I2X%P*"_IQMS-4"O-]$WJNZ>,F6^#GY\*L0^/VE/>]OS315 M8R5D19R94.]^5U^?FL^M7_OE0%X]S#\G7"FQV%'.OS"=5J>N*OO9L4Z);_0; ML^)9'%&*!J'_!88I*I"BD$=WBAQE\0@4V>8K3HS:0U8XW&K*7C26/YVV_H\$ M3)'62^]L<(Z9SYZ.2QUJ+M3>-/95C[(\F_.EU4]^]_%,&(H>Z^W?)' MZ6'ANHE IW7+"=YV]XO. _3IZ[N\;K>C[_%U#OZ7^^MV'[6^_X4G].\#4G=B MYW[;I7=!E$=_?GUJ/3CS5>^OVXLDWV[\CA>>R(?W25$H#CQEN>_AN/"I+4A5 M=LVQZ3G[@).;CYS?]1J[6^KC73X<4)>1Q05(0?P\OR1E"OE4%MH^RO'8]=TX M0OZ1PT8*+\#QJAC<@$/Z ([7=T4#G%#D/5S@A$(2 @Y=R+FT+=T-'&?_VFDC MAGY-!7!@,@ *D:'0MU0I14 2I@ ^^QF(B\C]8*_,USV'B$_@+:3R6:_'I\5T M;X87CH5W6#OB&+U_.=!_H&(WD0R,$-!C6;'-"GQ=*K-306/%C94(0(D_OQ7I M*K@)4B5PV/:X%86$?@"U(!&<0>1IP>#"N6C.J,CDR%3.K=-.4L3'!\<.74K/ MI>A2)D46]V]%\"\^]J"E S16D !?914)0EEE.&XVF>E[+2I@*'""MB%)Q;N; MWL^QEO\U#;+1-,R6%Q:=D(TZH5%CX\-N<.SG9$CV"=+T[T7:X=#R3"95H [H M*K"6=4)E3P;[B9XP@3Y:$[P0'7G"2BGCBQ31!8HPO+CZN)& 2A3_ U@[-_Z3 MQ5**)EWXOY,%']UEM;3>E\8:D;[)$EKSJ0+&0%*A,V8T)&[(*NI%W!KVV/F& MX#;%7[>W?WK\W^FQSR9SWX%H$V)C[S5G'Q+:@ S'=.Y%63ZG-9*-QS"8*.'M M1B>;OT.]A5*J4'3I2AG%ID5Z9_&7;=,B4CS+2EVYOGB8D$^]G]='J@+;4Y:[ MOT3L7!&[/6?1G%FL%SN47+;C8[T2RBP=W@25SD'?L;B_:0(NVTU^_:;+=G/' MCJ>V'1>Z_M;JQ<>[BC;X.X]H8]OA?;']=T3=\>XWV&MY'R1P5^VW/-.)[;?] M63\.#7Z"GZ=^$QQ?T-F4(P$^GW2I,P^8-[$(-9,GTP/I2VOR5*?1_-/BW0;5 M'$"=R0(3W1N#]^]8#L7IK+1 2T>2K*$5;040:)D0/GRDZ)EN1>_[!0,B%4 < ML#->0&$^1!4/(R/CTZJ;V%"06(D3X(TJJ@1!A]FIGT[%&FMBC-?"%_\GG29J M A#Y2Z+-CJ $=L'3#$@D+\2+PVA@Q MD/S'%"I5> 4&1]%K7)TUR$80A(9!>HM[@O1A-K,F(VFC'A,V6_Z;-V%?ME\OQN%2%=8FN+K9SA9#O,V MA>]+#Q3 /J8' "I!2 (KOK +=1UI29LM]&B/S+!S&7'?P/>!>C6P-OHZ6%(] MN I-782M,U<5%,]]DLQ=+"D=7#$W3+OZ_IW>%['5:;:L9[-(.K%;G;\)^[:K/7)5HUHM6N&L,Q?/%RZZ[=J=["^^H/ M5:+>A']7B0^-5K?[,>[C_7#?9.XK=3C$^)-J=#SB%N_?@?E4 :IJ].^\EW3S MJ]=9JD0%*1=%)3Z@H(@FO]QW_Z=_HKY\3!%@S@'X+JC>".C;H>(/:,>-0IUX M#]_9H?*FAJT0.4-6^Q25Z;\.:]7G1H\K?L7;;.FZKQ<39DFJWU_MMGEX;F0Z MK0=U4ER5D?O*M 2@@BI95,!/.A5\;_+ZK9'_*69+1Z&B:G" 6N?%TVOEZ?GY M&Z!JV:-043(X0*WSXMNOK/:#$I\6XZ!4>,S[N,*D$B&BPJ%WM!P\>R>1O0]#SY\)^>-/'A?#[4. M> ;2#-04>0)#%+TMST]!&UNG'57GZ) 'B QTSB:*%E'E&*K9^$-/^Z_-1?6N M+':XVWI$:WYF6))%44FG^E!MWE==$G;T/RZ2M)'+^L?3,HMU]>;EGA9/ K!T M?3T%W6FLG&73)!5*QVB*3-'D_F+[G5QR5G0GX;^W#= 07.X;H),RU&-!C8+_ MU60,MN!@RX< MGW[66P3OG[FP4HILS?7D^'SMY_?'X,<*W)P]W]332_;!7>J M#3W[VV8ZYU\ZYSH]$2OX3"J?\[]N[JE$"T^6/EE4R9HL].F0RS4Z,H=G]!_ MG=_] ,_,8$Y.QR<\%=ZHA'2)I;PFIOV\T'-Z)"C$HK:MJ1R=217S^Q5VF.Q( M+../;RR#*O MEY\#Y5G@@-J%2.\+S3XO]">JY57=M!\KO[A'A=(+<2+PJEP<\W*KVT-E;"Z> M5/+<^3W[Y]VG)%KW*UN YBC,\.LCGJK('+9"B@HSL8&G*CHG#\O5$>0J)+>0 M*J &2:%/%?8*,35QHL;)*[1WR+]19%5M*_(0=9WJ6=VF-: MWV/(]DS6(1[A:K)<&F$5'+N2OEV?XV"Q"NX08L$Z[FP=XA&ZS54VD\JZ-?4+ M;[D+^X>8FM-3L[?7&!!%"/+J?(JVW%F90K;\^GVQZ+^6?CWTZ.'M)*\$.6TP MV"F3U4:CWKR)FI=[K/TZ6R)>+"6+J:)CP_I]$_TQ]EP*+U&63^7(\^11J,N0 M9"F5R>UO/)9$/H67'"JDBMD#>.2D4^UG?W2AVZ&BOO""JJ(=RHS$UP"J<%E7 MKG]Z['SDD[U/+=T "2BL"*>"X2>")*#SQ-&9 M(RZ^WWV-DB?R4^MUR)XZ-5AM5CM,0V]YPE3NZLUZMX?:H#Q4S<-:B>0'R?NR M3[OG+EH5FJ.RJ0*-E[VBG:_P7.4(9BW9Q M.9KIVE?A9?8\6@9)**+HZ39;,VUV_B]U3RY*\]FWQQ!#BD!-A-?ZPIM]RYHW M1/57&[4YZV[RZL"M_YZ1=D!-[,$/]X;LK5F.NE2?)/,IB@KCLE?]YI\^I+-\AIC ?XT!=7 M:QU\B5JG=6?K^+M7Q<9Z,Y@#RR/> P&=VM*;VHWGU1#MGH&#"MF@RUGR MX'*&Y&F")"JC]SGH8L='K(_4<+8E\L,?X&IL:? M+T;9?+&F+,GKHF@&2LQ U7NS]87K_FNW_CC,_7BL_FJ"2&LE6KW;:F=YDH*5 MK(R\-B;YTXRI\2<"]A8X^A&WKG* S@S4HQ/U0>J_YICZ:#B;-VXRI6.ORJ._ MK"-R=)+-PZ2)#\!,;7Q,$1*(_-#X/79])S.CC3EHZ.A25(#JDUC4[/CG7 2Q M DVE\ID##GQ/$/6. 1_*U4BZ?B5]9I&?:8UC2Z9GV7/QH#TLY>Q*^(X7_=#Y%'J*AG11-U:9H M[ECE$>@G='4!-U/T\VCO)07 9[T"_H85)#W?C32-N1O_*[WNB)S>4_7\ M*7W+%;$$.C\7'8@Z@E03<%8GR[$1ZG)PIS5 % M5EFTE&U+ 3;B\8IEX3[+T5$NR]%9+LO>TI]0TFI]'&C!3:CQHD3[%/0Y7[T'R@DTA@ MR @%5E"0;XJ&7Y>,4:X\UG5-] +$NT[I]BFKGK:5C[.N6HV%$%%H"363:V"Y MLT@I_*)USR)6W"-B@>K,5Z MD<183PK60\Y/1(5U)V-7\K(0C,R<<38$LG/+.KU?PC?^#DS&*G<G&*:%9[R4?K;K_L1(ML5"&7HJC]"32L6PZ8KBAL:+&8RA8RR;>A\16P\+K( MT*EB4/G?;7:H/U:7)V$;(] MXA(NFDIER$)2:[B.S/<(W,1L%KJ)@8KH3ET!=@+,A[]%A$QEL_M]]#?/_"B< MMV(V1>4/ #[VTC U,:7&6W$DE$HS7KH&$M!/K# /+C.=J^_LN-2^_?7X1XS2 MN7)-^7UH=UH/==1(DX#N%O*ZFE5T6D6KYNAYG6V8ZS);41_7GDV1^?V.6>S3 M1UZ78$K[JA'P$DP,P!W>@>EG N^C94=]3%0$WEH^54'WLJ//1?J<7DKB5(8O%U?.SN*LUJCUA+FVV./6X=#/8L M-MAY':WO52RDZ.S^(ZC>3B^5O;P_86+L373O\ 3^\+-CV6PJ1X4D"&<_!5'D MR J%%%7:O\")>ZJM]5F%QW<8#AB<60ZIB8IU#B) M1\:#>-1D!9H&J3Q3H!1PBY["2JIA2!B)U_\2]24CAO\[,TIO/0C3X9I*/B(^*RA6**S ;N\7R^R=Z8 M R"\MNY9&!OB^4_:_(=Z]EDN5<002!P$0MR2FJ*CVA:!3[7&U,2)&I>-TTO/ MWT&@+?&$?XDS) &.X%MQZ_<1O#R#_')2&__SI+3=G^)):X<\OQ%7KE"Y%%WT;YGIPRQSS"=X M3W;Y"#,9-U]H-UZYVB.XMT\'+2YB:"(/,/6*A M+PB]/O[MCNZF3?7Z((W.>7A/,=P/!1/E1M! MG)8P2N[VS'BH862]65OW1]KZ*]6+*_(3N;\$R67RPRT:.DL(['%E V @<*"I M8\#1.3T>&((<[8IQX*H+ H:B& EGA83 P6J,<(#K)C$U,:5F7]WD'HG5UX0K M@LJ)LCJ#,K46X'[_SI8I^F^E]RU*?_[BZF>U?G/;JU8(YJ':86ZJ1//^[AH& MMJT:JJ2\:S6-$+=+M.Y[W1[3K, (.(YS@:E)"C7[TD _=7P"GH%X9T>@.9L, M@-(:ZA+4FFFJ!N-'*%7.87";FW/#+%V7CI46>EL1L8]ZF?##XF# B#!:MERA M3"&?RA1(B!G_/?'.+6 ^$X0<%DL[(H0NY%(YG%(Y%X0<&F4[:Q&:3A4+@1=\ M,4;BA9'#XN]8:!'36_NL+Y3#3_#SU(X9PY$A>L($J$03O! =><)**>.+%-$% MBC#\@@Y4&PGP^>3ZZSB 5MHW>M5X?>J*3K-MS31FY/7&X/T[EN., Y'0^7*2 MK,$;X&1"CX\0X,-'"BM".5,T=)@2# =5 &>=G?$P?.,1GGC4<43_I!<>L^CK MH2"Q$B? &R$2-:"?*?@I>B98S#9> %_QGW2:J E Y"^)-A23+_ Y3S,@<>"2 MR'XA'EAQ!C]11#IMJ0E>>-XIR6L5U@8URROR2/-\-8[DXX HFO#6RRK0WW#T MG/7W^CN@;R^R4Q728GWZ0KP(O#9&7"'_,45"%5Z!Y9/OR#5I\M2QU])*[LQ' M9S+_>(F.#.8N":<1]-N=6LH!,X*N_?P8_=5J->85 .K=N#_]Q5F[TN MRI_%?A2W3/.FVGW_KMZ$E+?*WV];C4JUT_V__Q9IJO"%J/ZXK_=^QWT4'^Z; MS'VE#MG_,?:D6MM\WK\#\RETZ9!M%R3B7M+M?1>96^ M^S_]$_7E8XH PW?VU;R9""M/F"')/D5E^Z_U:O9^ MUA/H;TV4YIM-(,D+_9)+@XGZ^6]IHKQTH,IV!VIYB8J85QZSTL@XPU(_\0^= M!0P4]?_8J0RMFG$X$O'AWO+*/E[XYZ@WVW:QOLR%CMD4V<4E=!HE>&$4#1/B MFR,^E)IE9OF:Z2\3R\MY-R85%0M#UD(8,'-![=LW]4QD22?@KO_S=-?CLJ09/]E]+RASDJ,Y#=\3O(C$7= UJYR*1 M>\& C[39KJW+4&4C@_CO17XS$-H1&N_)X5B&VEJ^19[=ONP0Y9(=.B!;Z&G8 M](5?BIS'RE2@!P@#!Z81]D@##BOPT^+,Y'+Y_NZ^H4J^E5?O9B.(., MG<*APUSJ#%L/>58K2U7(@U^#?:0;P)$=B5 M+@W775@&0YE2GT/KR"1%4OV^_BF3H6QU<_;LE1$A]H5N__5GO@6>2YV[!5N* MIB3.OG9US8HL6G9B]=1:!7!ZH$EDJ!0!*2ZZ+$51_[A,X>9E'DH%+'Z5BO:& M\<8*NFWQ'K%F*DQ)1YYZ#;EWYHSXV\YK7NI,VE7V@M $#0WD&D 11.D'R&F= M42G35;K8&&KQGP!U"UN#7"])8-36$$U"FJ+3<)#F7?TMTGUM$8 @ NN]2((4 M*_B9X!"AL[65XR#N;XE?I.S?[LM62.7I_95#;YC5.W.>0=F>2]&E3(KTT',\&'-ZJ!4I!-_C2$.0O!.ZR6#G'OT3:)\+6$H+\WZB7(K=/H3K46ZO%0 MODPVKQ/M>!Y?[&DOQ)#V,(\8R81IV=:%O^"MN6KL(5!Z Q XZ1SO.Y- MU5U M59T!OC)34-LSH @RKU?E,APT7JKN"D-M+Q;JA3^-Y_9K35QJ^\"U)P&:CEY< M(3+UK($\A(Q'X1"\%I*/2G+@1$C F+ 701L3[(IV=#DS8J> Z,ZF:'0*T1"> M47#=Y27B>LR'@ZA50F$KV;+-7R/X76-PM%F&4>E79M@2)KG;99(A*G9NY2H. M4!"Y8@P5!*8#TQ$:'4X*NN+Q3*7@3>'[KX7YM\R(ZTR$.7O2$V'>T.DO^*QK MKVH_3[JK?UMJ8WP< M@(^8SK;3^GPUP/I\M?^Z>*Z"RFO^[_ YA&3KQ@+\':MP8VOUO11V/%S9O MC7J!_=MS6Y*'=T]B;AG[5O5WNZZN1[2DOJG+XK"D'L\TF\(J50I/E=L2>?MTNW.?'_:%XBOAV!?"OE#,;#CVA; O%$-A MCZ$O1-+NU78C523%@EKH/0V.LV!G%-Z)\.51SVKBRNZ*.Y9:8D_[CA6/F-H= M3T57ZUUXHS8^V6PQE:7BJ2.] B'[%H!P^IEVTO/50"5XK\/K7F,P?\A6P>$A MK_?ZZZ34W7FH:]Q==Q=!1"USLC $CY5?#!U&/5PIALH;TX'IB+8>+GN$>KB[ MUQY5KC^!V8*+<#,++H+#17">=?T._PPSS8UI.??Z/4NVJ6A2GRXGV*RO M_'Z;28#(D.L+OWN>X!O,ZZ?4^ A^RSZ*["*(HMHP*8$&.+8YPH2:4:0RZI(VG[. I._%"^MN:P="6G8^Q M@E+(D5!WABB$>S=8O,G9.U[10*&$YS(*71K#] 8&MY)M(#!/8L MO:PV[6WQ-)2E%R%7*Q6JY.\IMUIZB?YX@!(^'N"4S:/#8C\^'L WJ_'Q !XX M'U8R^RC' U"0\:443>Y/8+^-SO1;B(^ZWJB4*A3W=SI.!O+-]X0X#\$7 .@< ME:*+^6A/",B[[UED[F^RT\YH).:SD9\0@#2P>IT,(WLV(=S-Z5OL[G#C,-#>F[3C^!C/-C6D[#A5[>TR+ MR9:U'8%OY-G%0JI0\+\_!T/C9-"(X42[-O+WN4Y>[;_^^C:6YW=3=?H]C*3H MCD[^-!EVM%KSNLDPFL!T3-(@UZ"NR\UAQ.UIMY14'):W3Q;]A+"6$1I#WV)[ MVFV3B=O3AL?,R!:5,S29*N7V+RJ?(O4>"2JC=N2H0BJ7B_&IQR$R-?B:+TD7 M4AER_YJO?W^G:%KV[-*R>VK4WY*Y5NE7Z>;>M@A\Y$;]X7M"51\U?^O\"L43 MNL\R#$76_[S\Y; GE$P)QYX0]H2P)X0](>P))A/YV24_(XZV]& MX9N@OSWJ*4UX33YGV5/"4769Y0VTPLR[WQ4**SL;8A?0( M@=R.(]#/!@(GG>-]BMUSN5MPG7]^/?ASA]:S11 L"]5!A^'IWLUOM.]H#OX6,'X8>G/DH0DY)SJC_([ "#/- MC6D[#BS$3'-CVH[#MMX>TV)4+>CFA$:==:>+*3*+S\5($#;B.--.I177 4HK MJOW73J\D2_.7N^SW7(C9)[^G8:RJ*_8\P3>$ Y^&4?)1J!I!QJG1J2LDO^"J MMX/=+<&.<1K&T5).J((C"YU^RD/:Z6TUY@]K/32ZTS"R>,J.,&61I,GRJ4R. M3.4*> 8CJI$YQFD85(K.9%(%"I^A$+$$1GYT7BZ5*Q6P*$8VE0<4]9%DBBSM M7[D)_3@,HQ5N6I.G>CM<\T_K\>3%ZHB*V/39M8:V?H)&;,CKC<'[=RP'Q17> MOD#KV9*LP1N@(TK YPGPX2.%%8DIJV@H6H&BK@(("'8! +7LE'LJ\\4D/ M;)%&((:"!$,< =ZH6LZ_^BEZ)EC,-EX 7_&?=)JH"4#D+XDV.X(RU05/,Q@@ M@TLB]X70%S+@BXETVA)S7GCV'L%OX"^/-(>_PU&\'7EB-A]6A5=@L F]QO5 M B@=3C)FDTNK_V_F'S>UN,W<)4%ZU^!:VLY:BZE?B-YB"DED%'8@<%^()M1. M!N.;,N)QQG[39^LN],OF^]TH1,K!4@U?/\/)J ]C$] %#%01)8 M\85=J,L)T_5'TF;+./O&$S/L7$;<-_ =JL2A+)(P7"1$+:)\QG.?) L7RU;G M@;NF,S=,N_K^'=-K$^56I]WJ,.C\FHTNZO%2\GI7^F:EVNQ6*^_?P8_=5J-> MT8\!Z/;@/W?59J]+M&I$F>G>$K5&ZVTBVHGAU3B0I2)8I*?$#-Z6GRRWWW?_HGZDN\!^@LR-[4JI5F MS)#E/D73_=?QD-+^UH8SIO8(E>YL DE>Z)=<$LLD(I$FRDNGHVQW.I:7Z'G5 M,JN.B9HHOT">WEO^RL=C'4OF_?&'IYF]O\MRR)&-,>[P'BGYAX13\.2=5L]) MZFRIU-]HE(#RSZ_,0R?SYU=S6+_-!)AUA^#K,+ZSQFG7U-JYUZ\9NO'4 M>,RIPUP2&+UUHI?NK@W9B2 N+H-)JZM0HG-"?),'^L#A=!2IH_Q9*ES$@(<'3B5:'8L7+F&F=2/Q2 M!Y0<9MI#I/*-C-*I!)Y9WX*-PN:V(C\+T-FX7MS#(+LNM:9 8348.#*<)CP+ MF@!49J!J:-FG+USW7Z?WXY]3\J%2D/\&&'2H!?$':!4S\1I,I%'FS"!&3Y\1 MM4[KCFBUJR@[V+PAF'*O_E#OU:O=RSCZY2%$6*>,5?87)Y^4H-,S"(/FS8/& M2?53[MTWX&_ZMJ7^A"V_LNT__=<>J%/%)T:J=85(E7PT64XS4YLG'4_F"LAF MR#.#3./(K -GWR21_B<>TKKS*+. !/XO+"91>9=3^X+1%=8A1)H8MXQ&-'=7YLO#3(T61"L5A*2.8)E^A; M])E#R\0SMKA)L$MVXH -^]XX8(L!3]X8:)Q,AKU9<@5,H5836&0"X6<1 MF)L]F8D,]?>K_CTT ?0J@LO\S0E\A7PH_N$2%\$%YJR=35@H8RV4NWU/+W@/ M/S;;ZA9;<.Q8%6,]@G$>.YQ[;)M1S-C;9L088DZFBG:,;FJRXFZ?OC]4:98> M_OU399,3MH1HJNR::I<\1ZU?; R(X=LKT:IWR"C9,] M];;,H#4 JX(.8EYK>*\"1E6!9A?>ZGR*-AVLVRR)?A+JH^\__MZ6$A=3A9ES ML_')H%$>VK)I.B33\C ]4U';&\C80Y?+L!HXI8'S*S-1V[T,G2KD<%R&,7\< MTU^WK%DAR MG!8B[Q$+#=J&D)$$T#E)"$LF8L$_"\$O40D1? RQV$%LIS_E21&'7F_A7&5! MYU-DT>E$M!CCW(?L&;RX6G&.0+VF4'PW8E'QA(2N M,AE-J$M.QV1C'U9+WNN]&*;7OO0H-5'60VZLOD'5E,\[M82+BVHZM/81PSTF MCEXN(8[>O@U=EI2VI"Z4J=;0.-%%ZLX&JL +K+)H*=O>!@#;,1_3K67Y<>VU M/,WBF$^?#<1:,]4I0?T%)M >HM/899454?93U9LYHZI"P>0J87;9PTKB/)1$ M(2%* D,L;A#;4V8?4&N''2!NGM27RI%.797C@OS]%?>554A8AYI84%!B). J\N%HQT$?'%[WP'EI$AP0ICA'CJJP\VL,< M26)[B"$68G94ST+L4]1'RHIF\OE4,>-T,D2,@>YD Z_7MA ,@:*@;60H_=QC MY^9R_360P%#0UBM=I@I=4:7G%^UOD,XFYQ@!6NPS=YFQ6^QSV@"Z]+U9B51L L55G?[ZP791*LQ!.BP X$$>]] M3H"0)V ;*P8-!DTHNI[9J>L9CH,Z5U,[@ /",UJTAEH^LU&W.!^*SZUN1QL6 M<02CL][BFD&?LN0=#F#B+<)[U@^\B$?T)?ET*I>-2?&S9NNV(1L$KM^R(S+/V.MB%OW'>EN9DW AVM1%%? MX'Y6$SE*6P*,?1C#?UP>C=N-"3(9%*93#$Q MT-^W8K;-ZE*IJ#+&X0I>G;(D-S/)[;14;05,68'OL7,G4Z4QO?:3_%W^/<>AF,%TDU_+TD,-)CAW2/UHRF$VS-*EZLV:H+Y88]N^.F=?[W MO/XW.TAX*Q-VS,27S'5O"WKN]@VE#\6$BUT[P9W$H4# MO_TV$]?*)% _[>KKY5^&HJX5I5.%8IP3GK@\)MYH]QP=%A,<'>[>ZV85_+39 MA;7Y8;5U^Z9X<]^E;KKE6>8MAX;KY:!3@U-8M&,MVH$KWTQ!.-ZR7:I(QOGP M'6S#X@UTKS8LDY0>Y/Y+*3=$=WNKP\JB_5GFBT_S][[]JG]VU&^&^/\%_O;0S9QXG=_"R+T_9"G?Y8O/_T^N9QV/UEG?=J6>M+CGB.L5"F:.9.W0@^ M-+=MN2E9X1F)I8W$%O'8QS/A-8FYP]S)89H-S.=6J-?='K/'+/B2J0FT7P3= M'J-"SV/Y'P_JQ7WO>K537E-N9Q+V(DY5WB53Y>@+=\O,&-.:&-/S)E>LR62-MU)+=H'2YC9]U!998D;^7.SQ):N?8;HX9Z^., V@@)C=$HKP> MP.*.9>C:1R4=A+QZB-=LKL3=L[5YHO>*<*,VQR.779G7>&7F=2+M'VZ($RE. MV)9#PK;&W++J]*YLZU[7F'8ZO'707^%S@A+<-M&R#&V]Z ;<<5C:@$'% \2-#9[P<3>51.8$/ WL M8_TX7@H/60CLE^:_=^B+!Q_G$3:^K63Q#3I7!VE[*[]+2[M *O^\%) M/K=_]$15]J5O4J H;(;YG+GC7K,[;@,&^61$DQ'-4LRQRFQSC,\$CLBR8.+? M:7-TQ@[*^6-$$\?OCT+\'IE]J?W'TVVFH3U"_W9T-!>:>K[0 M[*NU\M7I[>CSWDESM/>GX-Y7BMY#.>ON(O@_H"]HZT)N. 8(O%<-9KJ**A"K MN#W87[?'?\&QJU@=I=15!TQI>& HZI:M7(!D-;M*0S.5TYZ6W?U4W_WI+H$I MUVKE,\ZQ1W[NN)#FP3"9=-L$"I\S%'6P*:-'9O0_ YNGS9CFX)5L .O=VJ6 MV5?M.^9B_LU>:"I#R[4^*3PT>SAQQ M*PH^X$H[ 685QT>MXEK9@*+-XA+)S= 6O%"K%I!'^5SAJ<[QS3OCC.Y3(ATW MO"^:+QU%&\,;2^BU<)Y5RQ_NS\N/]C%MQ6FBR9*#@0VE=90>2^R)C_ _P1. ML[3)M/"V%TCU6BC3*^8ZKB!K,F$,>"%7/,[G3DX*:4_WFD-)R*[4*[Q2BV5/ MSGFGGI4]Z=^HI"$?3]S3;;SG53-=O) M691?3O\MWMYZNF[NORGS+#:+\KQ:*]7*619E=G4S?I\ZG+PQHDGH&!*7.7+& M.LRVF5;OP'^!U9O\YO3S818,(Y1+I''X+($Z M,/>;$I^-$VG%0*1= M^W,KZYUPJ6DQW V8[J3.=)! MF:G-9YQZ)]8W#*]PF#LX2G-3WF-TOH(6%D>O82[1>;R)&"M/ _/PP>OO MGV@7M7];[2K > MY/9271HZ.S_R>*% &\^/Q.Z1*&0C69&E;_;E)3L\U]67-%[3F179D9B<-RLR MXV*O@8LME+(5<^M67NR^G\\=[QVEF)]E@O^-7)G%TASGO#,K4 3V

IKH+- M\AK3R2_2Q@VRE(6,:#*B69T3,]RLO]+IL+9;[U0>VSW5[+)K,&'K)LHU_%_% M[WSE7#/'M?4V&+C4"5N66^7\O%*^X>#4SY7*/^4OI=KGBG)=NJDH M]9J""95*J7;&_U'Y?EO]4;JHU&X:6?7-6ZN^F:Z5OOR%7K6%N%_,Y9\Z9SME MU)7=SNQVINAV+K-6OU@XW,"KF2YC=/V,(3,N,N,B(YHTG-&K)YHXB[0TUK]Z M86%X!9^UM,DQE$)$AL4N%\5-/6BQ$C)#[W[IG_N]PMG)/[]3GOVZO/9EM?)U MI=2H<%C>GU7XCQ^4ZJ+69\8.7IH=S&YIO;Z;MK[^*8?'>[EB/@LA9I=GE>&_ ME[\]*^V4RI+54F_J M/2O"4'+J'5)0"\6=O<*B<85B[FA_/[=_D!EUV57+KMKTJW;\O*NV!]>LF#LI M;-A5R^R_M+"9=-!#ILIG1),1S9K:IKV0_5=ICO3?)U?_:MW[FKO:,41IRQ>= M900R4YO3_$MK%EJ1U#S-\EH&>[DTM/\\13-=&LBO63]];OHGZ*?%H]SAX?X& MIIEE=R^[>R_LAGG6W2OFC@^.<@?'3[0-4W'W,@,QT_4S73\CFHQH7J!IFF\@ M-KS!PBDXU4+Z=&]9#U>32".1(9'C"_0\WKZJC^L^+SINR[1JW5U<7E4LP MY$H7'"BR[_@DA6KMO'Y]6;JIUFO9;[!2KSV[4 M1^9W\WA]G'7!).1R3''H7,07?$[?N&2-.,M[L_P$ M:W81A%^;TO;RY#!K>YG1:,II]&A#:#1.:!4B0LME-G/UO;+NF:W M4IYM_LB'7/Z/1MTJCA_G-F]^S&<;1Z[V?Z:"'S!&1 M$4U&-.LP!/+A_O.6B:&1.>^02J&ULU'3[&%GLJ<*Z/T>FJR?_- M6-GJPZ+#&RO\1Y 2?=6^8ZX*]D\#%K7]D23-4?'Q\/OW/>NH>[?:FM3-"72$ MQWVY ,?18-$G3,O<"9"O.#[V4\PS,HM_G19_-B\L MH]&7HM'D66$KD3BK;>=Z5-S/'19.-K42-!+JD8*_"CO45>.:M:TN_M,RZYUK M/'.KXSFLY#C,=<#HN\"&3!>ZVM*-D&C_=NR>?+>=S[]7+-I3'Q$B''+P[ "3 M6')$]V?'ZNP -A65T*FHI@8?!(0J1H#1C!6^65:XX!U<>6?YPT+NH%C<+':7 MW9S7=W/F570W)?P:)Y*/ I'<4 U6[R1H.#=6>+!JU92]$<\MN^087"R;Q;.? M!\<-R_JN9Q8W=] "2CEL()(3+>:8N=MH83.!8F2C2JEQD?&;5\YODB7U,Z[F MJJ7UX<%A;O_D()/6V>W9"&E=*&ZPM"Z&#&C'\52S#6RA;/7[EMEPK?9=]/*W M_WBZ0WK]E3I$_T6]X\MJMWWO7/QL]^S;EYSP]N("6F+1%])M0B8L!-B<$,)J M@%$ BU"*[V2R^?5SERE6]*(7<>4SO'-Y;!.0/\YD5#D]_-HM?#WJ?^OVLG(]?APQ MHGDLP8AN^ZA6'@#7F0A_NTPH680OY;ZN6IR?Y)\^TP+1<'JYAGC"03U#OP7Q%W9F]9>LZ M+*I5CL%PZ%D!+JP))((0YE@$+@IHS+C(*^FH?=T8_IT"V?E?BDC!O^#?@Z??A+YJ=W6 +A\%MLVP MXGU9X Y2!MY-CVUO@5#D688H^$S+A1=4FRDJ)F"[K&NK!EFR:*&Z/>8PX$VJ MI^EHX0+7 XIQ^+]H# <9OAU>)04O.B[\ JT39W?U2)#(YA^ 3_R?G1WE7&>& M]K=RI7;ASC38'X^!>?6W&BVM> M+7\KK4^IY8[\-33([IOY/)B2$M+6I]+GTE5E>PM41:5G];*]V>50'\#ZD'M>R!Z6"VA]M;['%@,PVL>/O/O?/QJA W M:&I>'QYJSVU%,:>M#E!0@7GV;JRQ^JGGZ":@]@P>LO4!M9(UM5/5T9UZYPKP MA UG\;>+>!W61W'+>P" MOGV61GLM'C1'^]7Z5\;VOOYYZ+[[5+_^7*I5_R5N1N-$3F\;U5JET5!.2^5O MGZ_KM[4S_P@WC]K2 U^I"P0L!(AE#RS>J3^GJ/#*O:JI,/>A8CV8<%*.UW)T35?M84ZA1908[O"2N3U+"PK\ZD ME6>S9ANE8?YP+]]L.K:[LU,.F=\5TR5?9>E1=YI-O\@=]PF[I Y^)FU2-;YP MB"_T/BH@EPP5BN;HY&'?M/)5W=$*[Q18"Q'J T5. 6P!B .E!'A)KE0IDN?> MY[0A06(GS;DW,J>SM5H[!S$--AEZPHHASRLB^MVG0K+;]2^%T<8"E "=!!+PQ?W=S>NE2'RC'*MV(^IX2$IT*: M/.&:$C8:J#\K,ED.CM!FY+3B-_C2WH43>8 #N5/*/0N.):>4*W6J9-1TF[5= MRY9BMAQT*J D#YN-ZUPG^=/P# 3*TW, H$[P/EP8V46RY@;,4FAEX.= M_)'_KV/)/*8B0CP3M]6G\!*?@33$3D]R!R=Y^-]A$B,!X0ZL ?0 @9R<8EKH M+U5#,\&0.^UINSG4 M/QB>QJ0(R33#96F&5V C8NF_%XN MQF3+CN_9\%%L2\ICE-5H?_DF%V9^,+.+[G&X+8AZD[D/EGVG\.HV/&D';K2C MM(0+2#[WA:D&YG#"BC^98="?0&H"M/9P5X&O*@.05VU]@$H?7O9[O)]C^H%. M]98.3D :*CV]V]OY R(7'^P%RS_(Y8'?:U[;=<@JX8/_^+L\M$9"P7%TSC4P M>J'TL3X/&+;3SVUO:='1V\*T:1D62.6V;K<]0]J9P$5VU"XNC%^6'P0F MY\!A -5BZZ4^_/J>T3[@O[8*WQ'0.D/'97VYR9X'QZ&T+&V8D>\20[,+A5T5 MFW4,4%'I8 0U4M93A!X3_ _;6SZ+P[]:/>8YJ&>'R@]]8XX*YGF)-6@NBW^@ G(0K,*^<$3W.M MUJ^&-3K),V.1S,85G>$9L%S=<+:WHE<+2;%P]#$J>O[>-%),'7S1.,;I27/T MV&MX]MY]__*QZQ.%ICL#4*3^QK8'H(E+#@L?V_=\7Q7+>-ON:V!:0IS!(X8DMZ!U-^I80%E';^=&^1CV1@/3 [U8#V MF#&.R064GXF)/$O3P*;\.'6M\:SG5_MZ#'MZVE+S'MZ")>E22]_[:XEU#H5= M):'L0GXN]FOQ^KIXI?A7@@#PHT?'YT'-(:9OUSM@R0I#5L2$"OF"B$ ^*SHD M RPR>CBA6Y/GXMWX#O+Q.)[74S)'\$<"%BH&&\>$" V,>\MDB$> D71P4[W:TO,,Z#!U6H%0",*12EKE&N=JSFJ;+IN:D$G%# M.38B\DV*6B08CK^Y;?RGH#"UW5O>J848G:].EWQM>K7'%:.^I^:4)G&!+;[' M4]R>>PX+B++@Z([2DN$@TQNN[ULW6J-:+!=/0H><8'TH80U?"6O1"FJJ$X10 M'$..+.!\P?R(U:?7/4'C^>O9*EY2_X)YM:NG*/AIT:E3]_J\"!;DO\A)K-8* M6)KF7TS4_!EW-=-]D3]?K4Z?0B>.=7ZJ4'M).GW%$UQ76K]Y%', MJ]FO6ON(/Y2I"KV?%YT3*CV6L"B%Z1K]K%,Y7;_^'G,H,KYS"O&(U97.E1W'ZO-T?[/7U\?\OF[TW-U>=I[RC3V$!&M M2VE_-9KZ9NK3F3J^)'5\;W=%VOCINK3Q4#E#*K3Q$#QS:..)Z?>+ZA+G+Z"% M3QY!6K3P^,.8JH4'%;!<"X]6,RQZ+(7UJ^$QIY(*-3SA3*:HX;+"['BJ&GY] M^3PM_'2-6GC,V;RD%IYP))NIA:?&@1XJ$?Q<;U]VV-[MWOG1J]7"UU17F.GA M*5*D,SU\27KX_JKT\+5YQ6]Z-DN77SP"T3RZ^%C)U:**Q-%+J. QV$^-$IYP M#D]2PWEZRSYIX?N;I(7''4PZ]/"D8YFBB1=7JH$7UJF!QYW+B^K@2<<1IX7_ MJ%9HI,XR?0C/E\\+RC[8S$+"+Z8S]OB&0Y6;I4IS=%EM=ZK6]9DY4--363FM M6RPODV6/6!;//DWK^'R4=7Q>=\?G@ZSC\XMU?*:;+N]%RFIX-Z3]<];F.46; MRMH\KZ?-\_.WOXZKO00.)%L[;V_5[]'QRAXRQ*ZL&2ZUQ9(>#K>GNN@2O]K;0-G0:)*#^IQ1)L0#>&<$7 7J"_LPY<%Q<'>FUOJ:Y+#E'L MQDKF!+.=2%LTI0YO3'Z*'Q+VZ,(6'K)W#6SF7^:JLO73E6UU;;4O;FM.>>CI M8'G3%OEFMK<&_)%(_R2 #^,@G MF'FOVY9);7RP1QA?>PCO "PVM8I3[[C[(OBCH7<8'9J3 RSP5DY]BS:7&(9*0S?4D5T9G)9_[7^VZIV4M+E<=^O319M@4M.D M4N,BQSON(G5U+1[T"A!RR1L3M?B ,N?&&:R9SE MM.&DFT1: V.H=(E.A$(5<80FA4T-L9DE_$73\0W4E'P5+=R?\N^DZY<#,BSF M"Q]KE>O/_%\WU>^W%:X2G59*MS7\Z";K_NHD_AA2#U6 MXK1CJ7Z&V$.7F=AEE-)H6@PO?_0%KD*+%Z0F#0QTZ:KTDQ1F3F.!QCQ#1?;M MGZ"?ZQ-TY4 M1H&#B(+/ W0V:&WPYSY)<$>TJ@]X7T;XRR?\6(8CF5R(9M#J M!6)P+1=(&RB@C_U:I?&+^H@O@/"40;PS -E$ZJ>31R&,[FH,/RH&7 %C=WL+ MR5-\">X9VMFV[M \:WJ^PC6)2]6Y$X_EE"]#U?#@3NAMI=36-=R*UR="N;0\ MQV'*N4JM9,L& ^IB=D8RRR<97Q#YZJ$X1')J,$?Z(7#.&$7W,:CL<6/85^^ M_8 VC8\"0P&0D%*0 >O/TN#5/@C((9^CU# M.B3^ T]9?7@J0J- =\0VI7FT<0K2>!QT!;UV 7IJN@WF9[MM>2;JW5>6 >R: M.3W'YS]/O??_3/W5EZ?J74C]7&M7/M>IYM5RJW2BEV')X/,MT!SU*[_^E/\9?[SHZ2EB+;"K]'"&FL+3_/? M?)@"FMGR01\#A\?-T;?K3L=YZ%W\^5)X]XFP0+Z'06B4XWC[W\TBMO3 MZP. M]CWUGG%'#)S20.5SFQ1-LE7LE,:3&7T:A&HW& MH?^)[J<:!.1V&[O*YU+IRN\F/_!LQU/Y%!Z2RYXA#%*;=<4LA6#B(CFNT+_" M+0)_O!08P])=$K2L+P>Q/^J*3W,>&'I>%-,B'9%_!M;DWC -CT>,?T!7%QR MRIV=X[,FR)R&.P%PF R]M&CQ<$6SH^IVA/:ENRHXB('E!"9(X'2"=SP#@S'4 M*4'ORU_0Z'C3H6UOM5"= M4ND)0,QOS^2.5Z*AY*4FO6I@8ID",T"5EDT:F/S<-Q]8 3XS<:DSP D:9-M; M>[QIP4D.,(UVG._V#*A&22(:\L6C-E@\XN[X=2A?DMD\->OJ.,NZ6G?6U6&6 M=?5*LJZ>HWV'%.7HW4U52D.68)6:364)5NM)L'KM:K^P_.>W[)7W90L5=X]I M&XGZU;N2@NH-T/^F&_GED)$_[;7FZ,[U]+L#=MA@*1JBM+!I7VB.M!^%ZR.O M='N4+_@S$L@&A)O=#J,B,_"7:. O9M-+^Y;LN;@'QN?330QO%+/CMK>HT@?] MU3QX'!GS_,CLMD[I=; IVR(C&O/U&!BIZF -P+5NAP?-\<=[W'K8":(*M

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